Unnamed: 0,datetime,title,source,link
0.0,1/18/2005 1:07:00 PM,Abbott Announces Groundbreaking New Trial in Stroke Prevention,PR Newswire,/news/stocks/abbott-announces-groundbreaking-new-trial-in-stroke-prevention-1030561630
1.0,5/27/2005 1:52:00 PM,Abbott Announces FDA Approval of Zemplar(R) (paricalcitol) Capsules for Earlier Treatment of Kidney Disease Complication,PR Newswire,/news/stocks/abbott-announces-fda-approval-of-zemplar-r-paricalcitol-capsules-for-earlier-treatment-of-kidney-disease-complication-1027837759
2.0,7/26/2005 1:07:00 PM,Clinicians Stress the Importance of Tests for Reproductive Health and Thyroid Disorders During 'Trends in Women's Health Workshop',PR Newswire,/news/stocks/clinicians-stress-the-importance-of-tests-for-reproductive-health-and-thyroid-disorders-during-trends-in-women-s-health-workshop-1030691916
3.0,3/31/2006 4:02:00 PM,Abbott and Morgan Stanley Welcome the 14th Annual International Biotechnology Convention to Chicago for Its Midwestern Debut,PR Newswire,/news/stocks/abbott-and-morgan-stanley-welcome-the-14th-annual-international-biotechnology-convention-to-chicago-for-its-midwestern-debut-1029679158
4.0,10/11/2006 3:12:00 PM,"Abbott Awards Virginia Mother $130,000 in National Similac(R) Contest",PR Newswire,/news/stocks/abbott-awards-virginia-mother-130-000-in-national-similac-r-contest-1030131913
5.0,5/22/2007 3:04:00 PM,"Neue Datenauswertung zeigt, dass die Behandlung mit Abbotts HUMIRA(R) (Adalimumab) krankheitsbedingte Krankenhauseinweisungen von Morbus Crohn Patienten signifikant verringert",PR Newswire,/news/stocks/neue-datenauswertung-zeigt-dass-die-behandlung-mit-abbotts-humira-r-adalimumab-krankheitsbedingte-krankenhauseinweisungen-von-morbus-crohn-patienten-signifikant-verringert-1027484730
6.0,6/15/2007 1:27:00 PM,"Drei Studien legen nah, dass Abbotts HUMIRA(R) (Adalimumab) möglicherweise die arbeitsbezogene Leistungsfähigkeit von Patienten mit rheumatoider Arthritis verbessert",PR Newswire,/news/stocks/drei-studien-legen-nah-dass-abbotts-humirar-adalimumab-moeglicherweise-die-arbeitsbezogene-leistungsfahigkeit-von-patienten-mit-rheumatoider-arthritis-verbessert-1000168994
7.0,5/21/2008 4:15:00 PM,"Abbott stellt Langzeitergebnisse einer Erweiterungsstudie vor, die zeigen dass die Remission bei erwachsenen, mit HUMIRA(R) (Adalimumab) behandelten Morbus-Crohn-Patienten anhält",PR Newswire,/news/stocks/abbott-stellt-langzeitergebnisse-einer-erweiterungsstudie-vor-die-zeigen-dass-die-remission-bei-erwachsenen-mit-humira-r-adalimumab-behandelten-morbus-crohn-patienten-anhaelt-1028299853
8.0,9/28/2016 7:10:21 PM,BRIEF-Abbott receives FDA approval for the FreeStyle Libre Pro System (ABT),Reuters,/news/stocks/brief-abbott-receives-fda-approval-for-the-freestyle-libre-pro-system-abt-1001424116
9.0,9/29/2016 10:20:22 PM,"BRIEF-Terumo Corp looks to purchase portion of Abbott Laboratories' medical device business - Nikkei (4543, ABT)",Reuters,/news/stocks/brief-terumo-corp-looks-to-purchase-portion-of-abbott-laboratories-medical-device-business-nikkei-4543-abt-1001427697
10.0,10/4/2016 2:20:21 PM,"EU ruling on $25 bln Abbott, St Jude deal due by Nov. 9 (ABT, STJ)",Reuters,/news/stocks/eu-ruling-on-$25-bln-abbott-st-jude-deal-due-by-nov-9-abt-stj-1001435092
11.0,10/4/2016 9:00:22 PM,"EU mergers and takeovers (Oct 4) (DISI, SGRO, F34, BG, WAB, LEY, RAX, APO, ABT, STJ)",Reuters,/news/stocks/eu-mergers-and-takeovers-oct-4-disi-sgro-f34-bg-wab-ley-rax-apo-abt-stj-1001435877
12.0,10/11/2016 2:10:24 PM,"St. Jude warns of heart-device battery issue linked to 2 deaths (ABT, STJ)",Reuters,/news/stocks/st-jude-warns-of-heart-device-battery-issue-linked-to-2-deaths-abt-stj-1001448994
13.0,10/12/2016 4:30:28 PM,"BRIEF-Celgene & Agios collaborates with Abbott to develop diagnostic tests for leukemia (ABT, CELG)",Reuters,/news/stocks/brief-celgene-&-agios-collaborates-with-abbott-to-develop-diagnostic-tests-for-leukemia-abt-celg-1001451992
14.0,10/17/2016 10:20:20 PM,"Omnicare to pay $28 mln to settle charges it got kickbacks from Abbott Labs (CVS, ABT)",Reuters,/news/stocks/omnicare-to-pay-$28-mln-to-settle-charges-it-got-kickbacks-from-abbott-labs-cvs-abt-1001460348
15.0,10/17/2016 10:30:22 PM,"UPDATE 1-Omnicare to pay $28 mln to settle charges it got kickbacks from Abbott Labs (CVS, ABT, PMC)",Reuters,/news/stocks/update-1-omnicare-to-pay-$28-mln-to-settle-charges-it-got-kickbacks-from-abbott-labs-cvs-abt-pmc-1001460491
16.0,10/18/2016 3:30:23 PM,"St. Jude and Abbott to sell some medical devices for $1.12 bln (ABT, STJ, 4543)",Reuters,/news/stocks/st-jude-and-abbott-to-sell-some-medical-devices-for-$1-12-bln-abt-stj-4543-1001462642
17.0,10/18/2016 4:30:21 PM,"BRIEF-St. Jude and Abbott to divest two businesses to Terumo Corp (ABT, 4543, STJ)",Reuters,/news/stocks/brief-st-jude-and-abbott-to-divest-two-businesses-to-terumo-corp-abt-4543-stj-1001462695
18.0,10/18/2016 6:20:24 PM,"UPDATE 1-St. Jude and Abbott to sell some medical devices for $1.12 bln (STJ, ABT, 4543)",Reuters,/news/stocks/update-1-st-jude-and-abbott-to-sell-some-medical-devices-for-$1-12-bln-stj-abt-4543-1001462861
19.0,10/19/2016 3:20:21 PM,"BRIEF-St. Jude Medical Q3 earnings per share $0.73 (STJ, ABT)",Reuters,/news/stocks/brief-st-jude-medical-q3-earnings-per-share-$0-73-stj-abt-1001465254
20.0,10/19/2016 4:00:36 PM,Abbott's third-quarter revenue rises nearly 3 percent (ABT),Reuters,/news/stocks/abbotts-third-quarter-revenue-rises-nearly-3-percent-abt-1001465328
21.0,10/19/2016 4:30:27 PM,BRIEF-Abbott Q3 GAAP loss per share $0.24 from continuing ops (ABT),Reuters,/news/stocks/brief-abbott-q3-gaap-loss-per-share-$0-24-from-continuing-ops-abt-1001465422
22.0,10/19/2016 5:40:23 PM,"UPDATE 1-Abbott's third-quarter results edge past Street (ALR, STJ, ABT)",Reuters,/news/stocks/update-1-abbotts-third-quarter-results-edge-past-street-alr-stj-abt-1001465489
23.0,10/19/2016 5:50:22 PM,"BRIEF-St. Jude says Muddy Waters misleading patients for own financial gain (STJ, ABT)",Reuters,/news/stocks/brief-st-jude-says-muddy-waters-misleading-patients-for-own-financial-gain-stj-abt-1001465487
24.0,10/19/2016 8:36:22 PM,"BRIEF-Abbott says pursuing all necessary regulatory approvals to buy Alere (ABT, STJ, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-says-pursuing-all-necessary-regulatory-approvals-to-buy-alere-2016-10
25.0,10/20/2016 10:16:21 PM,"BRIEF-China clears Abbott's acquisition of Alere (ALR, ABT)",Reuters,http://www.businessinsider.com/r-brief-china-clears-abbotts-acquisition-of-alere-2016-10
26.0,10/21/2016 11:08:22 PM,"BRIEF-Alere shareholders approve merger with Abbott (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-alere-shareholders-approve-merger-with-abbott-2016-10
27.0,10/24/2016 3:52:21 PM,"Muddy Waters says outside experts found St Jude devices can be hacked (STJ, ABT)",Reuters,http://www.businessinsider.com/r-muddy-waters-says-outside-experts-found-st-jude-devices-can-be-hacked-2016-10
28.0,10/24/2016 4:22:19 PM,"UPDATE 1-Hired experts support claims St. Jude heart devices can be hacked (STJ, ABT)",Reuters,http://www.businessinsider.com/r-update-1-hired-experts-support-claims-st-jude-heart-devices-can-be-hacked-2016-10
29.0,10/24/2016 7:28:21 PM,"UPDATE 2-Hired experts back claims St. Jude heart devices can be hacked (STJ, ABT)",Reuters,http://www.businessinsider.com/r-update-2-hired-experts-back-claims-st-jude-heart-devices-can-be-hacked-2016-10
30.0,11/3/2016 9:18:20 PM,"Abbott offers EU concessions over $25 bln St Jude deal (ABT, STJ)",Reuters,http://www.businessinsider.com/r-abbott-offers-eu-concessions-over-25-bln-st-jude-deal-2016-11
31.0,11/3/2016 9:18:20 PM,"EU mergers and takeovers (Nov 3) (ABT, STJ, AF, MT)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-nov-3-2016-11
32.0,11/7/2016 3:10:18 PM,BRIEF-Abbott says Japan approves its absorbable heart stent (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-says-japan-approves-its-absorbable-heart-stent-2016-11
33.0,11/7/2016 10:50:18 PM,BRIEF-Absolute Software Q1 revenue $22.5 mln (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-software-q1-revenue-225-mln-2016-11
34.0,11/23/2016 10:04:18 PM,EU regulator conditionally approves Abbott's purchase of St Jude,Reuters,http://www.businessinsider.com/r-eu-regulator-conditionally-approves-abbotts-purchase-of-st-jude-2016-11
35.0,11/25/2016 12:48:20 AM,"EU mergers and takeovers (Nov 24) (ABT, STJ, SMIN, SAF)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-nov-24-2016-11
36.0,11/25/2016 7:28:21 AM,"UPDATE 1-J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg (JNJ, ABT)",Reuters,http://www.businessinsider.com/r-update-1-jj-makes-takeover-approach-for-swiss-drugmaker-actelion--bloomberg-2016-11
37.0,11/30/2016 2:40:09 PM,BRIEF-Abbott announces CE Mark for i-STAT Alinity (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-announces-ce-mark-for-i-stat-alinity-2016-11
38.0,11/30/2016 3:04:04 PM,"EU mergers and takeovers (Nov 30) (ABT, ALR)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-nov-30-2016-11
39.0,12/7/2016 7:46:05 PM,"BRIEF-Abbott says seeks to terminate Alere acquisition (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-says-seeks-to-terminate-alere-acquisition-2016-12
40.0,12/7/2016 7:56:05 PM,"Abbott seeks to abort planned acquisition of Alere (ABT, ALR)",Reuters,http://www.businessinsider.com/r-abbott-seeks-to-abort-planned-acquisition-of-alere-2016-12
41.0,12/7/2016 8:04:27 PM,"Abbott wants out of a $5.8 billion deal with Alere (ALR, ABT)",Reuters,http://www.businessinsider.com/r-update-1-abbott-seeks-to-abort-planned-acquisition-of-alere-2016-12
42.0,12/7/2016 9:40:09 PM,"BRIEF-Alere comments on Abbott's lawsuit (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-alere-comments-on-abbotts-lawsuit-2016-12
43.0,12/9/2016 9:58:09 PM,BRIEF-Abbott raising qtrly dividend to 26.5 cents per share (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-raising-qtrly-dividend-to-265-cents-per-share-2016-12
44.0,12/9/2016 11:10:03 PM,"US IG breaks records for sixth year (BNP, ABI, C, ACA, T, ABT, GS)",Reuters,http://www.businessinsider.com/r-us-ig-breaks-records-for-sixth-year-2016-12
45.0,12/10/2016 12:14:03 AM,"BRIEF-St. Jude Medical announces quarterly dividend (ABT, STJ)",Reuters,http://www.businessinsider.com/r-brief-st-jude-medical-announces-quarterly-dividend-2016-12
46.0,12/16/2016 11:38:03 PM,"BRIEF-Abbott Laboratories enters into a bridge term loan agreement (ABT, STJ)",Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-enters-into-a-bridge-term-loan-agreement-2016-12
47.0,12/27/2016 9:34:03 PM,Abbott gets U.S. antitrust approval to buy St. Jude Medical,Reuters,http://www.businessinsider.com/r-abbott-gets-us-antitrust-approval-to-buy-st-jude-medical-2016-12
48.0,12/27/2016 10:24:03 PM,"UPDATE 1-Abbott gets U.S. antitrust approval to buy St. Jude Medical (STJ, ABT)",Reuters,http://www.businessinsider.com/r-update-1-abbott-gets-us-antitrust-approval-to-buy-st-jude-medical-2016-12
49.0,12/29/2016 10:22:03 PM,"LPC: US syndicated lending flat in 2016 after late-year spurt (T, TWX, ABT, STJ, ALR, MQG)",Reuters,http://www.businessinsider.com/r-lpc-us-syndicated-lending-flat-in-2016-after-late-year-spurt-2016-12
50.0,12/30/2016 11:20:03 AM,"BRIEF-China conditionally approves Abbott Laboratories' acquisition of St Jude (STJ, ABT)",Reuters,http://www.businessinsider.com/r-brief-china-conditionally-approves-abbott-laboratories-acquisition-of-st-jude-2016-12
51.0,12/30/2016 7:14:07 PM,"BRIEF-Abbott Acquisition of St. Jude Medical set to close on Jan 4, 2017 (ABT, STJ)",Reuters,http://www.businessinsider.com/r-brief-abbott-acquisition-of-st-jude-medical-set-to-close-on-jan-4-2017-2016-12
52.0,1/9/2017 6:16:08 PM,Abbott releases cyber updates for St. Jude devices after government probe,Reuters,http://www.businessinsider.com/r-abbott-releases-cyber-updates-for-st-jude-devices-after-government-probe-2017-1
53.0,1/9/2017 6:28:06 PM,"BRIEF-St. Jude to deploy cyber-security updates for Merlin remote monitoring system (JUD, ABT)",Reuters,http://www.businessinsider.com/r-brief-st-jude-to-deploy-cyber-security-updates-for-merlin-remote-monitoring-system-2017-1
54.0,1/9/2017 6:50:03 PM,UPDATE 1-St. Jude release cyber updates for heart devices after gov't probe (ABT),Reuters,http://www.businessinsider.com/r-update-1-st-jude-release-cyber-updates-for-heart-devices-after-govt-probe-2017-1
55.0,1/10/2017 1:22:07 PM,"BRIEF-Abbott announces CE mark for its ""Alinity s"" blood and plasma screening system (ABT)",Reuters,http://www.businessinsider.com/r-brief-abbott-announces-ce-mark-for-its-alinity-s-blood-and-plasma-screening-system-2017-1
56.0,1/25/2017 2:04:05 PM,BRIEF-Abbott reports Q4 sales of $5.3 billion (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-reports-q4-sales-of-53-billion-2017-1
57.0,1/25/2017 2:04:05 PM,Abbott Labs' sales rise 2.8 pct (ABT),Reuters,http://www.businessinsider.com/r-abbott-labs-sales-rise-28-pct-2017-1
58.0,1/25/2017 2:40:05 PM,UPDATE 1-Abbott's sales miss estimates as nutrition products drag (ABT),Reuters,http://www.businessinsider.com/r-update-1-abbotts-sales-miss-estimates-as-nutrition-products-drag-2017-1
59.0,1/25/2017 4:34:09 PM,BRIEF-Abbott CEO says is optimistic about the Trump administration: Conf Call (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-ceo-says-is-optimistic-about-the-trump-administration-conf-call-2017-1
60.0,1/25/2017 4:40:08 PM,EU clears Abbott acquisition of Alere subject to divestments,Reuters,http://www.businessinsider.com/r-eu-clears-abbott-acquisition-of-alere-subject-to-divestments-2017-1
61.0,1/25/2017 5:20:08 PM,"Siemens to pick banks for Healthineers listing - sources (SIE, GS, PHIA, GE, 6502, ABT, BAX, BSX, AMBU , XRAY, DHR, EOAN, GNMK, BAYN)",Reuters,http://www.businessinsider.com/r-siemens-to-pick-banks-for-healthineers-listing---sources-2017-1
62.0,1/25/2017 5:28:06 PM,"BRIEF-European Commission clears Abbott acquisition of Alere (ALR, ABT)",Reuters,http://www.businessinsider.com/r-brief-european-commission-clears-abbott-acquisition-of-alere-2017-1
63.0,1/25/2017 5:56:05 PM,"UPDATE 1-Siemens to pick banks for blockbuster Healthineers listing - sources (SIE, GS, PHIA, GE, 6502, ABT, BAX, BSX, AMBU , XRAY, DHR, EOAN, GNMK, BAYN)",Reuters,http://www.businessinsider.com/r-update-1-siemens-to-pick-banks-for-blockbuster-healthineers-listing---sources-2017-1
64.0,1/25/2017 6:30:06 PM,"EU mergers and takeovers (Jan 25) (ABT, ALR, FFH, POW, ACA)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-jan-25-2017-1
65.0,2/2/2017 2:09:09 PM,Abbott Says FDA Oks Molecular Test To Detect Zika Virus In Whole Blood ,RTTNews,/news/stocks/abbott-says-fda-oks-molecular-test-to-detect-zika-virus-in-whole-blood-1001717793
66.0,2/2/2017 2:30:07 PM,BRIEF-FDA grants Abbott first commercial authorization for molecular test to detect zika virus using whole blood (ABT),Reuters,http://www.businessinsider.com/r-brief-fda-grants-abbott-first-commercial-authorization-for-molecular-test-to-detect-zika-virus-using-whole-blood-2017-2
67.0,2/6/2017 10:46:08 PM,BRIEF-Absolute reports qtrly loss per share $0.05 (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-reports-qtrly-loss-per-share-005-2017-2
68.0,2/12/2017 9:09:19 PM,Abbott Laboratories may see boost from St. Jude's acquisition: Barron's,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/5Y2fv5kyM_8/us-usa-abbott-barron-s-idUSKBN15R0YJ
69.0,2/17/2017 7:00:11 PM,BRIEF-ABBOTT SETS QUARTERLY DIVIDEND OF $0.265 PER SHARE (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-sets-quarterly-dividend-of-0265-per-share-2017-2
70.0,2/17/2017 10:34:11 PM,BRIEF-Abbott Laboratories says board of directors shall consist of 12 persons from 11 (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-says-board-of-directors-shall-consist-of-12-persons-from-11-2017-2
71.0,2/21/2017 3:24:11 PM,"BRIEF-Abbott Laboratories commences exchange offers, consent solicitations for St. Jude Medical notes (ABT)",Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-commences-exchange-offers-consent-solicitations-for-st-jude-medical-notes-2017-2
72.0,2/22/2017 7:36:13 PM,"EU mergers and takeovers (Feb 22) (KKR, 6501, 6581, JNJ, ABT, TECD, AVT, SIE, MENT, NKT, AKE, 2502, ABI, 2317, 005930, HAR, MCRO, GFK, COL, BEAV, MQG, PETG, FFH, AIG, AHL1V, 8031, GAM, BX, NG.",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-feb-22-2017-2
73.0,2/24/2017 8:22:12 PM,"BRIEF-FTC approves final order settling charges for Boehringer Ingelheim’s asset swap with Sanofi (SAN, BAYN, LLY)",Reuters,http://www.businessinsider.com/r-brief-ftc-approves-final-order-settling-charges-for-boehringer-ingelheims-asset-swap-with-sanofi-2017-2
74.0,3/1/2017 1:06:19 PM,"Diagnostic company Alere says to delay filing annual report (ALR, ABT)",Reuters,http://www.businessinsider.com/r-diagnostic-company-alere-says-to-delay-filing-annual-report-2017-3
75.0,3/1/2017 1:48:20 PM,"UPDATE 1-Diagnostic company Alere says to delay filing annual report (ALR, ABT)",Reuters,http://www.businessinsider.com/r-update-1-diagnostic-company-alere-says-to-delay-filing-annual-report-2017-3
76.0,3/7/2017 3:00:00 PM,Abbott Announces Results of Early Tenders and Consents in Exchange Offers and Execution of Supplemental Indenture,PR Newswire,/news/stocks/abbott-announces-results-of-early-tenders-and-consents-in-exchange-offers-and-execution-of-supplemental-indenture-1001811376
77.0,3/8/2017 3:24:22 PM,BRIEF-Abbott says findings from Lotus I study may have important implications for women undergoing IVF (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-says-findings-from-lotus-i-study-may-have-important-implications-for-women-undergoing-ivf-2017-3
78.0,3/8/2017 10:15:00 PM,Abbott to Present at Barclays Capital 2017 Global Healthcare Conference,PR Newswire,/news/stocks/abbott-to-present-at-barclays-capital-2017-global-healthcare-conference-1001817379
79.0,3/16/2017 1:00:00 PM,The Most Promising Biotech Innovation of 2017,PR Newswire,/news/stocks/the-most-promising-biotech-innovation-of-2017-1001841725
80.0,3/17/2017 12:50:43 PM,BRIEF-Abbott Laboratories says CEO Miles White total compensation for 2016 $20.3 mln vs. $19.4 mln in 2015 (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-says-ceo-miles-white-total-compensation-for-2016-203-mln-vs-194-mln-in-2015-2017-3
81.0,3/18/2017 5:18:44 PM,Higher heart risk seen with Abbott dissolving stent after two years: study,Reuters,http://www.businessinsider.com/r-higher-heart-risk-seen-with-abbott-dissolving-stent-after-two-years-study-2017-3
82.0,3/18/2017 5:30:00 PM,"Late-Breaking Data on Abbott's MitraClip® System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease",PR Newswire,/news/stocks/late-breaking-data-on-abbott-s-mitraclip-system-show-continued-benefit-for-people-with-mitral-regurgitation-most-common-heart-valve-disease-1001847847
83.0,3/18/2017 7:50:49 PM,UPDATE 1-Higher heart risk seen with Abbott dissolving stent after 2 years -study (ABT),Reuters,http://www.businessinsider.com/r-update-1-higher-heart-risk-seen-with-abbott-dissolving-stent-after-2-years--study-2017-3
84.0,3/18/2017 8:02:32 PM,Abbott: MitraClip Reduces Severity Of Mitral Regurgitation In One-year Study ,RTTNews,/news/stocks/abbott-mitraclip-reduces-severity-of-mitral-regurgitation-in-one-year-study-1001847888
85.0,3/19/2017 7:00:00 PM,Late-Breaking Data Shows the CardioMEMS HF System is Effective in Reducing Heart Failure Hospitalizations and Cost of Care,PR Newswire,/news/stocks/late-breaking-data-shows-the-cardiomems-hf-system-is-effective-in-reducing-heart-failure-hospitalizations-and-cost-of-care-1001848216
86.0,3/21/2017 12:10:00 PM,"Technical Reports on Medical Equipment Stocks -- EnteroMedics, Abbott Labs, Boston Scientific, and Medtronic",PR Newswire,/news/stocks/technical-reports-on-medical-equipment-stocks-enteromedics-abbott-labs-boston-scientific-and-medtronic-1001853280
87.0,3/21/2017 3:07:42 PM,Not All's Well With Abbott's Absorb Stent? ,RTTNews,/news/stocks/not-all-s-well-with-abbott-s-absorb-stent-1001854402
88.0,3/22/2017 2:00:00 PM,Recent Developments in the Electrophysiology Markets,PR Newswire,/news/stocks/recent-developments-in-the-electrophysiology-markets-1001858039
89.0,3/22/2017 2:00:00 PM,Abbott Hosts Conference Call for First-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-first-quarter-earnings-1001857979
90.0,4/12/2017 7:12:52 AM,"Smithfield makes move on market for pig-human transplants (288, ABT, MDT, UTHR)",Reuters,http://www.businessinsider.com/r-smithfield-makes-move-on-market-for-pig-human-transplants-2017-4
91.0,4/13/2017 4:39:08 PM,BRIEF-U.S. FDA says issued a warning letter to Abbott Laboratories (ABT),Reuters,http://www.businessinsider.com/r-brief-us-fda-says-issued-a-warning-letter-to-abbott-laboratories-2017-4
92.0,4/14/2017 11:43:03 AM,"Abbott Laboratories to buy Alere for $4.4 bln - FT (ALR, ABT)",Reuters,http://www.businessinsider.com/r-abbott-laboratories-to-buy-alere-for-44-bln---ft-2017-4
93.0,4/14/2017 11:43:03 AM,"RPT-Abbott Laboratories to buy Alere for $4.4 bln - FT (ABT, ALR)",Reuters,http://www.businessinsider.com/r-rpt-abbott-laboratories-to-buy-alere-for-44-bln---ft-2017-4
94.0,4/14/2017 12:00:00 PM,Abbott and Alere Amend Terms of Merger Agreement,PR Newswire,/news/stocks/abbott-and-alere-amend-terms-of-merger-agreement-1001922403
95.0,4/14/2017 12:14:11 PM,Abbott Agrees To Buy Alere At Lower Price ,RTTNews,/news/stocks/abbott-agrees-to-buy-alere-at-lower-price-1001922419
96.0,4/14/2017 2:29:04 PM,"BRIEF-Abbott and Alere amend terms of merger agreement (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-and-alere-amend-terms-of-merger-agreement-2017-4
97.0,4/14/2017 2:49:02 PM,"UPDATE 1-Abbott Laboratories to buy Alere for about $4.48 bln (ABT, ALR)",Reuters,http://www.businessinsider.com/r-update-1-abbott-laboratories-to-buy-alere-for-about-448-bln-2017-4
98.0,4/17/2017 3:13:03 PM,"US STOCKS-Wall Street looks set to open slightly higher (NFLX, UAL, INCY, LLY, PFE, ALR, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-looks-set-to-open-slightly-higher-2017-4
99.0,4/17/2017 4:55:07 PM,"US STOCKS-Wall St edges higher as tech, financials gain (NFLX, UAL, INCY, LLY, ALR, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-edges-higher-as-tech-financials-gain-2017-4
100.0,4/19/2017 1:45:00 PM,Abbott Reports First-Quarter 2017 Results,PR Newswire,/news/stocks/abbott-reports-first-quarter-2017-results-1001930390
101.0,4/19/2017 1:49:58 PM,Abbott Laboratories Q1 Profit Climbs 37%,RTTNews,/news/stocks/abbott-laboratories-q1-profit-climbs-37-1001930386
102.0,4/19/2017 2:01:08 PM,BRIEF-Abbott Q1 adjusted earnings per share $0.48 from continuing operations (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-q1-adjusted-earnings-per-share-048-from-continuing-operations-2017-4
103.0,4/19/2017 2:11:11 PM,"Abbott posts 29.7 pct rise in quarterly sales (ABT, ALR)",Reuters,http://www.businessinsider.com/r-abbott-posts-297-pct-rise-in-quarterly-sales-2017-4
104.0,4/19/2017 2:41:06 PM,"UPDATE 1-Abbott sales, profit propped up by St. Jude acquisition (ABT, ALR)",Reuters,http://www.businessinsider.com/r-update-1-abbott-sales-profit-propped-up-by-st-jude-acquisition-2017-4
105.0,4/19/2017 4:59:04 PM,"BRIEF-Abbott CFO says ""We're not going to really be in a good position to give a lot of detailed guidance (on Alere) until minimum Q4"" - Conf Call (ABT)",Reuters,http://www.businessinsider.com/r-brief-abbott-cfo-says-were-not-going-to-really-be-in-a-good-position-to-give-a-lot-of-detailed-guidance-on-alere-until-minimum-q4---conf-call-2017-4
106.0,4/20/2017 9:05:06 PM,"LPC: US healthcare lending rouses from policy-induced sedation (ALR, HUM, MDT, PPG, AKZA, ABT, AET, CI, CAH)",Reuters,http://www.businessinsider.com/r-lpc-us-healthcare-lending-rouses-from-policy-induced-sedation-2017-4
107.0,4/25/2017 3:11:10 PM,"US STOCKS-Wall St set to open higher as earnings take center stage (CAT, MCD, BIIB, CNC, T, TSN)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-higher-as-earnings-take-center-stage-2017-4
108.0,4/26/2017 12:20:00 PM,"Medical Equipment Stocks on Investors' Radar -- Abbott, Boston Scientific, Medtronic, and EnteroMedics",PR Newswire,/news/stocks/medical-equipment-stocks-on-investors-radar-abbott-boston-scientific-medtronic-and-enteromedics-1001950583
109.0,4/26/2017 2:00:00 PM,Abbott Introduces Science-Based Nutrition Drinks to Help Patients Have a Better Recovery from Surgery,PR Newswire,/news/stocks/abbott-introduces-science-based-nutrition-drinks-to-help-patients-have-a-better-recovery-from-surgery-1001951188
110.0,4/26/2017 2:35:06 PM,BRIEF-Abbott Laboratories develops 2 new science-based nutrition drinks for patients undergoing surgery (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-develops-2-new-science-based-nutrition-drinks-for-patients-undergoing-surgery-2017-4
111.0,4/28/2017 3:05:09 PM,"Global med-tech firms, India locked in tussle after stent price sting (ABT, BSX, JNJ, MDT, ABBOTINDIA)",Reuters,http://www.businessinsider.com/r-global-med-tech-firms-india-locked-in-tussle-after-stent-price-sting-2017-4
112.0,4/28/2017 4:31:12 PM,"LPC: US loan market welcomes M&A surge (BX, FRE, ALR, DH, MDT, PPG, AKZA, ABT, TSN, AKRX, PNRA, BCR, BDX, CAH, WFM)",Reuters,http://www.businessinsider.com/r-lpc-us-loan-market-welcomes-ma-surge-2017-4
113.0,5/4/2017 10:56:05 PM,"Tesla in talks to resolve issues with legacy Grohmann clients (TSLA, BMW, VOW3, DAI, INTC, ABT)",Reuters,http://www.businessinsider.com/r-tesla-in-talks-to-resolve-issues-with-legacy-grohmann-clients-2017-5
114.0,5/5/2017 2:30:00 PM,Dodge Momentum Index Loses Steam in April,PR Newswire,/news/stocks/dodge-momentum-index-loses-steam-in-april-636172
115.0,5/8/2017 12:00:00 PM,"Abbott Announces National Reimbursement for FreeStyle® Libre in France, Providing Access to Revolutionary Technology for People with Diabetes",PR Newswire,/news/stocks/abbott-announces-national-reimbursement-for-freestyle-libre-in-france-providing-access-to-revolutionary-technology-for-people-with-diabetes-1001988590
116.0,5/8/2017 3:00:00 PM,Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor,PR Newswire,/news/stocks/abbott-announces-ce-mark-and-first-use-of-the-worlds-first-smartphone-compatible-insertable-cardiac-monitor-645568
117.0,5/8/2017 3:28:02 PM,BRIEF-Abbott announces CE Mark and first use of the world's first smartphone compatible insertable cardiac monitor (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-announces-ce-mark-and-first-use-of-the-worlds-first-smartphone-compatible-insertable-cardiac-monitor-2017-5
118.0,5/8/2017 10:44:05 PM,BRIEF-Absolute Software Corp qtrly loss per share $0.01 (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-software-corp-qtrly-loss-per-share-001-2017-5
119.0,5/9/2017 3:00:00 PM,"Abbott Announces CE Mark for TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™",PR Newswire,/news/stocks/abbott-announces-ce-mark-for-tacticath-contact-force-ablation-catheter-sensor-enabled-1001994389
120.0,5/9/2017 3:20:10 PM,BRIEF-Abbott reports CE Mark for tacticath contact force ablation catheter (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-reports-ce-mark-for-tacticath-contact-force-ablation-catheter-2017-5
121.0,5/9/2017 7:26:03 PM,"India government panel rejects Boston Scientific plea on stent price caps (BSX, ABT, MDT)",Reuters,http://www.businessinsider.com/r-india-government-panel-rejects-boston-scientific-plea-on-stent-price-caps-2017-5
122.0,5/12/2017 10:56:09 PM,Retired baseball player DeCinces found guilty of insider trading (ABT),Reuters,http://www.businessinsider.com/r-retired-baseball-player-decinces-found-guilty-of-insider-trading-2017-5
123.0,5/18/2017 12:46:07 PM,"UPDATE 1-India's drug pricing regulator clamps down on drug cocktails (ABT, SAN, SUNPHARMA, LUPIN, GLENMARK, CADILAHC, ABBOTINDIA, 500672)",Reuters,http://www.businessinsider.com/r-update-1-indias-drug-pricing-regulator-clamps-down-on-drug-cocktails-2017-5
124.0,6/2/2017 12:25:00 PM,"Medical Equipment Stocks on Investors' Radar -- Abbott Labs, Boston Scientific, Medtronic, and EnteroMedics",PR Newswire,/news/stocks/medical-equipment-stocks-on-investors-radar-abbott-labs-boston-scientific-medtronic-and-enteromedics-1002062835
125.0,6/5/2017 11:00:03 PM,"BRIEF-Alere Q4 loss per share $1.38 from continuing operations (ALR, ABT)",Reuters,http://www.businessinsider.com/r-brief-alere-q4-loss-per-share-138-from-continuing-operations-2017-6
126.0,6/9/2017 4:15:00 PM,Abbott Declares 374th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-374th-consecutive-quarterly-dividend-1002082291
127.0,6/9/2017 8:22:03 PM,BRIEF-Abbott sets quarterly dividend of $0.265 per share (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-sets-quarterly-dividend-of-0265-per-share-2017-6
128.0,6/21/2017 3:00:00 PM,Abbott Hosts Conference Call for Second-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-second-quarter-earnings-1002112082
129.0,6/29/2017 7:32:00 PM,Abbott Secures Health Canada License for FreeStyle® Libre System for People with Diabetes,PR Newswire,/news/stocks/abbott-secures-health-canada-license-for-freestyle-libre-system-for-people-with-diabetes-1002136241
130.0,6/29/2017 7:42:05 PM,BRIEF-Abbott secures Health Canada license for Freestyle Libre system for people with diabetes (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-secures-health-canada-license-for-freestyle-libre-system-for-people-with-diabetes-2017-6
131.0,6/29/2017 10:38:03 PM,BRIEF-Abbott Laboratories names John Stratton to its board (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-names-john-stratton-to-its-board-2017-6
132.0,7/7/2017 10:22:03 PM,"BRIEF-Alere shareholders approve amended merger with Abbott (ALR, ABT)",Reuters,http://www.businessinsider.com/r-brief-alere-shareholders-approve-amended-merger-with-abbott-2017-7
133.0,7/13/2017 1:37:38 PM,Abbott And Bigfoot Collaborate To Develop Breakthrough Diabetes Tech ,RTTNews,/news/stocks/abbott-and-bigfoot-collaborate-to-develop-breakthrough-diabetes-tech-1002170725
134.0,7/13/2017 1:42:08 PM,"BRIEF-Abbott, Bigfoot Biomedical enter deal to develop diabetes management systems (ABT)",Reuters,http://www.businessinsider.com/r-brief-abbott-bigfoot-biomedical-enter-deal-to-develop-diabetes-management-systems-2017-7
135.0,7/17/2017 12:13:36 PM,Quidel To Buy Alere Triage Assets ,RTTNews,/news/stocks/quidel-to-buy-alere-triage-assets-1002177806
136.0,7/17/2017 2:38:03 PM,"BRIEF-Abbott says commences tender offer for Series B preferred stock of Alere (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-says-commences-tender-offer-for-series-b-preferred-stock-of-alere-2017-7
137.0,7/20/2017 1:49:09 PM,Abbott Laboratories Reveals 36% Gain In Q2 Earnings,RTTNews,/news/stocks/abbott-laboratories-reveals-36-gain-in-q2-earnings-1002190762
138.0,7/20/2017 1:58:06 PM,BRIEF-Abbott Q2 adjusted EPS $0.62 from continuing operations excluding items (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-q2-adjusted-eps-062-from-continuing-operations-excluding-items-2017-7
139.0,7/20/2017 2:04:10 PM,"Abbott's quarterly profit halves as costs soar (ABT, ALR)",Reuters,http://www.businessinsider.com/r-abbotts-quarterly-profit-halves-as-costs-soar-2017-7
140.0,7/20/2017 2:38:03 PM,UPDATE 1-Abbott raises full-year profit forecast (ABT),Reuters,http://www.businessinsider.com/r-update-1-abbott-raises-full-year-profit-forecast-2017-7
141.0,7/20/2017 2:40:25 PM,"Abbott Q2 Profit Falls, But Results Top View; Lifts 2017 Profit Outlook ",RTTNews,/news/stocks/abbott-q2-profit-falls-but-results-top-view-lifts-2017-profit-outlook-1002191109
142.0,7/20/2017 2:52:03 PM,"US STOCKS-Wall St set to open higher on earnings optimism (MSFT, AMZN, V, EBAY, COF, PM, AXP, ABT, TRV)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-higher-on-earnings-optimism-2017-7
143.0,7/20/2017 4:14:07 PM,"US STOCKS-Wall St flat as earnings from some big names disappoint (QCOM, PM, HD, V, EBAY, COF, MSFT, AMZN, AXP, ABT, TRV)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-earnings-from-some-big-names-disappoint-2017-7
144.0,7/20/2017 5:28:03 PM,"US STOCKS-Wall St flat as consumer stocks, weak earnings weigh (HD, SHLD, AMZN, BBY, PM, QCOM, V, MSFT, EBAY, ABT, TRV)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-consumer-stocks-weak-earnings-weigh-2017-7
145.0,7/20/2017 7:08:05 PM,"US STOCKS-S&P, Dow flat as retailers weigh; Nasdaq edges higher (HD, SHLD, AMZN, BBY, LOW, QCOM, V, MSFT, EBAY, VZ, T, ABT, TRV)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-flat-as-retailers-weigh-nasdaq-edges-higher-2017-7
146.0,7/21/2017 7:10:03 PM,"BRIEF-Alere Inc enters into purchase agreement with Siemens Diagnostics ​‍​ (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-alere-inc-enters-into-purchase-agreement-with-siemens-diagnostics--2017-7
147.0,7/25/2017 2:36:03 PM,BRIEF-Roxwood Medical enters into an exclusive agreement with Abbott for distribution of roxwood products in United States (ABT),Reuters,http://www.businessinsider.com/r-brief-roxwood-medical-enters-into-an-exclusive-agreement-with-abbott-for-distribution-of-roxwood-products-in-united-states-2017-7
148.0,7/26/2017 12:10:00 PM,"Breakfast Technical Briefing on Medical Equipment Stocks -- Abbott Labs, Boston Scientific, Medtronic, and MiMedx",PR Newswire,/news/stocks/breakfast-technical-briefing-on-medical-equipment-stocks-abbott-labs-boston-scientific-medtronic-and-mimedx-1002205248
149.0,7/31/2017 11:47:03 PM,BRIEF-Abbott Laboratories says entered into term loan agreement with lenders (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-says-entered-into-term-loan-agreement-with-lenders-2017-7
150.0,8/1/2017 9:00:00 AM,Entries for 21st Japan Media Arts Festival Now Open,PR Newswire,/news/stocks/entries-for-21st-japan-media-arts-festival-now-open-538297
151.0,8/1/2017 5:22:03 PM,"BRIEF-FDA approves Idhifa for treating relapsed/refractory Acute Myeloid Leukemia (ABT, CELG)",Reuters,http://www.businessinsider.com/r-brief-fda-approves-idhifa-for-treating-relapsed-refractory-acute-myeloid-leukemia-2017-8
152.0,8/1/2017 6:12:16 PM,"UPDATE 1-FDA approves leukemia treatment developed by Celgene, Agios (CELG, ABT)",Reuters,http://www.businessinsider.com/r-update-1-fda-approves-leukemia-treatment-developed-by-celgene-agios-2017-8
153.0,8/2/2017 2:47:03 PM,"UPDATE 1-No more freebies? India plans crackdown on marketing by drugmakers (SUNPHARMA, ABT, GSK, ABBOTINDIA)",Reuters,http://www.businessinsider.com/r-update-1-no-more-freebies-india-plans-crackdown-on-marketing-by-drugmakers-2017-8
154.0,8/7/2017 5:57:05 PM,"Siemens to update medical scanner software to deal with security bugs (SIE, MSFT, ABT)",Reuters,http://www.businessinsider.com/r-siemens-to-update-medical-scanner-software-to-deal-with-security-bugs-2017-8
155.0,8/9/2017 7:07:03 PM,"UPDATE 1-Mexico watchdog finds big pharma faces no competition on some drugs (GSK, PFE, MRK, ABT, LLY, SAN, AZN)",Reuters,http://www.businessinsider.com/r-update-1-mexico-watchdog-finds-big-pharma-faces-no-competition-on-some-drugs-2017-8
156.0,8/10/2017 3:00:00 PM,"The Cost of Malnutrition: Study Shows Nutrition Program Could Save Hospitals up to $3,800 per Patient",PR Newswire,/news/stocks/the-cost-of-malnutrition-study-shows-nutrition-program-could-save-hospitals-up-to-3-800-per-patient-1002248626
157.0,8/10/2017 7:12:04 PM,A nutrition scientist predicts a future in which pizza is nutritious as a superfood (ABT),Business Insider,http://www.businessinsider.com/abbott-nutrition-director-predicts-nutritious-pizza-2017-8
158.0,8/14/2017 2:00:00 PM,Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002255099
159.0,8/14/2017 2:00:00 PM,Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002255095
160.0,8/14/2017 2:12:03 PM,BRIEF-Abbott announces extension of cash tender offer for all outstanding shares of series B convertible perpetual preferred stock of Alere Inc (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-2017-8
161.0,8/15/2017 2:00:00 PM,"North West London Pathology and Abbott Partner for Diagnostics Products and Services, including Alinity™, in Three NHS Trusts",PR Newswire,/news/stocks/north-west-london-pathology-and-abbott-partner-for-diagnostics-products-and-services-including-alinity-in-three-nhs-trusts-1002258378
162.0,8/16/2017 12:32:03 PM,"BRIEF-Enzo Biochem says federal judge in a U.S. Court has entered an order in action entitled Enzo Life Sciences v. Abbott Laboratories ​ (ENZ, ABT)",Reuters,http://www.businessinsider.com/r-brief-enzo-biochem-says-federal-judge-in-a-us-court-has-entered-an-order-in-action-entitled-enzo-life-sciences-v-abbott-laboratories--2017-8
163.0,8/16/2017 11:37:17 PM,"UPDATE 2-Seven charged in U.S. insider trading ring (BAC, RY, ABT, MON, BAYN)",Reuters,http://www.businessinsider.com/r-update-2-seven-charged-in-us-insider-trading-ring-2017-8
164.0,8/17/2017 10:17:08 PM,BRIEF-Absolute Software reports Q4 loss per share ‍$0.05​ (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-software-reports-q4-loss-per-share-005-2017-8
165.0,8/18/2017 5:17:03 PM,"CANADA STOCKS-TSX slides as investors shun riskier assets, gold shines (MFC, BMO, ABT, ABX, AEM)",Reuters,http://www.businessinsider.com/r-canada-stocks-tsx-slides-as-investors-shun-riskier-assets-gold-shines-2017-8
166.0,8/18/2017 10:57:08 PM,"CANADA STOCKS-TSX slides as inflation, stronger loonie cloud sentiment (MFC, ABX, G, GIB., ABT, CNR)",Reuters,http://www.businessinsider.com/r-canada-stocks-tsx-slides-as-inflation-stronger-loonie-cloud-sentiment-2017-8
167.0,8/28/2017 12:15:00 PM,"Technical Snapshots for These Medical Equipment Stocks -- Abbott Labs, Boston Scientific, Edwards Lifesciences, and Medtronic",PR Newswire,/news/stocks/technical-snapshots-for-these-medical-equipment-stocks-abbott-labs-boston-scientific-edwards-lifesciences-and-medtronic-1002287926
168.0,8/28/2017 3:00:00 PM,Abbott Introduces HeartMate 3 Left Ventricular Assist System - the Latest Milestone In Therapy For Advanced Heart Failure Patients,PR Newswire,/news/stocks/abbott-introduces-heartmate-3-left-ventricular-assist-system-the-latest-milestone-in-therapy-for-advanced-heart-failure-patients-1002288513
169.0,8/28/2017 3:14:03 PM,Abbott Receives FDA Approval For MagLev HeartMate 3 System - Quick Facts ,RTTNews,/news/stocks/abbott-receives-fda-approval-for-maglev-heartmate-3-system-quick-facts-1002288603
170.0,8/29/2017 6:02:03 PM,Abbott releases new round of cyber updates for St. Jude pacemakers (ABT),Reuters,http://www.businessinsider.com/r-abbott-releases-new-round-of-cyber-updates-for-st-jude-pacemakers-2017-8
171.0,8/29/2017 6:22:03 PM,"BRIEF-Abbott says has notified physicians of updates to its implantable pacemakers, defibrillators (ABT)",Reuters,http://www.businessinsider.com/r-brief-abbott-says-has-notified-physicians-of-updates-to-its-implantable-pacemakers-defibrillators-2017-8
172.0,8/29/2017 6:27:05 PM,UPDATE 1-Abbott releases new round of cyber updates for St. Jude pacemakers (ABT),Reuters,http://www.businessinsider.com/r-update-1-abbott-releases-new-round-of-cyber-updates-for-st-jude-pacemakers-2017-8
173.0,8/29/2017 7:07:03 PM,BRIEF-U.S. FDA says has approved St. Jude medical’s firmware update ‍​ (ABT),Reuters,http://www.businessinsider.com/r-brief-us-fda-says-has-approved-st-jude-medicals-firmware-update--2017-8
174.0,8/29/2017 9:02:00 PM,Abbott and the Abbott Fund Donate $1 Million to Support Hurricane Harvey Relief Efforts,PR Newswire,/news/stocks/abbott-and-the-abbott-fund-donate-1-million-to-support-hurricane-harvey-relief-efforts-1002292643
175.0,8/30/2017 6:02:03 PM,BRIEF-Abbott initiates study of AMPLATZER device to correct congenital heart defect in newborns (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-initiates-study-of-amplatzer-device-to-correct-congenital-heart-defect-in-newborns-2017-8
176.0,8/31/2017 3:00:00 PM,Revolutionary Glucose Monitoring Technology FreeStyle® Libre Now Reimbursed Across Japan,PR Newswire,/news/stocks/revolutionary-glucose-monitoring-technology-freestyle-libre-now-reimbursed-across-japan-1002298698
177.0,9/1/2017 2:00:00 PM,Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002301877
178.0,9/1/2017 2:22:03 PM,"BRIEF-Abbott extends cash tender offer for all outstanding shares of series B convertible perpetual preferred stock of Alere (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-extends-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-2017-9
179.0,9/7/2017 3:07:03 PM,BRIEF-Absolute announces approval of normal course issuer bid (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-announces-approval-of-normal-course-issuer-bid-2017-9
180.0,9/7/2017 5:49:00 PM,Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index (DJSI),PR Newswire,/news/stocks/abbott-named-industry-leader-for-responsible-and-sustainable-business-for-five-consecutive-years-on-the-dow-jones-sustainability-index-djsi-1002350837
181.0,9/8/2017 10:37:04 PM,"UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9
182.0,9/11/2017 10:07:03 AM,"RPT-UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-rpt-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9
183.0,9/14/2017 6:28:00 PM,Abbott Declares 375th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-375th-consecutive-quarterly-dividend-1002371534
184.0,9/14/2017 6:37:19 PM,BRIEF-Abbott sets quarterly dividend of $0.265 per share (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-sets-quarterly-dividend-of-0265-per-share-2017-9
185.0,9/18/2017 2:00:00 PM,Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002378415
186.0,9/18/2017 2:17:03 PM,"BRIEF-Abbott announces extension of cash tender offer (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-announces-extension-of-cash-tender-offer-2017-9
187.0,9/19/2017 3:52:04 AM,"BRIEF-Alere announces intent to voluntarily delist Series B Convertible Perpetual Preferred Stock from the NYSE (ALR, ABT)",Reuters,http://www.businessinsider.com/r-brief-alere-announces-intent-to-voluntarily-delist-series-b-convertible-perpetual-preferred-stock-from-the-nyse-2017-9
188.0,9/20/2017 3:00:00 PM,Abbott Hosts Conference Call for Third-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-third-quarter-earnings-1002387305
189.0,9/22/2017 2:00:00 PM,Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse™ ICD,PR Newswire,/news/stocks/abbott-secures-fda-approval-for-mri-compatibility-for-the-company-s-ellipse-icd-1002422445
190.0,9/22/2017 2:22:04 PM,BRIEF-Abbott secures FDA approval for MRI-compatibility for the co's Ellipse ICD (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-secures-fda-approval-for-mri-compatibility-for-the-cos-ellipse-icd-2017-9
191.0,9/26/2017 8:07:14 PM,"Pregnant women still unaware of epilepsy drug risks - EMA hearing (SAN, ABT, SUNPHARMA)",Reuters,http://www.businessinsider.com/r-pregnant-women-still-unaware-of-epilepsy-drug-risks---ema-hearing-2017-9
192.0,9/27/2017 9:24:00 PM,New Marine Refuges in Canada's Atlantic Ocean,PR Newswire,/news/stocks/new-marine-refuges-in-canadas-atlantic-ocean-452702
193.0,9/27/2017 11:02:32 PM,BRIEF-U.S. FDA says approved Freestyle Libre Flash glucose monitoring system‍​ (ABT),Reuters,http://www.businessinsider.com/r-brief-us-fda-says-approved-freestyle-libre-flash-glucose-monitoring-system-2017-9
194.0,9/27/2017 11:42:00 PM,No More Routine Finger Sticks(1) for Americans with Diabetes: Abbott′s FreeStyle® Libre Approved in the U.S.,PR Newswire,/news/stocks/no-more-routine-finger-sticks-1-for-americans-with-diabetes-abbott-s-freestyle-libre-approved-in-the-u-s-1002678029
195.0,9/27/2017 11:57:06 PM,"FDA approves Abbott's blood glucose monitoring device (ABT, DXCM, MDT)",Reuters,http://www.businessinsider.com/r-fda-approves-abbotts-blood-glucose-monitoring-device-2017-9
196.0,9/28/2017 12:41:00 AM,No More Routine Finger Sticks(1) for Americans with Diabetes: Abbott′s FreeStyle® Libre Approved in the U.S.,PR Newswire,/news/stocks/no-more-routine-finger-sticks-1-for-americans-with-diabetes-abbott-s-freestyle-libre-approved-in-the-u-s-1002681727
197.0,9/28/2017 12:42:17 AM,"UPDATE 1-FDA approves Abbott's blood glucose monitoring device (ABT, DXCM, MDT)",Reuters,http://www.businessinsider.com/r-update-1-fda-approves-abbotts-blood-glucose-monitoring-device-2017-9
198.0,9/28/2017 4:26:29 AM,Abbott : FDA Oks FreeStyle Libre Flash Glucose Monitoring System ,RTTNews,/news/stocks/abbott-fda-oks-freestyle-libre-flash-glucose-monitoring-system-1002694665
199.0,9/28/2017 1:32:03 PM,"US STOCKS-Futures flat ahead of GDP, jobs data (DXCM, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-flat-ahead-of-gdp-jobs-data-2017-9
200.0,9/28/2017 3:07:03 PM,"US STOCKS-Wall St set to open lower after economic data (ACN, DXCM, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-lower-after-economic-data-2017-9
201.0,9/28/2017 4:07:03 PM,"US STOCKS-Wall St opens lower after economic data (ACN, DXCM, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-lower-after-economic-data-2017-9
202.0,9/28/2017 4:36:03 PM,"The FDA just approved a device that can monitor blood sugar without finger pricks (ABT, DXCM)",Business Insider,http://www.businessinsider.com/fda-approves-abbotts-no-routine-finger-stick-diabetes-device-2017-9
203.0,9/28/2017 5:42:05 PM,"US STOCKS-McDonald's props up Dow; financial, tech stocks slip (MCD, AAPL, AMGN, ABT, RAD)",Reuters,http://www.businessinsider.com/r-us-stocks-mcdonalds-props-up-dow-financial-tech-stocks-slip-2017-9
204.0,9/28/2017 6:47:15 PM,"UPDATE 1-Alere to pay more than $13 million to resolve U.S. SEC probe (ALR, ABT)",Reuters,http://www.businessinsider.com/r-update-1-alere-to-pay-more-than-13-million-to-resolve-us-sec-probe-2017-9
205.0,9/28/2017 7:12:07 PM,"US STOCKS-McDonald's lifts Dow; Trump tax trade fades (MCD, AAPL, AMGN, ABT, 6502)",Reuters,http://www.businessinsider.com/r-us-stocks-mcdonalds-lifts-dow-trump-tax-trade-fades-2017-9
206.0,9/28/2017 7:52:12 PM,"Abbott wins U.S. antitrust approval to buy Alere with conditions (ABT, ALR)",Reuters,http://www.businessinsider.com/r-abbott-wins-us-antitrust-approval-to-buy-alere-with-conditions-2017-9
207.0,9/28/2017 8:27:17 PM,"BRIEF-Canadian Competition Bureau clears Abbott Laboratories' takeover of Alere (ALR, ABT, SIE, QDEL)",Reuters,http://www.businessinsider.com/r-brief-canadian-competition-bureau-clears-abbott-laboratories-takeover-of-alere-2017-9
208.0,9/28/2017 8:27:17 PM,"UPDATE 1-Abbott wins U.S. antitrust approval to buy Alere with conditions (ABT, ALR, QDEL, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-abbott-wins-us-antitrust-approval-to-buy-alere-with-conditions-2017-9
209.0,9/28/2017 8:47:13 PM,"US STOCKS-Wall St edges up on healthcare, tax plan hopes (MCD, AMGN, ABT, ALR)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-edges-up-on-healthcare-tax-plan-hopes-2017-9
210.0,9/28/2017 10:17:12 PM,"US STOCKS-S&P ekes out record on healthcare gains, tax plan hopes (MCD, AMGN, ABT, ALR)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-ekes-out-record-on-healthcare-gains-tax-plan-hopes-2017-9
211.0,9/29/2017 3:20:00 PM,"Abbott Acquisition of Alere Set to Close on Tuesday, October 3, 2017",PR Newswire,/news/stocks/abbott-acquisition-of-alere-set-to-close-on-tuesday-october-3-2017-1002852832
212.0,9/29/2017 3:27:51 PM,Abbott Plans To Close Acquisition Of Alere On Oct. 3 ,RTTNews,/news/stocks/abbott-plans-to-close-acquisition-of-alere-on-oct-3-1002852855
213.0,9/29/2017 3:47:03 PM,"BRIEF-Abbott acquisition of Alere set to close on October 3, 2017 (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-acquisition-of-alere-set-to-close-on-october-3-2017-2017-9
214.0,10/2/2017 2:00:00 PM,Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002914359
215.0,10/2/2017 2:27:04 PM,"BRIEF-Abbott extends previous cash tender offer for outstanding Series B shares of Alere Inc (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-extends-previous-cash-tender-offer-for-outstanding-series-b-shares-of-alere-inc-2017-10
216.0,10/4/2017 2:00:00 PM,Abbott Completes Cash Tender Offer for Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-completes-cash-tender-offer-for-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002993764
217.0,10/4/2017 2:00:00 PM,Abbott Completes Cash Tender Offer for Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-completes-cash-tender-offer-for-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002993748
218.0,10/4/2017 2:27:06 PM,BRIEF-Abbott completes cash tender offer for Series B Convertible Perpetual Preferred Stock of Alere Inc (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-completes-cash-tender-offer-for-series-b-convertible-perpetual-preferred-stock-of-alere-inc-2017-10
219.0,10/5/2017 9:34:00 PM,Alere Inc. -- Moody's to withdraw Alere's ratings following debt redemption,Moodys,/news/bonds/alere-inc-moody-s-to-withdraw-alere-s-ratings-following-debt-redemption-1003103718
220.0,10/16/2017 3:00:00 PM,Patients Battling Complex Regional Pain Syndrome Find a Host of New Benefits in Abbott's Proclaim™ DRG System,PR Newswire,/news/stocks/patients-battling-complex-regional-pain-syndrome-find-a-host-of-new-benefits-in-abbott-s-proclaim-drg-system-1004488056
221.0,10/16/2017 3:00:00 PM,Patients Battling Complex Regional Pain Syndrome Find a Host of New Benefits in Abbott's Proclaim™ DRG System,PR Newswire,/news/stocks/patients-battling-complex-regional-pain-syndrome-find-a-host-of-new-benefits-in-abbott-s-proclaim-drg-system-1001762160
222.0,10/16/2017 3:12:09 PM,BRIEF-Abbott Laboratories says ‍announced U.S. Launch of company's proclaim DRG neurostimulator system​ (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-says-announced-us-launch-of-companys-proclaim-drg-neurostimulator-system-2017-10
223.0,10/18/2017 1:45:00 PM,Abbott Reports Third-Quarter 2017 Results,PR Newswire,/news/stocks/abbott-reports-third-quarter-2017-results-1004762307
224.0,10/18/2017 1:51:52 PM,Abbott Laboratories Q3 Earnings Rise 32%,RTTNews,/news/stocks/abbott-laboratories-q3-earnings-rise-32-1004762329
225.0,10/18/2017 1:52:03 PM,"US STOCKS-Dow set to open above 23,000 for the first time (IBM, ABT, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-set-to-open-above-23000-for-the-first-time-2017-10
226.0,10/18/2017 1:57:05 PM,Abbott Labs posts quarterly profit vs. year-ago loss (ABT),Reuters,http://www.businessinsider.com/r-abbott-labs-posts-quarterly-profit-vs-year-ago-loss-2017-10
227.0,10/18/2017 2:06:45 PM,Abbot Narrows FY17 Adj. Earnings Outlook - Quick Facts ,RTTNews,/news/stocks/abbot-narrows-fy17-adj-earnings-outlook-quick-facts-1004763442
228.0,10/18/2017 2:22:03 PM,UPDATE 1-Abbott tops profit estimates on strong medical device sales (ABT),Reuters,http://www.businessinsider.com/r-update-1-abbott-tops-profit-estimates-on-strong-medical-device-sales-2017-10
229.0,10/18/2017 2:57:03 PM,"US STOCKS-Dow set to crack 23,000-mark at open for the first time (IBM, ABT, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-set-to-crack-23000-mark-at-open-for-the-first-time-2017-10
230.0,10/18/2017 3:02:03 PM,BRIEF-Abbott Q3 adjusted EPS $0.66 from continuing operations (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-q3-adjusted-eps-066-from-continuing-operations-2017-10
231.0,10/18/2017 4:07:03 PM,"US STOCKS-Dow opens above 23,000, powered by IBM (IBM, ABT, CVS, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-opens-above-23000-powered-by-ibm-2017-10
232.0,10/18/2017 5:07:03 PM,BRIEF-Abbott CFO says Alere is expected to contribute around $475 mln to reported sales this year (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-cfo-says-alere-is-expected-to-contribute-around-475-mln-to-reported-sales-this-year-2017-10
233.0,10/18/2017 5:52:04 PM,"US STOCKS-Dow hovers above 23,000, boosted by IBM (IBM, WFC, BAC, GS, ABT, CVS, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-hovers-above-23000-boosted-by-ibm-2017-10
234.0,10/18/2017 7:22:03 PM,"US STOCKS-Dow stays above 23,000-mark on IBM surge (IBM, CVX, WFC, BAC, GS, ABT, CVS, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-stays-above-23000-mark-on-ibm-surge-2017-10
235.0,10/18/2017 9:17:08 PM,"US STOCKS-Dow trades above 23,000-mark as IBM's stock jumps (IBM, ABT, CVS)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-trades-above-23000-mark-as-ibms-stock-jumps-2017-10
236.0,10/18/2017 10:32:11 PM,"US STOCKS-Dow closes above 23,000 for first time; IBM jumps (IBM, ABT, EBAY)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-closes-above-23000-for-first-time-ibm-jumps-2017-10
237.0,10/18/2017 11:02:14 PM,"US STOCKS-Dow closes above 23,000 for first time; IBM soars (IBM, ABT, EBAY)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-closes-above-23000-for-first-time-ibm-soars-2017-10
238.0,10/19/2017 1:32:12 AM,"US STOCKS-Dow ends above 23,000 for first time; IBM jumps (IBM, ABT, EBAY)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-ends-above-23000-for-first-time-ibm-jumps-2017-10
239.0,10/19/2017 8:59:00 PM,A Great Place to Do Great Things: Developing Game-Changing Technology at Abbott,PR Newswire,/news/stocks/a-great-place-to-do-great-things-developing-game-changing-technology-at-abbott-1004938345
240.0,10/20/2017 8:12:04 PM,"Wall St Weekahead-Recent hurricanes take toll on quarterly earnings (HOG, COST, USB, ABT, AIG, DOV, SNA, PG, STZ, USG, OC, EXP, HD, DAL)",Reuters,http://www.businessinsider.com/r-wall-st-weekahead-recent-hurricanes-take-toll-on-quarterly-earnings-2017-10
241.0,10/23/2017 3:00:00 PM,Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.,PR Newswire,/news/stocks/abbott-launches-the-first-and-only-smartphone-compatible-insertable-cardiac-monitor-in-the-u-s-1005334020
242.0,10/23/2017 3:13:18 PM,Abbott Announces FDA Clearance For Confirm Rx Insertable Cardiac Monitor ,RTTNews,/news/stocks/abbott-announces-fda-clearance-for-confirm-rx-insertable-cardiac-monitor-1005334913
243.0,10/23/2017 3:27:06 PM,BRIEF-Abbott says ‍secured FDA clearance for confirm Rx Insertable Cardiac Monitor​ (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-says-secured-fda-clearance-for-confirm-rx-insertable-cardiac-monitor-2017-10
244.0,10/30/2017 12:00:00 PM,Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1],PR Newswire,/news/stocks/abbott-introduces-next-generation-of-most-widely-used-heart-stent-for-people-with-coronary-artery-disease-in-europe-1-1006165257
245.0,10/30/2017 12:00:00 PM,Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1],PR Newswire,/news/stocks/abbott-introduces-next-generation-of-most-widely-used-heart-stent-for-people-with-coronary-artery-disease-in-europe-1-1001807352
246.0,10/30/2017 6:20:00 PM,Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease with XIENCE Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery,PR Newswire,/news/stocks/analysis-of-landmark-study-showed-patients-treated-for-left-main-coronary-artery-disease-with-xience-stent-felt-better-faster-and-had-similar-long-term-outcomes-to-open-heart-surgery-1006198590
247.0,10/30/2017 6:20:00 PM,Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease with XIENCE Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery,PR Newswire,/news/stocks/analysis-of-landmark-study-showed-patients-treated-for-left-main-coronary-artery-disease-with-xience-stent-felt-better-faster-and-had-similar-long-term-outcomes-to-open-heart-surgery-1002135158
248.0,10/31/2017 2:00:00 PM,Abbott Announces FDA Clearance for its Alinity™ ci-series Next-generation Diagnostic Systems,PR Newswire,/news/stocks/abbott-announces-fda-clearance-for-its-alinity-ci-series-next-generation-diagnostic-systems-1006305187
249.0,10/31/2017 2:17:08 PM,BRIEF-Abbott gets FDA clearance for its Alinity ci-series instruments (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-gets-fda-clearance-for-its-alinity-ci-series-instruments-2017-10
250.0,11/1/2017 6:00:00 PM,Minneapolis-based Pohlad family acquires PaR Systems from MML Capital Partners,PR Newswire,/news/stocks/minneapolis-based-pohlad-family-acquires-par-systems-from-mml-capital-partners-1001815862
251.0,11/3/2017 5:52:03 PM,"LPC: US healthcare brightens tame US high-grade M&A lending (CVS, AET, CAH, MDT, ABT, HUM, CI, BDX, GILD, AMZN)",Reuters,http://www.businessinsider.com/r-lpc-us-healthcare-brightens-tame-us-high-grade-ma-lending-2017-11
252.0,11/6/2017 2:00:00 PM,Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan,PR Newswire,/news/stocks/abbott-s-mitraclip-approved-as-first-transcatheter-mitral-valve-repair-device-in-japan-1007055739
253.0,11/6/2017 2:30:00 PM,Homewood Health Proud to Honour Military Women and Their Families,PR Newswire,/news/stocks/homewood-health-proud-to-honour-military-women-and-their-families-640293
254.0,11/13/2017 10:27:08 PM,BRIEF-Absolute Software Corp reports Q1 loss per share of $0.00 (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-software-corp-reports-q1-loss-per-share-of-000-2017-11
255.0,11/15/2017 6:52:00 AM,Huawei Creates a Smart City Nervous System for More Than 100 Cities with Leading New ICT,PR Newswire,/news/stocks/huawei-creates-a-smart-city-nervous-system-for-more-than-100-cities-with-leading-new-ict-527774
256.0,11/15/2017 2:57:08 PM,BRIEF-Absolute and EVRY sign Managed Service Provider and Reseller agreements (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-and-evry-sign-managed-service-provider-and-reseller-agreements-2017-11
257.0,11/17/2017 6:52:00 PM,Counsel Proposes Merger of Funds and Other Changes to its Investment Lineup,PR Newswire,/news/stocks/counsel-proposes-merger-of-funds-and-other-changes-to-its-investment-lineup-492232
258.0,12/6/2017 2:00:00 PM,"Symitar, Synergent Broaden Scope of Core Processing Partnership",PR Newswire,/news/stocks/symitar-synergent-broaden-scope-of-core-processing-partnership-1001595828
259.0,12/13/2017 2:00:00 PM,SC Johnson Goes Above and Beyond Regulatory and Industry Standards with Skin Allergen Transparency,PR Newswire,/news/stocks/sc-johnson-goes-above-and-beyond-regulatory-and-industry-standards-with-skin-allergen-transparency-582919
260.0,12/15/2017 4:17:00 PM,Abbott Raising Quarterly Dividend for 46th Straight Year,PR Newswire,/news/stocks/abbott-raising-quarterly-dividend-for-46th-straight-year-1011552695
261.0,12/15/2017 5:22:03 PM,BRIEF-Abbott Increases Quarterly Dividend To 28 Cents Per Share (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-increases-quarterly-dividend-to-28-cents-per-share-2017-12
262.0,12/18/2017 3:00:00 PM,Abbott Hosts Conference Call for Fourth-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-fourth-quarter-earnings-1011617639
263.0,12/19/2017 8:35:00 PM,Global Television Gives The Gift of Connected Viewing With New Global Go App For Apple TV,PR Newswire,/news/stocks/global-television-gives-the-gift-of-connected-viewing-with-new-global-go-app-for-apple-tv-578956
264.0,12/29/2017 9:00:00 AM,"Bottos: Where Blockchain, AI and Big Data Meet",PR Newswire,/news/stocks/bottos-where-blockchain-ai-and-big-data-meet-629955
265.0,1/2/2018 3:00:00 PM,"Abbott Launches Alinity™ h-series Integrated Hematology System, Combining Speed, Accuracy and Seamless Integration",PR Newswire,/news/stocks/abbott-launches-alinity-h-series-integrated-hematology-system-combining-speed-accuracy-and-seamless-integration-1012407868
266.0,1/2/2018 3:17:04 PM,BRIEF-Abbott Launches Alinity H-Series Integrated Hematology System (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-launches-alinity-h-series-integrated-hematology-system-2018-1
267.0,1/2/2018 4:07:03 PM,"US STOCKS-Wall Street kicks off 2018 on a strong note (DIS, NFLX, DISCA, WYNN, LVS, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-kicks-off-2018-on-a-strong-note-2018-1
268.0,1/2/2018 5:57:05 PM,"US STOCKS-Wall Street off to strong start to 2018 as techs gain (AAPL, MSFT, DIS, NFLX, DISCA, CMCSA, WYNN, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-off-to-strong-start-to-2018-as-techs-gain-2018-1
269.0,1/2/2018 7:07:03 PM,"US STOCKS-Wall Street carries momentum into 2018 as techs climb (AAPL, MSFT, AMZN, DIS, NFLX, DISCA, JCP, JWN, KSS, WYNN, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-carries-momentum-into-2018-as-techs-climb-2018-1
270.0,1/2/2018 10:32:03 PM,"US STOCKS-Wall St begins 2018 with gains; tech drives momentum (AAPL, MSFT, AMZN, JCP, JWN, KSS, WYNN, ABT, ALL)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-begins-2018-with-gains-tech-drives-momentum-2018-1
271.0,1/2/2018 10:57:03 PM,"US STOCKS-Wall St starts year on strong note; Nasdaq ends above 7,000 (AAPL, MSFT, AMZN, JCP, JWN, KSS, WYNN, ABT, ALL)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-starts-year-on-strong-note-nasdaq-ends-above-7000-2018-1
272.0,1/3/2018 12:07:03 AM,"US STOCKS-Wall St starts year on strong note; Nasdaq ends above 7,000 (AAPL, AMZN, JCP, JWN, KSS, WYNN, ABT, ALL)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-starts-year-on-strong-note-nasdaq-ends-above-7000-2018-1
273.0,1/3/2018 3:00:00 PM,New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Portfolio of MRI-Ready Devices,PR Newswire,/news/stocks/new-fda-mr-conditional-labeling-approvals-further-expand-abbott-s-portfolio-of-mri-ready-devices-1012434762
274.0,1/4/2018 3:00:00 PM,"Abbott's Revolutionary Continuous Glucose Monitoring System, FreeStyle® Libre, Now Available To Medicare Patients",PR Newswire,/news/stocks/abbott-s-revolutionary-continuous-glucose-monitoring-system-freestyle-libre-now-available-to-medicare-patients-1002309458
275.0,1/8/2018 1:41:13 PM,Mylan To Close $1 Bln Share Repurchase Plan ,RTTNews,/news/stocks/mylan-to-close-1-bln-share-repurchase-plan-1012662174
276.0,1/16/2018 8:09:00 AM,APRINOIA Therapeutics Closes US$11 Million Series B Financing to Advance Its Tau PET Imaging Tracer and Tau Therapeutic Programs for Alzheimer's Disease,PR Newswire,/news/stocks/aprinoia-therapeutics-closes-us-11-million-series-b-financing-to-advance-its-tau-pet-imaging-tracer-and-tau-therapeutic-programs-for-alzheimer-s-disease-1001654713
277.0,1/24/2018 10:05:42 AM,"Earnings In Focus: Jan. 24 (ABT, CMCSA, F, GE, WHR) ",RTTNews,/news/stocks/earnings-in-focus-jan-24-abt-cmcsa-f-ge-whr-1013830542
278.0,1/24/2018 1:45:00 PM,Abbott Reports Fourth-Quarter 2017 Results,PR Newswire,/news/stocks/abbott-reports-fourth-quarter-2017-results-1013848766
279.0,1/24/2018 1:51:27 PM,Abbott Laboratories Reports Rise In Q4 Bottom Line,RTTNews,/news/stocks/abbott-laboratories-reports-rise-in-q4-bottom-line-1013848773
280.0,1/24/2018 7:44:04 PM,Abbott Labs Posting Strong Gain On Better Than Expected Q4 Results ,RTTNews,/news/stocks/abbott-labs-posting-strong-gain-on-better-than-expected-q4-results-1013884225
281.0,1/25/2018 2:00:00 PM,Industry Frontrunners Recognized at Frost & Sullivan Best Practices Awards Gala,PR Newswire,/news/stocks/industry-frontrunners-recognized-at-frost-&-sullivan-best-practices-awards-gala-452202
282.0,1/29/2018 10:00:00 AM,Aliyah Media Releases Inaugural Issue,PR Newswire,/news/stocks/aliyah-media-releases-inaugural-issue-701016
283.0,2/7/2018 3:00:00 PM,Abbott's App for FreeStyle® Libre System Now Available in Europe for Both iPhone™ and Android™,PR Newswire,/news/stocks/abbott-s-app-for-freestyle-libre-system-now-available-in-europe-for-both-iphone-and-android-1015048487
284.0,2/12/2018 11:24:00 PM,"Abbott Laboratories -- Moody's upgrades Abbott Laboratories to Baa2, positive outlook",Moodys,/news/bonds/abbott-laboratories-moody-s-upgrades-abbott-laboratories-to-baa2-positive-outlook-1015557925
285.0,2/16/2018 5:20:00 PM,Abbott Declares 377th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-377th-consecutive-quarterly-dividend-1016035646
286.0,2/27/2018 3:00:00 PM,Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon,PR Newswire,/news/stocks/abbott-and-surmodics-announce-agreement-for-next-generation-drug-coated-balloon-1017303628
287.0,3/1/2018 3:00:00 PM,Abbott to Present at the Barclays Capital 2018 Global Healthcare Conference,PR Newswire,/news/stocks/abbott-to-present-at-the-barclays-capital-2018-global-healthcare-conference-1002125366
288.0,3/7/2018 12:07:00 AM,FDA Approves the World's Smallest Mechanical Heart Valve for Pediatric Patients with Heart Defects,PR Newswire,/news/stocks/fda-approves-the-world-s-smallest-mechanical-heart-valve-for-pediatric-patients-with-heart-defects-1018188096
289.0,3/7/2018 12:34:48 AM,Abbott's Masters HP15mm Heart Valve Gets FDA Approval ,RTTNews,/news/stocks/abbott-s-masters-hp15mm-heart-valve-gets-fda-approval-1018190047
290.0,3/7/2018 7:14:11 AM,"FDA Approves New HIV Drug, Mark Your Calendar For BHVN, Watch Out For ZFGN ",RTTNews,/news/stocks/fda-approves-new-hiv-drug-mark-your-calendar-for-bhvn-watch-out-for-zfgn-1018228185
291.0,3/9/2018 5:29:00 PM,Moody's: Outlook for US medical products and devices industry changed to positive,Moodys,/news/bonds/moody-s-outlook-for-us-medical-products-and-devices-industry-changed-to-positive-1018563273
292.0,3/11/2018 3:59:00 PM,New Long-Term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott's HeartMate 3 Heart Pump,PR Newswire,/news/stocks/new-long-term-data-show-improved-survival-and-lower-rates-of-stroke-and-pump-thrombosis-for-abbott-s-heartmate-3-heart-pump-1018613251
293.0,3/11/2018 6:20:10 PM,Abbott Announces New Clinical Trial Data From MOMENTUM 3 Clinical Study ,RTTNews,/news/stocks/abbott-announces-new-clinical-trial-data-from-momentum-3-clinical-study-1018613448
294.0,3/12/2018 5:30:17 AM,"SVRA Disappoints, SNY/REGN's Praluent Price To Be Cut, OBSV On Watch ",RTTNews,/news/stocks/svra-disappoints-sny-regn-s-praluent-price-to-be-cut-obsv-on-watch-1018614563
295.0,3/19/2018 2:00:00 PM,Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation,PR Newswire,/news/stocks/abbott-s-mitraclip-therapy-receives-national-reimbursement-in-japan-to-treat-patients-with-mitral-regurgitation-1018917372
296.0,3/20/2018 8:16:36 AM,"ARNA Soars After-hours, Remoxy Now 2 Steps Away From Approval, APLS On Watch ",RTTNews,/news/stocks/arna-soars-after-hours-remoxy-now-2-steps-away-from-approval-apls-on-watch-1018936376
297.0,3/21/2018 2:00:00 PM,Abbott Hosts Conference Call for First-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-first-quarter-earnings-498259
298.0,3/29/2018 3:00:00 PM,Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor,PR Newswire,/news/stocks/abbott-initiates-trial-to-evaluate-improved-survival-and-outcomes-with-the-cardiomems-monitor-524836
299.0,4/11/2018 3:00:00 PM,Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease,PR Newswire,/news/stocks/abbott-initiates-groundbreaking-study-to-assess-superiority-of-high-resolution-imaging-versus-standard-of-care-angiography-in-treating-coronary-artery-disease-1021172127
300.0,4/11/2018 3:00:00 PM,Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease,PR Newswire,/news/stocks/abbott-initiates-groundbreaking-study-to-assess-superiority-of-high-resolution-imaging-versus-standard-of-care-angiography-in-treating-coronary-artery-disease-564323
301.0,4/17/2018 3:30:00 PM,Abbott's New Ensure® Max Protein Helps Americans Go for Their #HealthGoals,PR Newswire,/news/stocks/abbott-s-new-ensure-max-protein-helps-americans-go-for-their-healthgoals-1021437748
302.0,4/18/2018 11:54:07 AM,"Earnings In Focus: Apr. 18 (ABT, PIR, STLD) ",RTTNews,/news/stocks/earnings-in-focus-apr-18-abt-pir-stld-1021488769
303.0,4/18/2018 1:45:00 PM,Abbott Reports First-Quarter 2018 Results,PR Newswire,/news/stocks/abbott-reports-first-quarter-2018-results-1021494590
304.0,4/18/2018 1:53:13 PM,Abbott Laboratories Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q1-adjusted-earnings-beat-estimates-1021494609
305.0,4/20/2018 4:10:00 PM,Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023,PR Newswire,/news/stocks/abbott-extends-title-sponsorship-of-abbott-world-marathon-majors-through-2023-1021687316
306.0,4/20/2018 4:10:00 PM,Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023,PR Newswire,/news/stocks/abbott-extends-title-sponsorship-of-abbott-world-marathon-majors-through-2023-601878
307.0,4/23/2018 3:00:00 PM,"Sanquin Selects Abbott's ""Alinity™ s"" Solution for Blood and Plasma Screening",PR Newswire,/news/stocks/sanquin-selects-abbott-s-alinity-s-solution-for-blood-and-plasma-screening-1021997877
308.0,4/23/2018 3:00:00 PM,"Sanquin Selects Abbott's ""Alinity™ s"" Solution for Blood and Plasma Screening",PR Newswire,/news/stocks/sanquin-selects-abbott-s-alinity-s-solution-for-blood-and-plasma-screening-1021997884
309.0,4/23/2018 3:14:23 PM,"BRIEF-Abbott Laboratories - Co, Sanquin Sign Multiple-Year Contract For Supply Of Primary Serological Equipment And Consumables",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/1ePRzKsAt4s/brief-abbott-laboratories-co-sanquin-sign-multiple-year-contract-for-supply-of-primary-serological-equipment-and-consumables-idUSFWN1S00XX
310.0,4/25/2018 10:15:00 PM,Briggs & Stratton Declares Dividend And Approves $50 Million Share Repurchase Authorization,PR Newswire,/news/stocks/briggs-stratton-declares-dividend-and-approves-50-million-share-repurchase-authorization-1002295564
311.0,4/27/2018 9:20:00 AM,Asarina Pharma: First Patients Begin Phase IIB Trials of World's First-ever Therapy Developed Specifically to Treat PMDD,PR Newswire,/news/stocks/asarina-pharma-first-patients-begin-phase-iib-trials-of-worlds-first-ever-therapy-developed-specifically-to-treat-pmdd-629671
312.0,4/30/2018 11:35:00 PM,BRIEF-Abbott Laboratories Says Shareholders Rejected Proposal Requesting Board Of Directors Adopt Policy That Board Chairman Be Independent Director,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/AG3gcXKD7e8/brief-abbott-laboratories-says-shareholders-rejected-proposal-requesting-board-of-directors-adopt-policy-that-board-chairman-be-independent-director-idUSFWN1S71D6
313.0,5/2/2018 3:00:00 PM,Abbott's XIENCE Sierra™ Heart Stent Receives National Reimbursement in Japan to Treat People with Coronary Artery Disease,PR Newswire,/news/stocks/abbott-s-xience-sierra-heart-stent-receives-national-reimbursement-in-japan-to-treat-people-with-coronary-artery-disease-1023137871
314.0,5/3/2018 3:00:00 PM,Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter,PR Newswire,/news/stocks/abbott-expands-cardiac-arrhythmias-portfolio-with-fda-clearance-of-advanced-mapping-catheter-1023265258
315.0,5/7/2018 3:00:00 PM,University of Kansas Opens New Space to Serve Students in Leavenworth,PR Newswire,/news/stocks/university-of-kansas-opens-new-space-to-serve-students-in-leavenworth-1002365549
316.0,5/22/2018 12:01:00 PM,Argus Worldwide unit to launch global aggregator in Q3 2018,PR Newswire,/news/stocks/argus-worldwide-unit-to-launch-global-aggregator-in-q3-2018-1001717725
317.0,5/22/2018 12:20:00 PM,Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions,PR Newswire,/news/stocks/five-year-study-data-confirm-positive-outcomes-for-patients-when-abbott-diagnostic-tool-was-used-to-guide-heart-stenting-decisions-1025084050
318.0,5/22/2018 12:38:06 PM,Abbott Reports Five-year Results From FAME 2 Study - Quick Facts ,RTTNews,/news/stocks/abbott-reports-five-year-results-from-fame-2-study-quick-facts-1025084309
319.0,5/23/2018 12:00:00 PM,Abbott's Investigational Tendyne™ Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study,PR Newswire,/news/stocks/abbott-s-investigational-tendyne-device-for-mitral-valve-replacement-demonstrates-positive-outcomes-at-30-days-in-global-study-1001718575
320.0,5/23/2018 3:00:00 PM,Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease,PR Newswire,/news/stocks/newest-generation-of-leading-heart-stent-is-now-approved-in-the-u-s-for-people-with-coronary-artery-disease-1025137098
321.0,5/31/2018 2:00:00 PM,Abbott Introduces the Afinion™ 2 Analyzer Rapid Test System for Diabetes Management,PR Newswire,/news/stocks/abbott-introduces-the-afinion-2-analyzer-rapid-test-system-for-diabetes-management-1025975690
322.0,6/8/2018 4:15:00 PM,Abbott Declares 378th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-378th-consecutive-quarterly-dividend-1026809161
323.0,6/14/2018 2:22:25 PM,Allergan appoints former Abbott executive to its board,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/JEFsTLIk0-g/allergan-appoints-former-abbott-executive-to-its-board-idUSL4N1TG4LJ
324.0,6/20/2018 3:00:00 PM,Abbott Hosts Conference Call for Second-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-second-quarter-earnings-1027253924
325.0,7/12/2018 3:10:22 PM,Abbott : FDA Oks MitraClip Device To Treat People With Leaky Heart Valves ,RTTNews,/news/stocks/abbott-fda-oks-mitraclip-device-to-treat-people-with-leaky-heart-valves-1027362735
326.0,7/16/2018 3:01:24 PM,Abbott Laboratories earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-q2-quarterly-earnings-preview-1027369928
327.0,7/18/2018 1:51:42 PM,Abbott Laboratories Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q2-adjusted-earnings-beat-estimates-1027377751
328.0,7/18/2018 2:02:01 PM,Abbott Raises FY18 Earnings Outlook - Quick Facts ,RTTNews,/news/stocks/abbott-raises-fy18-earnings-outlook-quick-facts-1027377815
329.0,9/14/2018 6:24:00 PM,Abbott Ireland Financing DAC -- Moody's assigns Baa1 to Abbott Lab's proposed Euro notes offering,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-assigns-baa1-to-abbott-lab-s-proposed-euro-notes-offering-1027536592
330.0,9/18/2018 9:23:35 AM,"Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam ",RTTNews,/news/stocks/pharma-companies-avoid-3-8-bln-in-tax-per-year-says-oxfam-1027542053
331.0,9/23/2018 8:07:01 PM,Abbott Announces Positive Study Results On MitraClip Device ,RTTNews,/news/stocks/abbott-announces-positive-study-results-on-mitraclip-device-1027556777
332.0,10/15/2018 3:01:24 PM,Abbott Laboratories earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-q3-earnings-preview-1027616801
333.0,10/17/2018 1:51:39 PM,Abbott Laboratories Q3 adjusted earnings Inline With Estimates,RTTNews,/news/stocks/abbott-laboratories-q3-adjusted-earnings-inline-with-estimates-1027625064
334.0,10/17/2018 1:52:35 PM,Abbott Labs quarterly profit falls 6.6 pct on tax expense,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/YljO2ZUQy5E/abbott-labs-quarterly-profit-falls-6-6-pct-on-tax-expense-idUSL3N1WX3W1
335.0,10/17/2018 2:09:29 PM,Abbott Sees Q4 Profit In Line With View; Narrows FY18 Profit Outlook ,RTTNews,/news/stocks/abbott-sees-q4-profit-in-line-with-view-narrows-fy18-profit-outlook-1027625238
336.0,10/17/2018 2:25:46 PM,UPDATE 1-Abbott Labs quarterly profit falls on higher tax expense,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/oGwesaRaTRY/update-1-abbott-labs-quarterly-profit-falls-on-higher-tax-expense-idUSL3N1WX3WJ
337.0,10/26/2018 8:56:11 PM,"Abbott, AbbVie settle U.S. case over TriCor marketing for $25 mln",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/82Fp5LcIPz0/abbott-abbvie-settle-u-s-case-over-tricor-marketing-for-25-mln-idUSL2N1X61H0
338.0,10/26/2018 9:39:15 PM,"UPDATE 1-Abbott, AbbVie to pay $25 mln to settle TriCor marketing case",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/wZr-U3s9SiY/update-1-abbott-abbvie-to-pay-25-mln-to-settle-tricor-marketing-case-idUSL2N1X61K5
339.0,10/26/2018 11:16:01 PM,"UPDATE 2-Abbott, AbbVie settle TriCor marketing case for $25 mln",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/L0FT0bDriM0/update-2-abbott-abbvie-settle-tricor-marketing-case-for-25-mln-idUSL2N1X61K5
340.0,10/27/2018 1:54:35 AM,"Abbott, AbbVie settle TriCor marketing case for $25 million",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/LBOGWyYVxhI/abbott-abbvie-settle-tricor-marketing-case-for-25-million-idINKCN1N02XY
341.0,1/14/2019 3:15:31 PM,Abbott: FDA Approves Amplatzer Piccolo Occluder Medical Device - Quick Facts ,RTTNews,/news/stocks/abbott-fda-approves-amplatzer-piccolo-occluder-medical-device-quick-facts-1027865566
342.0,1/15/2019 7:38:34 AM,"First Device For Congenital Heart Defect, AIMT & US Shutdown, ASLN On Watch ",RTTNews,/news/stocks/first-device-for-congenital-heart-defect-aimt-us-shutdown-asln-on-watch-1027867299
343.0,1/22/2019 3:01:31 PM,Here's what Wall Street expects from Abbott Laboratories's earnings report,Markets Insider Automation,/news/stocks/abbott_laboratories-q4-earnings-preview-1027886006
344.0,1/23/2019 1:52:18 PM,Abbott Laboratories Q4 adjusted earnings Inline With Estimates,RTTNews,/news/stocks/abbott-laboratories-q4-adjusted-earnings-inline-with-estimates-1027889262
345.0,1/23/2019 1:53:13 PM,Abbott Lab's fourth-quarter revenue rises 2.3 pct,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/3k1xkSrp8-s/abbott-labs-fourth-quarter-revenue-rises-2-3-pct-idUSL3N1ZN44H
346.0,1/23/2019 1:58:20 PM,Abbott Sees Q1 Profit Below View ,RTTNews,/news/stocks/abbott-sees-q1-profit-below-view-1027889275
347.0,1/23/2019 2:38:08 PM,"UPDATE 1-Abbott Lab's revenue misses estimate, forecasts lackluster first-qtr profit",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/izfR6ggE7as/update-1-abbott-labs-revenue-misses-estimate-forecasts-lackluster-first-qtr-profit-idUSL3N1ZN44X
348.0,1/23/2019 4:09:11 PM,Abbott Labs says M&A not a high priority now,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/yfsf50TwYSA/abbott-labs-says-ma-not-a-high-priority-now-idUSL3N1ZN4KU
349.0,1/23/2019 5:12:47 PM,"UPDATE 2-Abbott Lab's revenue misses estimate, forecasts lackluster first-qtr profit",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Nkd799eGFNc/update-2-abbott-labs-revenue-misses-estimate-forecasts-lackluster-first-qtr-profit-idUSL3N1ZN44X
350.0,1/23/2019 8:36:12 PM,"UPDATE 3-Abbott misses revenue estimates, sees lackluster first-qtr profit",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/UIJMgV5kwYo/update-3-abbott-misses-revenue-estimates-sees-lackluster-first-qtr-profit-idUSL3N1ZN44X
351.0,2/20/2019 3:10:54 PM,"Abbott, Novo Provide Digital Solution To People With Diabetes Using Insulin ",RTTNews,/news/stocks/abbott-novo-provide-digital-solution-to-people-with-diabetes-using-insulin-1027968392
352.0,4/15/2019 3:01:27 PM,Abbott Laboratories is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/abbott_laboratories-q1-earnings-preview-stock-1028110936
353.0,4/17/2019 1:50:58 PM,Abbott Lab's first-quarter sales beat expectations,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/j5PUtwdGjFk/abbott-labs-first-quarter-sales-beat-expectations-idUSL3N21Z31Q
354.0,4/17/2019 1:51:17 PM,Abbott Laboratories Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q1-adjusted-earnings-beat-estimates-1028118122
355.0,4/17/2019 2:22:57 PM,UPDATE 1-Abbott Labs beats first-quarter expectations on higher diabetes devices sales,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/DtDG_ORW9bc/update-1-abbott-labs-beats-first-quarter-expectations-on-higher-diabetes-devices-sales-idUSL3N21Z32E
356.0,4/17/2019 4:36:45 PM,Abbott Labs beats first-quarter expectations on higher diabetes devices sales,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Szn4Dlx1mFM/abbott-labs-beats-first-quarter-expectations-on-higher-diabetes-devices-sales-idINKCN1RT1QG
357.0,4/17/2019 6:21:02 PM,UPDATE 2-Abbott Labs quarterly beat overshadowed by unchanged forecast,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/P0-negm31FE/update-2-abbott-labs-quarterly-beat-overshadowed-by-unchanged-forecast-idUSL3N21Z32E
358.0,5/2/2019 2:32:07 PM,Abbott Gets WHO Prequalification Approval For HIV Point-of-Care Test ,RTTNews,/news/stocks/abbott-gets-who-prequalification-approval-for-hiv-point-of-care-test-1028161785
359.0,5/3/2019 7:09:00 PM,"Abbott Ireland Financing DAC -- Moody's upgrades Abbott Laboratories' senior unsecured rating to A3, stable outlook",Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-upgrades-abbott-laboratories-senior-unsecured-rating-to-a3-stable-outlook-1028166304
360.0,6/25/2019 7:51:21 PM,3 Biopharma Stocks to Buy for Income,InvestorPlace,/news/stocks/3-biopharma-stocks-to-buy-for-income-1028307925
361.0,6/26/2019 11:42:00 PM,Abbott Ireland Financing DAC -- Moody's announces completion of a periodic review of ratings of Abbott Laboratories,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-abbott-laboratories-1028311633
362.0,7/12/2019 3:00:28 PM,Notable Earnings Next Week ,RTTNews,/news/stocks/notable-earnings-next-week-1028349139
363.0,7/12/2019 7:46:29 PM,4 Healthcare Stocks That Are Feeling Sick  ,InvestorPlace,/news/stocks/4-healthcare-stocks-that-are-feeling-sick-1028350342
364.0,7/15/2019 12:10:13 PM,4 Best Marijuana ETFs for Conservative Portfolios,InvestorPlace,/news/stocks/4-best-marijuana-etfs-for-conservative-portfolios-1028246284
365.0,7/15/2019 3:01:21 PM,Abbott Laboratories earnings preview: what to expect,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-q2-earnings-preview-1028352623
366.0,7/16/2019 12:00:00 PM,FOCUS- Abbott to hike production of lower-cost glucose monitors as diabetes soars,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/7kzw9VMUIJE/focus-abbott-to-hike-production-of-lower-cost-glucose-monitors-as-diabetes-soars-idUSL2N24E003
367.0,7/16/2019 12:34:09 PM,Abbott to hike production of lower-cost glucose monitors as diabetes soars,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Wos3UYGEQkU/abbott-to-hike-production-of-lower-cost-glucose-monitors-as-diabetes-soars-idINKCN1UB102
368.0,7/17/2019 1:38:38 PM,Abbott Laboratories Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q2-adjusted-earnings-beat-estimates-1028360121
369.0,7/17/2019 1:40:40 PM,Abbott Labs quarterly profit jumps 37%,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/hL_CRX_sieM/abbott-labs-quarterly-profit-jumps-37-idUSL4N24I2K5
370.0,7/17/2019 1:57:51 PM,Abbott Labs Raises 2019 Outlook ,RTTNews,/news/stocks/abbott-labs-raises-2019-outlook-1028360179
371.0,7/17/2019 2:03:06 PM,"UPDATE 1-Abbott beats profit estimates, raises FY forecast on diabetes device strength",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/t6fsD3v0594/update-1-abbott-beats-profit-estimates-raises-fy-forecast-on-diabetes-device-strength-idUSL4N24I2MU
372.0,7/17/2019 5:13:52 PM,"Abbott Laboratories Earnings: ABT Stock Surges on Guidance, Q2 Beat",InvestorPlace,/news/stocks/abbott-laboratories-earnings-have-abt-stock-up-1028363016
373.0,7/17/2019 5:53:48 PM,UPDATE 3-Abbott hits record high as diabetes device fuels profit beat,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/ldfag7-9Ewo/update-3-abbott-hits-record-high-as-diabetes-device-fuels-profit-beat-idUSL4N24I2MU
374.0,7/17/2019 6:07:40 PM,Abbott hits record high as diabetes device fuels profit beat,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/CFHZiT1PIvg/abbott-hits-record-high-as-diabetes-device-fuels-profit-beat-idINKCN1UC1NL
375.0,7/17/2019 6:19:54 PM,Abbott hits record high as diabetes device fuels profit beat,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/MzkXsooQR94/abbott-hits-record-high-as-diabetes-device-fuels-profit-beat-idUSKCN1UC1D7
376.0,7/17/2019 7:41:03 PM,"5 Top Stock Trades for Thursday: TSLA, GLD, ABT",InvestorPlace,/news/stocks/5-top-stock-trades-for-thursday-tsla-gld-abt-1028363004
377.0,9/5/2019 3:10:29 PM,Abbott Begins Trial To Evaluate Transcatheter Tricuspid Valve Repair ,RTTNews,/news/stocks/abbott-begins-trial-to-evaluate-transcatheter-tricuspid-valve-repair-1028502041
378.0,9/10/2019 3:20:05 PM,Abbott Develops Algorithm For Diagnosing Heart Attacks - Quick Facts ,RTTNews,/news/stocks/abbott-develops-algorithm-for-diagnosing-heart-attacks-quick-facts-1028513039
379.0,9/16/2019 7:16:06 AM,"Sanofi, Abbott To Integrate Glucose Sensing And Insulin Delivery Technologies ",RTTNews,/news/stocks/sanofi-abbott-to-integrate-glucose-sensing-and-insulin-delivery-technologies-1028525254
380.0,9/23/2019 11:22:22 AM,"3 Big Stock Charts for Monday: MSCI, Macerich and Abbott Laboratories",InvestorPlace,/news/stocks/3-big-stock-charts-for-monday-msci-macerich-and-abbott-laboratories-1028546669
381.0,9/25/2019 2:56:28 PM,Abbott's Newly Approved Blood Test Could Help Identify Heart Attacks Sooner ,RTTNews,/news/stocks/abbott-s-newly-approved-blood-test-could-help-identify-heart-attacks-sooner-1028552418
382.0,9/26/2019 2:22:12 PM,FDA Approves Abbott's Spinal Cord Stimulation System For Chronic Pain ,RTTNews,/news/stocks/fda-approves-abbott-s-spinal-cord-stimulation-system-for-chronic-pain-1028555850
383.0,10/1/2019 3:08:33 PM,4 Healthcare Stocks to Buy Now,InvestorPlace,/news/stocks/4-healthcare-stocks-to-buy-now-1028569344
384.0,10/3/2019 3:56:03 PM,Are These 10 High-Yielding S&P Dividend Stocks Traps or Treasures?,InvestorPlace,/news/stocks/are-these-10-high-yielding-sp-500-stocks-traps-or-treasures-1028575945
385.0,10/14/2019 3:27:28 PM,Abbott: Omada To Provide FreeStyle Libre As Exclusive CGM - Quick Facts ,RTTNews,/news/stocks/abbott-omada-to-provide-freestyle-libre-as-exclusive-cgm-quick-facts-1028596648
386.0,10/16/2019 7:00:00 AM,Abbott Laboratories to Host Earnings Call,Accesswire,/news/stocks/abbott-laboratories-to-host-earnings-call-1028605077
387.0,10/16/2019 1:34:18 PM,Abbott Laboratories Q3 adjusted earnings Inline With Estimates,RTTNews,/news/stocks/abbott-laboratories-q3-adjusted-earnings-inline-with-estimates-1028603184
388.0,10/16/2019 1:39:34 PM,Abbott Labs quarterly profit rises 70.5%,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/enmYfpnxbi4/abbott-labs-quarterly-profit-rises-70-5-idUSL3N2712WQ
389.0,10/16/2019 1:46:10 PM,Abbott Labs quarterly profit rises 70.5%,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/ZkoAuAExVoI/abbott-labs-quarterly-profit-rises-70-5-idUSKBN1WV1HQ
390.0,10/16/2019 1:49:57 PM,Abbott Sees Q4 Profit In Line With View; Narrows FY Profit View ,RTTNews,/news/stocks/abbott-sees-q4-profit-in-line-with-view-narrows-fy-profit-view-1028603247
391.0,10/16/2019 2:18:47 PM,"Abbott Labs misses revenue estimates, trims profit forecast",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/-KcutBbbznY/abbott-labs-misses-revenue-estimates-trims-profit-forecast-idUSKBN1WV1HQ
392.0,10/16/2019 3:36:02 PM,Abbott Labs trims profit forecast after revenue miss,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/3-DefZ5cmqQ/abbott-labs-trims-profit-forecast-after-revenue-miss-idUSKBN1WV1HQ
393.0,10/16/2019 6:18:45 PM,Abbott revenue misses as heart devices eclipse diabetes gains,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/gX5fWtwULfo/abbott-revenue-misses-as-heart-devices-eclipse-diabetes-gains-idUSKBN1WV1HQ
394.0,10/16/2019 7:49:53 PM,"5 Top Stock Trades for Thursday: ADBE, NFLX, ABT",InvestorPlace,/news/stocks/5-top-stock-trades-for-thursday-adbe-nflx-abt-1028605297
395.0,10/30/2019 5:13:03 PM,7 Buy-and-Hold Stocks to Play Investing’s Biggest Trends,InvestorPlace,/news/stocks/7-buy-and-hold-stocks-to-play-investings-biggest-trends-1028645322
396.0,11/12/2019 12:23:00 PM,Abbott Ireland Financing DAC -- Moody's assigns A3 ratings to Abbott's unsecured euro note offering,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-assigns-a3-ratings-to-abbott-s-unsecured-euro-note-offering-1028680010
397.0,11/12/2019 10:06:08 PM,Abbott Laboratories Profit Climbs In Q1,RTTNews,/news/stocks/abbott-laboratories-profit-climbs-in-q1-1028682897
398.0,11/13/2019 1:55:36 PM,Abbott CEO Miles White to step down next year,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Z-IfAkwXHN4/abbott-ceo-miles-white-to-step-down-next-year-idUSL4N27T3AE
399.0,11/13/2019 2:08:39 PM,Abbott CEO Miles White To Step Down After Two Decades ,RTTNews,/news/stocks/abbott-ceo-miles-white-to-step-down-after-two-decades-1028685182
400.0,11/13/2019 2:23:09 PM,UPDATE 1-Abbott CEO Miles White to step down next year,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/CBYJ9mSDSgU/update-1-abbott-ceo-miles-white-to-step-down-next-year-idUSL4N27T3AZ
401.0,11/13/2019 3:50:21 PM,UPDATE 2-Abbott CEO Miles White to step down next year,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/qtUz5_lIa1U/update-2-abbott-ceo-miles-white-to-step-down-next-year-idUSL4N27T3AZ
402.0,12/11/2019 7:18:55 PM,Best ETFs for 2020: The AdvisorShares Vice ETF Is a Long-Term Winner,InvestorPlace,/news/stocks/best-etfs-for-2020-the-advisorshares-vice-etf-is-a-long-term-winner-1028756681
403.0,12/20/2019 6:50:00 PM,"LifeScan Global Corporation -- Moody's revises LifeScan's outlook to negative, affirms B2 CFR",Moodys,/news/bonds/lifescan-global-corporation-moody-s-revises-lifescan-s-outlook-to-negative-affirms-b2-cfr-1028779871
404.0,12/30/2019 4:06:03 PM,7 High-Yield Dividend Stocks for Growth and Income in the 2020s,InvestorPlace,/news/stocks/7-dividend-stocks-growth-income-2020s-1028788477
405.0,1/7/2020 4:47:31 PM,Abbott : FDA Okays Less Invasive Surgical Approach To Avoid Open Heart Surgery ,RTTNews,/news/stocks/abbott-fda-okays-less-invasive-surgical-approach-to-avoid-open-heart-surgery-1028800228
406.0,1/10/2020 3:25:18 PM,7 High-Yield Dividend Stocks Set for Growth,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-growth-1028550794
407.0,1/17/2020 11:51:46 AM,"3 Big Stock Charts for Friday: IBM, Abbott Labs, and FuelCell Energy",InvestorPlace,/news/stocks/3-big-stock-charts-for-friday-ibm-abbott-labs-and-fuelcell-energy-1028826112
408.0,1/22/2020 1:36:06 PM,Abbott Laboratories Q4 adjusted earnings Inline With Estimates,RTTNews,/news/stocks/abbott-laboratories-q4-adjusted-earnings-inline-with-estimates-1028835506
409.0,1/22/2020 1:38:15 PM,Abbott quarterly profit soars 60%,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/nfACISOXtQE/abbott-quarterly-profit-soars-60-idUSL4N29R394
410.0,1/22/2020 1:55:45 PM,Abbott Laboratories Guides FY20 Adj. EPS In Line - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-guides-fy20-adj-eps-in-line-quick-facts-1028835571
411.0,1/22/2020 4:32:17 PM,Incoming Abbott CEO says not looking to do any deals,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/et7arTDzMV4/incoming-abbott-ceo-says-not-looking-to-do-any-deals-idUSL4N29R3XF
412.0,1/22/2020 5:56:09 PM,UPDATE 3-Abbott hits all-time high on quarterly revenue beat,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/4h33eivjmcg/update-3-abbott-hits-all-time-high-on-quarterly-revenue-beat-idUSL4N29R3A4
413.0,1/22/2020 6:02:34 PM,Abbott hits all-time high on quarterly revenue beat,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/NC2dvKG9-3c/abbott-hits-all-time-high-on-quarterly-revenue-beat-idUSKBN1ZL1OG
414.0,1/22/2020 6:30:29 PM,Abbott hits all-time high on quarterly revenue beat,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/t28TUa3gqZo/abbott-hits-all-time-high-on-quarterly-revenue-beat-idINKBN1ZL2IT
415.0,1/22/2020 7:58:09 PM,Abbott Labs Earnings: ABT Stock Jumps 3% on Q4 Beat,InvestorPlace,/news/stocks/abbott-labs-earnings-abt-stock-jumps-3-on-q4-beat-1028837411
416.0,1/23/2020 3:23:49 PM,Abbott Announces Positive Results In Chronic Pain Study ,RTTNews,/news/stocks/abbott-announces-positive-results-in-chronic-pain-study-1028839855
417.0,2/3/2020 3:55:51 PM,Abbott's Trial To Assess New Therapy Option For People At Risk Of Stroke ,RTTNews,/news/stocks/abbott-s-trial-to-assess-new-therapy-option-for-people-at-risk-of-stroke-1028868304
418.0,2/3/2020 10:14:28 PM,Abbott Laboratories Reports Rise In Q2 Earnings,RTTNews,/news/stocks/abbott-laboratories-reports-rise-in-q2-earnings-1028869359
419.0,2/18/2020 1:07:52 PM,New Abbott ICD and CRT-D devices CE Mark'd,Seeking Alpha,https://seekingalpha.com/news/3542646-new-abbott-icd-and-crt-d-devices-ce-markd?utm_source=markets.businessinsider.com&utm_medium=referral
420.0,2/20/2020 2:21:11 PM,"Abbott's FreeStyle Libre Shows Positive Outcomes For Type 1, Type 2 Diabetes ",RTTNews,/news/stocks/abbott-s-freestyle-libre-shows-positive-outcomes-for-type-1-type-2-diabetes-1028923585
421.0,3/3/2020 5:37:27 PM,Race in full-stride for tests to identify coronavirus illness,Seeking Alpha,https://seekingalpha.com/news/3548128-race-in-full-stride-for-tests-to-identify-coronavirus-illness?utm_source=markets.businessinsider.com&utm_medium=referral
422.0,3/3/2020 6:37:30 PM,Investor guide to coronavirus plays - diagnostic tests,Seeking Alpha,https://seekingalpha.com/news/3548182-investor-guide-to-coronavirus-plays-diagnostic-tests?utm_source=markets.businessinsider.com&utm_medium=referral
423.0,3/3/2020 8:38:58 PM,FDA cautions on SweynTooth vulnerability in certain medical devices,Seeking Alpha,https://seekingalpha.com/news/3548257-fda-cautions-on-sweyntooth-vulnerability-in-certain-medical-devices?utm_source=markets.businessinsider.com&utm_medium=referral
424.0,3/4/2020 8:29:38 PM,Outlook brightens for availability of coronavirus tests in U.S.,Seeking Alpha,https://seekingalpha.com/news/3548695-outlook-brightens-for-availability-of-coronavirus-tests-in-u-s?utm_source=markets.businessinsider.com&utm_medium=referral
425.0,3/5/2020 12:37:07 PM,New sell-side coverage - healthcare,Seeking Alpha,https://seekingalpha.com/news/3548949-new-sell-side-coverage-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral
426.0,3/5/2020 2:26:51 PM,Abbott FlaxNav system CE Mark'd,Seeking Alpha,https://seekingalpha.com/news/3549031-abbott-flaxnav-system-ce-markd?utm_source=markets.businessinsider.com&utm_medium=referral
427.0,3/5/2020 3:48:52 PM,Abbott Receives EU Approval For FlexNav Delivery System ,RTTNews,/news/stocks/abbott-receives-eu-approval-for-flexnav-delivery-system-1028968823
428.0,3/9/2020 5:52:45 PM,Coronavirus testing available in every state - CDC,Seeking Alpha,https://seekingalpha.com/news/3549837-coronavirus-testing-available-in-every-state-cdc?utm_source=markets.businessinsider.com&utm_medium=referral
429.0,3/11/2020 3:03:41 PM,Parallax Health up 13% on planned coronavirus test,Seeking Alpha,https://seekingalpha.com/news/3550582-parallax-health-up-13-on-planned-coronavirus-test?utm_source=markets.businessinsider.com&utm_medium=referral
430.0,3/17/2020 1:39:04 AM,FDA to allow states to authorize coronavirus tests,Seeking Alpha,https://seekingalpha.com/news/3552325-fda-to-allow-states-to-authorize-coronavirus-tests?utm_source=markets.businessinsider.com&utm_medium=referral
431.0,3/18/2020 11:42:04 PM,"U.S. approves Abbott coronavirus test; company set to ship 150,000",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/BLKpAogjtzI/u-s-approves-abbott-coronavirus-test-company-set-to-ship-150000-idUSL4N2BB5N0
432.0,3/19/2020 2:23:23 AM,"Abbott Labs to ship 150K coronavirus tests, ramping up for more",Seeking Alpha,https://seekingalpha.com/news/3553199-abbott-labs-to-ship-150k-coronavirus-tests-ramping-up-for?utm_source=markets.businessinsider.com&utm_medium=referral
433.0,3/19/2020 1:26:25 PM,Israel OKs use of generic Abbott drug to treat coronavirus despite patent,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/QknHict6AS8/israel-oks-use-of-generic-abbott-drug-to-treat-coronavirus-despite-patent-idUSL8N2BC5D6
434.0,3/26/2020 9:41:11 PM,Trump says G-20 nations coordinating on Covid-19: Coronavirus briefing,Seeking Alpha,https://seekingalpha.com/news/3555710-trump-says-gminus-20-nations-coordinating-on-covidminus-19-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral
435.0,3/28/2020 12:38:30 AM,Abbott launches five-minute coronavirus test,Seeking Alpha,https://seekingalpha.com/news/3556045-abbott-launches-five-minute-coronavirus-test?utm_source=markets.businessinsider.com&utm_medium=referral
436.0,3/28/2020 1:25:48 AM,Abbott wins U.S. approval for test that can detect coronavirus in minutes,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/vCNdg9Yguao/abbott-wins-u-s-approval-for-test-that-can-detect-coronavirus-in-minutes-idUSL1N2BK3C0
437.0,3/28/2020 6:19:02 PM,Abbott wins U.S. approval for test that can detect coronavirus in minutes,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/x4V71Y2u5a0/abbott-wins-u-s-approval-for-test-that-can-detect-coronavirus-in-minutes-idINKBN21F0SO
438.0,3/30/2020 2:00:28 PM,Stock Alert: Abbott Shares Up 9% In Early Trading ,RTTNews,/news/stocks/stock-alert-abbott-shares-up-9-in-early-trading-1029044191
439.0,3/30/2020 3:06:04 PM,Abbott surges 13% after FDA approval of 5-minute coronavirus test (ABT),Business Insider,https://markets.businessinsider.com/news/stocks/abbott-stock-price-spikes-fda-approval-5-minute-coronavirus-test-2020-3-1029044661
440.0,3/30/2020 6:16:03 PM,Abbott Labs News: ABT Stock Surges 7% on 5-Minute Coronavirus Test,InvestorPlace,/news/stocks/abbott-labs-news-coronavirus-test-sends-abt-stock-up-1029046278
441.0,3/30/2020 8:16:47 PM,Stock Market Today: Healthcare Stocks Leads the Way; Buy Zoom?,InvestorPlace,/news/stocks/stock-market-today-healthcare-stocks-leads-the-way-buy-zoom-1029046564
442.0,3/30/2020 8:36:04 PM,FDA Approves Abbott's 5-minute Coronavirus Test ,RTTNews,/news/stocks/fda-approves-abbott-s-5-minute-coronavirus-test-1029046047
443.0,3/30/2020 8:47:44 PM,"5 Top Stock Trades for Tuesday: ZM, WORK, TWTR, ABT, DDD",InvestorPlace,/news/stocks/5-top-stock-trades-for-tuesday-zm-work-twtr-abt-ddd-1029046562
444.0,3/30/2020 9:20:08 PM,U.S. Covid-19 testing reaches more than 1M: Coronavirus briefing,Seeking Alpha,https://seekingalpha.com/news/3556550-u-s-covidminus-19-testing-reaches-1m-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral
445.0,3/31/2020 11:32:18 AM,"3 Big Stock Charts for Tuesday: Abbott Laboratories, Johnson & Johnson, and Regeneron Pharmaceuticals",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-abbott-laboratories-johnson-johnson-and-regeneron-pharmaceuticals-1029048681
446.0,3/31/2020 6:02:00 PM,FDA OKs emergency use of 2-minute coronavirus test,Seeking Alpha,https://seekingalpha.com/news/3556928-fda-oks-emergency-use-of-2-minute-coronavirus-test?utm_source=markets.businessinsider.com&utm_medium=referral
447.0,3/31/2020 9:39:47 PM,"White House crisis update: Ventilator figures, bracing for casualties",Seeking Alpha,https://seekingalpha.com/news/3557035-white-house-crisis-update-ventilator-figures-bracing-for-casualties?utm_source=markets.businessinsider.com&utm_medium=referral
448.0,4/1/2020 3:03:22 PM,Danaher Stock Still Offers Investors the Best of Both Worlds,InvestorPlace,/news/stocks/short-term-catalysts-danaher-stock-buy-1029055589
449.0,4/4/2020 12:37:09 PM,Amazon advances pandemic response,Seeking Alpha,https://seekingalpha.com/news/3558428-amazon-advances-pandemic-response?utm_source=markets.businessinsider.com&utm_medium=referral
450.0,4/5/2020 11:10:41 PM,"FEMA sending 1,700 ventilators to hot spots: coronavirus briefing",Seeking Alpha,https://seekingalpha.com/news/3558463-fema-sending-1700-ventilators-to-hot-spots-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral
451.0,4/8/2020 4:59:07 PM,Abbott's CGM Available For Hospitalized Patients With Diabetes During COVID-19 ,RTTNews,/news/stocks/abbott-s-cgm-available-for-hospitalized-patients-with-diabetes-during-covid-19-1029076628
452.0,4/8/2020 6:57:57 PM,Walgreens Coronavirus Testing Sites to Open in 7 States,InvestorPlace,/news/stocks/walgreens-coronavirus-testing-sites-to-open-in-7-states-1029077617
453.0,4/9/2020 1:24:42 PM,Abbott's TriClip device CE Mark'd for tricuspid valve repair,Seeking Alpha,https://seekingalpha.com/news/3559680-abbotts-triclip-device-ce-markd-for-tricuspid-valve-repair?utm_source=markets.businessinsider.com&utm_medium=referral
454.0,4/9/2020 3:45:38 PM,Abbott's TriClip Transcatheter Tricuspid Valve Repair System Gets CE Mark ,RTTNews,/news/stocks/abbott-s-triclip-transcatheter-tricuspid-valve-repair-system-gets-ce-mark-1029080265
455.0,4/13/2020 4:58:21 PM,Study shows viability of saliva testing for COVID-19,Seeking Alpha,https://seekingalpha.com/news/3560222-study-shows-viability-of-saliva-testing-for-covidminus-19?utm_source=markets.businessinsider.com&utm_medium=referral
456.0,4/13/2020 10:02:58 PM,Trump agreed to mitigation efforts at first recommendation: Coronavirus briefing,Seeking Alpha,https://seekingalpha.com/news/3560344-trump-agreed-to-mitigation-efforts-first-recommendation-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral
457.0,4/15/2020 1:19:33 PM,Abbott launches third COVID-19 test,Seeking Alpha,https://seekingalpha.com/news/3560863-abbott-launches-third-covidminus-19-test?utm_source=markets.businessinsider.com&utm_medium=referral
458.0,4/15/2020 3:01:19 PM,Abbott Laboratories earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-quarter-earnings-preview-q1-1029094181
459.0,4/15/2020 3:24:31 PM,"Abbott launches antibody test for coronavirus, plans to deliver 20 mln tests by June",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/0u7G4DLrzkE/abbott-launches-antibody-test-for-coronavirus-plans-to-deliver-20-mln-tests-by-june-idUSL3N2C33BC
460.0,4/15/2020 3:25:41 PM,Abbott Launches Antibody Blood Test For COVID-19 - Quick Facts ,RTTNews,/news/stocks/abbott-launches-antibody-blood-test-for-covid-19-quick-facts-1029094443
461.0,4/15/2020 4:06:12 PM,What looming recession? Abbott at pre-selloff levels,Seeking Alpha,https://seekingalpha.com/news/3560951-what-looming-recession-abbott-pre-selloff-levels?utm_source=markets.businessinsider.com&utm_medium=referral
462.0,4/15/2020 4:08:02 PM,"UPDATE 1-Abbott launches COVID-19 antibody test, plans 20 mln tests per month by June",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/O7cNaqqfFDM/update-1-abbott-launches-covid-19-antibody-test-plans-20-mln-tests-per-month-by-june-idUSL3N2C33E9
463.0,4/15/2020 4:14:40 PM,"Abbott launches COVID-19 antibody test, plans 20 million tests per month by June",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Ze6PNTtKo1g/abbott-launches-covid-19-antibody-test-plans-20-million-tests-per-month-by-june-idINKCN21X23N
464.0,4/15/2020 5:50:34 PM,"UPDATE 2-Abbott launches COVID-19 antibody test, plans 20 mln tests per month by June",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/I7UKtzo9v2A/update-2-abbott-launches-covid-19-antibody-test-plans-20-mln-tests-per-month-by-june-idUSL3N2C33E9
465.0,4/15/2020 8:18:25 PM,Stock Market Today: Apple’s New iPhone; Abbott’s New Coronavirus Test,InvestorPlace,/news/stocks/stock-market-today-apples-new-iphone-abbotts-new-coronavirus-test-1029096340
466.0,4/15/2020 9:30:13 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3560977-notable-earnings-thursdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
467.0,4/15/2020 9:30:22 PM,Abbott Laboratories Q1 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3560986-abbott-laboratories-q1-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
468.0,4/16/2020 11:31:49 AM,"Abbott Laboratories EPS beats by $0.04, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3561213-abbott-laboratories-eps-beats-0_04-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral
469.0,4/16/2020 11:49:14 AM,Abbott reports strong Q1 but pulls guidance,Seeking Alpha,https://seekingalpha.com/news/3561223-abbott-reports-strong-q1-pulls-guidance?utm_source=markets.businessinsider.com&utm_medium=referral
470.0,4/16/2020 1:34:23 PM,Abbott Laboratories Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q1-adjusted-earnings-beat-estimates-1029097900
471.0,4/16/2020 1:42:35 PM,"Abbott posts 16% fall in profit, suspends 2020 forecast on coronavirus concerns",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/xJQL4XW0fUA/abbott-posts-16-fall-in-profit-suspends-2020-forecast-on-coronavirus-concerns-idUSL3N2C431S
472.0,4/16/2020 2:12:06 PM,Abbott Laboratories Q1 Adj. Earnings Beat View; Suspends FY20 Outlook ,RTTNews,/news/stocks/abbott-laboratories-q1-adj-earnings-beat-view-suspends-fy20-outlook-1029098192
473.0,4/16/2020 2:14:33 PM,"Abbott beats quarterly profit, but pulls forecast on coronavirus concerns",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/itHrJQhk93Q/abbott-beats-quarterly-profit-but-pulls-forecast-on-coronavirus-concerns-idUSKCN21Y1MP
474.0,4/16/2020 2:20:58 PM,"Abbott beats quarterly profit, but pulls forecast on coronavirus concerns",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/LFOrt-cK9ug/abbott-beats-quarterly-profit-but-pulls-forecast-on-coronavirus-concerns-idINKCN21Y1RQ
475.0,4/16/2020 3:20:44 PM,Triage Your Portfolio With Abbott Laboratories,InvestorPlace,/news/stocks/triage-portfolio-abbott-abt-stock-coronavirus-1029099447
476.0,4/16/2020 3:27:08 PM,Abbott beats profit estimates but suspends forecast on coronavirus concerns,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/L7HyDG87o_c/abbott-beats-profit-estimates-but-suspends-forecast-on-coronavirus-concerns-idUSKCN21Y1MP
477.0,4/16/2020 3:56:48 PM,Abbott beats profit estimates but suspends forecast on coronavirus concerns,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/eIrKPYOECQo/abbott-beats-profit-estimates-but-suspends-forecast-on-coronavirus-concerns-idINKCN21Y1RQ
478.0,4/16/2020 5:39:18 PM,Abbott Labs Earnings: ABT Stock Jumps on Q1 Beats,InvestorPlace,/news/stocks/abbott-labs-earnings-abt-stock-jumps-on-q1-beats-1029099911
479.0,4/16/2020 5:49:15 PM,Coronavirus test ramp-up to help Abbott weather 'toughest quarter',Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/3KmQLi2gvYY/coronavirus-test-ramp-up-to-help-abbott-weather-toughest-quarter-idUSKCN21Y1MP
480.0,4/17/2020 8:43:32 AM,Roche To Launch New Serology Test To Detect COVID-19 Antibodies ,RTTNews,/news/stocks/roche-to-launch-new-serology-test-to-detect-covid-19-antibodies-1029101168
481.0,4/17/2020 3:03:57 PM,Steer Clear of Co-Diagnostics Stock and Its Multitude of Red Flags,InvestorPlace,/news/stocks/steer-clear-of-codx-stock-red-flags-1029103013
482.0,4/17/2020 6:54:35 PM,U.S. COVID-19 testing capacity still constrained - AACC,Seeking Alpha,https://seekingalpha.com/news/3561778-u-s-covidminus-19-testing-capacity-still-constrained-aacc?utm_source=markets.businessinsider.com&utm_medium=referral
483.0,4/26/2020 5:45:13 PM,Italy picks U.S. firm Abbott Laboratories to supply coronavirus blood tests,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/RCgb9OlFawo/italy-picks-u-s-firm-abbott-laboratories-to-supply-coronavirus-blood-tests-idUSL5N2CE0F6
484.0,5/1/2020 7:41:50 PM,Fluidigm up 54% on potential early blood test for coronavirus,Seeking Alpha,https://seekingalpha.com/news/3567791-fluidigm-up-54-on-potential-early-blood-test-for-coronavirus?utm_source=markets.businessinsider.com&utm_medium=referral
485.0,5/5/2020 6:18:48 PM,3 Healthcare Stocks Popping Off Support,InvestorPlace,/news/stocks/3-healthcare-stocks-popping-off-support-1029167820
486.0,5/5/2020 8:35:00 PM,"LifeScan Global Corporation -- Moody's downgrades LifeScan's CFR to B3, stable outlook",Moodys,/news/bonds/lifescan-global-corporation-moody-s-downgrades-lifescan-s-cfr-to-b3-stable-outlook-1029167567
487.0,5/5/2020 9:50:25 PM,"5 Top Stock Trades for Wednesday: ATVI, SHOP, CHGG, ABT, ABBV",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-atvi-shop-chgg-abt-abbv-1029168272
488.0,5/8/2020 4:33:14 PM,FDA OKs emergency use of COVID-19 test with saliva specimens,Seeking Alpha,https://seekingalpha.com/news/3572277-fda-oks-emergency-use-of-covidminus-19-test-saliva-specimens?utm_source=markets.businessinsider.com&utm_medium=referral
489.0,5/8/2020 5:05:45 PM,Study suggests Abbott COVID-19 antibody test highly likely to give correct results,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/4MGSoIQQE_M/study-suggests-abbott-covid-19-antibody-test-highly-likely-to-give-correct-results-idUSL4N2CQ3A1
490.0,5/8/2020 6:00:48 PM,Study suggests Abbott COVID-19 antibody test highly likely to give correct results,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Wshf3tm5Q3Y/study-suggests-abbott-covid-19-antibody-test-highly-likely-to-give-correct-results-idINKBN22K27B
491.0,5/11/2020 1:41:20 PM,FDA OKs emergency use of Abbott blood test on automated analyzer,Seeking Alpha,https://seekingalpha.com/news/3572723-fda-oks-emergency-use-of-abbott-blood-test-on-automated-analyzer?utm_source=markets.businessinsider.com&utm_medium=referral
492.0,5/11/2020 3:47:17 PM,FDA Approves Abbott's Covid-19 Antibody Blood Test On Alinity I System ,RTTNews,/news/stocks/fda-approves-abbott-s-covid-19-antibody-blood-test-on-alinity-i-system-1029187807
493.0,5/11/2020 3:49:31 PM,Don’t Buy Into the Bitcoin Halvening Hype,InvestorPlace,/news/stocks/dont-buy-into-the-bitcoin-halvening-hype-1029188397
494.0,5/12/2020 1:25:30 PM,Abbott nabs another emergency use nod for COVID-19 test,Seeking Alpha,https://seekingalpha.com/news/3573389-abbott-nabs-another-emergency-use-nod-for-covidminus-19-test?utm_source=markets.businessinsider.com&utm_medium=referral
495.0,5/12/2020 3:16:12 PM,Abbott: FDA Issues Emergency Use Authorization For Its Fifth COVID-19 Test ,RTTNews,/news/stocks/abbott-fda-issues-emergency-use-authorization-for-its-fifth-covid-19-test-1029192471
496.0,5/13/2020 4:46:17 PM,Abbott defends COVID-19 test after reports of false negatives in study,Seeking Alpha,https://seekingalpha.com/news/3574022-abbott-defends-covidminus-19-test-after-reports-of-false-negatives-in-study?utm_source=markets.businessinsider.com&utm_medium=referral
497.0,5/15/2020 1:54:57 AM,FDA alerts on potential false negative results on Abbott ID Now system,Seeking Alpha,https://seekingalpha.com/news/3574860-fda-alerts-on-potential-false-negative-results-on-abbott-id-now-system?utm_source=markets.businessinsider.com&utm_medium=referral
498.0,5/15/2020 8:29:05 AM,"Britain approves Abbott, Roche antibody test",Seeking Alpha,https://seekingalpha.com/news/3574894-britain-approves-abbott-roche-antibody-test?utm_source=markets.businessinsider.com&utm_medium=referral
499.0,5/15/2020 9:01:46 AM,FDA : Abbott's Rapid Coronavirus Test May Deliver Inaccurate Results ,RTTNews,/news/stocks/fda-abbott-s-rapid-coronavirus-test-may-deliver-inaccurate-results-1029205188
500.0,5/19/2020 10:10:54 AM,Stop the Insanity with Co-Diagnostics Stock Already,InvestorPlace,/news/stocks/codx-stock-1029214738
501.0,5/19/2020 5:51:31 PM,Co-Diagnostics Stock Positioned for Continued Growth in 2020,InvestorPlace,/news/stocks/codx-stock-positioned-for-continued-growth-in-2020-1029216835
502.0,5/19/2020 10:04:00 PM,Abbott Ireland Financing DAC -- Moody's announces completion of a periodic review of ratings of Abbott Laboratories,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-abbott-laboratories-1029217111
503.0,5/20/2020 4:50:49 PM,Glaxo teams up with early-stage gene editing firm to develop coronavirus test,Seeking Alpha,https://seekingalpha.com/news/3576432-glaxo-teams-up-early-stage-gene-editing-firm-to-develop-coronavirus-test?utm_source=markets.businessinsider.com&utm_medium=referral
504.0,5/21/2020 11:29:19 AM,Abbott COVID-19 blood test OK'd in Canada,Seeking Alpha,https://seekingalpha.com/news/3576706-abbott-covidminus-19-blood-test-okd-in-canada?utm_source=markets.businessinsider.com&utm_medium=referral
505.0,5/21/2020 1:36:28 PM,Abbott: Health Canada Approves New COVID-19 Antibody Test - Quick Facts ,RTTNews,/news/stocks/abbott-health-canada-approves-new-covid-19-antibody-test-quick-facts-1029223041
506.0,5/21/2020 4:51:43 PM,Roche and Abbott land COVID-19 test deal in Britain,Seeking Alpha,https://seekingalpha.com/news/3576871-roche-and-abbott-land-covidminus-19-test-deal-in-britain?utm_source=markets.businessinsider.com&utm_medium=referral
507.0,5/21/2020 6:29:07 PM,Britain signs deals for 10 million antibody tests from Roche and Abbott,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Xr7ANHgY-UI/britain-signs-deals-for-10-million-antibody-tests-from-roche-and-abbott-idUSL9N2AV00Q
508.0,5/21/2020 6:49:47 PM,Britain signs deals for 10 million antibody tests from Roche and Abbott,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/gq9TcUb-dLQ/britain-signs-deals-for-10-million-antibody-tests-from-roche-and-abbott-idINKBN22X27T
509.0,5/21/2020 7:16:04 PM,UPDATE 2-Britain to buy 10 million antibody tests from Roche and Abbott,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/bJw8a0u-7C8/update-2-britain-to-buy-10-million-antibody-tests-from-roche-and-abbott-idUSL8N2D33ZE
510.0,5/21/2020 7:18:20 PM,Britain to buy 10 million antibody tests from Roche and Abbott,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/ZYNomcO5frQ/britain-to-buy-10-million-antibody-tests-from-roche-and-abbott-idINKBN22X27T
511.0,5/21/2020 11:44:50 PM,Abbott says new data on rapid coronavirus test used in White House shows high accuracy,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/JALjcIwQx9M/abbott-says-new-data-on-rapid-coronavirus-test-used-in-white-house-shows-high-accuracy-idUSL1N2D32F0
512.0,6/2/2020 6:43:52 PM,AbbVie Will Be in Big Trouble When Its Patent Cliff Arrives,InvestorPlace,/news/stocks/abbvie-will-be-in-big-trouble-when-its-patent-cliff-arrives-1029274239
513.0,6/3/2020 5:35:17 PM,Make This Biotech Play if You Like Co-Diagnostics’ Chances,InvestorPlace,/news/stocks/make-this-biotech-play-if-you-like-co-diagnostics-codx-stock-chances-1029278063
514.0,6/12/2020 2:30:32 PM,Abbott Laboratories declares $0.36 dividend,Seeking Alpha,https://seekingalpha.com/news/3582659-abbott-laboratories-declares-0_36-dividend?utm_source=markets.businessinsider.com&utm_medium=referral
515.0,6/13/2020 2:58:41 PM,Medtronic next-gen closed-loop insulin system successful in U.S. trial,Seeking Alpha,https://seekingalpha.com/news/3582830-medtronic-next-gen-closed-loop-insulin-system-successful-in-u-s-trial?utm_source=markets.businessinsider.com&utm_medium=referral
516.0,6/14/2020 2:37:04 AM,Abbott : Data Shows FreeStyle Libre System Reduces HbA1C Levels In Type 2 Diabetes People ,RTTNews,/news/stocks/abbott-data-shows-freestyle-libre-system-reduces-hba1c-levels-in-type-2-diabetes-people-1029305937
517.0,6/16/2020 3:15:54 PM,Abbott's FreeStyle Libre System Reduces Diabetic Ketoacidosis-Related Hospitalization Rates ,RTTNews,/news/stocks/abbott-s-freestyle-libre-system-reduces-diabetic-ketoacidosis-related-hospitalization-rates-1029313250
518.0,6/22/2020 3:14:00 PM,Abbott Laboratories -- Moody's assigns A3 rating to Abbott Laboratories' note offering,Moodys,/news/bonds/abbott-laboratories-moody-s-assigns-a3-rating-to-abbott-laboratories-note-offering-1029329698
519.0,6/29/2020 2:30:11 PM,Getting Into the Testing Business May Spell Disaster for XpresSpa Stock,InvestorPlace,/news/stocks/testing-business-disaster-xspa-stock-1029351022
520.0,6/29/2020 3:15:54 PM,"Abbott, Tandem Diabetes Care Partner To Develop Integrated Diabetes Solutions ",RTTNews,/news/stocks/abbott-tandem-diabetes-care-partner-to-develop-integrated-diabetes-solutions-1029350327
521.0,7/1/2020 3:09:05 PM,Best ETFs for 2020: The AdvisorShares Vice ETF Bets Big on Booze,InvestorPlace,/news/stocks/best-etfs-for-2020-the-advisorshares-vice-etf-bets-big-on-booze-1029360049
522.0,7/6/2020 1:39:21 PM,"FDA Approves Abbott's NexGen Gallant ICD, CRT-D Devices - Quick Facts ",RTTNews,/news/stocks/fda-approves-abbott-s-nexgen-gallant-icd-crt-d-devices-quick-facts-1029368539
523.0,7/6/2020 5:56:43 PM,7 Healthcare ETFs Which Should Continue Growing Into 2021,InvestorPlace,/news/stocks/7-healthcare-etfs-growing-into-2021-1029369965
524.0,7/15/2020 3:01:26 PM,Here's what Wall Street expects from Abbott Laboratories's earnings report,Markets Insider Automation,/news/stocks/abbott_laboratories-q2-quarterly-earnings-preview-stock-1029397201
525.0,7/16/2020 1:34:33 PM,Abbott Laboratories Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q2-adjusted-earnings-beat-estimates-1029401049
526.0,7/16/2020 1:47:17 PM,Abbott Laboratories Sees FY20 Adj. Earnings Above Estimates - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-sees-fy20-adj-earnings-above-estimates-quick-facts-1029401092
527.0,8/4/2020 9:16:14 AM,3 Key Questions to Answer Before Buying Sorrento Therapeutics Stock,InvestorPlace,/news/stocks/srne-stock-3-things-to-consider-before-buying-sorrento-therapeutics-1029465725
528.0,8/4/2020 3:20:01 PM,Abbott Begins Study To Evaluate New Device To Treat Recurrent Atrial Fibrillation ,RTTNews,/news/stocks/abbott-begins-study-to-evaluate-new-device-to-treat-recurrent-atrial-fibrillation-1029467338
529.0,8/7/2020 10:16:18 AM,The Next Bull Run Will Be Harder For Sorrento Therapeutics,InvestorPlace,/news/stocks/srne-stock-sorrento-therapeutics-bull-run-1029481915
530.0,8/18/2020 4:46:58 PM,Abbott Laboratories Is a Surefire Covid-19 Diagnostics Investment,InvestorPlace,/news/stocks/abt-stock-is-a-surefire-covid-19-diagnostics-investment-1029514265
531.0,8/20/2020 5:48:21 PM,Let High Flyer Fulgent Genetics Take a Breather Before Dipping In,InvestorPlace,/news/stocks/let-high-flyer-fulgent-genetics-stock-take-a-breather-before-dipping-in-1029522068
532.0,8/20/2020 6:46:35 PM,Only Testing Can Save JetBlue Airways,InvestorPlace,/news/stocks/only-testing-can-save-jblu-stock-1029522315
533.0,8/24/2020 6:47:14 PM,The 4 Best Dividend Aristocrats to Buy Now,InvestorPlace,/news/stocks/4-best-dividend-aristocrats-to-buy-now-abt-rost-pep-vfc-1029529077
534.0,8/27/2020 6:04:47 AM,FDA Approves Abbott's $5 COVID-19 Antigen Portable Rapid Test ,RTTNews,/news/stocks/fda-approves-abbott-s-5-covid-19-antigen-portable-rapid-test-1029538141
535.0,8/27/2020 12:24:06 PM,"Pre-market Movers In Healthcare Sector: EYPT, CLVS, ABT, VBIV, LPCN... ",RTTNews,/news/stocks/pre-market-movers-in-healthcare-sector-eypt-clvs-abt-vbiv-lpcn-1029539208
536.0,8/27/2020 3:56:15 PM,Stock Alert: Abbott Shares Hit All-Time High ,RTTNews,/news/stocks/stock-alert-abbott-shares-hit-all-time-high-1029540544
537.0,8/27/2020 4:27:01 PM,Abbott soars 10% after its 15-minute COVID-19 test wins FDA approval,Business Insider,https://www.businessinsider.com/abbott-stock-price-minute-covid19-test-wins-fda-approval-coronavirus-2020-8
538.0,8/27/2020 9:07:26 PM,"4 Top Stock Trades for Friday: WMT, ULTA, ABT, QDEL",InvestorPlace,/news/stocks/4-top-stock-trades-for-friday-wmt-ulta-abt-qdel-1029542121
539.0,8/28/2020 9:16:04 AM,XpresSpa Group’s Stock Drop Ignores the Potential of Pivot to Virus Testing,InvestorPlace,/news/stocks/xpresspa-groups-stock-falls-20-time-to-buy-xspa-stock-1029543408
540.0,8/28/2020 1:37:59 PM,7 Top Stocks Under $5,InvestorPlace,/news/stocks/7-top-stocks-to-buy-under-5-1029544433
541.0,8/31/2020 12:10:58 PM,"Sorrento’s Covid-19 Test, Acquisitions Should Help SRNE Stock Surge",InvestorPlace,/news/stocks/sorrentos-covid-19-test-acquisitions-should-help-srne-stock-surge-1029547892
542.0,9/1/2020 9:16:45 AM,Carnival Stock Could Rebound Significantly Once a Vaccine Arrives,InvestorPlace,/news/stocks/ccl-stock-could-rebound-from-here-as-a-covid-19-vaccine-nears-1029551126
543.0,9/1/2020 3:30:29 PM,Abbott Announces Availability Of FreeStyle Libre 2 ICGM System For Medicare Patients ,RTTNews,/news/stocks/abbott-announces-availability-of-freestyle-libre-2-icgm-system-for-medicare-patients-1029552515
544.0,9/2/2020 2:21:45 PM,4 Pharmaceutical Stocks With Deep Pipelines,InvestorPlace,/news/stocks/4-pharmaceutical-stocks-deep-pipelines-coronavirus-1029557234
545.0,9/9/2020 2:07:00 PM,Moody's – US healthcare risk heat map - Overall outlook improves as patients return and COVID testing accelerates,Moodys,/news/bonds/moody-s-us-healthcare-risk-heat-map-overall-outlook-improves-as-patients-return-and-covid-testing-accelerates-1029573470
546.0,9/14/2020 6:44:44 PM,Thermo Fisher Is a Buy Despite Recent Setbacks,InvestorPlace,/news/stocks/despite-recent-setbacks-tmo-stock-is-a-buy-1029587798
547.0,9/15/2020 5:24:53 PM,The Key Question Surrounding XpresSpa Group Right Now,InvestorPlace,/news/stocks/key-question-surrounding-xspa-stock-right-now-1029591780
548.0,9/16/2020 1:22:00 PM,"Moody's – Outlook for the US medical products and devices industry revised to positive on higher earnings, increased demand",Moodys,/news/bonds/moody-s-outlook-for-the-us-medical-products-and-devices-industry-revised-to-positive-on-higher-earnings-increased-demand-1029593947
549.0,9/18/2020 9:31:13 AM,20/20 GeneSystems Stock: Leveraging AI for More Accurate Cancer Screening,InvestorPlace,/news/stocks/20-20-genesystems-stock-leveraging-ai-for-more-accurate-cancer-screening-1029601945
550.0,9/18/2020 1:26:13 PM,Is Sorrento Stock Really Worth the Speculation?,InvestorPlace,/news/stocks/sorrento-srne-stock-worth-speculation-1029602943
551.0,9/24/2020 11:44:26 AM,7 High-Potential Undervalued Stocks to Buy,InvestorPlace,/news/stocks/7-high-potential-undervalued-stocks-to-buy-1029619857
552.0,9/25/2020 6:19:26 PM,7 Sin Stocks To Buy That Will Outperform the S&P 500,InvestorPlace,/news/stocks/7-sin-stocks-to-buy-that-will-outperform-the-sp-500-1029624209
553.0,9/30/2020 10:54:07 AM,Abbott Labs Stock is Not Cheap But Should Do Well as Virus Test Debuts,InvestorPlace,/news/stocks/abt-stock-should-do-well-with-its-new-covid-19-test-1029635842
554.0,9/30/2020 2:51:51 PM,Is Norwegian Cruise Stock Finally a Buy? ,InvestorPlace,/news/stocks/is-norwegian-cruise-line-stock-finally-a-buy-cseo-1029636595
555.0,10/1/2020 6:43:07 PM,Best ETFs for 2020: The AdvisorShares Vice ETF Saved by SAM and TMO,InvestorPlace,/news/stocks/best-etfs-for-2020-the-advisorshares-vice-etf-sam-1029642036
556.0,10/6/2020 5:27:20 PM,Canada to buy up to 20.5M Abbott rapid coronavirus antigen tests,Seeking Alpha,https://seekingalpha.com/news/3620219-canada-to-buy-up-to-20_5m-abbott-rapid-coronavirus-antigen-tests?utm_source=markets.businessinsider.com&utm_medium=referral
557.0,10/7/2020 2:18:57 PM,Abbott: ID NOW COVID-19 Interim Results Confirm Previous Data Submitted To FDA ,RTTNews,/news/stocks/abbott-id-now-covid-19-interim-results-confirm-previous-data-submitted-to-fda-1029656908
558.0,10/8/2020 11:55:08 AM,The Risk-to-Reward Proposition for Sorrento Has Gone Bad,InvestorPlace,/news/stocks/the-risk-to-reward-proposition-for-sorrento-therapeutics-srne-stock-has-gone-negative-1029661288
559.0,10/9/2020 6:09:50 PM,Sorrento Stock Investors Should Play Powerball Instead,InvestorPlace,/news/stocks/srne-stock-how-to-get-rich-off-shareholders-1029666739
560.0,10/11/2020 11:24:33 AM,30-second coronavirus test could help out the travel sector and more,Seeking Alpha,https://seekingalpha.com/news/3621273-30-second-coronavirus-test-help-out-travel-sector-and?utm_source=markets.businessinsider.com&utm_medium=referral
561.0,10/12/2020 1:07:34 PM,Abbott gets FDA emergency use OK for COVID antibody test,Seeking Alpha,https://seekingalpha.com/news/3621356-abbott-gets-fda-emergency-use-ok-for-covid-antibody-test?utm_source=markets.businessinsider.com&utm_medium=referral
562.0,10/12/2020 3:12:10 PM,Abbott Gets Emergency Use Authorization For COVID-19 IgM Antibody Test - Quick Facts ,RTTNews,/news/stocks/abbott-gets-emergency-use-authorization-for-covid-19-igm-antibody-test-quick-facts-1029670053
563.0,10/15/2020 12:10:15 PM,Germany ramps up capacity of rapid COVID tests,Seeking Alpha,https://seekingalpha.com/news/3622402-germany-ramps-up-capacity-of-rapid-covid-tests?utm_source=markets.businessinsider.com&utm_medium=referral
564.0,10/16/2020 9:16:53 AM,5 High-Yield Stocks for 5%-Plus Dividend Payouts,InvestorPlace,/news/stocks/5-high-yield-stocks-abbv-enb-pm-unm-ibm-for-5-plus-dividend-payouts-1029687693
565.0,10/20/2020 3:01:35 PM,Abbott Laboratories is about to announce its earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-quarter-earnings-preview-q3-1029698639
566.0,10/20/2020 4:11:53 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3623754-notable-earnings-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
567.0,10/20/2020 8:48:55 PM,"5 Top Stock Trades for Wednesday: LOGI, PM, VZ, IRBT, ABT",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-logi-pm-vz-irbt-abt-1029701059
568.0,10/20/2020 9:35:12 PM,Abbott Laboratories Q3 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3623808-abbott-laboratories-q3-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
569.0,10/21/2020 11:32:31 AM,"Abbott Laboratories EPS beats by $0.07, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3624125-abbott-laboratories-eps-beats-0_07-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral
570.0,10/21/2020 11:43:53 AM,"Abbott Q3 top line up 10%, diagnostics up 38% on COVID-19 demand",Seeking Alpha,https://seekingalpha.com/news/3624134-abbott-q3-top-line-up-10-diagnostics-up-38-on-covidminus-19-demand?utm_source=markets.businessinsider.com&utm_medium=referral
571.0,10/21/2020 1:38:48 PM,Abbott Laboratories Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q3-adjusted-earnings-beat-estimates-1029704055
572.0,10/21/2020 2:15:38 PM,ASTC Stock News: Why Astrotech Stock Is Soaring 160% Today,InvestorPlace,/news/stocks/astc-stock-news-why-astrotech-stock-is-soaring-160-today-1029706122
573.0,10/29/2020 12:33:25 PM,9 Companies to Invest In Before We Hit 2021,InvestorPlace,/news/stocks/9-companies-to-invest-in-before-2021-1029741057
574.0,11/2/2020 11:05:35 AM,3 Biotech Stocks With Eye-Catching Pipelines,InvestorPlace,/news/stocks/3-biotech-stocks-with-eye-catching-pipelines-1029752447
575.0,11/2/2020 1:18:09 PM,"With the Pandemic Peaking, Hold Off on United Airlines Stock",InvestorPlace,/news/stocks/with-the-pandemic-peaking-hold-off-on-united-airlines-stock-1029754094
576.0,11/3/2020 1:42:00 PM,Your First Instinct About Sorrento Therapeutics Is Probably Right,InvestorPlace,/news/stocks/srne-stock-day-late-dollar-short-1029759222
577.0,11/4/2020 5:12:44 PM,Healthcare rallies as Presidential vote count continues,Seeking Alpha,https://seekingalpha.com/news/3631239-healthcare-rallies-presidential-vote-count-continues?utm_source=markets.businessinsider.com&utm_medium=referral
578.0,11/9/2020 11:08:28 AM,5 Real Estate Stocks to Buy for a Hot Housing Market,InvestorPlace,/news/stocks/5-real-estate-stocks-to-buy-for-a-hot-housing-market-dhi-are-invh-low-tsco-1029780301
579.0,11/9/2020 2:42:48 PM,Positive data on Pfizer/BioNTech COVID-19 vaccine pressures test makers,Seeking Alpha,https://seekingalpha.com/news/3633699-positive-data-on-pfizer-biontech-covidminus-19-vaccine-pressures-test-makers?utm_source=markets.businessinsider.com&utm_medium=referral
580.0,11/10/2020 2:18:40 PM,Abbott launches new device for chronic pain,Seeking Alpha,https://seekingalpha.com/news/3634370-abbott-launches-new-device-for-chronic-pain?utm_source=markets.businessinsider.com&utm_medium=referral
581.0,11/11/2020 2:24:45 PM,9 Outbreak-Fueled Stocks to Buy This Week,InvestorPlace,/news/stocks/stocks-to-buy-this-week-second-coronavirus-wave-1029421408
582.0,11/13/2020 8:12:37 AM,Musk questions accuracy of rapid coronavirus antigen tests,Seeking Alpha,https://seekingalpha.com/news/3635981-musk-questions-accuracy-of-rapid-coronavirus-antigen-tests?utm_source=markets.businessinsider.com&utm_medium=referral
583.0,11/18/2020 5:20:53 AM,FDA authorizes first at-home rapid COVID-19 test,Seeking Alpha,https://seekingalpha.com/news/3637350-fda-authorizes-first-home-rapid-covidminus-19-test?utm_source=markets.businessinsider.com&utm_medium=referral
584.0,11/24/2020 7:21:41 PM,"Pfizer, Moderna Lead the Vaccine Race: Here’s Where 7 Other Top Vaccine Stocks Stand",InvestorPlace,/news/stocks/7-biotech-stocks-locked-in-the-race-for-a-vaccine-1029836075
585.0,12/2/2020 2:45:06 PM,Abbott: Health Canada Approves FreeStyle Libre 2 For Adults And Children With Diabetes ,RTTNews,/news/stocks/abbott-health-canada-approves-freestyle-libre-2-for-adults-and-children-with-diabetes-1029857677
586.0,12/3/2020 6:53:40 PM,3 Dividend Stocks for Big Total Returns in 2021,InvestorPlace,/news/stocks/3-dividend-stocks-for-big-total-returns-in-2021-abbv-jnj-mdt-1029863076
587.0,12/7/2020 2:03:50 PM,9 Stocks to Buy Despite the Rocky Transition,InvestorPlace,/news/stocks/9-stocks-to-buy-during-rocky-transition-1029869814
588.0,12/10/2020 7:17:05 PM,9 Stocks to Buy for a Divided Government,InvestorPlace,/news/stocks/9-stocks-to-buy-for-a-divided-government-1029883312
589.0,12/11/2020 4:19:44 PM,Abbott Laboratories increases dividend by 25% to $0.45,Seeking Alpha,https://seekingalpha.com/news/3643742-abbott-laboratories-increases-dividend-25-to-0_45?utm_source=markets.businessinsider.com&utm_medium=referral
590.0,12/15/2020 3:20:32 PM,Abbott Obtains CE Mark For COVID-19 IgG Quantitative Antibody Blood Test ,RTTNews,/news/stocks/abbott-obtains-ce-mark-for-covid-19-igg-quantitative-antibody-blood-test-1029894287
591.0,12/16/2020 10:47:45 AM,Micro-cap oncology biotech Scopus Biopharma prices downsized $2.75M IPO,Seeking Alpha,https://seekingalpha.com/news/3644762-micro-cap-oncology-biotech-scopus-biopharma-prices-downsized-2_75m-ipo?utm_source=markets.businessinsider.com&utm_medium=referral
592.0,12/16/2020 6:44:13 PM,Abbott scores an EUA win with COVID-19 rapid antigen test,Seeking Alpha,https://seekingalpha.com/news/3645019-abbott-scores-eua-win-covidminus-19-rapid-antigen-test?utm_source=markets.businessinsider.com&utm_medium=referral
593.0,12/17/2020 10:43:26 AM,FDA Nod For Abbott's At-home Covid-19 Test ,RTTNews,/news/stocks/fda-nod-for-abbott-s-at-home-covid-19-test-1029901352
594.0,12/17/2020 7:43:14 PM,"9 Stocks to Buy With $5,000 in Starter Money",InvestorPlace,/news/stocks/9-stocks-to-buy-with-5000-in-starter-money-1029904303
595.0,1/11/2021 2:30:36 PM,Abbott gets FDA nod for handheld concussion blood test,Seeking Alpha,https://seekingalpha.com/news/3650295-abbott-gets-fda-nod-for-handheld-concussion-blood-test?utm_source=markets.businessinsider.com&utm_medium=referral
596.0,1/11/2021 3:30:06 PM,Abbott Gets FDA Clearance For Rapid Handheld Blood Test For Mild Traumatic Brain Injury ,RTTNews,/news/stocks/abbott-gets-fda-clearance-for-rapid-handheld-blood-test-for-mild-traumatic-brain-injury-1029955794
597.0,1/12/2021 3:40:01 PM,Abbott To Complete U.S. Govt Order For 150 Mln BinaxNOW COVID-19 Rapid Tests ,RTTNews,/news/stocks/abbott-to-complete-u-s-govt-order-for-150-mln-binaxnow-covid-19-rapid-tests-1029960328
598.0,1/12/2021 4:52:55 PM,Abbott to supply additional 30M COVID-19 tests to U.S. Government,Seeking Alpha,https://seekingalpha.com/news/3650773-abbott-to-supply-additional-30m-covidminus-19-tests-to-u-s-government?utm_source=markets.businessinsider.com&utm_medium=referral
599.0,1/13/2021 2:10:07 PM,Quanterix guides FY20 revenue below consensus,Seeking Alpha,https://seekingalpha.com/news/3651078-quanterix-guides-fy20-revenue-below-consensus?utm_source=markets.businessinsider.com&utm_medium=referral
600.0,1/14/2021 3:26:56 PM,Abbott To Launch NeuroSphere MyPath Digital Health App - Quick Facts ,RTTNews,/news/stocks/abbott-to-launch-neurosphere-mypath-digital-health-app-quick-facts-1029969060
601.0,1/20/2021 1:20:33 PM,Abbott secures expanded medicare reimbursement for MitraClip,Seeking Alpha,https://seekingalpha.com/news/3652620-abbott-secures-expanded-medicare-reimbursement-for-mitraclip?utm_source=markets.businessinsider.com&utm_medium=referral
602.0,1/20/2021 3:24:21 PM,The 7 Best Healthcare Stocks to Buy for 2021,InvestorPlace,/news/stocks/the-7-best-healthcare-stocks-to-buy-for-2021-1029987247
603.0,1/21/2021 4:25:23 PM,Biden Stocks: 16 Stocks to Watch for a Defense Production Act Boost,InvestorPlace,/news/stocks/biden-stocks-16-stocks-to-watch-for-a-defense-production-act-boost-1029991455
604.0,1/23/2021 3:14:04 PM,"The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-24-30-j-j-lilly-to-kickstart-big-pharma-earnings-amgen-fda-decision-and-more-1029996049
605.0,1/25/2021 11:58:38 AM,3 Reasons To Invest in Pfizer Stock Despite Its Dismal Performance,InvestorPlace,/news/stocks/3-reasons-to-invest-in-pfizer-stock-despite-its-dismal-performance-1029999021
606.0,1/25/2021 3:01:29 PM,Here's what Wall Street expects from Abbott Laboratories's earnings,Markets Insider Automation,/news/stocks/abbott_laboratories-q4-quarterly-earnings-preview-stock-1029999373
607.0,1/26/2021 12:59:46 PM,Abbott's Panbio rapid antigen test scores CE mark for two new uses,Seeking Alpha,https://seekingalpha.com/news/3654285-abbotts-panbio-rapid-antigen-test-receives-ce-mark-for-two-new-uses?utm_source=markets.businessinsider.com&utm_medium=referral
608.0,1/26/2021 2:07:40 PM,"The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market",Benzinga,/news/stocks/the-daily-biotech-pulse-novartis-misses-j-j-beats-in-big-pharma-earnings-vaccine-developer-curevac-taps-equity-market-1030004007
609.0,1/26/2021 3:38:25 PM,Abbott Receives CE Mark For Two New Uses Of Panbio COVID-19 Ag Rapid Test Device ,RTTNews,/news/stocks/abbott-receives-ce-mark-for-two-new-uses-of-panbio-covid-19-ag-rapid-test-device-1030004976
610.0,1/26/2021 4:29:52 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3654433-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
611.0,1/26/2021 6:12:25 PM,Abbott Laboratories Q4 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3654454-abbott-laboratories-q4-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
612.0,1/27/2021 12:33:31 PM,"Abbott Laboratories EPS beats by $0.10, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3654827-abbott-laboratories-eps-beats-0_10-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral
613.0,1/27/2021 1:04:00 PM,"Abbott tops Q4 consensus, COVID-19 testing-related sales of $2.4B",Seeking Alpha,https://seekingalpha.com/news/3654858-abbott-tops-q4-consensus-covid-19-testing-related-sales-of-24b?utm_source=markets.businessinsider.com&utm_medium=referral
614.0,1/27/2021 1:21:28 PM,"The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF",InvestorPlace,/news/stocks/genomics-telehealth-and-the-future-of-healthcare-with-the-anew-etf-1029891558
615.0,1/27/2021 1:35:59 PM,"The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement",Benzinga,/news/stocks/the-daily-biotech-pulse-sorrento-immutep-surge-on-covid-19-study-data-t2-biosystems-sinks-on-preannouncement-1030009241
616.0,1/27/2021 1:38:56 PM,Abbott Laboratories Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q4-adjusted-earnings-beat-estimates-1030009238
617.0,1/27/2021 1:41:45 PM,Abbott Projects 2021 EPS Growth Of More Than 35% - Quick Facts ,RTTNews,/news/stocks/abbott-projects-2021-eps-growth-of-more-than-35-quick-facts-1030009249
618.0,1/27/2021 10:30:36 PM,"4 Top Stock Trades for Thursday: BB, MSFT, ABT, TXN",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-bb-msft-abt-txn-1030012231
619.0,1/28/2021 1:53:40 PM,Abbott upgraded to Buy at BTIG following strong Q4 results,Seeking Alpha,https://seekingalpha.com/news/3655508-abbott-upgraded-to-buy-at-btig-following-strong-q4-results?utm_source=markets.businessinsider.com&utm_medium=referral
620.0,1/28/2021 2:03:49 PM,"The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-decision-day-for-amgen-zymeworks-sinks-on-data-ortho-clinical-diagnostics-ipo-1030014922
621.0,1/28/2021 2:07:10 PM,10 Biggest Price Target Changes For Thursday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-thursday-1030014923
622.0,1/28/2021 4:04:02 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 28, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-28-2021-1030015872
623.0,1/28/2021 7:29:12 PM,BioThera BLA for Roche Avastin biosimilar accepted by FDA,Seeking Alpha,https://seekingalpha.com/news/3655629-biothera-bla-for-roche-avastin-biosimilar-accepted-by-fda?utm_source=markets.businessinsider.com&utm_medium=referral
624.0,1/29/2021 1:45:44 PM,"The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-novavax-vaccine-readout-clinical-hold-on-bellicum-study-lifted-lilly-earnings-nls-pharma-ipo-1030019600
625.0,2/1/2021 1:55:19 PM,COVID-19 test kit developer Lucira Health to price IPO between $15-$17,Seeking Alpha,https://seekingalpha.com/news/3656589-covid-19-test-kit-developer-lucira-health-to-price-ipo-between-15-17?utm_source=markets.businessinsider.com&utm_medium=referral
626.0,2/2/2021 2:05:48 PM,"The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment",Benzinga,/news/stocks/the-daily-biotech-pulse-vertex-pfizer-earnings-tiziana-covid-19-vaccine-data-decision-day-for-mallinckrodt-s-burn-treatment-1030032611
627.0,2/9/2021 2:10:28 PM,"The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement",Benzinga,/news/stocks/the-daily-biotech-pulse-dynavax-poaches-gsk-vaccine-exec-kalvista-jumps-on-data-readout-corcept-issues-negative-preannouncement-1030060223
628.0,2/11/2021 1:26:22 PM,"The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts",Benzinga,/news/stocks/the-daily-biotech-pulse-dermtech-soars-on-contract-fluidigm-plunges-on-earnings-decision-day-for-regeneron-bioventus-debuts-1030072237
629.0,2/19/2021 6:48:45 PM,Abbott Laboratories declares $0.45 dividend,Seeking Alpha,https://seekingalpha.com/news/3664033-abbott-laboratories-declares-0_45-dividend?utm_source=markets.businessinsider.com&utm_medium=referral
630.0,2/22/2021 2:07:58 PM,Six stocks hedge funds and mutual funds love (and 20 they don't): At the Open,Seeking Alpha,https://seekingalpha.com/news/3664311-six-stocks-hedge-funds-and-mutual-funds-love?utm_source=markets.businessinsider.com&utm_medium=referral
631.0,2/28/2021 2:36:40 PM,"The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More",Benzinga,/news/stocks/the-past-week-s-notable-insider-buys-agree-realty-avis-budget-zoetis-and-more-1030132210
632.0,3/3/2021 2:31:53 PM,7 Blue-Chip Stocks That May Be Perfect For Retirement,InvestorPlace,/news/stocks/7-blue-chip-stocks-that-may-be-perfect-for-retirement-1030146050
633.0,3/3/2021 4:03:43 PM,Health Canada OKs expanded use of Abbott's FreeStyle Libre system,Seeking Alpha,https://seekingalpha.com/news/3668802-health-canada-oks-expanded-use-of-abbott-freestyle-libre-system?utm_source=markets.businessinsider.com&utm_medium=referral
634.0,3/4/2021 1:50:49 PM,Big Tech and non-tech valuations may be closer than they appear: At the Open,Seeking Alpha,https://seekingalpha.com/news/3669326-big-tech-and-non-tech-valuations?utm_source=markets.businessinsider.com&utm_medium=referral
635.0,3/5/2021 2:10:36 PM,Abbott wins FDA emergency use nod for PCR assay differentiating Sars-Cov-2 from other respiratory infections,Seeking Alpha,https://seekingalpha.com/news/3669915-abbott-secures-fda-eua-for-alinity-m-resp-4-plex-molecular-assay?utm_source=markets.businessinsider.com&utm_medium=referral
636.0,3/5/2021 3:26:29 PM,Abbott Gets EUA For Laboratory PCR Assay That Detects Four Viruses In One Test ,RTTNews,/news/stocks/abbott-gets-eua-for-laboratory-pcr-assay-that-detects-four-viruses-in-one-test-1030155154
637.0,3/8/2021 2:25:32 PM,Abbott launches NeuroSphere Virtual Clinic in U.S.,Seeking Alpha,https://seekingalpha.com/news/3670253-abbott-launches-neurosphere-virtual-clinic-in-us?utm_source=markets.businessinsider.com&utm_medium=referral
638.0,3/9/2021 12:02:32 AM,Abbott Announces U.S. Launch Of NeuroSphere Virtual Clinic ,RTTNews,/news/stocks/abbott-announces-u-s-launch-of-neurosphere-virtual-clinic-1030161312
639.0,3/9/2021 8:38:33 AM,"Corporate vaccination drives get underway, as well as mask policies",Seeking Alpha,https://seekingalpha.com/news/3670551-corporate-vaccination-drives-get-underway-as-well-as-mask-policies?utm_source=markets.businessinsider.com&utm_medium=referral
640.0,3/11/2021 3:53:46 PM,Abbott Pandemic Defense Coalition Formed For Early Detection Of Future Pandemic Threats ,RTTNews,/news/stocks/abbott-pandemic-defense-coalition-formed-for-early-detection-of-future-pandemic-threats-1030173982
641.0,3/15/2021 4:30:50 PM,8 of the Best Index Funds With Ultra-Low Fees,InvestorPlace,/news/stocks/8-of-the-best-index-funds-with-ultra-low-fees-1030206599
642.0,3/16/2021 3:39:23 PM,Abbott suspends study comparing HeartMate PHP against Abiomed's Impella,Seeking Alpha,https://seekingalpha.com/news/3673196-abbott-suspends-study-for-heartmate-php-against-abiomeds-impella?utm_source=markets.businessinsider.com&utm_medium=referral
643.0,3/16/2021 8:17:29 PM,FDA streamlines path for emergency use authorization of COVID-19 tests,Seeking Alpha,https://seekingalpha.com/news/3673294-fda-streamlines-path-for-emergency-use-authorization-of-covid-19-tests?utm_source=markets.businessinsider.com&utm_medium=referral
644.0,3/17/2021 10:01:32 PM,Abbott secures $255M defense logistics agency contract for BinaxNOW COVID-19 test,Seeking Alpha,https://seekingalpha.com/news/3673849-abbott-secures-255m-defense-logistics-agency-contract-for-binaxnow-covid-19-test?utm_source=markets.businessinsider.com&utm_medium=referral
645.0,3/23/2021 4:46:16 PM,Drug pricing legislation introduced by Sanders weighs on pharmas,Seeking Alpha,https://seekingalpha.com/news/3675361-drug-pricing-legislation-introduced-by-sanders-weighs-on-pharmas?utm_source=markets.businessinsider.com&utm_medium=referral
646.0,3/26/2021 4:12:59 PM,Covid Fatigue Threatens to Derail Once Relevant Quidel,InvestorPlace,/news/stocks/covid-fatigue-threatens-to-derail-qdel-stock-1030250781
647.0,4/1/2021 5:53:16 AM,Abbott's BinaxNOW COVID-19 Ag Self Test Receives FDA EUA To Detect COVID-19 Infection ,RTTNews,/news/stocks/abbott-s-binaxnow-covid-19-ag-self-test-receives-fda-eua-to-detect-covid-19-infection-1030267000
648.0,4/1/2021 6:28:47 AM,FDA OKs emergency use of Abbott's rapid COVID-19 self test,Seeking Alpha,https://seekingalpha.com/news/3678407-fda-oks-emergency-use-of-abbotts-rapid-covid-19-self-test?utm_source=markets.businessinsider.com&utm_medium=referral
649.0,4/1/2021 1:46:30 PM,"The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-preps-for-bla-filing-sonoma-surges-bioxcel-readout-ortho-clinical-lands-contract-1030268533
650.0,4/1/2021 6:29:05 PM,7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-to-prepare-your-portfolio-for-the-next-pandemic-1030270707
651.0,4/1/2021 9:18:58 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-acy-stock-clean-energy-stocks-1030270991
652.0,4/6/2021 1:21:08 PM,Abbott's XIENCE stent indication gets European approval,Seeking Alpha,https://seekingalpha.com/news/3679499-abbotts-xience-stent-indication-gets-european-approval?utm_source=markets.businessinsider.com&utm_medium=referral
653.0,4/6/2021 3:10:45 PM,Abbott: XIENCE Stent Gets CE Mark In Europe For Shorter Duration Of Dual Anti-platelet Therapy ,RTTNews,/news/stocks/abbott-xience-stent-gets-ce-mark-in-europe-for-shorter-duration-of-dual-anti-platelet-therapy-1030277191
654.0,4/8/2021 1:29:28 PM,Abbott gets CE mark approval for next-generation TriClip device,Seeking Alpha,https://seekingalpha.com/news/3680341-abbott-gets-ce-mark-approval-for-next-generation-triclip-device?utm_source=markets.businessinsider.com&utm_medium=referral
655.0,4/8/2021 3:21:09 PM,Abbott Gets CE Mark Approval For Next-Generation TriClip Device - Quick Facts ,RTTNews,/news/stocks/abbott-gets-ce-mark-approval-for-next-generation-triclip-device-quick-facts-1030285907
656.0,4/9/2021 6:35:31 PM,3 Stocks Near 52-Week Lows That Could Bounce Back,Benzinga,/news/stocks/3-stocks-near-52-week-lows-that-could-bounce-back-1030289942
657.0,4/9/2021 10:05:00 PM,Abbott Ireland Financing DAC -- Moody's announces completion of a periodic review of ratings of Abbott Laboratories,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-abbott-laboratories-1030290304
658.0,4/15/2021 4:03:31 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-15-2021-1030308913
659.0,4/17/2021 3:25:15 PM,"The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-johnson-johnson-biogen-earnings-neurology-conference-and-ipos-1030314413
660.0,4/18/2021 3:01:24 PM,What Wall Street expects from Abbott Laboratories's earnings,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-q1-earnings-preview-1030315034
661.0,4/19/2021 1:13:52 PM,Abbott to sell rapid COVID-19 self test at Walgreens stores,Seeking Alpha,https://seekingalpha.com/news/3682931-abbott-to-sell-rapid-covid-19-self-test-at-walgreens-stores?utm_source=markets.businessinsider.com&utm_medium=referral
662.0,4/19/2021 2:57:46 PM,Abbott Begins Shipping BinaxNOW COVID-19 Ag Self Test To Retailers Today - Quick Facts ,RTTNews,/news/stocks/abbott-begins-shipping-binaxnow-covid-19-ag-self-test-to-retailers-today-quick-facts-1030317913
663.0,4/19/2021 3:38:36 PM,"Walgreens, Abbott Agree To Sell BinaxNOW Antigen Self Test Through Walgreens Stores ",RTTNews,/news/stocks/walgreens-abbott-agree-to-sell-binaxnow-antigen-self-test-through-walgreens-stores-1030318196
664.0,4/19/2021 4:21:32 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3683044-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
665.0,4/19/2021 5:57:54 PM,Abbott Laboratories Q1 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3683080-abbott-laboratories-q1-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
666.0,4/20/2021 11:31:09 AM,"Abbott Laboratories EPS beats by $0.05, misses on revenue",Seeking Alpha,https://seekingalpha.com/news/3683304-abbott-laboratories-eps-beats-0_05-misses-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral
667.0,4/20/2021 12:13:41 PM,Abbott stock falls as 2021 guidance misses estimates,Seeking Alpha,https://seekingalpha.com/news/3683338-abbott-falls-as-2021-2021-guidance-misses-estimates?utm_source=markets.businessinsider.com&utm_medium=referral
668.0,4/20/2021 1:41:45 PM,Abbott Laboratories Backs FY21 Outlook - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-backs-fy21-outlook-quick-facts-1030322386
669.0,4/20/2021 2:06:58 PM,"The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex",Benzinga,/news/stocks/the-daily-biotech-pulse-q1-beat-from-johnson-johnson-kalvista-study-placed-on-hold-european-label-expansion-for-gw-pharma-s-epidiolex-1030322640
670.0,4/20/2021 3:29:30 PM,Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology,Benzinga,/news/stocks/remote-monitoring-telemedicine-company-sees-spiked-growth-of-products-and-technology-1030323571
671.0,4/21/2021 2:40:05 PM,Abbott Q1 results highlight pressure on COVID-19 test makers as vaccinations ramp up,Seeking Alpha,https://seekingalpha.com/news/3683988-abbott-q1-results-highlights-pressure-on-covid-19-test-makers?utm_source=markets.businessinsider.com&utm_medium=referral
672.0,4/22/2021 7:47:21 PM,House Democrats reintroduce bill to lower drug prices,Seeking Alpha,https://seekingalpha.com/news/3684755-house-democrats-reintroduce-bill-to-lower-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral
673.0,4/26/2021 5:30:41 PM,3 Top Blue-Chip Healthcare Stocks With Healthy Dividends,InvestorPlace,/news/stocks/3-top-blue-chip-healthcare-stocks-with-healthy-dividends-1030347105
674.0,4/28/2021 2:29:03 PM,7 Pharmaceutical Stocks With Dividends in Hand,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-dividends-in-hand-1030359387
675.0,5/7/2021 7:30:30 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3693377-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral
676.0,5/12/2021 3:14:32 PM,7 Great Growth Stocks to Consider for Your Short List,InvestorPlace,/news/stocks/7-great-growth-stocks-to-consider-for-your-short-list-1030422219
677.0,5/13/2021 6:06:24 PM,Abbott recalls certain pacemakers over potential electrical short,Seeking Alpha,https://seekingalpha.com/news/3696084-abbott-recalls-certain-pacemakers-over-potential-electrical-short?utm_source=markets.businessinsider.com&utm_medium=referral
678.0,5/14/2021 5:19:53 PM,"If You Do the Math, Senseonics Makes No Sense",InvestorPlace,/news/stocks/sens-stock-math-makes-no-sense-1030431757
679.0,5/17/2021 1:18:58 PM,Abbott receives CE mark for Navitor,Seeking Alpha,https://seekingalpha.com/news/3697125-abbott-receives-ce-mark-for-navitor?utm_source=markets.businessinsider.com&utm_medium=referral
680.0,5/19/2021 5:37:15 PM,FDA says public shouldn't use antibody tests to determine COVID-19 immunity,Seeking Alpha,https://seekingalpha.com/news/3698328-fda-says-public-shouldnt-use-antibody-tests-to-determine-covid-19-immunity?utm_source=markets.businessinsider.com&utm_medium=referral
681.0,5/20/2021 8:47:00 PM,Abbott Ireland Financing DAC -- Moody's upgrades Abbott Laboratories to A2,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-upgrades-abbott-laboratories-to-a2-1030452702
682.0,5/24/2021 11:01:37 AM,Dogs who sniff Covid could be coming to an airport near you,Seeking Alpha,https://seekingalpha.com/news/3699351-dogs-who-sniff-covid-could-be-coming-to-an-airport-near-you?utm_source=markets.businessinsider.com&utm_medium=referral
683.0,5/25/2021 4:02:44 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-25-2021-1030463045
684.0,5/25/2021 6:07:34 PM,"Barclays sees ""renaissance"" in medical device industry",Seeking Alpha,https://seekingalpha.com/news/3699979-barclays-sees-renaissance-in-medical-device-industry?utm_source=markets.businessinsider.com&utm_medium=referral
685.0,6/1/2021 10:00:45 AM,This Significant New Partnership Makes Senseonics Stock Worth Another Look,InvestorPlace,/news/stocks/sens-stock-worth-another-look-1030480773
686.0,6/1/2021 2:21:19 PM,Abbott Laboratories Slashes FY21 Outlook - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-slashes-fy21-outlook-quick-facts-1030481662
687.0,6/1/2021 2:22:27 PM,Abbott sinks after slashing 2021 guidance,Seeking Alpha,https://seekingalpha.com/news/3701731-abbott-sinks-after-slashing-2021-guidance?utm_source=markets.businessinsider.com&utm_medium=referral
688.0,6/1/2021 7:39:01 PM,Abbott highlights base business as waning COVID-19 test sales prompt cut to guidance,Seeking Alpha,https://seekingalpha.com/news/3702015-abbott-highlights-base-business-as-waning-covid-19-test-sales-prompt-cut-to-guidance?utm_source=markets.businessinsider.com&utm_medium=referral
689.0,6/2/2021 11:00:33 AM,68 Biggest Movers From Yesterday,Benzinga,/news/stocks/68-biggest-movers-from-yesterday-1030486020
690.0,6/2/2021 12:50:04 PM,"iRhythm downgraded on CEO exit, UBS bullish on aducanumab approval; in today’s analyst action",Seeking Alpha,https://seekingalpha.com/news/3702278-irhythm-downgraded-on-ceo-exit-ubs-bullish-on-aducanumab-approval-in-todays-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral
691.0,6/2/2021 1:41:41 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1030486666
692.0,6/2/2021 2:51:35 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-amc-stock-bb-stock-dogecoin-prices-1030488344
693.0,6/2/2021 3:58:01 PM,Abbott’s revised guidance prompts model update for COVID-19 test makers at UBS,Seeking Alpha,https://seekingalpha.com/news/3702385-abbotts-revised-guidance-prompts-model-update-for-covid-19-test-makers-at-ubs?utm_source=markets.businessinsider.com&utm_medium=referral
694.0,6/3/2021 4:48:19 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1030492081
695.0,6/3/2021 10:58:34 PM,Why Senseonics Shares Are Rocketing Higher After Hours Thursday,Benzinga,/news/stocks/why-senseonics-shares-are-rocketing-higher-after-hours-thursday-1030493163
696.0,6/4/2021 5:07:04 PM,Senseonics rallies as CGM data shows promise against rivals,Seeking Alpha,https://seekingalpha.com/news/3703405-senseonics-rallies-as-cgm-data-shows-promise-against-rivals?utm_source=markets.businessinsider.com&utm_medium=referral
697.0,6/6/2021 1:52:43 AM,Thermo Fisher Scientific targets M&A as COVID-19-related impact wanes,Seeking Alpha,https://seekingalpha.com/news/3703520-thermo-fisher-scientific-targets-ma-as-covid-19-related-impact-wanes?utm_source=markets.businessinsider.com&utm_medium=referral
698.0,6/11/2021 5:19:00 PM,Abbott Declares 390th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-390th-consecutive-quarterly-dividend-1030516275
699.0,6/18/2021 1:46:55 PM,"Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic",Benzinga,/news/stocks/cramer-weighs-in-on-senseonics-holdings-celsius-and-contextlogic-1030535178
700.0,6/22/2021 1:00:00 PM,Abbott Earns First-of-its-Kind Recommendation for High School STEM Interns to Receive College Credit,PR Newswire,/news/stocks/abbott-earns-first-of-its-kind-recommendation-for-high-school-stem-interns-to-receive-college-credit-1030542303
701.0,6/23/2021 3:25:01 PM,Citius Shows a Promising Future as Share Prices Keep Going up,Benzinga,/news/stocks/citius-shows-a-promising-future-as-share-prices-keep-going-up-1030547404
702.0,6/24/2021 3:00:00 PM,People Who Exercise Intensely Could Improve Recovery by Adjusting Their Hydration Habits,PR Newswire,/news/stocks/people-who-exercise-intensely-could-improve-recovery-by-adjusting-their-hydration-habits-1030551377
703.0,6/25/2021 11:50:45 AM,3 High-Yield Stocks With Secure Payouts,InvestorPlace,/news/stocks/3-high-yield-dividend-stocks-with-secure-payouts-1030554651
704.0,6/25/2021 3:00:00 PM,Abbott Hosts Conference Call for Second-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-second-quarter-earnings-1030554985
705.0,6/25/2021 5:30:00 PM,Late-Breaking Data Demonstrate Abbott's FreeStyle® Libre System Supports Health Equity for Millions of Americans Living with Diabetes,PR Newswire,/news/stocks/late-breaking-data-demonstrate-abbott-s-freestyle-libre-system-supports-health-equity-for-millions-of-americans-living-with-diabetes-1030555435
706.0,6/30/2021 2:10:33 PM,Abbott Xient stents receive FDA approval for shorter blood thinning indication,Seeking Alpha,https://seekingalpha.com/news/3711393-abbott-xient-stents-receive-fda-approval-for-shorter-blood-thinning-indication?utm_source=markets.businessinsider.com&utm_medium=referral
707.0,6/30/2021 3:00:00 PM,Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients,PR Newswire,/news/stocks/abbott-s-xience-stent-receives-fda-approval-for-shortest-blood-thinner-course-for-high-bleeding-risk-patients-1030567382
708.0,6/30/2021 3:22:19 PM,Abbott's XIENCE Stent Receives FDA Approval For High Bleeding Risk Patients ,RTTNews,/news/stocks/abbott-s-xience-stent-receives-fda-approval-for-high-bleeding-risk-patients-1030567226
709.0,6/30/2021 3:41:40 PM,NIH study suggests antigen tests and PCR tests are equally effective in detecting COVID-19,Seeking Alpha,https://seekingalpha.com/news/3711452-nih-study-suggests-antigen-tests-and-pcr-tests-are-equally-effective-in-detecting-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral
710.0,7/1/2021 4:04:10 PM,3 Pros and 3 Cons to Consider Before Joining the Senseonics Frenzy,InvestorPlace,/news/stocks/3-pros-3-cons-sens-stock-consider-1030572638
711.0,7/2/2021 5:40:11 PM,The 7 Best Dividend Stocks to Buy for Income Investors In July 2021 ,InvestorPlace,/news/stocks/the-7-best-dividend-stocks-to-buy-for-income-investors-in-july-2021-1030576310
712.0,7/3/2021 3:26:32 AM,Intellia and gene editors lead weekly healthcare gainers; CEL-SCI and Citius trail,Seeking Alpha,https://seekingalpha.com/news/3712730-intellia-and-gene-editors-lead-weekly-healthcare-gainers-cel-sci-and-citius-trail?utm_source=markets.businessinsider.com&utm_medium=referral
713.0,7/6/2021 3:11:44 PM,Wait For a Pullback Before Taking a Position In Senseonics,InvestorPlace,/news/stocks/wait-for-a-pullback-before-taking-position-in-sens-stock-1030582593
714.0,7/7/2021 3:39:05 PM,Abbott selling STARLIMS informatics suite to Francisco Partners for undisclosed amount,Seeking Alpha,https://seekingalpha.com/news/3713355-abbott-selling-starlims-informatics-suite-to-francisco-partners-for-undisclosed-amount?utm_source=markets.businessinsider.com&utm_medium=referral
715.0,7/9/2021 5:25:23 AM,Abbott's St. Jude Medical To Pay $27 Mln To Settle Allegations Over Heart Devices ,RTTNews,/news/stocks/abbott-s-st-jude-medical-to-pay-27-mln-to-settle-allegations-over-heart-devices-1030591765
716.0,7/9/2021 8:02:53 PM,7 Super-Safe Dividend Stock Performers to Buy,InvestorPlace,/news/stocks/7-super-safe-dividend-stocks-to-buy-1030594111
717.0,7/12/2021 8:18:56 PM,QIAGEN guidance cut pressures rival COVID-19 test makers,Seeking Alpha,https://seekingalpha.com/news/3714475-qiagen-guidance-cut-pressures-rival-covid-19-test-makers?utm_source=markets.businessinsider.com&utm_medium=referral
718.0,7/15/2021 4:13:26 PM,FDA devices head says progress being made on diabetes devices backlog,Seeking Alpha,https://seekingalpha.com/news/3715640-fda-devices-head-says-progress-being-made-on-diabetes-devices-backlog?utm_source=markets.businessinsider.com&utm_medium=referral
719.0,7/16/2021 4:10:20 PM,7 Best Dividend Stocks to Buy to Juice Your Portfolio Yield,InvestorPlace,/news/stocks/7-best-dividend-stocks-to-buy-to-juice-your-portfolio-yield-1030615780
720.0,7/18/2021 1:04:02 AM,Moderna headlines weekly healthcare gainers; FibroGen and Biogen trail,Seeking Alpha,https://seekingalpha.com/news/3716141-moderna-headlines-weekly-healthcare-gainers-fibrogen-and-biogen-trail?utm_source=markets.businessinsider.com&utm_medium=referral
721.0,7/18/2021 4:25:56 PM,"The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-earnings-kickstart-with-j-j-and-biogen-albireo-awaits-fda-decisions-more-ipos-1030617574
722.0,7/19/2021 3:39:32 PM,Moderna leads COVID-19 vaccine developers; Test makers trade higher amid pandemic concerns,Seeking Alpha,https://seekingalpha.com/news/3716375-moderna-leads-covid-19-vaccine-developers-test-makers-trade-higher-amid-pandemic-concerns?utm_source=markets.businessinsider.com&utm_medium=referral
723.0,7/19/2021 4:40:06 PM,3 High-Yield Dividend Aristocrats To Buy Now,InvestorPlace,/news/stocks/3-high-yield-dividend-stocks-aristocrats-to-buy-now-1030621331
724.0,7/20/2021 3:01:32 PM,Here's what Wall Street expects from Abbott Laboratories's earnings report,Markets Insider Automation,/news/stocks/abbott_laboratories-quarter-earnings-preview-q2-1030625198
725.0,7/21/2021 1:41:50 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3717408-notable-earnings-before-thursdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
726.0,7/21/2021 9:47:26 PM,7 Vice Stocks To Buy To Be Cynically Defensive,InvestorPlace,/news/stocks/7-vice-stocks-to-buy-for-cynical-defensiveness-1030632441
727.0,7/22/2021 11:16:54 AM,"Abbott Laboratories EPS beats by $0.15, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3717920-abbott-laboratories-eps-beats-0_15-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral
728.0,7/22/2021 12:14:24 PM,Abbott accelerates quarterly growth as medical devices outperform diagnostics,Seeking Alpha,https://seekingalpha.com/news/3717979-abbott-accelerates-quarterly-growth-as-medical-devices-outperform-diagnostics?utm_source=markets.businessinsider.com&utm_medium=referral
729.0,7/22/2021 1:15:00 PM,Abbott Reports Second-Quarter 2021 Results,PR Newswire,/news/stocks/abbott-reports-second-quarter-2021-results-1030634453
730.0,7/22/2021 1:34:54 PM,Abbott Laboratories Q2 Income Advances,RTTNews,/news/stocks/abbott-laboratories-q2-income-advances-1030634534
731.0,7/22/2021 1:44:20 PM,Abbott Laboratories Maintains FY21 Outlook - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-maintains-fy21-outlook-quick-facts-1030634603
732.0,7/22/2021 2:18:49 PM,"The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-nod-for-merck-eisai-seres-ulcerative-colitis-drug-flunks-midstage-study-pfizer-to-invest-in-arvinas-absci-ipo-1030634923
733.0,7/22/2021 8:40:28 PM,The 10 Best Dividend Income Growers in the S&P 500,InvestorPlace,/news/stocks/the-10-best-dividend-income-growers-in-the-sp-500-1030636942
734.0,7/29/2021 3:00:00 PM,"New Study: Half of Americans Living with Diabetes May be Consuming Less Than the Recommended Amount of Protein, which is Associated with Greater Physical Limitations",PR Newswire,/news/stocks/new-study-half-of-americans-living-with-diabetes-may-be-consuming-less-than-the-recommended-amount-of-protein-which-is-associated-with-greater-physical-limitations-1030662793
735.0,8/2/2021 3:00:00 PM,"Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management",PR Newswire,/news/stocks/abbott-s-freestyle-libre-2-ios-app-cleared-in-u-s-providing-a-seamless-digital-experience-to-simplify-diabetes-management-1030676704
736.0,8/2/2021 3:22:04 PM,FDA Clears Abbott's FreeStyle Libre 2 IOS App For Diabetes Management ,RTTNews,/news/stocks/fda-clears-abbott-s-freestyle-libre-2-ios-app-for-diabetes-management-1030676772
737.0,8/2/2021 6:12:23 PM,Abbott to pay $160M to Feds to resolve Medicare diabetes false claims allegations,Seeking Alpha,https://seekingalpha.com/news/3723310-abbott-to-pay-160m-to-feds-to-resolve-medicare-diabetes-false-claims-allegations?utm_source=markets.businessinsider.com&utm_medium=referral
738.0,8/3/2021 7:29:47 AM,Senseonics Financials Don’t Support Its Billion-Dollar-Plus Market Cap,InvestorPlace,/news/stocks/senseonics-financials-doesnt-support-its-high-market-cap-1030681657
739.0,8/3/2021 1:32:47 PM,Abbott gets FDA clearance for Ultreon powered OCT imaging platform,Seeking Alpha,https://seekingalpha.com/news/3723887-abbott-gets-fda-clearance-for-ultreon-powered-oct-imaging-platform?utm_source=markets.businessinsider.com&utm_medium=referral
740.0,8/3/2021 3:00:00 PM,Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart,PR Newswire,/news/stocks/abbott-receives-fda-clearance-for-its-imaging-technology-using-artificial-intelligence-for-vessels-in-the-heart-1030684117
741.0,8/3/2021 3:47:13 PM,FDA OKs Abbott's OCT Imaging Platform With Artificial Intelligence - Quick Facts ,RTTNews,/news/stocks/fda-oks-abbott-s-oct-imaging-platform-with-artificial-intelligence-quick-facts-1030684158
742.0,8/6/2021 8:00:09 PM,Bioethicist Ezekiel Emanuel under consideration for FDA commissioner - Politico,Seeking Alpha,https://seekingalpha.com/news/3727179-bioethicist-ezekiel-emanuel-under-consideration-for-fda-commissioner-politico?utm_source=markets.businessinsider.com&utm_medium=referral
743.0,8/16/2021 2:00:00 PM,Abbott's Amplatzer™ Amulet™ Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke,PR Newswire,/news/stocks/abbott-s-amplatzer-amulet-device-approved-by-fda-to-treat-people-with-atrial-fibrillation-at-risk-of-stroke-1030734059
744.0,8/16/2021 2:27:22 PM,FDA OKs Abbott's Amplatzer Amulet Device To Treat Atrial Fibrillation - Quick Facts ,RTTNews,/news/stocks/fda-oks-abbott-s-amplatzer-amulet-device-to-treat-atrial-fibrillation-quick-facts-1030734169
745.0,8/20/2021 2:14:06 AM,Acting FDA head Woodcock ruled out as permanent nominee - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3732564-acting-fda-head-woodcock-ruled-out-as-permanent-nominee-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral
746.0,8/21/2021 5:22:50 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1030750231
747.0,8/25/2021 10:00:32 AM,"Senseonics Can Move Higher, but Competitive Concerns Abound",InvestorPlace,/news/stocks/sens-stock-can-move-higher-but-competition-is-tight-1030757136
748.0,8/27/2021 2:46:00 PM,GUIDE-HF Study Data Show Abbott's CardioMEMS™ Device Can Improve Care for More Patients with Heart Failure,PR Newswire,/news/stocks/guide-hf-study-data-show-abbott-s-cardiomems-device-can-improve-care-for-more-patients-with-heart-failure-1030763613
749.0,8/27/2021 3:07:56 PM,Abbott: CardioMEMS Device Shows Potential Benefits In New Groups Of Patients ,RTTNews,/news/stocks/abbott-cardiomems-device-shows-potential-benefits-in-new-groups-of-patients-1030763676
750.0,8/30/2021 5:55:00 PM,Late-Breaking Data Shows Abbott's Amplatzer™ Amulet™ Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman‡ Device for People With Atrial Fibrillation at Risk of Stroke,PR Newswire,/news/stocks/late-breaking-data-shows-abbott-s-amplatzer-amulet-occluder-offers-superior-left-atrial-appendage-closure-compared-to-watchman-device-for-people-with-atrial-fibrillation-at-risk-of-stroke-1030767458
751.0,9/2/2021 3:30:00 PM,"Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC",PR Newswire,/news/stocks/abbott-expands-peripheral-vascular-offerings-with-acquisition-of-walk-vascular-llc-1030776806
752.0,9/2/2021 3:58:10 PM,Abbott Announces Acquisition Of Walk Vascular - Quick Facts ,RTTNews,/news/stocks/abbott-announces-acquisition-of-walk-vascular-quick-facts-1030776916
753.0,9/2/2021 5:34:14 PM,7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In ,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-before-3-5-trillion-floods-in-1030777655
754.0,9/3/2021 1:31:13 PM,"The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself",Benzinga,/news/stocks/the-daily-biotech-pulse-cellect-jumps-on-first-apograft-transplantation-astrazeneca-european-commission-bury-legal-hatchet-cassava-defends-itself-1030779479
755.0,9/9/2021 2:17:07 PM,"The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization",Benzinga,/news/stocks/the-daily-biotech-pulse-proqr-lilly-r-d-partnership-sanofi-s-pemphigus-trial-disappointment-humanigen-s-covid-19-drug-denied-emergency-use-authorization-1030789942
756.0,9/10/2021 5:56:12 PM,Why Biden's Action Plan Is Bullish For COVID-19 Testing Stocks,Benzinga,/news/stocks/why-biden-s-action-plan-is-bullish-for-covid-19-testing-stocks-1030793082
757.0,9/13/2021 10:00:07 AM,7 S&P 500 Dividend Stocks To Buy Yielding 4%  ,InvestorPlace,/news/stocks/7-sp-500-dividend-stocks-to-buy-yielding-4-1030795279
758.0,9/14/2021 1:50:13 PM,"The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-nrx-rises-on-covid-19-drug-collaboration-amgen-s-lung-cancer-drug-conditionally-approved-in-canada-coherus-data-readout-1030798122
759.0,9/15/2021 6:46:00 PM,Abbott Declares 391st Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-391st-consecutive-quarterly-dividend-1030802564
760.0,9/15/2021 8:23:34 PM,Narrower drug pricing bill introduced in House by centrist Democrats,Seeking Alpha,https://seekingalpha.com/news/3740127-narrower-drug-pricing-bill-introduced-in-house-by-centrist-democrats?utm_source=markets.businessinsider.com&utm_medium=referral
761.0,9/15/2021 9:20:09 PM,House committee approves portion of spending package that includes drug price negotiation,Seeking Alpha,https://seekingalpha.com/news/3740192-house-committee-approves-portion-of-spending-package-that-includes-drug-price-negotiation?utm_source=markets.businessinsider.com&utm_medium=referral
762.0,9/17/2021 9:27:41 PM,Abbott bags ~$119.5M contract for antigen test kikts,Seeking Alpha,https://seekingalpha.com/news/3740991-abbott-bags-1195m-contract-for-antigen-test?utm_source=markets.businessinsider.com&utm_medium=referral
763.0,9/20/2021 3:00:00 PM,Abbott Receives FDA Approval for Minimally Invasive Portico™ with FlexNav™ TAVR System to Treat Patients with Aortic Valve Disease,PR Newswire,/news/stocks/abbott-receives-fda-approval-for-minimally-invasive-portico-with-flexnav-tavr-system-to-treat-patients-with-aortic-valve-disease-1030809994
764.0,9/20/2021 3:12:40 PM,Abbott Reports FDA Approval For Portico With FlexNav TAVR System - Quick Facts ,RTTNews,/news/stocks/abbott-reports-fda-approval-for-portico-with-flexnav-tavr-system-quick-facts-1030810073
765.0,9/22/2021 2:40:41 PM,7 Healthcare Stocks to Buy Now as the Pandemic Forces a Rethink,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-now-as-the-pandemic-forces-a-rethink-1030816434
766.0,9/23/2021 3:00:00 PM,Abbott Hosts Conference Call for Third-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-third-quarter-earnings-1030818999
767.0,9/24/2021 6:19:15 AM,COVID-19 test maker Cue Health prices 12.5M-share IPO at $16,Seeking Alpha,https://seekingalpha.com/news/3743862-covid-19-test-maker-cue-health-prices-125m-share-ipo-at-16?utm_source=markets.businessinsider.com&utm_medium=referral
768.0,9/24/2021 7:21:46 PM,FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations,Benzinga,/news/stocks/fda-establishes-additional-conditions-of-emergency-use-nod-for-covid-19-tests-for-viral-mutations-1030822366
769.0,9/30/2021 11:17:26 AM,Meet members of the 2021 IPO class: Healthcare - 2,Seeking Alpha,https://seekingalpha.com/news/3746475-meet-members-of-the-2021-ipo-class-healthcare-2?utm_source=markets.businessinsider.com&utm_medium=referral
770.0,9/30/2021 3:48:00 PM,Abbott Commits to Reducing Malnutrition Globally with Launch of Abbott Center for Malnutrition Solutions,PR Newswire,/news/stocks/abbott-commits-to-reducing-malnutrition-globally-with-launch-of-abbott-center-for-malnutrition-solutions-1030834363
771.0,10/11/2021 12:43:40 PM,ChemoCentryx appoints rheumatologist Rita I. Jain as chief medical officer,Seeking Alpha,https://seekingalpha.com/news/3751206-chemocentryx-appoints-rheumatologist-rita-i-jain-as-chief-medical-officer?utm_source=markets.businessinsider.com&utm_medium=referral
772.0,10/14/2021 5:18:23 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-14-2021-1030867192
773.0,10/14/2021 6:41:30 PM,Expert Ratings For Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1030867408
774.0,10/18/2021 1:00:00 PM,Abbott and Real Madrid Team Up to Support the Health and Nutrition of Children Globally,PR Newswire,/news/stocks/abbott-and-real-madrid-team-up-to-support-the-health-and-nutrition-of-children-globally-1030873217
775.0,10/18/2021 1:34:17 PM,"The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-18-23-j-j-biogen-kickstart-big-pharma-earnings-regeneron-sanofi-roche-await-fda-decisions-and-ipos-1030873336
776.0,10/18/2021 3:01:24 PM,Here's what Wall Street expects from Abbott Laboratories's earnings,Markets Insider Automation,/news/stocks/abbott_laboratories-q3-quarterly-earnings-preview-1030873640
777.0,10/18/2021 3:22:00 PM,"Jason Sudeikis Joins Abbott, Real Madrid at New York Stock Exchange to Support Children's Health",PR Newswire,/news/stocks/jason-sudeikis-joins-abbott-real-madrid-at-new-york-stock-exchange-to-support-children-s-health-1030873917
778.0,10/19/2021 3:06:57 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3755050-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
779.0,10/20/2021 1:30:00 PM,Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance,PR Newswire,/news/stocks/abbott-reports-third-quarter-2021-results-achieves-strong-double-digit-earnings-growth-and-raises-guidance-1030881349
780.0,10/20/2021 1:33:59 PM,Abbott Laboratories Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q3-adjusted-earnings-beat-estimates-1030881346
781.0,10/20/2021 1:41:19 PM,Abbott Laboratories Boosts FY21 Outlook - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-boosts-fy21-outlook-quick-facts-1030881374
782.0,10/20/2021 2:16:25 PM,"The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review",Benzinga,/news/stocks/the-daily-biotech-pulse-novavax-retreats-amid-vaccine-issues-lumiradx-covid-test-approved-in-india-sesen-shines-on-positive-bladder-cancer-review-1030881679
783.0,10/20/2021 4:34:30 PM,Abbot Labs and Biogen Outshine Novavax in the Health Care Sector,Benzinga,/news/stocks/abbot-labs-and-biogen-outshine-novavax-in-the-health-care-sector-1030882395
784.0,10/21/2021 1:46:38 PM,10 Biggest Price Target Changes For Thursday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-thursday-1030885393
785.0,10/21/2021 6:58:26 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1030886780
786.0,10/26/2021 2:07:45 PM,"Becton, Dickinson launches new rapid antigen test for COVID-19",Seeking Alpha,https://seekingalpha.com/news/3758130-becton-dickinson-launches-new-rapid-antigen-test-for-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral
787.0,10/27/2021 4:08:17 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-27-2021-1030905856
788.0,11/3/2021 2:00:00 PM,Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations,PR Newswire,/news/stocks/abbott-launches-new-initiative-to-drive-diversity-in-medical-research-and-improve-care-among-under-represented-populations-1030932063
789.0,11/3/2021 2:38:24 PM,7 Dividend Aristocrat Stocks That Should Grace Your Portfolio,InvestorPlace,/news/stocks/7-dividend-aristocrat-stocks-that-should-grace-your-portfolio-1030933089
790.0,11/5/2021 5:55:56 PM,10 S&P 500 Stocks to Buy After Winning in Q3,InvestorPlace,/news/stocks/10-sp-500-stocks-to-buy-after-winning-in-the-third-quarter-1030943473
791.0,11/9/2021 3:00:00 PM,"Abbott and the American Diabetes Association® Launch First-of-Its-Kind Community Initiative in Columbus, Ohio, to Advance Access to Diabetes Care and Technology",PR Newswire,/news/stocks/abbott-and-the-american-diabetes-association-launch-first-of-its-kind-community-initiative-in-columbus-ohio-to-advance-access-to-diabetes-care-and-technology-1030954266
792.0,11/12/2021 3:00:00 PM,Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial,PR Newswire,/news/stocks/abbott-s-new-leadless-pacemaker-system-meets-primary-endpoints-in-pivotal-trial-1030970204
793.0,11/12/2021 3:23:03 PM,Abbott's New Leadless Pacemaker System Meets Main Goal In Pivotal Trial ,RTTNews,/news/stocks/abbott-s-new-leadless-pacemaker-system-meets-main-goal-in-pivotal-trial-1030970266
794.0,11/15/2021 4:48:00 PM,Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow Jones Sustainability Index (DJSI),PR Newswire,/news/stocks/abbott-achieves-highest-score-in-its-industry-for-the-ninth-consecutive-year-on-the-dow-jones-sustainability-index-djsi-1030977044
795.0,11/15/2021 9:59:15 PM,Talis Biomedical appoints former Abbott executive as CEO,Seeking Alpha,https://seekingalpha.com/news/3771019-talis-biomedical-appoints-former-abbott-executive-as-ceo?utm_source=markets.businessinsider.com&utm_medium=referral
796.0,11/16/2021 2:30:12 PM,"The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment",Benzinga,/news/stocks/the-daily-biotech-pulse-kezar-jumps-on-data-biogen-r-d-chief-to-retire-molecular-partners-wilts-on-covid-trial-disappointment-1030980303
797.0,11/16/2021 7:00:00 PM,"Abbott Launches Similac® 360 Total Care® with Exclusive Blend of Five HMO Prebiotics and Designed to Support the Immune System, Digestive Health and Brain Development",PR Newswire,/news/stocks/abbott-launches-similac-360-total-care-with-exclusive-blend-of-five-hmo-prebiotics-and-designed-to-support-the-immune-system-digestive-health-and-brain-development-1030981619
798.0,11/29/2021 7:10:31 PM,3 Top Stock Trades for the Week,InvestorPlace,/news/stocks/3-top-stock-trades-for-the-week-1029510280
799.0,12/2/2021 4:01:44 PM,"At-home COVID tests to be covered by private insurance, Biden to announce - Reuters",Seeking Alpha,https://seekingalpha.com/news/3776489-at-home-covid-tests-to-be-covered-by-private-insurance-biden-to-announce-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
800.0,12/3/2021 9:32:33 PM,Even Good Penny Stocks Like Senseonics Aren’t Always Profitable,InvestorPlace,/news/stocks/even-good-penny-stocks-like-senseonics-arent-always-profitable-1031024049
801.0,12/6/2021 11:00:09 AM,7 Stocks to Buy to Give Your Portfolio a Booster Shot,InvestorPlace,/news/stocks/7-stocks-to-buy-to-give-portfolio-booster-shot-1031025563
802.0,12/10/2021 6:40:47 PM,"Abbott Laboratories raises quarterly dividend by ~4%, $5B authorized in share repurchase",Seeking Alpha,https://seekingalpha.com/news/3779238-abbott-laboratories-raises-quarterly-dividend-by-4-5b-authorized-in-share-repurchase?utm_source=markets.businessinsider.com&utm_medium=referral
803.0,12/10/2021 6:41:32 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-10-2021-1031039422
804.0,12/10/2021 7:00:00 PM,Abbott Increases Quarterly Dividend for 50th Consecutive Year,PR Newswire,/news/stocks/abbott-increases-quarterly-dividend-for-50th-consecutive-year-1031039455
805.0,12/10/2021 7:00:53 PM,Expert Ratings For Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1031039450
806.0,12/10/2021 7:08:46 PM,3 Healthcare Stocks for Long-Term Dividend Growth,InvestorPlace,/news/stocks/3-healthcare-stocks-for-long-term-dividend-growth-1031039566
807.0,12/10/2021 7:19:25 PM,"Abbott says White to retire as Executive Chair, names CEO Ford as Chairman",Seeking Alpha,https://seekingalpha.com/news/3779257-abbott-says-white-to-retire-as-executive-chair-names-ceo-ford-as-chairman?utm_source=markets.businessinsider.com&utm_medium=referral
808.0,12/10/2021 8:00:00 PM,Abbott Names Robert B. Ford Chairman of the Board; Miles D. White to Retire as Executive Chairman,PR Newswire,/news/stocks/abbott-names-robert-b-ford-chairman-of-the-board-miles-d-white-to-retire-as-executive-chairman-1031039555
809.0,12/15/2021 2:35:00 PM,"Diabetes tech market still has a clear favorite, Baird says",Seeking Alpha,https://seekingalpha.com/news/3780179-diabetes-tech-market-still-has-a-clear-favorite-baird-says?utm_source=markets.businessinsider.com&utm_medium=referral
810.0,12/16/2021 7:33:48 PM,"NYC to distribute 500K at-home COVID tests, 1M face masks to fight Omicron",Seeking Alpha,https://seekingalpha.com/news/3781020-nyc-to-distribute-500k-at-home-covid-tests-1m-kn95-masks-to-fight-omicron?utm_source=markets.businessinsider.com&utm_medium=referral
811.0,12/21/2021 3:00:00 PM,Abbott to Present at J.P. Morgan Healthcare Conference,PR Newswire,/news/stocks/abbott-to-present-at-j-p-morgan-healthcare-conference-1031059248
812.0,12/21/2021 4:26:35 PM,"As COVID cases and testing rises, test makers are mixed",Seeking Alpha,https://seekingalpha.com/news/3782381-as-covid-cases-and-testing-rises-test-makers-are-mixed?utm_source=markets.businessinsider.com&utm_medium=referral
813.0,12/22/2021 9:08:01 AM,"COVID roundup: More mandates, halving quarantine, FDA pill approval?",Seeking Alpha,https://seekingalpha.com/news/3782556-covid-roundup-israels-fourth-dose-halving-quarantine-fda-pill-approval?utm_source=markets.businessinsider.com&utm_medium=referral
814.0,12/24/2021 9:37:35 PM,COVID uptick to hurt MedTech firms and healthcare providers in early 2022 - Goldman Sachs,Seeking Alpha,https://seekingalpha.com/news/3783326-covid-uptick-to-hurt-medtech-firms-and-healthcare-providers-in-early-2022-goldman-sachs?utm_source=markets.businessinsider.com&utm_medium=referral
815.0,12/27/2021 2:09:56 PM,Abbott price target raised at Raymond James on benefiting from COVID wave,Seeking Alpha,https://seekingalpha.com/news/3783417-abbott-price-target-raised-at-raymond-james-on-benefiting-from-covid-wave?utm_source=markets.businessinsider.com&utm_medium=referral
816.0,12/27/2021 4:21:53 PM,"As demand surges, at-home COVID test makers rise led by Cue Health and Lucira Health",Seeking Alpha,https://seekingalpha.com/news/3783460-as-demand-surges-at-home-covid-test-makers-continue-to-rise?utm_source=markets.businessinsider.com&utm_medium=referral
817.0,12/27/2021 7:33:40 PM,"As demand surges, at-home COVID test makers rise led by Cue Health and Lucira Health",Seeking Alpha,https://seekingalpha.com/news/3783460-as-demand-surges-at-home-covid-test-makers-continue-to-rise-led-by-cue-health-and-lucira-health?utm_source=markets.businessinsider.com&utm_medium=referral
818.0,12/28/2021 8:50:51 PM,"FDA: COVID antigen tests can detect Omicron, but there may be some false negatives",Seeking Alpha,https://seekingalpha.com/news/3783764-fda-covid-antigen-tests-can-detect-omicron-but-there-may-be-some-false-negatives?utm_source=markets.businessinsider.com&utm_medium=referral
819.0,12/30/2021 7:42:41 PM,Best Stocks for 2022: Why AbbVie Looks Like High Dividend Growth Stock,InvestorPlace,/news/stocks/best-stocks-for-2022-why-abbvie-abbv-stock-looks-like-high-dividend-growth-stock-1031071815
820.0,1/3/2022 4:28:09 PM,"Abbott, Baxter among MedTech favorites at Raymond James for early 2022",Seeking Alpha,https://seekingalpha.com/news/3784631-abbott-baxter-among-medtech-favorites-at-raymond-james-for-early-2022?utm_source=markets.businessinsider.com&utm_medium=referral
821.0,1/3/2022 11:09:10 PM,"6 Stocks Taking Center Stage At CES 2022, Including For The First Time A Healthcare Company",Benzinga,/news/stocks/6-stocks-taking-center-stage-at-ces-2022-including-for-the-first-time-a-healthcare-company-1031074929
822.0,1/4/2022 3:00:00 PM,Abbott's Proclaim™ XR Spinal Cord Stimulation System Now Offers Expanded MRI Compatibility in U.S.,PR Newswire,/news/stocks/abbott-s-proclaim-xr-spinal-cord-stimulation-system-now-offers-expanded-mri-compatibility-in-u-s-1031076199
823.0,1/4/2022 3:08:07 PM,FDA expands MRI compatibility for Abbott's Proclaim XR Spinal Cord Stimulation System,Seeking Alpha,https://seekingalpha.com/news/3785008-fda-expands-mri-compatibility-for-abbotts-proclaim-xr-spinal-cord-stimulation-system?utm_source=markets.businessinsider.com&utm_medium=referral
824.0,1/4/2022 5:44:53 PM,US FDA approves expanded MRI compatibility for Abbott's Proclaim XR system,Seeking Alpha,https://seekingalpha.com/news/3785149-us-fda-approves-expanded-mri-compatibility-for-abbotts-proclaim-xr-system?utm_source=markets.businessinsider.com&utm_medium=referral
825.0,1/4/2022 7:08:56 PM,"Walmart, Kroger increase prices for Abbott rapid COVID-19 antigen tests",Seeking Alpha,https://seekingalpha.com/news/3785169-walmart-kroger-increase-prices-for-abbott-rapid-covid-19-antigen-tests?utm_source=markets.businessinsider.com&utm_medium=referral
826.0,1/4/2022 11:00:00 PM,Abbott Hosts Conference Call for Fourth-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-fourth-quarter-earnings-1031077864
827.0,1/5/2022 9:26:40 AM,CES 2022: What to expect at the Consumer Electronics Show,Seeking Alpha,https://seekingalpha.com/news/3785276-ces-2022-what-to-expect-at-the-consumer-electronics-show?utm_source=markets.businessinsider.com&utm_medium=referral
828.0,1/5/2022 6:17:57 PM,Rapid antigen tests lag PCR tests in early detection of COVID-19 - study,Seeking Alpha,https://seekingalpha.com/news/3785522-rapid-antigen-tests-lag-pcr-tests-in-early-detection-of-covid-19-study?utm_source=markets.businessinsider.com&utm_medium=referral
829.0,1/6/2022 7:15:00 PM,Abbott Announces Future of Biowearables at Consumer Electronics Show,PR Newswire,/news/stocks/abbott-announces-future-of-biowearables-at-consumer-electronics-show-1031082311
830.0,1/6/2022 9:24:33 PM,Abbott aims to increase production of home COVID tests to 100M per month - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3786007-abbott-aims-to-increase-production-of-home-covid-tests-to-100m-per-month-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral
831.0,1/10/2022 8:01:06 PM,"3 Top Stock Trades for the Week of Jan. 10, 2022",InvestorPlace,/news/stocks/3-top-stock-trades-for-the-week-of-jan-10-2022-1031091902
832.0,1/10/2022 10:57:12 PM,Private health insurers must cover up to 8 at-home COVID tests per month per person,Seeking Alpha,https://seekingalpha.com/news/3786901-private-health-insurers-must-cover-up-to-8-at-home-covid-tests-per-month-per-person?utm_source=markets.businessinsider.com&utm_medium=referral
833.0,1/11/2022 1:45:00 PM,ACELYRIN Appoints Melanie Gloria as Chief Operating Officer,PR Newswire,/news/stocks/acelyrin-appoints-melanie-gloria-as-chief-operating-officer-1031093657
834.0,1/12/2022 2:29:44 PM,Abbott gets FDA clearance for cardiac mapping system to treat abnormal heart rhythms,Seeking Alpha,https://seekingalpha.com/news/3787505-abbott-gets-fda-clearance-for-cardiac-mapping-system-to-treat-abnormal-heart-rhythms?utm_source=markets.businessinsider.com&utm_medium=referral
835.0,1/12/2022 3:00:00 PM,Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms,PR Newswire,/news/stocks/abbott-receives-u-s-fda-clearance-for-new-cardiac-mapping-system-to-improve-how-doctors-treat-abnormal-heart-rhythms-1031097079
836.0,1/12/2022 3:31:01 PM,Abbott Receives FDA Clearance For Cardiac Mapping System ,RTTNews,/news/stocks/abbott-receives-fda-clearance-for-cardiac-mapping-system-1031097244
837.0,1/17/2022 4:32:10 PM,Abbott Labs awarded $310M army contract,Seeking Alpha,https://seekingalpha.com/news/3788516-abbott-labs-awarded-310m-army-contract?utm_source=markets.businessinsider.com&utm_medium=referral
838.0,1/19/2022 11:00:09 AM,3 Dividend Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-and-hold-forever-abbv-kr-cvx-1031111966
839.0,1/19/2022 5:51:57 PM,DexCom raised to Overweight at Wells Fargo on upcoming catalyst and sales potential,Seeking Alpha,https://seekingalpha.com/news/3789296-dexcom-raised-to-overweight-at-wells-fargo-on-upcoming-catalyst-and-sales-potential?utm_source=markets.businessinsider.com&utm_medium=referral
840.0,1/20/2022 7:29:04 PM,3 Dividend Aristocrats Yielding Over 4%,InvestorPlace,/news/stocks/3-dividend-aristocrats-yielding-over-4-1031117369
841.0,1/21/2022 8:21:49 PM,USPS begins shipping free at-home COVID-19 rapid tests,Seeking Alpha,https://seekingalpha.com/news/3790428-usps-begins-shipping-free-at-home-covid-19-rapid-tests?utm_source=markets.businessinsider.com&utm_medium=referral
842.0,1/25/2022 3:01:13 PM,Abbott Laboratories is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-price-quarter-earnings-preview-q4-1031126422
843.0,1/25/2022 3:30:55 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3791285-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
844.0,1/25/2022 4:02:13 PM,Will Abbott Laboratories maintain EPS beat run in Q4 amid COVID challenges?,Seeking Alpha,https://seekingalpha.com/news/3791300-will-abbott-laboratories-maintain-eps-beat-run-in-q4-amid-covid-challenges?utm_source=markets.businessinsider.com&utm_medium=referral
845.0,1/26/2022 12:31:14 PM,"Abbott Laboratories Non-GAAP EPS of $1.32 beats by $0.11, revenue of $11.5B beats by $790M",Seeking Alpha,https://seekingalpha.com/news/3791701-abbott-laboratories-non-gaap-eps-of-1_32-beats-0_11-revenue-of-11_5b-beats-790m?utm_source=markets.businessinsider.com&utm_medium=referral
846.0,1/26/2022 1:17:31 PM,Abbott beats Street estimates on top and bottom lines; COVID-19 testing sales reached $2.3B,Seeking Alpha,https://seekingalpha.com/news/3791736-abbott-beats-street-estimates-on-top-and-bottom-lines-covid-19-testing-sales-reached-23b?utm_source=markets.businessinsider.com&utm_medium=referral
847.0,1/26/2022 1:30:00 PM,Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast,PR Newswire,/news/stocks/abbott-reports-strong-fourth-quarter-2021-results-issues-2022-forecast-1031130382
848.0,1/26/2022 1:52:02 PM,Abbott Q4 Profit Tops Estimates; Net Sales Up 7.7% On Organic Basis ,RTTNews,/news/stocks/abbott-q4-profit-tops-estimates-net-sales-up-7-7-on-organic-basis-1031130558
849.0,1/26/2022 2:29:25 PM,"The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data",Benzinga,/news/stocks/the-daily-biotech-pulse-gilead-s-blood-cancer-studies-placed-on-partial-clinical-hold-immunocore-gets-fda-nod-nrx-touts-positive-covid-19-data-1031130804
850.0,1/27/2022 6:02:35 PM,What 5 Analyst Ratings Have To Say About Abbott Laboratories,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-abbott-laboratories-1031136557
851.0,1/28/2022 6:15:32 PM,7 Technology Stocks Reporting Earnings the Week of January 31,InvestorPlace,/news/stocks/earnings-reports-to-watch-next-week-1028709625
852.0,1/31/2022 4:09:17 PM,Abbott on a roll since reporting Q4 earnings last week; shares up 6% since then,Seeking Alpha,https://seekingalpha.com/news/3793580-abbott-on-a-roll-since-reporting-q4-earnings-last-week-shares-up-6-since-then?utm_source=markets.businessinsider.com&utm_medium=referral
853.0,2/7/2022 3:00:00 PM,Abbott Announces World's First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial,PR Newswire,/news/stocks/abbott-announces-world-s-first-implant-of-dual-chamber-leadless-pacemaker-in-pivotal-trial-1031167297
854.0,2/17/2022 11:11:00 PM,Abbott Voluntarily Recalls Powder Formulas Manufactured at One Plant,PR Newswire,/news/stocks/abbott-voluntarily-recalls-powder-formulas-manufactured-at-one-plant-1031206683
855.0,2/18/2022 12:08:14 PM,Abbott issues voluntary recall of certain infant formulas,Seeking Alpha,https://seekingalpha.com/news/3801866-abt-stock-lower-after-voluntary-recall-of-certain-infant-formulas?utm_source=markets.businessinsider.com&utm_medium=referral
856.0,2/18/2022 4:36:24 PM,Abbott Laboratories declares $0.47 dividend,Seeking Alpha,https://seekingalpha.com/news/3801995-abbott-laboratories-declares-0_47-dividend?utm_source=markets.businessinsider.com&utm_medium=referral
857.0,2/18/2022 5:26:00 PM,Abbott Declares 393rd Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-393rd-consecutive-quarterly-dividend-1031209210
858.0,2/18/2022 10:16:33 PM,Abbott infant formula recall could mean $325M revenue hit - Cowen,Seeking Alpha,https://seekingalpha.com/news/3802189-abbott-infant-formula-recall-could-mean-325m-revenue-hit-cowen?utm_source=markets.businessinsider.com&utm_medium=referral
859.0,2/21/2022 1:42:42 PM,China warns against use of certain Abbott formula products after U.S. recall,Seeking Alpha,https://seekingalpha.com/news/3802225-abt-stock-in-focus-as-china-warns-against-products-after-us-recall?utm_source=markets.businessinsider.com&utm_medium=referral
860.0,2/21/2022 3:00:00 PM,Abbott's CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure,PR Newswire,/news/stocks/abbott-s-cardiomems-hf-system-receives-fda-approval-to-support-patients-battling-earlier-stage-heart-failure-1031212652
861.0,2/21/2022 3:18:02 PM,FDA Approves Expanded Indication For Abbott's CardioMEMS HF System ,RTTNews,/news/stocks/fda-approves-expanded-indication-for-abbott-s-cardiomems-hf-system-1031212728
862.0,2/23/2022 5:32:21 PM,Abbott CardioMEMS HF System gains expanded heart failure indication,Seeking Alpha,https://seekingalpha.com/news/3804354-abbott-cardiomems-hf-system-gains-expanded-heart-failure-indication?utm_source=markets.businessinsider.com&utm_medium=referral
863.0,3/1/2022 9:36:49 PM,Abbott Recalls Another Lot Of Simila After A Second Infant-fatality ,RTTNews,/news/stocks/abbott-recalls-another-lot-of-simila-after-a-second-infant-fatality-1031244546
864.0,3/2/2022 11:22:37 AM,Abbott expands voluntary recall of infant formula after FDA informs of 2nd infant death,Seeking Alpha,https://seekingalpha.com/news/3808301-abbott-expands-voluntary-recall-of-infant-formula-after-fda-informs-of-2nd-infant-death?utm_source=markets.businessinsider.com&utm_medium=referral
865.0,3/2/2022 8:48:55 PM,36 Stocks To Watch After Biden's First State of The Union Address,Benzinga,/news/stocks/36-stocks-to-watch-after-biden-s-first-state-of-the-union-address-1031248946
866.0,3/3/2022 11:00:45 AM,7 Long-Term Stocks to Buy Now and Hold Forever,InvestorPlace,/news/stocks/7-long-term-stocks-to-buy-now-and-hold-forever-1031250895
867.0,3/7/2022 4:39:22 PM,U.S. supplies of COVID-19 therapies and vaccines at risk amid funding dispute,Seeking Alpha,https://seekingalpha.com/news/3810273-dispute-with-gop-senators-could-jeopardize-additional-finding-for-covid-19-treatments?utm_source=markets.businessinsider.com&utm_medium=referral
868.0,3/12/2022 7:20:14 PM,Drugmakers face clinical trial disruptions amid Russia - Ukraine conflict,Seeking Alpha,https://seekingalpha.com/news/3812903-drugmakers-face-clinical-trial-disruptions-amid-russia-ukraine-conflict?utm_source=markets.businessinsider.com&utm_medium=referral
869.0,3/22/2022 9:45:34 PM,FDA inspection found violations at Abbott infant formula plant months before recall,Seeking Alpha,https://seekingalpha.com/news/3816229-fda-inspection-found-violations-at-abbott-infant-formula-plant-months-before-recall?utm_source=markets.businessinsider.com&utm_medium=referral
870.0,3/23/2022 7:50:36 PM,Cue Health plunges to a post-IPO low as COVID-19 test makers drop,Seeking Alpha,https://seekingalpha.com/news/3816623-hlth-stock-plunges-to-post-ipo-low-as-covid-19-test-makers-drop?utm_source=markets.businessinsider.com&utm_medium=referral
871.0,3/24/2022 2:00:00 PM,Abbott's FreeStyle® Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin,PR Newswire,/news/stocks/abbott-s-freestyle-libre-is-first-and-only-cgm-system-to-gain-expanded-reimbursement-in-japan-to-include-all-people-with-diabetes-who-use-insulin-1031304977
872.0,3/24/2022 3:42:17 PM,Abbott's glucose monitoring system FreeStyle gets expanded reimbursement in Japan,Seeking Alpha,https://seekingalpha.com/news/3817014-abbotts-glucose-monitoring-system-freestyle-gets-expanded-reimbursement-in-japan?utm_source=markets.businessinsider.com&utm_medium=referral
873.0,3/24/2022 9:45:45 PM,Abbott granted $1B U.S. Army contract for COVID-19 test kits,Seeking Alpha,https://seekingalpha.com/news/3817288-abbott-granted-1b-us-army-contract-for-covid-19-test-kits?utm_source=markets.businessinsider.com&utm_medium=referral
874.0,3/28/2022 3:00:00 PM,Abbott Hosts Conference Call for First-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-first-quarter-earnings-1031312031
875.0,3/30/2022 1:30:00 PM,Abbott and LISC Team Up to Address Diversity and Equity Gaps in the Healthcare Industry Supply Chain,PR Newswire,/news/stocks/abbott-and-lisc-team-up-to-address-diversity-and-equity-gaps-in-the-healthcare-industry-supply-chain-1031318457
876.0,4/4/2022 2:10:57 PM,Baxter cut to Sell as Goldman Sachs flags macro risks in MedTech space,Seeking Alpha,https://seekingalpha.com/news/3820395-baxter-cut-to-sell-as-goldman-sachs-flags-macro-concerns-on-medtech-space?utm_source=markets.businessinsider.com&utm_medium=referral
877.0,4/4/2022 3:00:00 PM,Abbott Receives FDA Approval for Aveir™ VR Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms,PR Newswire,/news/stocks/abbott-receives-fda-approval-for-aveir-vr-leadless-pacemaker-system-to-treat-patients-with-slow-heart-rhythms-1031330035
878.0,4/4/2022 3:40:17 PM,Abbott: FDA Approves Aveir Pacemaker For Treatment Of Patients With Slow Heart Rhythms ,RTTNews,/news/stocks/abbott-fda-approves-aveir-pacemaker-for-treatment-of-patients-with-slow-heart-rhythms-1031330258
879.0,4/8/2022 11:35:39 AM,"Best Stocks for 2022: Up 20% This Year, AbbVie Is Doing Great",InvestorPlace,/news/stocks/best-stocks-for-2022-up-20-this-year-abbv-stock-is-doing-great-1031342773
880.0,4/12/2022 1:31:27 PM,Retailers Ration Baby Formula Sales Amid Widespread Shortage ,RTTNews,/news/stocks/retailers-ration-baby-formula-sales-amid-widespread-shortage-1031349330
881.0,4/14/2022 9:27:57 PM,Raymond James Thinks Med Tech Investors are Somewhat 'Paralyzed' Ahead Of Q1 Earnings,Benzinga,/news/stocks/raymond-james-thinks-med-tech-investors-are-somewhat-paralyzed-ahead-of-q1-earnings-1031357902
882.0,4/17/2022 8:31:32 PM,"The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-april-17-april-23-j-j-abbott-earnings-adcom-test-for-tg-therapeutics-and-more-1031359853
883.0,4/19/2022 12:02:36 PM,Abbott contaminated-baby-formula probe faces uncertainty - WSJ,Seeking Alpha,https://seekingalpha.com/news/3824225-abbott-contaminated-baby-formula-probe-faces-uncertainty-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
884.0,4/19/2022 2:53:30 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3824327-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
885.0,4/19/2022 3:01:13 PM,Abbott Laboratories earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-quarter-earnings-preview-q1-1031364014
886.0,4/19/2022 3:47:20 PM,Abbott's Q1 result to be a litmus test for COVID-19 test demand,Seeking Alpha,https://seekingalpha.com/news/3824353-abbotts-q1-result-to-be-a-litmus-test-for-covid-19-test-demand?utm_source=markets.businessinsider.com&utm_medium=referral
887.0,4/19/2022 8:19:41 PM,"This Week's Earnings Spotlight: Tesla, Netflix, IBM, American Express, Snap And More",Benzinga,/news/stocks/this-week-s-earnings-spotlight-tesla-netflix-ibm-american-express-snap-and-more-1031365103
888.0,4/20/2022 11:31:04 AM,"Abbott Laboratories Non-GAAP EPS of $1.73 beats by $0.27, revenue of $11.9B beats by $900M",Seeking Alpha,https://seekingalpha.com/news/3824658-abbott-laboratories-non-gaap-eps-of-1_73-beats-0_27-revenue-of-11_9b-beats-900m?utm_source=markets.businessinsider.com&utm_medium=referral
889.0,4/20/2022 12:03:17 PM,Abbott Laboratories declares $0.47 dividend,Seeking Alpha,https://seekingalpha.com/news/3824672-abbott-laboratories-declares-dividend?utm_source=markets.businessinsider.com&utm_medium=referral
890.0,4/20/2022 12:29:44 PM,"Abbott beats revenue, profit estimates on strong COVID test demand; 2022 forecast unchanged",Seeking Alpha,https://seekingalpha.com/news/3824690-abbott-beats-street-revenue-profit-estimates-on-strong-covid-test-demand-2022-forecast-unchanged?utm_source=markets.businessinsider.com&utm_medium=referral
891.0,4/20/2022 1:30:00 PM,Abbott Reports First-Quarter 2022 Results,PR Newswire,/news/stocks/abbott-reports-first-quarter-2022-results-1031367614
892.0,4/20/2022 1:34:52 PM,"Abbott Laboratories Q1 Profit Increases, beats estimates",RTTNews,/news/stocks/abbott-laboratories-q1-profit-increases-beats-estimates-1031367654
893.0,4/20/2022 2:13:16 PM,Abbott: FY22 Adj. EPS Guidance Remains Unchanged ,RTTNews,/news/stocks/abbott-fy22-adj-eps-guidance-remains-unchanged-1031367856
894.0,4/20/2022 3:28:06 PM,"Benzinga's Daily Brief On Trending Tickers For April 20, 2022: Procter & Gamble, Lululemon, Netflix, And More",Benzinga,/news/stocks/benzinga-s-daily-brief-on-trending-tickers-for-april-20-2022-procter-gamble-lululemon-netflix-and-more-1031368314
895.0,4/21/2022 10:20:16 AM,"Abbott Q1 EPS, Sales Rise, ANTM Hits All-time High, Healthcare Services' Q1 Results Trump Estimates ",RTTNews,/news/stocks/abbott-q1-eps-sales-rise-antm-hits-all-time-high-healthcare-services-q1-results-trump-estimates-1031370869
896.0,4/21/2022 3:28:58 PM,Expert Ratings for Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1031372164
897.0,4/21/2022 9:43:38 PM,"What Does Raymond James, Wells Fargo Have To Say On Abbott's Q1 Earnings",Benzinga,/news/stocks/what-does-raymond-james-wells-fargo-have-to-say-on-abbott-s-q1-earnings-1031373178
898.0,4/22/2022 10:15:59 AM,7 Stocks to Buy If You Think Inflation Is Topping Out,InvestorPlace,/news/stocks/7-stocks-to-buy-if-you-think-inflation-topping-out-1031374796
899.0,4/25/2022 3:00:00 PM,Abbott Strengthens Its Connected Care Technologies with Latest NeuroSphere™ myPath™ Digital Health App,PR Newswire,/news/stocks/abbott-strengthens-its-connected-care-technologies-with-latest-neurosphere-mypath-digital-health-app-1031380293
900.0,4/26/2022 10:16:16 AM,3 Dividend Stocks for Value Investors Seeking Regular Income,InvestorPlace,/news/stocks/dividend-stocks-investors-seeking-income-1031384022
901.0,4/26/2022 3:00:00 PM,Abbott Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Investment Corporation,PR Newswire,/news/stocks/abbott-recommends-rejection-of-below-market-mini-tender-offer-by-trc-capital-investment-corporation-1031385148
902.0,4/26/2022 5:12:05 PM,EXCLUSIVE: Verano CIO Aaron Miles Says Company Is 'Strategically Building' As Crucial Markets Come Online,Benzinga,/news/stocks/exclusive-verano-cio-aaron-miles-says-company-is-strategically-building-as-crucial-markets-come-online-1031385748
903.0,4/27/2022 1:14:16 PM,"Abbott, CamDiab, Ypsomed partner to develop automated insulin delivery system",Seeking Alpha,https://seekingalpha.com/news/3827588-abbott-camdiab-ypsomed-partner-to-develop-automated-insulin-delivery-system?utm_source=markets.businessinsider.com&utm_medium=referral
904.0,4/27/2022 2:00:00 PM,"Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes",PR Newswire,/news/stocks/abbott-camdiab-and-ypsomed-unveil-new-automated-insulin-delivery-partnership-for-people-with-diabetes-1031390668
905.0,4/28/2022 1:00:00 PM,New Analysis Shows that Abbott's FreeStyle Libre® System Provides Similar and Sustained Reductions in Glucose Levels for People with Both Type 1 and Type 2 Diabetes,PR Newswire,/news/stocks/new-analysis-shows-that-abbott-s-freestyle-libre-system-provides-similar-and-sustained-reductions-in-glucose-levels-for-people-with-both-type-1-and-type-2-diabetes-1031396577
906.0,4/28/2022 3:00:00 PM,Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer™ Steerable Delivery Sheath for the Company's Amulet™ Device,PR Newswire,/news/stocks/abbott-strengthens-left-atrial-appendage-closure-leadership-with-u-s-availability-of-amplatzer-steerable-delivery-sheath-for-the-company-s-amulet-device-1031397579
907.0,4/29/2022 3:00:00 PM,Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months,PR Newswire,/news/stocks/study-finds-89-of-patients-treated-for-persistent-atrial-fibrillation-using-abbott-s-ablation-device-remain-symptom-free-for-at-least-15-months-1031402573
908.0,4/29/2022 10:35:00 PM,Abbott to Release Metabolic Nutrition Formulas,PR Newswire,/news/stocks/abbott-to-release-metabolic-nutrition-formulas-1031403702
909.0,5/2/2022 10:15:00 AM,Morgan Stanley issues list of 45 highest conviction stock picks,Seeking Alpha,https://seekingalpha.com/news/3829447-morgan-stanley-issues-list-of-45-highest-conviction-stock-picks?utm_source=markets.businessinsider.com&utm_medium=referral
910.0,5/2/2022 12:23:58 PM,Abbott to release certain batches of baby formulas,Seeking Alpha,https://seekingalpha.com/news/3829938-abbott-to-release-certain-batches-of-baby-formulas?utm_source=markets.businessinsider.com&utm_medium=referral
911.0,5/4/2022 1:26:34 PM,Abbott gets FDA clearance for test detecting 4 sexually transmitted infections,Seeking Alpha,https://seekingalpha.com/news/3832016-abbott-gets-fda-clearance-for-test-detecting-4-sexually-transmitted-infections?utm_source=markets.businessinsider.com&utm_medium=referral
912.0,5/4/2022 3:00:00 PM,Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise,PR Newswire,/news/stocks/abbott-obtains-fda-clearance-for-first-test-that-simultaneously-detects-four-common-sexually-transmitted-infections-stis-as-cases-are-on-the-rise-1031419833
913.0,5/4/2022 3:20:45 PM,Abbott Gets FDA Clearance For Alinity M STI Assay Test - Quick Facts ,RTTNews,/news/stocks/abbott-gets-fda-clearance-for-alinity-m-sti-assay-test-quick-facts-1031420473
914.0,5/10/2022 1:27:46 PM,"CVS, Walgreens and Target limit baby formula purchases amid supply constraints",Seeking Alpha,https://seekingalpha.com/news/3835946-cvs-walgreens-and-target-limit-baby-formula-purchases-amid-supply-constraints?utm_source=markets.businessinsider.com&utm_medium=referral
915.0,5/11/2022 3:00:00 PM,Abbott and Women as One Partner to Help More Underrepresented Physicians Lead Clinical Trials,PR Newswire,/news/stocks/abbott-and-women-as-one-partner-to-help-more-underrepresented-physicians-lead-clinical-trials-1031448593
916.0,5/11/2022 6:45:47 PM,FDA allows Abbott to release baby formula from plant amid nationwide shortage,Seeking Alpha,https://seekingalpha.com/news/3837096-fda-allows-abbott-to-release-baby-formula-from-plant-amid-nationwide-shortage?utm_source=markets.businessinsider.com&utm_medium=referral
917.0,5/13/2022 2:49:33 AM,White House announces actions to address baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3837883-biden-to-meet-retailers-manufacturers-to-address-baby-formula-shortage?utm_source=markets.businessinsider.com&utm_medium=referral
918.0,5/13/2022 3:17:51 PM,U.S. lawmakers launch probe into baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3838682-us-lawmakers-launch-probe-on-baby-formula-shortage-abc-news?utm_source=markets.businessinsider.com&utm_medium=referral
919.0,5/13/2022 5:44:27 PM,Perrigo CEO Kessler says to expect baby formula shortage through rest of year - Reuters,Seeking Alpha,https://seekingalpha.com/news/3838771-perrigo-ceo-kessler-says-to-expect-baby-formula-shortage-through-rest-of-year-reuters?utm_source=markets.businessinsider.com&utm_medium=referral
920.0,5/13/2022 6:18:42 PM,CDC completes Abbott baby formula probe,Seeking Alpha,https://seekingalpha.com/news/3838794-abt-stock-on-watch-as-cdc-completes-baby-formula-probe?utm_source=markets.businessinsider.com&utm_medium=referral
921.0,5/16/2022 1:26:24 PM,FDA to investigate why inspection of Abbott baby formula plant took so long - NBC News,Seeking Alpha,https://seekingalpha.com/news/3839178-fda-to-investigate-why-inspection-of-abbott-baby-formula-similac-plant-took-so-long-nbc-news?utm_source=markets.businessinsider.com&utm_medium=referral
922.0,5/16/2022 5:04:30 PM,"U.S. to offer transport, logistics support to baby formula makers to overcome shortage",Seeking Alpha,https://seekingalpha.com/news/3839347-us-to-offer-transport-logistics-support-to-address-baby-formula-shortage?utm_source=markets.businessinsider.com&utm_medium=referral
923.0,5/16/2022 8:39:54 PM,Abbott and FDA agree on steps to reopen baby formula production plant,Seeking Alpha,https://seekingalpha.com/news/3839529-abbott-and-fda-agree-on-steps-to-reopen-baby-formula-production-plant?utm_source=markets.businessinsider.com&utm_medium=referral
924.0,5/16/2022 10:22:00 PM,"Abbott Enters into Consent Decree with U.S. Food and Drug Administration for its Sturgis, Mich., Plant; Agreement Creates Pathway to Reopen Facility",PR Newswire,/news/stocks/abbott-enters-into-consent-decree-with-u-s-food-and-drug-administration-for-its-sturgis-mich-plant-agreement-creates-pathway-to-reopen-facility-1031465888
925.0,5/16/2022 11:21:57 PM,Baby formula imports allowed under FDA guidance to address nationwide shortage,Seeking Alpha,https://seekingalpha.com/news/3839683-baby-formula-imports-allowed-under-fda-guidance-to-address-nationwide-shortage?utm_source=markets.businessinsider.com&utm_medium=referral
926.0,5/17/2022 4:03:45 AM,Abbott Reaches Agreement With FDA To Restart Baby Formula Production Amid U.S. Shortage ,RTTNews,/news/stocks/abbott-reaches-agreement-with-fda-to-restart-baby-formula-production-amid-u-s-shortage-1031466360
927.0,5/17/2022 1:52:20 PM,"Abbott price target cut at Citi on higher inflation, slowing growth",Seeking Alpha,https://seekingalpha.com/news/3839997-abbott-price-target-cut-at-citi-on-higher-inflation-slowing-growth?utm_source=markets.businessinsider.com&utm_medium=referral
928.0,5/17/2022 2:07:56 PM,"Morning Brief: Top Financial Stories Dominating on Tuesday, May 17",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-tuesday-may-17-1031468262
929.0,5/17/2022 3:32:23 PM,ABT Stock Climbs as Abbott Reaches a Baby Formula Deal With the FDA,InvestorPlace,/news/stocks/abt-stock-climbs-as-abbott-reaches-a-baby-formula-deal-with-the-fda-1031469387
930.0,5/17/2022 4:09:37 PM,Nano Dimension (NNDM) Stock Gains 10% on Share Buyback News,InvestorPlace,/news/stocks/nano-dimension-nndm-stock-gains-10-on-share-buyback-news-1031469456
931.0,5/17/2022 4:56:22 PM,Nestlé exporting baby formula from Europe to alleviate shortage - WSJ,Seeking Alpha,https://seekingalpha.com/news/3840100-nestle-exporting-baby-formula-from-europe-to-alleviate-shortage-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
932.0,5/17/2022 7:04:14 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1031469588
933.0,5/17/2022 7:18:54 PM,Abbott shares spike after deal with FDA to reopen baby formula plant,Seeking Alpha,https://seekingalpha.com/news/3840146-abt-stock-spikes-after-deal-with-fda-to-reopen-formula-plan?utm_source=markets.businessinsider.com&utm_medium=referral
934.0,5/18/2022 5:05:37 PM,"Abbott tax, stock buyback practices focus of new probe by Sen. Wyden",Seeking Alpha,https://seekingalpha.com/news/3840558-abbott-tax-stock-buyback-practices-focus-of-new-probe-by-sen-wyden?utm_source=markets.businessinsider.com&utm_medium=referral
935.0,5/18/2022 9:24:54 PM,FDA Commissioner Califf to testify on baby formula shortage at House hearing Thursday,Seeking Alpha,https://seekingalpha.com/news/3840698-fda-commissioner-califf-to-testify-on-baby-formula-shortage-at-house-hearing-thursday?utm_source=markets.businessinsider.com&utm_medium=referral
936.0,5/18/2022 10:16:18 PM,7 Best Value Stocks to Buy if You Need Some Market Stability in Your Life ,InvestorPlace,/news/stocks/7-best-value-stocks-to-buy-if-you-need-some-market-stability-in-your-life-1031473820
937.0,5/18/2022 11:15:34 PM,Biden invokes Defense Production Act to alleviate baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3840720-biden-invokes-defense-production-act-to-alleviate-baby-formula-shortage?utm_source=markets.businessinsider.com&utm_medium=referral
938.0,5/19/2022 3:15:00 PM,New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies,PR Newswire,/news/stocks/new-late-breaking-data-highlight-abbott-structural-heart-transcatheter-valve-therapies-1031475958
939.0,5/19/2022 3:35:00 PM,Abbott Presents Data Reinforcing Impact Of Its Minimally Invasive Heart Devices ,RTTNews,/news/stocks/abbott-presents-data-reinforcing-impact-of-its-minimally-invasive-heart-devices-1031476036
940.0,5/19/2022 7:00:21 PM,Abbott in focus as U.S. lawmakers question FDA chief over baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3841101-abbott-in-focus-as-us-lawmakers-question-fda-chief-over-baby-formula-shortage?utm_source=markets.businessinsider.com&utm_medium=referral
941.0,5/20/2022 1:06:56 PM,Does Abbott become a buy following a deal to bring its baby formula plant back online?,Seeking Alpha,https://seekingalpha.com/news/3841206-abbotts-stock-hit-a-52-week-low-last-week-is-now-the-time-to-buy?utm_source=markets.businessinsider.com&utm_medium=referral
942.0,5/20/2022 1:09:55 PM,Danone ramps up baby formula shipments to U.S. after Abbott recall - Reuters,Seeking Alpha,https://seekingalpha.com/news/3841347-danone-boosts-baby-formula-shipments-to-us?utm_source=markets.businessinsider.com&utm_medium=referral
943.0,5/23/2022 12:57:14 PM,Morgan Stanley names 15 stocks that can weather a bear market,Seeking Alpha,https://seekingalpha.com/news/3841671-morgan-stanley-15-stocks-that-can-weather-a-bear-market?utm_source=markets.businessinsider.com&utm_medium=referral
944.0,5/23/2022 8:43:11 PM,Abbott should continue baby formula rebates throughout 2022 - Senators,Seeking Alpha,https://seekingalpha.com/news/3841976-abbott-should-continue-baby-formula-rebates-throughout-2022-senators?utm_source=markets.businessinsider.com&utm_medium=referral
945.0,5/24/2022 1:03:16 AM,Insulet jumps on report Dexcom in talks to acquire,Seeking Alpha,https://seekingalpha.com/news/3842032-insulet-jumps-on-report-dexcom-in-talks-to-acquire?utm_source=markets.businessinsider.com&utm_medium=referral
946.0,5/24/2022 7:37:12 PM,Federal Trade Commission launches probe on baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3842378-abt-stock-lower-as-ftc-launches-probe-on-baby-formula-shortage?utm_source=markets.businessinsider.com&utm_medium=referral
947.0,5/24/2022 9:28:17 PM,Abbott to release 300K cans of baby formula produced at Michigan plant,Seeking Alpha,https://seekingalpha.com/news/3842444-abbott-to-release-300k-cans-of-baby-formula-produced-at-michigan-plant?utm_source=markets.businessinsider.com&utm_medium=referral
948.0,5/24/2022 11:11:00 PM,Abbott to Release EleCare® Amino Acid-based Formulas to Help Meet Critical Patient Need,PR Newswire,/news/stocks/abbott-to-release-elecare-amino-acid-based-formulas-to-help-meet-critical-patient-need-1031486423
949.0,5/25/2022 2:02:01 PM,US To Get About 2 Mln Infant Formula Cans From UK's Kendal Nutricare: FDA ,RTTNews,/news/stocks/us-to-get-about-2-mln-infant-formula-cans-from-uk-s-kendal-nutricare-fda-1031488037
950.0,5/25/2022 2:53:14 PM,Report on Abbott baby formula plant took months to reach top FDA official - WaPo,Seeking Alpha,https://seekingalpha.com/news/3842676-report-on-abbott-baby-formula-plant-took-months-to-reach-top-fda-official-wapo?utm_source=markets.businessinsider.com&utm_medium=referral
951.0,5/25/2022 6:30:58 PM,"Despite 'lost confidence' in Abbott, FDA OKd baby formula plant reopening",Seeking Alpha,https://seekingalpha.com/news/3842780-despite-lost-confidence-in-abbott-fda-okd-baby-formula-plant-reopening?utm_source=markets.businessinsider.com&utm_medium=referral
952.0,5/26/2022 6:13:45 PM,Abbott says monkeypox test is currently under development,Seeking Alpha,https://seekingalpha.com/news/3843224-abbott-says-monkeypox-test-is-currently-under-development?utm_source=markets.businessinsider.com&utm_medium=referral
953.0,5/26/2022 9:31:16 PM,Quant Ratings Updated on 75 Stocks,InvestorPlace,/news/stocks/quant-ratings-updated-on-75-stocks-1031494096
954.0,5/27/2022 1:02:35 PM,Reckitt Benckiser said to get first round bids for infant formula unit,Seeking Alpha,https://seekingalpha.com/news/3843452-reckitt-benckiser-said-to-get-first-round-bids-for-infant-formula-unit?utm_source=markets.businessinsider.com&utm_medium=referral
955.0,5/27/2022 8:07:17 PM,Baby formula being sent from Danone and Bubs Australia to address shortage,Seeking Alpha,https://seekingalpha.com/news/3843593-baby-formula-being-sent-from-danone-and-bubs-australia-to-address-shortage?utm_source=markets.businessinsider.com&utm_medium=referral
956.0,5/31/2022 1:07:38 PM,Abbott announces FDA clearance for FreeStyle Libre 3 glucose monitor,Seeking Alpha,https://seekingalpha.com/news/3843925-abbott-announces-fda-clearance-for-freestyle-libre-3-glucose-monitor?utm_source=markets.businessinsider.com&utm_medium=referral
957.0,5/31/2022 2:00:00 PM,"Abbott's FreeStyle Libre® 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor",PR Newswire,/news/stocks/abbott-s-freestyle-libre-3-receives-u-s-fda-clearance-features-world-s-smallest-thinnest-and-most-accurate-14-day-glucose-sensor-1031498062
958.0,5/31/2022 2:19:14 PM,Abbott Says FDA Oks FreeStyle Libre 3 System As Glucose Monitor For Diabetic Patients ,RTTNews,/news/stocks/abbott-says-fda-oks-freestyle-libre-3-system-as-glucose-monitor-for-diabetic-patients-1031498199
959.0,6/2/2022 3:28:43 PM,FDA response to Abbott baby formula recall to undergo HHS review,Seeking Alpha,https://seekingalpha.com/news/3845065-abbott-baby-formula-fda-inspection-to-undergo-hhs-review?utm_source=markets.businessinsider.com&utm_medium=referral
960.0,6/3/2022 1:26:41 PM,Abbott says developing new continuous glucose-ketone monitoring system,Seeking Alpha,https://seekingalpha.com/news/3845489-abbott-says-developing-new-continuous-glucose-ketone-monitoring-system?utm_source=markets.businessinsider.com&utm_medium=referral
961.0,6/3/2022 3:00:00 PM,Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System,PR Newswire,/news/stocks/abbott-announces-development-of-novel-continuous-glucose-ketone-monitoring-system-1031508432
962.0,6/4/2022 3:56:32 PM,Abbott has restarted baby formula production at Michigan facility,Seeking Alpha,https://seekingalpha.com/news/3845723-abbott-has-restarted-baby-formula-production-at-michigan-facility?utm_source=markets.businessinsider.com&utm_medium=referral
963.0,6/5/2022 3:00:00 PM,Late-Breaking Data Demonstrate Abbott's FreeStyle Libre® 3 System is Most Accurate 14-Day Continuous Glucose Monitor,PR Newswire,/news/stocks/late-breaking-data-demonstrate-abbott-s-freestyle-libre-3-system-is-most-accurate-14-day-continuous-glucose-monitor-1031509811
964.0,6/6/2022 4:59:43 AM,Abbott Says Data Show FreeStyle Libre 3 System Most Accurate 14-Day Continuous Glucose Monitor ,RTTNews,/news/stocks/abbott-says-data-show-freestyle-libre-3-system-most-accurate-14-day-continuous-glucose-monitor-1031509995
965.0,6/6/2022 1:40:31 PM,Abbott Restarts Baby Formula Production At Michigan Plant ,RTTNews,/news/stocks/abbott-restarts-baby-formula-production-at-michigan-plant-1031510640
966.0,6/7/2022 6:52:04 PM,5 Analysts Have This to Say About Abbott Laboratories,Benzinga,/news/stocks/5-analysts-have-this-to-say-about-abbott-laboratories-1031514293
967.0,6/8/2022 11:10:53 AM,"Becton, Dickinson partners with CerTest Biotec for monkeypox test",Seeking Alpha,https://seekingalpha.com/news/3846602-becton-dickinson-partners-with-certest-biotec-for-monkeypox-test?utm_source=markets.businessinsider.com&utm_medium=referral
968.0,6/8/2022 8:04:49 PM,Abbott alerted to baby formula allegations months earlier - WSJ,Seeking Alpha,https://seekingalpha.com/news/3846855-abbott-alerted-to-baby-formula-allegations-months-earlier-wsj?utm_source=markets.businessinsider.com&utm_medium=referral
969.0,6/9/2022 10:28:31 AM,7 Monkeypox Stocks That May Take Off in Q2,InvestorPlace,/news/stocks/7-monkeypox-stocks-that-may-take-off-in-q2-1031518690
970.0,6/9/2022 11:47:37 AM,7 Undervalued Penny Stocks to Buy for Massive Gains,InvestorPlace,/news/stocks/7-undervalued-penny-stocks-to-buy-for-massive-gains-1031519069
971.0,6/10/2022 10:11:09 AM,3 Dividend Stocks to Buy Now for 20 Years of Income Growth,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-now-for-20-years-of-income-growth-1031521688
972.0,6/10/2022 3:28:42 PM,Abbott Laboratories declares $0.47 dividend,Seeking Alpha,https://seekingalpha.com/news/3847734-abbott-laboratories-declares-0_47-dividend?utm_source=businessinsider&utm_medium=referral
973.0,6/10/2022 5:26:00 PM,Abbott Declares 394th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-394th-consecutive-quarterly-dividend-1031522522
974.0,6/16/2022 10:48:03 AM,Abbott stops baby formula production after flooding at Michigan plant,Seeking Alpha,https://seekingalpha.com/news/3849136-abt-stock-falls-as-company-stops-baby-formula-production-after-flooding?utm_source=businessinsider&utm_medium=referral
975.0,6/16/2022 2:31:48 PM,"Benzinga Before The Bell: Tesla Raises Prices, Revlon Goes Bankrupt And Other Top Financial Stories Thursday, June 16",Benzinga,/news/stocks/benzinga-before-the-bell-tesla-raises-prices-revlon-goes-bankrupt-and-other-top-financial-stories-thursday-june-16-1031533079
976.0,6/17/2022 5:27:47 PM,U.S. COVID test makers anticipate layoffs as federal funding dries up – Stat,Seeking Alpha,https://seekingalpha.com/news/3849680-us-covid-test-makers-anticipate-layoffs-as-federal-funding-dries-up-stat?utm_source=businessinsider&utm_medium=referral
977.0,6/22/2022 7:42:58 PM,Abbott pares gains as FDA reports another death linked to baby formula,Seeking Alpha,https://seekingalpha.com/news/3850942-abbott-pares-gains-as-fda-reports-another-death-linked-to-baby-formula?utm_source=businessinsider&utm_medium=referral
978.0,6/23/2022 8:45:17 AM,FDA Probes Death Of Infant Who Consumed Abbott Infant Formula ,RTTNews,/news/stocks/fda-probes-death-of-infant-who-consumed-abbott-infant-formula-1031545044
979.0,6/24/2022 5:26:37 PM,What 6 Analyst Ratings Have To Say About Abbott Laboratories,Benzinga,/news/stocks/what-6-analyst-ratings-have-to-say-about-abbott-laboratories-1031549198
980.0,6/24/2022 9:22:54 PM,Amazon.com To $180? Here's The Biggest Price Target Changes For Friday,Benzinga,/news/stocks/amazon-com-to-180-here-s-the-biggest-price-target-changes-for-friday-1031549647
981.0,6/26/2022 12:18:50 AM,Monkeypox is not an international health emergency yet – WHO,Seeking Alpha,https://seekingalpha.com/news/3851872-monkeypox-is-not-an-international-health-emergency-yet-who?utm_source=businessinsider&utm_medium=referral
982.0,6/28/2022 7:37:36 PM,Cue Health hits new post-IPO low amid selloff in COVID-19 test makers,Seeking Alpha,https://seekingalpha.com/news/3852604-hlth-stock-hits-new-post-ipo-low-amid-selloff-in-covid-19-test-makers?utm_source=businessinsider&utm_medium=referral
983.0,6/28/2022 8:18:40 PM,CDC announces emergency operations center for monkeypox,Seeking Alpha,https://seekingalpha.com/news/3852623-cdc-announces-emergency-operations-center-for-monkeypox?utm_source=businessinsider&utm_medium=referral
984.0,6/29/2022 3:00:00 PM,Abbott Hosts Conference Call for Second-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-second-quarter-earnings-1031557601
985.0,7/1/2022 9:19:29 AM,"US To Import 17 Mln Bottles Of Infant Formula From New Zealand, Ireland ",RTTNews,/news/stocks/us-to-import-17-mln-bottles-of-infant-formula-from-new-zealand-ireland-1031562261
986.0,7/6/2022 4:06:52 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-6-2022-1031570726
987.0,7/6/2022 7:42:34 PM,FDA to help foreign baby formula makers to access U.S. market for long-term,Seeking Alpha,https://seekingalpha.com/news/3854763-fda-to-help-foreign-baby-formula-makers-to-access-us-market-for-long-term?utm_source=businessinsider&utm_medium=referral
988.0,7/7/2022 10:39:16 AM,Best Stocks for 2022: AbbVie Is a Recession-Resistant Dividend King,InvestorPlace,/news/stocks/best-stocks-for-2022-abbv-stock-1031572601
989.0,7/8/2022 12:03:34 PM,Siga Technologies receives approval from UK for tecovirimat,Seeking Alpha,https://seekingalpha.com/news/3855320-siga-technologies-receives-approval-from-uk-for-tecovirimat?utm_source=businessinsider&utm_medium=referral
990.0,7/10/2022 1:11:02 AM,Abbott baby formula plant resumes operations after flooding,Seeking Alpha,https://seekingalpha.com/news/3855509-abbott-baby-formula-plant-resumes-operations-after-flooding?utm_source=businessinsider&utm_medium=referral
991.0,7/11/2022 9:43:40 AM,US To Import 4.9 Mln Cans Of Baby Formula From Australia ,RTTNews,/news/stocks/us-to-import-4-9-mln-cans-of-baby-formula-from-australia-1031577611
992.0,7/12/2022 1:58:20 PM,Abbott's deep brain stimulation device gains Breakthrough Therapy status for depression,Seeking Alpha,https://seekingalpha.com/news/3856070-abbott-deep-brain-stimulation-device-gains-breakthrough-therapy-status-for-depression?utm_source=businessinsider&utm_medium=referral
993.0,7/12/2022 3:00:00 PM,Abbott Receives FDA's Breakthrough Device Designation to Explore Use of Deep Brain Stimulation to Manage Severe Depression,PR Newswire,/news/stocks/abbott-receives-fda-s-breakthrough-device-designation-to-explore-use-of-deep-brain-stimulation-to-manage-severe-depression-1031581263
994.0,7/12/2022 3:16:52 PM,Abbott: FDA Grants Breakthrough Device Designation To Investigate DBS System In TRD ,RTTNews,/news/stocks/abbott-fda-grants-breakthrough-device-designation-to-investigate-dbs-system-in-trd-1031581397
995.0,7/15/2022 4:27:23 PM,"Earnings week ahead: Tesla, Twitter, Netflix, Snap, and more",Seeking Alpha,https://seekingalpha.com/news/3857250-earnings-week-ahead-tesla-twitter-netflix-snap-and-more?utm_source=businessinsider&utm_medium=referral
996.0,7/15/2022 8:02:26 PM,7 Analysts Have This to Say About Abbott Laboratories,Benzinga,/news/stocks/7-analysts-have-this-to-say-about-abbott-laboratories-1031591016
997.0,7/19/2022 2:35:26 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3858105-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral
998.0,7/19/2022 3:01:13 PM,Abbott Laboratories earnings: here's what to expect,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-price-quarter-earnings-preview-q2-1031597199
999.0,7/19/2022 3:59:17 PM,All eyes on Abbott Q2 results amid potential impact due to baby formula woes,Seeking Alpha,https://seekingalpha.com/news/3858155-all-eyes-on-abbott-q2-results-amid-potential-impact-due-to-baby-formula-woes?utm_source=businessinsider&utm_medium=referral
1000.0,7/20/2022 11:32:41 AM,"Abbott Laboratories Non-GAAP EPS of $1.43 beats by $0.29, revenue of $11.3B beats by $930M, raises full-year EPS guidance",Seeking Alpha,https://seekingalpha.com/news/3858429-abbott-laboratories-non-gaap-eps-of-143-beats-by-029-revenue-of-113b-beats-by-930m-raises-full-year-eps-guidance?utm_source=businessinsider&utm_medium=referral
1001.0,7/20/2022 12:01:51 PM,Abbott raises guidance as COVID-19 testing sales drive 2Q beat,Seeking Alpha,https://seekingalpha.com/news/3858450-abt-stock-in-focus-as-company-raises-guidance-on-covid-19-testing-sales?utm_source=businessinsider&utm_medium=referral
1002.0,7/20/2022 1:30:00 PM,Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance,PR Newswire,/news/stocks/abbott-reports-second-quarter-2022-results-and-raises-full-year-eps-guidance-1031600587
1003.0,7/20/2022 1:37:11 PM,"Abbott Laboratories Q2 Profit Increases, beats estimates",RTTNews,/news/stocks/abbott-laboratories-q2-profit-increases-beats-estimates-1031600625
1004.0,7/20/2022 2:06:56 PM,Abbott Q2 Profit Tops Estimates; Raises 2022 Earnings Guidance ,RTTNews,/news/stocks/abbott-q2-profit-tops-estimates-raises-2022-earnings-guidance-1031600839
1005.0,7/20/2022 2:22:38 PM,Abbott Laboratories (ABT) Stock Slides Despite Q2 Earnings Beat,InvestorPlace,/news/stocks/abbott-laboratories-abt-stock-slides-despite-q2-earnings-beat-1031601542
1006.0,7/20/2022 2:46:22 PM,Cathie Wood’s Ark Invest Is Closing Its Transparency ETF. 12 Things to Know.,InvestorPlace,/news/stocks/cathie-woods-ark-invest-is-closing-its-transparency-etf-12-things-to-know-1031601593
1007.0,7/20/2022 6:02:24 PM,"Tech Shares Move Higher, Nasdaq Jumps 200 Points",Benzinga,/news/stocks/tech-shares-move-higher-nasdaq-jumps-200-points-1031601821
1008.0,7/21/2022 8:33:24 AM,"ABT Raises Earnings Forecast, BIIB Provides Rosy Revenue Outlook, ELV Q2 Revenue Up 15.6% ",RTTNews,/news/stocks/abt-raises-earnings-forecast-biib-provides-rosy-revenue-outlook-elv-q2-revenue-up-15-6-1031603549
1009.0,7/23/2022 2:37:15 PM,WHO declares monkeypox outbreak a global health emergency,Seeking Alpha,https://seekingalpha.com/news/3859824-who-declares-monkeypox-outbreak-a-global-health-emergency?utm_source=businessinsider&utm_medium=referral
1010.0,7/26/2022 2:49:53 PM,Abbott Unveils NeuroSphere Virtual Clinic In Canada ,RTTNews,/news/stocks/abbott-unveils-neurosphere-virtual-clinic-in-canada-1031615301
1011.0,7/27/2022 11:10:39 AM,7 Large-Cap Stocks to Buy on the Dip,InvestorPlace,/news/stocks/large-cap-stocks-to-buy-on-the-dip-1031619962
1012.0,7/27/2022 5:48:54 PM,"Abbott, Merck under Wyden scrutiny for not providing offshore taxable income info",Seeking Alpha,https://seekingalpha.com/news/3861579-abbott-merck-under-wyden-scrutiny-for-not-providing-offshore-taxable-income-info?utm_source=businessinsider&utm_medium=referral
1013.0,7/27/2022 6:52:02 PM,Medtronic Stock Keeps Ticking Forward,Benzinga,/news/stocks/medtronic-stock-keeps-ticking-forward-1031621716
1014.0,7/28/2022 8:20:28 PM,Senate Democrats propose $21B funding for next phase of COVID-19 response,Seeking Alpha,https://seekingalpha.com/news/3862718-senate-democrats-propose-21b-funding-for-next-phase-of-covid-19-response?utm_source=businessinsider&utm_medium=referral
1015.0,8/4/2022 1:58:56 PM,Why Is Senseonics (SENS) Stock Heating Up Today?,InvestorPlace,/news/stocks/why-is-senseonics-sens-stock-heating-up-today-1031651580
1016.0,8/4/2022 10:10:00 PM,Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals,PR Newswire,/news/stocks/abbott-and-weightwatchers-partner-to-support-people-living-with-diabetes-in-attaining-their-health-goals-1031652452
1017.0,8/9/2022 1:38:04 AM,The 3 Best Vanguard Funds to Buy in August,InvestorPlace,/news/stocks/best-vanguard-funds-1031663161
1018.0,8/11/2022 3:00:00 PM,New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions,PR Newswire,/news/stocks/new-study-shows-abbott-s-blood-test-for-concussion-could-predict-outcomes-from-brain-injury-and-inform-treatment-interventions-1031675961
1019.0,8/11/2022 4:00:06 PM,Abbott: Research Shows TBI Blood Test Helpful In Predicting Recovery From Traumatic Brain Injury ,RTTNews,/news/stocks/abbott-research-shows-tbi-blood-test-helpful-in-predicting-recovery-from-traumatic-brain-injury-1031676310
1020.0,8/12/2022 12:46:48 PM,Abbott to build new manufacturing plant in Ireland as part of €440M investment,Seeking Alpha,https://seekingalpha.com/news/3872336-abbott-to-build-new-manufacturing-plant-in-ireland-as-part-of-440m-investment?utm_source=businessinsider&utm_medium=referral
1021.0,8/17/2022 10:54:23 AM,"U.S. govt. to stop buying COVID-19 vaccines, therapies, tests from this fall – Jha",Seeking Alpha,https://seekingalpha.com/news/3874012-us-govt-to-stop-buying-covid-19-vaccines-therapies-tests-from-this-fall-jha?utm_source=businessinsider&utm_medium=referral
1022.0,8/17/2022 5:10:23 PM,CDC seeks reforms to correct COVID missteps,Seeking Alpha,https://seekingalpha.com/news/3874241-cdc-to-implement-reforms-to-correct-covid-missteps?utm_source=businessinsider&utm_medium=referral
1023.0,8/23/2022 1:20:48 PM,Abbott's spinal cord stimulation device for pain gets FDA approval,Seeking Alpha,https://seekingalpha.com/news/3875792-abbotts-spinal-cord-stimulation-device-for-pain-gets-fda-approval?utm_source=businessinsider&utm_medium=referral
1024.0,8/23/2022 3:00:00 PM,FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions,PR Newswire,/news/stocks/fda-approves-abbott-s-new-spinal-cord-stimulation-device-provides-tailored-relief-to-multiple-pain-areas-and-adds-more-treatment-options-for-evolving-pain-conditions-1031700567
1025.0,8/23/2022 3:15:17 PM,Abbott Announces FDA Approval For Its Proclaim Plus Spinal Cord Stimulation System ,RTTNews,/news/stocks/abbott-announces-fda-approval-for-its-proclaim-plus-spinal-cord-stimulation-system-1031700707
1026.0,8/23/2022 6:32:34 PM,Abbott to extend baby formula rebates for another month – Politico,Seeking Alpha,https://seekingalpha.com/news/3875926-abbott-to-extend-baby-formula-rebates-for-another-month?utm_source=businessinsider&utm_medium=referral
1027.0,8/29/2022 8:28:00 AM,Abbott resumes Similac baby formula production at Michigan plant,Seeking Alpha,https://seekingalpha.com/news/3877249-abbott-resumes-similac-baby-formula-production-at-michigan-plant?utm_source=businessinsider&utm_medium=referral
1028.0,8/29/2022 2:52:32 PM,Biden administration ending free at-home COVID tests due to lack of funding,Seeking Alpha,https://seekingalpha.com/news/3877465-biden-administration-ending-free-at-home-covid-tests-due-to-lack-of-funding?utm_source=businessinsider&utm_medium=referral
1029.0,8/29/2022 3:00:00 PM,New Data Show Abbott's HeartMate 3™ Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients,PR Newswire,/news/stocks/new-data-show-abbott-s-heartmate-3-heart-pump-extends-life-beyond-five-years-for-advanced-heart-failure-patients-1031710814
1030.0,8/29/2022 3:19:22 PM,Abbott: Study Shows HeartMate 3 Pump Extends Life Expectancy Of Advanced Heart Failure Patients ,RTTNews,/news/stocks/abbott-study-shows-heartmate-3-pump-extends-life-expectancy-of-advanced-heart-failure-patients-1031710938
1031.0,8/29/2022 6:58:22 PM,Abbott Laboratories hits 52-week low; stock down 26% YTD,Seeking Alpha,https://seekingalpha.com/news/3877556-abbott-laboratories-hits-52-week-low-stock-down-26-ytd?utm_source=businessinsider&utm_medium=referral
1032.0,9/4/2022 12:38:00 PM,"ROSEN, A LEADING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/rosen-a-leading-law-firm-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-abt-1031723224
1033.0,9/6/2022 9:00:07 PM,3 Dividend Kings for Income Investors to Count On,InvestorPlace,/news/stocks/dividend-kings-that-income-investors-can-count-on-1031584429
1034.0,9/8/2022 3:00:00 PM,Three-Year Data on World's Smallest Heart Device Show Benefits of Fixing Holes in Newborn Hearts Without Surgery,PR Newswire,/news/stocks/three-year-data-on-world-s-smallest-heart-device-show-benefits-of-fixing-holes-in-newborn-hearts-without-surgery-1031732072
1035.0,9/8/2022 8:15:20 PM,FDA alerts on potential clip lock malfunctions in Abbott's MitraClip heart implant device,Seeking Alpha,https://seekingalpha.com/news/3881393-fda-alerts-on-potential-clip-lock-malfunctions-in-abbotts-mitraclip-heart-implant-device?utm_source=businessinsider&utm_medium=referral
1036.0,9/9/2022 10:43:42 AM,Biden administration to procure over 100M at-home COVID tests,Seeking Alpha,https://seekingalpha.com/news/3881564-biden-administration-to-procure-over-100m-at-home-covid-tests?utm_source=businessinsider&utm_medium=referral
1037.0,9/9/2022 2:43:49 PM,"Top Financial Stories Friday, September 09: Elon Musk Hints At Potential Apple-SpaceX Partnership, GM's EV For Cost Conscious Buyers, Google Under DOJ Scanner For Search-Engine Dominance And More...",Benzinga,/news/stocks/top-financial-stories-friday-september-09-elon-musk-hints-at-potential-apple-spacex-partnership-gm-s-ev-for-cost-conscious-buyers-google-under-doj-scanner-for-search-engine-dominance-and-more-1031734640
1038.0,9/11/2022 11:03:19 PM,7 Blue-Chip Stocks to Buy Before the Bull Market Returns,InvestorPlace,/news/stocks/blue-chip-stocks-to-buy-before-bull-market-returns-1031630381
1039.0,9/12/2022 8:25:00 PM,"ABT INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/abt-investor-notice-rosen-nationally-regarded-investor-counsel-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-abt-1031738128
1040.0,9/13/2022 4:56:03 PM,Inari initiated Hold at Truist; notes competition overshadows market potential,Seeking Alpha,https://seekingalpha.com/news/3882433-inari-initiated-hold-at-truist-notes-competition-overshadows-market-growth?utm_source=businessinsider&utm_medium=referral
1041.0,9/14/2022 2:18:38 PM,"End in sight for COVID-19 pandemic, WHO chief says",Seeking Alpha,https://seekingalpha.com/news/3882728-end-in-sight-for-covid-19-pandemic-who-chief-says?utm_source=businessinsider&utm_medium=referral
1042.0,9/15/2022 4:58:31 PM,Abbott Laboratories declares $0.47 dividend,Seeking Alpha,https://seekingalpha.com/news/3883171-abbott-laboratories-declares-0_47-dividend?utm_source=businessinsider&utm_medium=referral
1043.0,9/15/2022 6:56:00 PM,Abbott Declares 395th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-395th-consecutive-quarterly-dividend-1031746500
1044.0,9/15/2022 7:00:16 PM,7 Top-Rated Biotech Stocks to Buy for Q4,InvestorPlace,/news/stocks/7-top-rated-biotech-stocks-to-buy-for-q4-1031746729
1045.0,9/17/2022 8:45:00 PM,Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies,PR Newswire,/news/stocks/late-breaking-data-show-breadth-of-abbott-s-minimally-invasive-structural-heart-technologies-1031749148
1046.0,9/17/2022 9:15:00 PM,"ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/rosen-a-leading-and-longstanding-firm-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-abt-1031749152
1047.0,9/20/2022 8:05:48 PM,FDA finds 'confluence of systemic vulnerabilities' led to Abbott baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3884566-abbott-baby-formula-shortage-due-to-confluence-of-systemic-vulnerabilities-fda-finds?utm_source=businessinsider&utm_medium=referral
1048.0,9/22/2022 5:52:24 PM,Abbott stock falls below $100 for first time in two years as it hits fresh 52-week low,Seeking Alpha,https://seekingalpha.com/news/3885376-abbott-stock-falls-below-100-for-first-time-in-two-years-as-it-hits-fresh-52-week-low?utm_source=businessinsider&utm_medium=referral
1049.0,9/27/2022 10:00:07 AM,7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’,InvestorPlace,/news/stocks/7-vaccine-stocks-to-sell-asap-now-that-the-pandemics-over-1031766411
1050.0,9/27/2022 3:47:00 PM,FDA updates COVID-19 test policy to cut emergency use requests,Seeking Alpha,https://seekingalpha.com/news/3886420-fda-updates-covid-19-test-policy-to-cut-emergency-use-requests?utm_source=businessinsider&utm_medium=referral
1051.0,9/28/2022 3:00:00 PM,Abbott Hosts Conference Call for Third-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-third-quarter-earnings-1031770099
1052.0,9/28/2022 9:15:00 PM,"ROSEN, A LONGSTANDING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/rosen-a-longstanding-law-firm-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-abt-1031771127
1053.0,10/3/2022 10:14:22 AM,"Svante Pääbo gets Nobel Prize for Medicine for discoveries on genome, human evolution",Seeking Alpha,https://seekingalpha.com/news/3887839-svante-pbo-gets-nobel-prize-for-medicine-for-discoveries-on-genome-human-evolution?utm_source=businessinsider&utm_medium=referral
1054.0,10/5/2022 6:15:52 PM,Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?,InvestorPlace,/news/stocks/best-stocks-2022-whats-not-to-like-about-abbvie-abbv-stock-1031785559
1055.0,10/6/2022 3:00:00 PM,New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life,PR Newswire,/news/stocks/new-study-published-in-the-new-england-journal-of-medicine-demonstrates-abbott-s-freestyle-libre-2-system-has-positive-impacts-on-glucose-levels-and-quality-of-life-1031787402
1056.0,10/7/2022 1:07:23 PM,DexCom adds 10% as Medicare updates coverage for glucose monitoring,Seeking Alpha,https://seekingalpha.com/news/3889667-dxcm-stock-gains-as-medicare-updates-coverage-for-glucose-monitoring?utm_source=businessinsider&utm_medium=referral
1057.0,10/7/2022 9:33:16 PM,Abbott monkeypox test wins Emergency Use Authorization from FDA,Seeking Alpha,https://seekingalpha.com/news/3889813-abbott-monkeypox-test-wins-emergency-use-authorization-from-fda?utm_source=businessinsider&utm_medium=referral
1058.0,10/8/2022 4:10:00 AM,"ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/rosen-top-ranked-investor-counsel-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-abt-1031790974
1059.0,10/10/2022 7:01:25 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1031793852
1060.0,10/10/2022 9:22:47 PM,Analyst Ratings for Abbott Laboratories,Benzinga,/news/stocks/analyst-ratings-for-abbott-laboratories-1031794005
1061.0,10/12/2022 3:42:00 PM,Abbott and The Home Edit Redesign the Medicine Cabinet to Help People Prepare for the Upcoming Virus Season,PR Newswire,/news/stocks/abbott-and-the-home-edit-redesign-the-medicine-cabinet-to-help-people-prepare-for-the-upcoming-virus-season-1031799886
1062.0,10/12/2022 4:02:53 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-12-2022-1031799955
1063.0,10/12/2022 9:13:54 PM,Expert Ratings for Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1031800764
1064.0,10/13/2022 1:50:23 AM,Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Humana (HUM),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-and-humana-hum-1031801105
1065.0,10/14/2022 5:10:04 PM,"Earnings week ahead: Tesla, Netflix, Johnson & Johnson, AT&T and more",Seeking Alpha,https://seekingalpha.com/news/3891460-earnings-week-ahead-tesla-netflix-johnson-johnson-att-and-more?utm_source=businessinsider&utm_medium=referral
1066.0,10/14/2022 6:30:00 PM,"Catalyst Watch: Tesla, Netflix, Fisker, TechCrunch Disrupt and Paris Motor Show headline big week",Seeking Alpha,https://seekingalpha.com/news/3891159-catalyst-watch-tesla-netflix-techcrunch-disrupt-and-paris-motor-show-headline-big-week?utm_source=businessinsider&utm_medium=referral
1067.0,10/15/2022 12:18:00 PM,"ROSEN, SKILLED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/rosen-skilled-investor-counsel-encourages-abbott-laboratories-investors-with-losses-to-secure-counsel-before-important-october-31-deadline-in-securities-class-action-abt-1031807311
1068.0,10/17/2022 7:38:04 AM,Abbott Recalls Certain Ready-to-Feed Liquid Products ,RTTNews,/news/stocks/abbott-recalls-certain-ready-to-feed-liquid-products-1031808927
1069.0,10/17/2022 2:34:50 PM,Morgan Stanley says large cap healthcare remains attractive amid macro concerns,Seeking Alpha,https://seekingalpha.com/news/3891861-morgan-stanely-says-large-cap-healthcare-remains-attractive-amid-macro-concerns?utm_source=businessinsider&utm_medium=referral
1070.0,10/17/2022 6:11:51 PM,Expert Ratings for Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1031810704
1071.0,10/18/2022 2:32:23 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3892262-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral
1072.0,10/18/2022 3:01:13 PM,Abbott Laboratories earnings preview: what to expect,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-quarter-earnings-preview-q3-1031813407
1073.0,10/18/2022 4:09:22 PM,Johnson & Johnson weighs job cuts ahead of consumer health spinoff,Seeking Alpha,https://seekingalpha.com/news/3892300-johnson-johnson-weighs-job-cuts-ahead-of-consumer-health-spinoff?utm_source=businessinsider&utm_medium=referral
1074.0,10/18/2022 4:17:24 PM,Can Abbott maintain EPS beat run in Q3 as industry faces slowdown in COVID products demand?,Seeking Alpha,https://seekingalpha.com/news/3892303-can-abbott-q3-results-maintain-eps-beat-run-as-industry-faces-slowdown-in-covid-products?utm_source=businessinsider&utm_medium=referral
1075.0,10/18/2022 4:21:58 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-18-2022-1031813984
1076.0,10/19/2022 11:33:00 AM,"Abbott Laboratories raises full-year profit guidance, Non-GAAP EPS of $1.15 beats by $0.21, revenue of $10.4B beats by $750M",Seeking Alpha,https://seekingalpha.com/news/3892575-abbott-laboratories-raises-full-year-profit-guidance-non-gaap-eps-of-115-beats-by-021-revenue-of-104b-beats-by-750m?utm_source=businessinsider&utm_medium=referral
1077.0,10/19/2022 12:15:38 PM,Abbott Q3 topline contracts amid falling COVID-19 testing and baby formula issue,Seeking Alpha,https://seekingalpha.com/news/3892592-abbott-q3-topline-weighed-down-by-falling-covid-19-testing-baby-formula-issue?utm_source=businessinsider&utm_medium=referral
1078.0,10/19/2022 1:30:00 PM,Abbott Reports Third-Quarter 2022 Results and Raises Full-Year EPS Guidance,PR Newswire,/news/stocks/abbott-reports-third-quarter-2022-results-and-raises-full-year-eps-guidance-1031816923
1079.0,10/19/2022 1:35:58 PM,"Abbott Laboratories Q3 Profit Decreases, but beats estimates",RTTNews,/news/stocks/abbott-laboratories-q3-profit-decreases-but-beats-estimates-1031816962
1080.0,10/19/2022 2:00:31 PM,Abbott Laboratories Boosts FY22 Outlook - Update ,RTTNews,/news/stocks/abbott-laboratories-boosts-fy22-outlook-update-1031817091
1081.0,10/19/2022 2:17:52 PM,"SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19",Benzinga,/news/stocks/spacex-starlink-s-new-in-flight-connectivity-service-amazon-s-ny-workers-reject-union-celsius-network-faces-several-federal-investigations-top-stories-wednesday-oct-19-1031817194
1082.0,10/19/2022 4:30:06 PM,Abbott falls 8% to hit 52-week low despite Q3 beat,Seeking Alpha,https://seekingalpha.com/news/3892731-abt-stock-falls-most-in-over-a-year-despite-q3-beat?utm_source=businessinsider&utm_medium=referral
1083.0,10/19/2022 4:36:11 PM,"Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday",Benzinga,/news/stocks/abbott-laboratories-m-t-bank-and-some-other-big-stocks-moving-lower-on-wednesday-1031817999
1084.0,10/19/2022 6:30:03 PM,Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session,Benzinga,/news/stocks/why-united-airlines-shares-are-trading-higher-here-are-43-stocks-moving-in-wednesday-s-mid-day-session-1031818321
1085.0,10/19/2022 8:39:37 PM,3 Stocks Set to Soar From 52-Week Lows,InvestorPlace,/news/stocks/3-stocks-set-to-soar-from-52-week-lows-1031818896
1086.0,10/20/2022 7:52:51 AM,Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday,Benzinga,/news/stocks/why-olaplex-shares-dipped-around-57-here-are-75-biggest-movers-from-yesterday-1031819854
1087.0,10/20/2022 12:36:11 PM,Morgan Stanley Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/morgan-stanley-keeps-their-buy-rating-on-abbott-labs-abt-1031821123
1088.0,10/21/2022 12:36:31 PM,Abbott Labs (ABT) Gets a Buy from Raymond James,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-raymond-james-1031824303
1089.0,10/21/2022 7:53:36 PM,Amazon To $175? Plus JP Morgan Cuts Price Target On Meta Platforms,Benzinga,/news/stocks/amazon-to-175-plus-jp-morgan-cuts-price-target-on-meta-platforms-1031825185
1090.0,10/23/2022 12:22:00 PM,"ABT APPROACHING DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses Over $100K to Secure Counsel Before Important October 31 Deadline in Securities Cl...",PR Newswire,/news/stocks/abt-approaching-deadline-rosen-respected-investor-counsel-encourages-abbott-laboratories-investors-with-losses-over-100k-to-secure-counsel-before-important-october-31-deadline-in-securities-cl-1031825986
1091.0,10/26/2022 4:07:48 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-26-2022-1031838805
1092.0,10/26/2022 6:38:29 PM,Abbott draws Neutral rating at Mizuho on COVID headwinds and baby formula recall,Seeking Alpha,https://seekingalpha.com/news/3895804-abbott-draws-neutral-rating-at-mizuho-on-covid-headwinds-infant-formula-issue?utm_source=businessinsider&utm_medium=referral
1093.0,10/28/2022 3:00:00 PM,Abbott's FreeStyle Libre® is Named Best Medical Technology in Last 50 Years by the Galien Foundation,PR Newswire,/news/stocks/abbott-s-freestyle-libre-is-named-best-medical-technology-in-last-50-years-by-the-galien-foundation-1031848415
1094.0,10/29/2022 8:00:00 PM,"With medical devices market expected to soar, here are companies set to benefit the most",Seeking Alpha,https://seekingalpha.com/news/3897411-with-medical-devices-market-expected-to-soar-here-are-companies-set-to-benefit-the-most?utm_source=businessinsider&utm_medium=referral
1095.0,10/31/2022 8:11:00 PM,"ABT FINAL DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/abt-final-deadline-today-rosen-a-top-ranked-law-firm-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-october-31-deadline-in-securities-class-action-abt-1031854965
1096.0,11/1/2022 3:02:58 PM,Monkeypox remains a global health emergency – WHO,Seeking Alpha,https://seekingalpha.com/news/3898590-monkeypox-remains-a-global-health-emergency-who?utm_source=businessinsider&utm_medium=referral
1097.0,11/5/2022 1:45:57 AM,RBC Capital Reaffirms Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-reaffirms-their-buy-rating-on-abbott-labs-abt-1031877340
1098.0,11/6/2022 11:53:00 AM,"Politician’s Picks: Senior Delaware Senator Favors CVS, ABT, TSM Stocks",TipRanks,/news/stocks/politician-s-picks-senior-delaware-senator-favors-cvs-abt-tsm-stocks-1031875664
1099.0,11/9/2022 6:51:44 PM,3 Food Processing Dividend Stocks That Could Benefit From Food Shortages Driven By Russia-Ukraine War,Benzinga,/news/stocks/3-food-processing-dividend-stocks-that-could-benefit-from-food-shortages-driven-by-russia-ukraine-war-1031893358
1100.0,11/11/2022 8:16:39 PM,"Healthcare stocks come off lows, worst performing sector among defensive losers (update)",Seeking Alpha,https://seekingalpha.com/news/3906637-healthcare-stocks-fall-across-the-board-as-traders-move-out-of-defensive-sectors?utm_source=businessinsider&utm_medium=referral
1101.0,11/12/2022 5:05:09 PM,7 No-Brainer Blue-Chip Stocks to Buy for 2023 and Beyond,InvestorPlace,/news/stocks/7-no-brainer-blue-chip-stocks-to-buy-for-2023-and-beyond-1031906025
1102.0,11/13/2022 1:59:54 AM,U.S. COVID health emergency to stay in place,Seeking Alpha,https://seekingalpha.com/news/3906753-us-covid-health-emergency-to-stay-in-place?utm_source=businessinsider&utm_medium=referral
1103.0,11/13/2022 1:18:00 PM,"T, ABT, or PG: Which Value Stock Could Fetch Higher Returns?",TipRanks,/news/stocks/t-abt-or-pg-which-value-stock-could-fetch-higher-returns-1031905396
1104.0,11/16/2022 9:54:37 PM,Shortages a Boon for These 2 Medical Device Stocks,TipRanks,/news/stocks/shortages-a-boon-for-these-2-medical-device-stocks-1031920308
1105.0,11/17/2022 3:00:00 PM,Abbott Receives Three CES 2023 Innovation Awards for Advancements in Health Technology,PR Newswire,/news/stocks/abbott-receives-three-ces-2023-innovation-awards-for-advancements-in-health-technology-1031922396
1106.0,12/6/2022 9:32:15 PM,Quant Ratings Updated on 92 Stocks,InvestorPlace,/news/stocks/20221206-quant-ratings-1031956530
1107.0,12/8/2022 7:28:42 PM,EU wants to delay medical device law amid supply challenges - Reuters,Seeking Alpha,https://seekingalpha.com/news/3915442-eu-wants-to-delay-medical-device-law-amid-supply-challenges-reuters?utm_source=businessinsider&utm_medium=referral
1108.0,12/9/2022 3:52:14 PM,Abbott Laboratories raises quarterly dividend by 8.5% to $0.51/share,Seeking Alpha,https://seekingalpha.com/news/3915744-abbott-laboratories-declares-0_51-dividend?utm_source=businessinsider&utm_medium=referral
1109.0,12/9/2022 4:48:00 PM,"Abbott Increases Quarterly Dividend, Marking 51 Consecutive Years of Dividend Growth",PR Newswire,/news/stocks/abbott-increases-quarterly-dividend-marking-51-consecutive-years-of-dividend-growth-1031963083
1110.0,12/12/2022 3:02:20 PM,11 Analysts Have This to Say About Abbott Laboratories,Benzinga,/news/stocks/11-analysts-have-this-to-say-about-abbott-laboratories-1031965384
1111.0,12/12/2022 7:02:12 PM,Expert Ratings for Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1031967429
1112.0,12/13/2022 2:30:00 PM,Abbott and the Brain Injury Association of America launch Concussion Awareness Now coalition; team up with Rebel Wilson to raise awareness on seriousness of concussions,PR Newswire,/news/stocks/abbott-and-the-brain-injury-association-of-america-launch-concussion-awareness-now-coalition-team-up-with-rebel-wilson-to-raise-awareness-on-seriousness-of-concussions-1031969106
1113.0,12/13/2022 11:39:28 PM,"A Career Politician Who Regularly Trades The SPY, Picked Up These 3 High Yielding ETFs Instead",Benzinga,/news/etf/a-career-politician-who-regularly-trades-the-spy-picked-up-these-3-high-yielding-etfs-instead-1031970409
1114.0,12/14/2022 5:23:02 PM,WHO chief hopeful COVID emergency will end next year,Seeking Alpha,https://seekingalpha.com/news/3917016-who-chief-hopeful-covid-emergency-will-end-next-year?utm_source=businessinsider&utm_medium=referral
1115.0,12/15/2022 12:33:20 PM,White House restarts program to ship free at-home COVID tests,Seeking Alpha,https://seekingalpha.com/news/3917481-white-house-restarts-program-to-ship-free-at-home-covid-tests?utm_source=businessinsider&utm_medium=referral
1116.0,12/19/2022 3:00:00 PM,"Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain",PR Newswire,/news/stocks/abbott-launches-the-world-s-smallest-implantable-rechargeable-spinal-cord-stimulation-system-for-chronic-pain-1031980099
1117.0,12/19/2022 4:56:10 PM,Abbott wins FDA approval of Eterna spinal cord stimulation system,Seeking Alpha,https://seekingalpha.com/news/3918462-abbott-wins-fda-approval-of-eterna-spinal-cord-stimulation-system?utm_source=businessinsider&utm_medium=referral
1118.0,12/20/2022 3:00:00 PM,Abbott to Present at J.P. Morgan Healthcare Conference,PR Newswire,/news/stocks/abbott-to-present-at-j-p-morgan-healthcare-conference-1031982443
1119.0,12/21/2022 3:00:00 PM,Abbott's FreeStyle Libre® 3 Integrated with Automated Insulin Delivery System mylife™ Loop in Germany,PR Newswire,/news/stocks/abbott-s-freestyle-libre-3-integrated-with-automated-insulin-delivery-system-mylife-loop-in-germany-1031984918
1120.0,12/21/2022 3:56:35 PM,Abbott : FreeStyle Libre 3 Integrated With Automated Insulin Delivery System Mylife Loop In Germany ,RTTNews,/news/stocks/abbott-freestyle-libre-3-integrated-with-automated-insulin-delivery-system-mylife-loop-in-germany-1031985097
1121.0,12/25/2022 5:00:44 PM,Goldman Sachs highlights key healthcare themes for 2023,Seeking Alpha,https://seekingalpha.com/news/3920634-goldman-sachs-micro-over-macro-healthcare-themes-2023?utm_source=businessinsider&utm_medium=referral
1122.0,12/28/2022 4:45:41 PM,Imported baby formula to face US tariffs again in 2023 - WSJ,Seeking Alpha,https://seekingalpha.com/news/3920955-imported-baby-formula-to-face-us-tariffs-again-in-2023-wsj?utm_source=businessinsider&utm_medium=referral
1123.0,12/30/2022 5:11:21 PM,Diabetes rates in children set to skyrocket by 2060 - study,Seeking Alpha,https://seekingalpha.com/news/3921303-diabetes-rates-in-children-set-to-skyrocket-by-2060-study?utm_source=businessinsider&utm_medium=referral
1124.0,1/4/2023 3:00:00 PM,Abbott Hosts Conference Call for Fourth-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-fourth-quarter-earnings-1031999915
1125.0,1/6/2023 4:26:21 PM,Abbott Labs (ABT) Gets a Buy from Morgan Stanley,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-morgan-stanley-1032004652
1126.0,1/6/2023 11:26:24 PM,5 Top Pharma Stocks of 2022 to Buy for the Long Haul,InvestorPlace,/news/stocks/5-top-pharma-stocks-of-2022-to-buy-for-the-long-haul-1032005182
1127.0,1/7/2023 3:00:00 AM,"Abbott, Blood Centers of America Launch First-of-its-Kind Mixed Reality Experience for Use During Blood Donation",PR Newswire,/news/stocks/abbott-blood-centers-of-america-launch-first-of-its-kind-mixed-reality-experience-for-use-during-blood-donation-1032005233
1128.0,1/10/2023 1:08:28 PM,WHO sets Jan. 27 meeting to decide on COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3923286-who-sets-jan-27-meeting-to-decide-on-covid-emergency?utm_source=businessinsider&utm_medium=referral
1129.0,1/11/2023 3:41:27 PM,"COVID-19 public health emergency extended by HHS, possibly for final time",Seeking Alpha,https://seekingalpha.com/news/3923735-covid-19-public-health-emergency-extended-by-hhs-possibly-for-final-time?utm_source=businessinsider&utm_medium=referral
1130.0,1/13/2023 1:56:59 AM,RBC Capital Sticks to Its Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-abbott-labs-abt-1032016258
1131.0,1/17/2023 1:45:29 AM,Abbott Labs (ABT) Gets a Buy from RBC Capital,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-rbc-capital-1032021130
1132.0,1/17/2023 2:47:29 PM,Abbott receives FDA approval for transcatheter  aortic valve implantation system,Seeking Alpha,https://seekingalpha.com/news/3925017-abbott-receives-fda-approval-for-transcatheter-aortic-valve-implantation-system?utm_source=businessinsider&utm_medium=referral
1133.0,1/17/2023 3:00:00 PM,"Abbott Receives FDA Approval for Navitor™, a Next-Generation TAVI System Designed to Treat Aortic Stenosis",PR Newswire,/news/stocks/abbott-receives-fda-approval-for-navitor-a-next-generation-tavi-system-designed-to-treat-aortic-stenosis-1032022647
1134.0,1/17/2023 3:19:04 PM,Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis ,RTTNews,/news/stocks/abbott-says-fda-oks-navitor-tavi-system-to-treat-severe-aortic-stenosis-1032022759
1135.0,1/19/2023 4:36:36 PM,Surmodics sinks as FDA declines to approve drug-coated balloon,Seeking Alpha,https://seekingalpha.com/news/3925969-srdx-stock-sinks-fda-declines-drug-coated-balloon?utm_source=businessinsider&utm_medium=referral
1136.0,1/20/2023 5:16:36 PM,"Earnings week ahead: Tesla, Microsoft, AT&T and more",Seeking Alpha,https://seekingalpha.com/news/3926380-earnings-week-ahead-tesla-microsoft-att-and-more?utm_source=businessinsider&utm_medium=referral
1137.0,1/20/2023 7:30:11 PM,"Catalyst watch: Tesla reverberations, Intel earnings, Rocket Lab launch and Macau stocks on holiday",Seeking Alpha,https://seekingalpha.com/news/3926434-catalyst-watch-tesla-reverberations-intel-earnings-rocket-lab-launch-and-macau-stocks-on-holiday?utm_source=businessinsider&utm_medium=referral
1138.0,1/21/2023 1:06:50 AM,Abbott under DOJ criminal probe over behavior at Michigan baby formula plant - WSJ,Seeking Alpha,https://seekingalpha.com/news/3926538-abbott-under-doj-criminal-probe-over-behavior-at-michigan-baby-formula-plant-wsj?utm_source=businessinsider&utm_medium=referral
1139.0,1/21/2023 5:29:01 PM,Abbott Reportedly Under Criminal Probe Over Baby Formula ,RTTNews,/news/stocks/abbott-reportedly-under-criminal-probe-over-baby-formula-1032031946
1140.0,1/24/2023 3:01:13 PM,What Wall Street expects from Abbott Laboratories's earnings,Markets Insider Automation,/news/stocks/abbott_laboratories-q4-earnings-preview-1032036909
1141.0,1/24/2023 3:12:43 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3927200-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral
1142.0,1/24/2023 4:03:50 PM,Abbott Q4 results in focus as DOJ probe on baby formula plant looms,Seeking Alpha,https://seekingalpha.com/news/3927227-abbott-q4-results-in-focus-as-doj-probe-on-baby-formula-plant-looms?utm_source=businessinsider&utm_medium=referral
1143.0,1/24/2023 7:36:56 PM,"CDC chief to add new offices, leadership in organizational revamp",Seeking Alpha,https://seekingalpha.com/news/3927373-cdc-chief-to-add-new-offices-leadership-in-organizational-revamp?utm_source=businessinsider&utm_medium=referral
1144.0,1/25/2023 12:30:40 PM,"Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.10, revenue of $10.1B beats by $410M",Seeking Alpha,https://seekingalpha.com/news/3927653-abbott-laboratories-non-gaap-eps-of-1_30-beats-0_37-revenue-of-10_1b-beats-410m?utm_source=businessinsider&utm_medium=referral
1145.0,1/25/2023 1:30:00 PM,Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook,PR Newswire,/news/stocks/abbott-reports-fourth-quarter-and-full-year-2022-results-issues-2023-financial-outlook-1032040053
1146.0,1/25/2023 1:37:16 PM,"Abbott posts 12% revenue drop amid baby formula disruption, waning COVID impact",Seeking Alpha,https://seekingalpha.com/news/3927717-abt-stock-falls-topline-drops-baby-formula-disruption?utm_source=businessinsider&utm_medium=referral
1147.0,1/25/2023 1:37:18 PM,"Abbott Laboratories Q4 Profit Decreases, but beats estimates",RTTNews,/news/stocks/abbott-laboratories-q4-profit-decreases-but-beats-estimates-1032040072
1148.0,1/25/2023 2:01:20 PM,"Abbott Issues FY23 Earnings, Sales Growth View - Update ",RTTNews,/news/stocks/abbott-issues-fy23-earnings-sales-growth-view-update-1032040194
1149.0,1/25/2023 7:45:10 PM,BTIG Sticks to Their Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/btig-sticks-to-their-buy-rating-for-abbott-labs-abt-1032041537
1150.0,1/26/2023 1:48:11 PM,NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday,Benzinga,/news/stocks/nike-to-rally-over-23-here-are-10-other-analyst-forecasts-for-thursday-1032043576
1151.0,1/26/2023 2:00:32 PM,What 5 Analyst Ratings Have To Say About Abbott Laboratories,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-abbott-laboratories-1032043633
1152.0,1/26/2023 2:26:52 PM,Abbott wins FDA approval of Proclaim XR for diabetic peripheral neuropathy,Seeking Alpha,https://seekingalpha.com/news/3928423-abbott-wins-fda-approval-of-proclaim-xr-for-diabetic-peripheral-neuropathy?utm_source=businessinsider&utm_medium=referral
1153.0,1/26/2023 3:00:00 PM,FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy,PR Newswire,/news/stocks/fda-approves-abbott-s-spinal-cord-stimulation-for-people-living-with-painful-diabetic-peripheral-neuropathy-1032043917
1154.0,1/26/2023 3:25:06 PM,Abbott Says FDA Oks Proclaim XR Spinal Cord Stimulation System To Treat DPN ,RTTNews,/news/stocks/abbott-says-fda-oks-proclaim-xr-spinal-cord-stimulation-system-to-treat-dpn-1032044061
1155.0,1/28/2023 1:45:29 AM,Abbott Labs (ABT) Gets a Buy from RBC Capital,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-rbc-capital-1032047806
1156.0,1/30/2023 12:00:56 PM,WHO maintains public health emergency on COVID but sees pandemic at 'transition point',Seeking Alpha,https://seekingalpha.com/news/3929274-who-maintains-public-health-emergency-on-covid-with-3-years-into-pandemic?utm_source=businessinsider&utm_medium=referral
1157.0,1/31/2023 5:28:03 PM,FDA to overhaul food safety division in wake of baby formula issues,Seeking Alpha,https://seekingalpha.com/news/3929983-fda-to-overhaul-food-safety-division-in-wake-of-baby-formula-issues?utm_source=businessinsider&utm_medium=referral
1158.0,1/31/2023 9:30:04 PM,Quant Ratings Updated on 105 Stocks,InvestorPlace,/news/stocks/20230131-quant-ratings-1032055811
1159.0,2/2/2023 4:45:39 PM,"Abbott receives FDA, European authorizations for cardiac catheters",Seeking Alpha,https://seekingalpha.com/news/3931361-abbott-receives-fda-european-authorizations-for-cardiac-catheters?utm_source=businessinsider&utm_medium=referral
1160.0,2/9/2023 12:05:00 AM,"Abbott to Acquire Cardiovascular Systems, Inc.",PR Newswire,/news/stocks/abbott-to-acquire-cardiovascular-systems-inc-1032080428
1161.0,2/9/2023 1:49:06 AM,Abbott To Acquire Cardiovascular Systems In $890 Mln Deal ,RTTNews,/news/stocks/abbott-to-acquire-cardiovascular-systems-in-890-mln-deal-1032080477
1162.0,2/9/2023 3:33:35 AM,Abbott to acquire heart device maker Cardiovascular Systems for $20/share,Seeking Alpha,https://seekingalpha.com/news/3933976-csii-stock-jumps-as-abbott-agrees-to-acquire?utm_source=businessinsider&utm_medium=referral
1163.0,2/9/2023 10:10:24 AM,Analysts Have Conflicting Sentiments on These Healthcare Companies: Abbott Labs (ABT) and Phibro Animal Health (PAHC),TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-abbott-labs-abt-and-phibro-animal-health-pahc-1032082205
1164.0,2/9/2023 11:10:09 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Teva Pharmaceutical (TEVA) and Galapagos (GLPG)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-teva-pharmaceutical-teva-and-galapagos-glpg-1032082361
1165.0,2/9/2023 11:15:08 AM,Abbott Labs (ABT) Gets a Buy from BTIG,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-btig-1032082410
1166.0,2/9/2023 12:57:55 PM,Abbott Adds Complementary Technologies To Its Vascular Offering Via Cardiovascular Systems Deal For $890M,Benzinga,/news/stocks/abbott-adds-complementary-technologies-to-its-vascular-offering-via-cardiovascular-systems-deal-for-890m-1032082584
1167.0,2/9/2023 1:15:59 PM,Why Is Cardiovascular Systems (CSII) Stock Up 48% Today?,InvestorPlace,/news/stocks/why-is-cardiovascular-systems-csii-stock-up-48-today-1032082955
1168.0,2/10/2023 12:18:08 PM,Medicare mulls rebates in 2025 for drug prices rising faster than inflation,Seeking Alpha,https://seekingalpha.com/news/3934728-medicare-mulls-rebates-in-2025-for-drug-prices-rising-faster-than-inflation?utm_source=businessinsider&utm_medium=referral
1169.0,2/13/2023 5:29:22 PM,Surmodics downgraded at Needham on uncertainty over drug-coated balloon,Seeking Alpha,https://seekingalpha.com/news/3935282-srdx-stock-downgraded-needham-uncertainty-drug-coated-balloon?utm_source=businessinsider&utm_medium=referral
1170.0,2/13/2023 6:57:52 PM,Abbott-Cardiovascular Systems Acquisition Could Further Add Uncertainty Over Surmodics' Product: Analyst Downgrades Stock,Benzinga,/news/stocks/abbott-cardiovascular-systems-acquisition-could-further-add-uncertainty-over-surmodics-product-analyst-downgrades-stock-1032092007
1171.0,2/13/2023 10:42:16 PM,The 7 Most Undervalued Dividend Aristocrats to Buy,InvestorPlace,/news/stocks/the-7-most-undervalued-dividend-aristocrats-to-buy-1032092498
1172.0,2/14/2023 9:05:22 PM,Which Healthcare Stock Is a Better Pick in 2023?,InvestorPlace,/news/stocks/which-healthcare-stock-is-a-better-pick-in-2023-1032095959
1173.0,2/15/2023 6:14:32 PM,Medicare mulls limiting per month costs for generic drugs at $2,Seeking Alpha,https://seekingalpha.com/news/3936542-medicare-mulls-limiting-per-month-costs-for-generic-drugs-at-2?utm_source=businessinsider&utm_medium=referral
1174.0,2/15/2023 7:11:38 PM,7 Hot Healthcare Stocks With the Potential to Outperform,InvestorPlace,/news/stocks/7-hot-healthcare-stocks-with-the-potential-to-outperform-1032103825
1175.0,2/17/2023 5:28:31 PM,Abbott Laboratories declares $0.51 dividend,Seeking Alpha,https://seekingalpha.com/news/3937785-abbott-laboratories-declares-0_51-dividend?utm_source=businessinsider&utm_medium=referral
1176.0,2/17/2023 6:26:00 PM,Abbott Declares 397th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-397th-consecutive-quarterly-dividend-1032106758
1177.0,2/17/2023 6:35:08 PM,I ‘Tricked’ ChatGPT Into Picking Stocks to Buy. Here’s What It Said.,InvestorPlace,/news/stocks/i-tricked-chatgpt-into-picking-stocks-to-buy-heres-what-it-said-1032106844
1178.0,2/21/2023 8:01:54 PM,Abbott slips as govt. scrutiny over baby formula shortage tightens,Seeking Alpha,https://seekingalpha.com/news/3938655-abt-stock-slips-govt-scrutiny-over-baby-formula-shortage-tightens?utm_source=businessinsider&utm_medium=referral
1179.0,2/22/2023 6:04:18 PM,Apple nears bid to shake up glucose monitoring market – Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3939276-apple-nears-bid-to-shake-up-glucose-monitoring-market?utm_source=businessinsider&utm_medium=referral
1180.0,2/27/2023 12:52:03 PM,Top 5 Health Care Stocks That May Rocket Higher In Q1 2023,Benzinga,/news/stocks/top-5-health-care-stocks-that-may-rocket-higher-in-q1-2023-1032127321
1181.0,2/28/2023 3:00:00 PM,Late-Breaking Data Reinforce Benefits of Abbott's Minimally Invasive Heart Devices,PR Newswire,/news/stocks/late-breaking-data-reinforce-benefits-of-abbott-s-minimally-invasive-heart-devices-1032131783
1182.0,2/28/2023 3:16:47 PM,Abbott touts new data on Navitor transcatheter aortic valve implant,Seeking Alpha,https://seekingalpha.com/news/3941872-abbott-touts-new-data-on-navitor-transcatheter-aortic-valve-implant?utm_source=businessinsider&utm_medium=referral
1183.0,3/1/2023 11:39:48 AM,FBI Director says novel coronavirus likely originated from China lab leak,Seeking Alpha,https://seekingalpha.com/news/3942433-fbi-director-says-novel-coronavirus-likely-originated-from-china-lab-leak?utm_source=businessinsider&utm_medium=referral
1184.0,3/2/2023 7:00:10 PM,DexCom rises as Medicare updates coverage for continuous glucose monitors,Seeking Alpha,https://seekingalpha.com/news/3943517-dexcom-rises-as-medicare-updates-coverage-for-continuous-glucose-monitors?utm_source=businessinsider&utm_medium=referral
1185.0,3/4/2023 1:45:13 AM,RBC Capital Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-abbott-labs-abt-1032145073
1186.0,3/4/2023 4:41:00 PM,New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation,PR Newswire,/news/stocks/new-data-show-superiority-of-abbott-s-triclip-device-compared-to-medical-therapy-for-tricuspid-regurgitation-1032145266
1187.0,3/5/2023 3:07:00 PM,Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott's MitraClip™ Device,PR Newswire,/news/stocks/late-breaking-data-from-landmark-coapt-trial-show-long-term-benefits-of-abbott-s-mitraclip-device-1032145646
1188.0,3/6/2023 3:16:19 AM,Abbott: Data Show Long-Term Benefits Of MitraClip Device For Treating Secondary Mitral Regurgitation ,RTTNews,/news/stocks/abbott-data-show-long-term-benefits-of-mitraclip-device-for-treating-secondary-mitral-regurgitation-1032145839
1189.0,3/6/2023 11:50:15 AM,"Analysts’ Top Healthcare Picks: Abbott Labs (ABT), Eli Lilly & Co (LLY)",TipRanks,/news/stocks/analysts-top-healthcare-picks-abbott-labs-abt-eli-lilly-co-lly-1032146876
1190.0,3/6/2023 1:00:00 PM,U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems,PR Newswire,/news/stocks/u-s-fda-clears-abbott-s-freestyle-libre-2-and-freestyle-libre-3-sensors-for-integration-with-automated-insulin-delivery-systems-1032146895
1191.0,3/6/2023 1:01:07 PM,FDA clears Abbott's FreeStyle Libre 2 and 3 sensors for integration with AID systems,Seeking Alpha,https://seekingalpha.com/news/3944374-fda-clears-abbotts-freestyle-libre-2-and-3-sensors-for-integration-with-aid-systems?utm_source=businessinsider&utm_medium=referral
1192.0,3/6/2023 1:30:40 PM,"Abbott: FDA Clears FreeStyle Libre 2, 3 Sensors For Integration With AID Systems ",RTTNews,/news/stocks/abbott-fda-clears-freestyle-libre-2-3-sensors-for-integration-with-aid-systems-1032147034
1193.0,3/6/2023 1:35:06 PM,Abbott Labs (ABT) Gets a Buy from BTIG,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-btig-1032147287
1194.0,3/6/2023 4:32:32 PM,DexCom slips as Abbott wins FDA nod for CGM integration,Seeking Alpha,https://seekingalpha.com/news/3944516-dexcom-slips-abbott-wins-fda-nod-for-cgm-integration?utm_source=businessinsider&utm_medium=referral
1195.0,3/6/2023 8:13:57 PM,"Nasdaq, S&P, Dow come off session highs ahead of Powell testimony, jobs data this week",Seeking Alpha,https://seekingalpha.com/news/3944519-nasdaq-sp-dow-rise-as-investors-eye-powell-testimony-jobs-data-this-week?utm_source=businessinsider&utm_medium=referral
1196.0,3/6/2023 9:51:35 PM,7 Dividend Kings to Buy for an Uncertain Market Environment,InvestorPlace,/news/stocks/7-dividend-kings-to-buy-for-an-uncertain-market-environment-1032148499
1197.0,3/7/2023 12:20:17 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Tenax Therapeutics (TENX) and Day One Biopharmaceuticals (DAWN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-tenax-therapeutics-tenx-and-day-one-biopharmaceuticals-dawn-1032150096
1198.0,3/7/2023 12:33:25 PM,Biden to announce plan to keep Medicare solvent beyond 2050,Seeking Alpha,https://seekingalpha.com/news/3944823-biden-to-announce-plan-to-keep-medicare-solvent-beyond-2050?utm_source=businessinsider&utm_medium=referral
1199.0,3/7/2023 2:41:03 PM,Abbott wins FDA nod for blood-based concussion test,Seeking Alpha,https://seekingalpha.com/news/3944908-abbott-wins-fda-nod-for-blood-based-concussion-test?utm_source=businessinsider&utm_medium=referral
1200.0,3/7/2023 3:00:00 PM,Abbott Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion,PR Newswire,/news/stocks/abbott-receives-fda-clearance-for-first-commercially-available-lab-based-blood-test-to-help-evaluate-concussion-1032150562
1201.0,3/8/2023 1:34:07 AM,Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason,Benzinga,/news/stocks/health-care-etfs-have-lost-in-the-last-month---these-top-pharma-stocks-are-the-reason-1032151775
1202.0,3/9/2023 4:10:32 AM,"Analysts Conflicted on These Healthcare Names: Abbott Labs (ABT), BioMarin Pharmaceutical (BMRN) and Marinus (MRNS)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-abbott-labs-abt-biomarin-pharmaceutical-bmrn-and-marinus-mrns-1032155138
1203.0,3/23/2023 2:00:00 PM,"Don't Mess with Your 'Melon': Abbott and the Brain Injury Association of America Urge 'If You Hit Your Head, Get it Checked' in New Public Service Announcement",PR Newswire,/news/stocks/don-t-mess-with-your-melon-abbott-and-the-brain-injury-association-of-america-urge-if-you-hit-your-head-get-it-checked-in-new-public-service-announcement-1032187849
1204.0,3/26/2023 4:00:27 PM,Global continuous glucose monitoring market to hit $32B by 2031 – report,Seeking Alpha,https://seekingalpha.com/news/3951266-global-cgm-market-to-hit-32b-by-2031?utm_source=businessinsider&utm_medium=referral
1205.0,3/28/2023 6:35:20 PM,FDA strategy aims to avoid another baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3951979-fda-strategy-aims-to-avoid-another-baby-formula-shortage-abbott?utm_source=businessinsider&utm_medium=referral
1206.0,3/29/2023 3:00:00 PM,Abbott Hosts Conference Call for First-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-first-quarter-earnings-1032200423
1207.0,3/29/2023 8:31:59 PM,Why did Tandem Diabetes Care stock go down today?,Seeking Alpha,https://seekingalpha.com/news/3952467-why-did-tandem-diabetes-care-stock-go-down-today?utm_source=businessinsider&utm_medium=referral
1208.0,3/30/2023 10:25:38 AM,Bank of America Securities Sticks to Their Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/bank-of-america-securities-sticks-to-their-buy-rating-for-abbott-labs-abt-1032202978
1209.0,3/31/2023 2:37:20 PM,3 Healthcare Stocks to Watch As the Industry Evolves,InvestorPlace,/news/stocks/3-healthcare-stocks-to-watch-as-the-industry-evolves-zts-cvs-abt-1032207411
1210.0,4/5/2023 11:07:35 AM,Democratic senators urge U.S. to maintain free COVID tests under Medicare,Seeking Alpha,https://seekingalpha.com/news/3954602-democratic-senators-urge-medicare-maintain-free-covid-tests?utm_source=businessinsider&utm_medium=referral
1211.0,4/5/2023 9:01:24 PM,10 Analysts Have This to Say About Abbott Laboratories,Benzinga,/news/stocks/10-analysts-have-this-to-say-about-abbott-laboratories-1032217622
1212.0,4/6/2023 1:50:42 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Verastem (VSTM) and Pliant Therapeutics (PLRX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-verastem-vstm-and-pliant-therapeutics-plrx-1032217896
1213.0,4/6/2023 6:14:11 PM,WHO chief expects COVID emergency to end this year,Seeking Alpha,https://seekingalpha.com/news/3955102-who-chief-expects-covid-emergency-end-this-year?utm_source=businessinsider&utm_medium=referral
1214.0,4/6/2023 9:02:12 PM,Abbott recalls millions of FreeStyle Libre glucose monitoring devices,Seeking Alpha,https://seekingalpha.com/news/3955151-abbott-stock-recalls-freestyle-libre-cgm-devices?utm_source=businessinsider&utm_medium=referral
1215.0,4/11/2023 12:00:38 PM,Biden signs bill to end COVID national emergency,Seeking Alpha,https://seekingalpha.com/news/3955581-biden-signs-bill-end-covid-national-emergency?utm_source=businessinsider&utm_medium=referral
1216.0,4/14/2023 1:59:01 PM,Abbott reader for FreeStyle Libre CGM system granted FDA nod,Seeking Alpha,https://seekingalpha.com/news/3956614-abbott-stock-reader-freestyle-libre-fda-nod?utm_source=businessinsider&utm_medium=referral
1217.0,4/14/2023 3:00:00 PM,FDA Clears Reader for Abbott's FreeStyle Libre® 3 System,PR Newswire,/news/stocks/fda-clears-reader-for-abbott-s-freestyle-libre-3-system-1032232842
1218.0,4/14/2023 3:23:49 PM,Abbott: FDA Clears Reader For FreeStyle Libre 3 Integrated Continuous Glucose Monitoring System ,RTTNews,/news/stocks/abbott-fda-clears-reader-for-freestyle-libre-3-integrated-continuous-glucose-monitoring-system-1032232925
1219.0,4/14/2023 6:30:56 PM,"Earnings Week Ahead: Tesla, AT&T, Charles Schwab, Netflix, and more",Seeking Alpha,https://seekingalpha.com/news/3956682-earnings-week-ahead-tesla-att-charles-schwab-netflix-and-more?utm_source=businessinsider&utm_medium=referral
1220.0,4/17/2023 12:50:30 PM,"Medicare continuous glucose monitor coverage changes help Abbott, DexCom",Seeking Alpha,https://seekingalpha.com/news/3956897-medicare-continuous-glucose-monitor-coverage-changes-help-abbott-dexcom?utm_source=businessinsider&utm_medium=referral
1221.0,4/17/2023 2:00:00 PM,Abbott's FreeStyle Libre® Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries,PR Newswire,/news/stocks/abbott-s-freestyle-libre-continuous-glucose-monitoring-systems-obtain-significantly-expanded-coverage-for-medicare-beneficiaries-1032236135
1222.0,4/17/2023 4:37:25 PM,Profit from the Artificial Intelligence Boom with These 7 AI ETFs,InvestorPlace,/news/stocks/profit-from-the-artificial-intelligence-boom-with-these-7-ai-etfs-1032237146
1223.0,4/18/2023 9:05:12 AM,Bank of America Securities Reaffirms Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-abbott-labs-abt-1032238930
1224.0,4/18/2023 2:44:20 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3957371-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral
1225.0,4/18/2023 3:01:13 PM,Abbott Laboratories is about to announce earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-q1-quarterly-earnings-preview-stock-1032239737
1226.0,4/18/2023 3:49:45 PM,All eyes on Abbott Q1 results amid baby formula woes and device recall,Seeking Alpha,https://seekingalpha.com/news/3957394-all-eyes-on-abbott-q1-results-amid-baby-formula-woes-device-recall?utm_source=businessinsider&utm_medium=referral
1227.0,4/19/2023 11:18:28 AM,"Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.05, revenue of $9.7B beats by $60M",Seeking Alpha,https://seekingalpha.com/news/3957631-abbott-laboratories-non-gaap-eps-of-1_03-beats-0_05-revenue-of-9_7b-beats-60m?utm_source=businessinsider&utm_medium=referral
1228.0,4/19/2023 12:07:24 PM,Abbott stock pops as sales grow on medical devices amid COVID test slowdown,Seeking Alpha,https://seekingalpha.com/news/3957654-abbott-stock-pops-sales-grow-medical-devices-amid-covid-test-slowdown?utm_source=businessinsider&utm_medium=referral
1229.0,4/19/2023 1:15:00 PM,Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business,PR Newswire,/news/stocks/abbott-reports-first-quarter-2023-results-increases-outlook-for-underlying-base-business-1032243109
1230.0,4/19/2023 1:38:45 PM,"Abbott Laboratories Q1 Profit Decreases, but beats estimates",RTTNews,/news/stocks/abbott-laboratories-q1-profit-decreases-but-beats-estimates-1032243165
1231.0,4/19/2023 3:34:38 PM,"Meta Prepares For Further Job Cuts, Google To Allow Developers To Use Alternative Payment Options, Intel Ditches Production Of Bitcoin Mining Chip: Today's Top Stories",Benzinga,/news/stocks/meta-prepares-for-further-job-cuts-google-to-allow-developers-to-use-alternative-payment-options-intel-ditches-production-of-bitcoin-mining-chip-today-s-top-stories-1032243704
1232.0,4/19/2023 4:57:22 PM,"Hot Stocks: ABT, TRV rise on earnings; crypto, EV stocks slide; BBBY surges",Seeking Alpha,https://seekingalpha.com/news/3957812-hot-stocks-abt-trv-rise-on-earnings-crypto-ev-stocks-slide-bbby-surges?utm_source=businessinsider&utm_medium=referral
1233.0,4/19/2023 7:04:49 PM,Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,Benzinga,/news/stocks/why-travelers-companies-shares-are-trading-higher-by-over-5-here-are-other-stocks-moving-in-wednesday-s-mid-day-session-1032244301
1234.0,4/19/2023 8:33:38 PM,Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results,Benzinga,/news/stocks/nasdaq-edges-higher-abbott-laboratories-reports-upbeat-results-1032244485
1235.0,4/20/2023 7:20:07 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Elevance Health (ELV) and Elanco Animal Health (ELAN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-elevance-health-elv-and-elanco-animal-health-elan-1032245849
1236.0,4/20/2023 8:35:07 AM,Bernstein Sticks to Their Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/bernstein-sticks-to-their-buy-rating-for-abbott-labs-abt-1032246011
1237.0,4/20/2023 10:20:49 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Revance Therapeutics (RVNC) and Actinium Pharmaceuticals (ATNM)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-revance-therapeutics-rvnc-and-actinium-pharmaceuticals-atnm-1032246271
1238.0,4/20/2023 12:30:20 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Alphatec Holdings (ATEC) and Inogen (INGN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-alphatec-holdings-atec-and-inogen-ingn-1032246890
1239.0,4/20/2023 3:00:00 PM,Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change,PR Newswire,/news/stocks/abbott-and-new-global-consortium-partnership-address-viral-outbreaks-caused-by-climate-change-1032247007
1240.0,4/20/2023 3:56:30 PM,Abbott Laboratories To Rally 17%? Here Are 10 Other Analyst Forecasts For Thursday,Benzinga,/news/stocks/abbott-laboratories-to-rally-17-here-are-10-other-analyst-forecasts-for-thursday-1032247303
1241.0,4/21/2023 1:00:27 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Elevance Health (ELV) and Arcutis Biotherapeutics (ARQT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-elevance-health-elv-and-arcutis-biotherapeutics-arqt-1032250002
1242.0,4/25/2023 1:35:17 PM,Abbott's life support system receives new FDA clearances,Seeking Alpha,https://seekingalpha.com/news/3959712-abbotts-life-support-system-receives-new-fda-clearances?utm_source=businessinsider&utm_medium=referral
1243.0,4/25/2023 3:00:00 PM,Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients,PR Newswire,/news/stocks/abbott-s-life-support-system-receives-new-fda-clearances-to-help-doctors-treat-more-critically-ill-patients-1032258591
1244.0,4/25/2023 3:29:46 PM,Abbott Announces Two New FDA Clearances For Life Support System ,RTTNews,/news/stocks/abbott-announces-two-new-fda-clearances-for-life-support-system-1032258728
1245.0,4/25/2023 11:54:00 PM,Cytek Biosciences Set to Join S&P SmallCap 600,PR Newswire,/news/stocks/cytek-biosciences-set-to-join-s-p-smallcap-600-1032260191
1246.0,4/27/2023 10:45:09 AM,7 Healthcare Stocks With Huge Return Potential for Long-Term Investors,InvestorPlace,/news/stocks/7-healthcare-stocks-with-huge-return-potential-for-long-term-investors-1032267993
1247.0,4/27/2023 10:10:00 PM,"Abbott Completes Acquisition of Cardiovascular Systems, Inc.",PR Newswire,/news/stocks/abbott-completes-acquisition-of-cardiovascular-systems-inc-1032270277
1248.0,5/1/2023 3:29:42 PM,3 Stocks to Buy Before They Soar to New Heights in 2023,InvestorPlace,/news/stocks/3-stocks-to-buy-before-they-soar-to-new-heights-in-2023-1032278717
1249.0,5/3/2023 10:08:01 AM,"Fentanyl overdose deaths rose 279%, oxycodone deaths fell in 5 years",Seeking Alpha,https://seekingalpha.com/news/3964240-fentanyl-overdose-deaths-rose-279-oxycodone-deaths-fell-in-5-years?utm_source=businessinsider&utm_medium=referral
1250.0,5/4/2023 6:28:34 PM,WHO meeting is set to decide whether to end COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3965903-who-meeting-is-set-to-decide-whether-to-end-covid-emergency?utm_source=businessinsider&utm_medium=referral
1251.0,5/11/2023 11:20:32 AM,Program for free COVID tests is ending as U.S. pandemic emergency winds down,Seeking Alpha,https://seekingalpha.com/news/3969917-program-free-covid-tests-ending-pandemic-emergency-winds-down?utm_source=businessinsider&utm_medium=referral
1252.0,5/11/2023 2:16:37 PM,Abbott wins FDA expanded indication for Eterna neuromodulation device,Seeking Alpha,https://seekingalpha.com/news/3970111-abbott-wins-fda-expanded-nod--eterna-neuromodulation-device?utm_source=businessinsider&utm_medium=referral
1253.0,5/11/2023 3:00:00 PM,Abbott Announces New Partnerships and Programs to Advance its Diversity in Clinical Trials Initiative,PR Newswire,/news/stocks/abbott-announces-new-partnerships-and-programs-to-advance-its-diversity-in-clinical-trials-initiative-1032318053
1254.0,5/11/2023 6:12:03 PM,Monkeypox is no longer a global health emergency – WHO,Seeking Alpha,https://seekingalpha.com/news/3970268-monkeypox-is-no-longer-a-global-health-emergency-who?utm_source=businessinsider&utm_medium=referral
1255.0,5/14/2023 7:30:40 PM,Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks,InvestorPlace,/news/stocks/investing-for-the-long-term-here-are-7-must-have-dividend-stocks-1032324961
1256.0,5/15/2023 10:17:32 PM,"Shell Asset boosts stake in AT&T, reduces Huntington Bancshares, Arch Capital",Seeking Alpha,https://seekingalpha.com/news/3971818-shell-asset-boosts-stake-in-att-reduces-huntington-bancshares-arch-capital?utm_source=businessinsider&utm_medium=referral
1257.0,5/16/2023 2:46:42 PM,Abbott spinal cord devices gain indication for back pain,Seeking Alpha,https://seekingalpha.com/news/3972152-abbott-spinal-cord-devices-gain-indication-for-back-pain?utm_source=businessinsider&utm_medium=referral
1258.0,5/16/2023 3:00:00 PM,Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options,PR Newswire,/news/stocks/abbott-receives-fda-approval-for-its-spinal-cord-stimulation-systems-to-treat-chronic-back-pain-in-people-who-have-limited-surgical-options-1032331347
1259.0,5/16/2023 3:19:01 PM,Abbott Says FDA Approves Spinal Cord Stimulation Devices To Treat Chronic Back Pain ,RTTNews,/news/stocks/abbott-says-fda-approves-spinal-cord-stimulation-devices-to-treat-chronic-back-pain-1032331503
1260.0,5/17/2023 4:55:50 PM,Billionaire Paul Tudor Jones Pours Millions Into These 2 Stocks Amid Recession Fears,TipRanks,/news/stocks/billionaire-paul-tudor-jones-pours-millions-into-these-2-stocks-amid-recession-fears-1032335705
1261.0,5/18/2023 1:37:27 PM,Abbott wins FDA nod for insertable cardiac monitor Assert-IQ,Seeking Alpha,https://seekingalpha.com/news/3973034-abbott-stock-wins-fda-nod-cardiac-monitor-assert-iq?utm_source=businessinsider&utm_medium=referral
1262.0,5/18/2023 3:00:00 PM,Abbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term,PR Newswire,/news/stocks/abbott-receives-fda-clearance-for-assert-iq-insertable-cardiac-monitor-to-help-doctors-monitor-people-s-heart-rhythms-long-term-1032337503
1263.0,5/18/2023 3:14:21 PM,Abbott Laboratories Says FDA Approves Assert-IQ Insertable Cardiac Monitor ,RTTNews,/news/stocks/abbott-laboratories-says-fda-approves-assert-iq-insertable-cardiac-monitor-1032337598
1264.0,5/19/2023 1:20:40 PM,Stereotaxis stock rises after pact with Abbott to improve abnormal heart beat treatment,Seeking Alpha,https://seekingalpha.com/news/3973466-stereotaxis-stock-rises-abbott-pact-abnormal-heart-beat-therapy?utm_source=businessinsider&utm_medium=referral
1265.0,5/19/2023 1:31:40 PM,Abbott gains approval of TactiFlex ablation catheter treatment,Seeking Alpha,https://seekingalpha.com/news/3973463-abbott-gains-approval-ablation-catheter-treatment?utm_source=businessinsider&utm_medium=referral
1266.0,5/19/2023 3:00:00 PM,Abbott Receives FDA Approval for TactiFlex™ Ablation Catheter for Treatment of Abnormal Heart Rhythm,PR Newswire,/news/stocks/abbott-receives-fda-approval-for-tactiflex-ablation-catheter-for-treatment-of-abnormal-heart-rhythm-1032339788
1267.0,5/19/2023 3:13:26 PM,Abbott Announces FDA Approval For TactiFlex Ablation Catheter ,RTTNews,/news/stocks/abbott-announces-fda-approval-for-tactiflex-ablation-catheter-1032339836
1268.0,5/20/2023 3:18:00 PM,Abbott Unveils Late-Breaking Data Showing the World's First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints,PR Newswire,/news/stocks/abbott-unveils-late-breaking-data-showing-the-world-s-first-dual-chamber-leadless-pacemaker-study-met-all-three-primary-endpoints-1032340737
1269.0,5/23/2023 11:39:57 AM,Goldman Sachs picks top stocks in case of a hard landing,Seeking Alpha,https://seekingalpha.com/news/3973813-goldman-sachs-picks-top-stocks-in-case-of-a-hard-landing?utm_source=businessinsider&utm_medium=referral
1270.0,5/23/2023 2:38:34 PM,Abbott recalled baby formula claims tossed by federal judge,Seeking Alpha,https://seekingalpha.com/news/3974216-abbott-recalled-baby-formula-claims-tossed-federal-judge?utm_source=businessinsider&utm_medium=referral
1271.0,5/24/2023 3:00:00 PM,European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations,PR Newswire,/news/stocks/european-study-finds-the-abbott-cardiomems-sensor-results-in-improved-quality-of-life-and-44-reduction-in-heart-failure-hospitalizations-1032348538
1272.0,5/24/2023 3:22:41 PM,Abbott: MONITOR-HF Trial With CardioMEMS Sensor Meets Primary Endpoint ,RTTNews,/news/stocks/abbott-monitor-hf-trial-with-cardiomems-sensor-meets-primary-endpoint-1032348687
1273.0,5/24/2023 3:37:03 PM,"Nvidia Chief Flags Dangers To US Chips Act, Disney, Shell, Gucci Allegedly Used Worthless Carbon Credits, Microsoft's Daring Attempt to Outshine Google In Search Game: Today's Top Stories",Benzinga,/news/stocks/nvidia-chief-flags-dangers-to-us-chips-act-disney-shell-gucci-allegedly-used-worthless-carbon-credits-microsoft-s-daring-attempt-to-outshine-google-in-search-game-today-s-top-stories-1032348757
1274.0,5/24/2023 4:48:47 PM,Abbott boasts of heart failure reduction data for CardioMEMS device,Seeking Alpha,https://seekingalpha.com/news/3974707-abbott-boasts-heart-failure-reduction-data-cardiomems?utm_source=businessinsider&utm_medium=referral
1275.0,5/25/2023 9:47:53 AM,"Abbott, IQVIA, Global Fund, partners commit $54M to boost laboratory system for pandemics",Seeking Alpha,https://seekingalpha.com/news/3974944-abbott-iqvia-global-fund-partners-commit-54m-to-boost-laboratory-system-for-pandemics?utm_source=businessinsider&utm_medium=referral
1276.0,5/30/2023 8:30:36 PM,Quant Ratings Updated on 107 Stocks,InvestorPlace,/news/stocks/20230530-quant-ratings-1032359328
1277.0,5/30/2023 10:58:47 PM,"Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson",Seeking Alpha,https://seekingalpha.com/news/3976048-morgan-stanley-medtech-picks-medtronic-alphatec-becton-dickinson?utm_source=businessinsider&utm_medium=referral
1278.0,5/31/2023 3:00:00 PM,"Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign",PR Newswire,/news/stocks/abbott-real-madrid-and-the-real-madrid-foundation-band-together-to-beat-malnutrition-globally-through-new-campaign-1032361041
1279.0,5/31/2023 5:03:25 PM,Abbott alleges former scientist in its nutrition unit stole trade secrets,Seeking Alpha,https://seekingalpha.com/news/3976296-abbott-accuses-former-nutrition-scientist-stole-trade-secrets?utm_source=businessinsider&utm_medium=referral
1280.0,6/1/2023 8:13:51 PM,Mark Cuban Helping Lower Cost Of Bestselling Humira With Cost Plus Drug Company: 'The Game Just Changed',Benzinga,/news/stocks/mark-cuban-helping-lower-cost-of-bestselling-humira-with-cost-plus-drug-company-the-game-just-changed-1032365572
1281.0,6/2/2023 2:31:17 PM,Senseonics spikes on UnitedHealthcare coverage for glucose monitoring device,Seeking Alpha,https://seekingalpha.com/news/3977157-senseonics-stock-up-unitedhealth-coverage-cgm-device?utm_source=businessinsider&utm_medium=referral
1282.0,6/9/2023 4:55:00 PM,Abbott Declares 398th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-398th-consecutive-quarterly-dividend-1032381079
1283.0,6/9/2023 8:02:30 PM,Abbott Laboratories declares $0.51 dividend,Seeking Alpha,https://seekingalpha.com/news/3978969-abbott-laboratories-declares-0_51-dividend?utm_source=businessinsider&utm_medium=referral
1284.0,6/12/2023 3:28:42 PM,Abbott names Philip Boudreau CFO effective Sept. 1,Seeking Alpha,https://seekingalpha.com/news/3979249-abbott-names-philip-boudreau-cfo-effective-sept-1?utm_source=businessinsider&utm_medium=referral
1285.0,6/13/2023 1:15:11 AM,Bank of America Securities Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-buy-rating-on-abbott-labs-abt-1032384711
1286.0,6/13/2023 8:40:13 PM,Second Time May Be a Charm: Analyst Is Bullish As Surmodics Resubmits SurVeil DCB Application,Benzinga,/news/stocks/second-time-may-be-a-charm-analyst-is-bullish-as-surmodics-resubmits-surveil-dcb-application-1032387123
1287.0,6/20/2023 12:15:16 PM,Surmodics spikes on FDA nod for SurVeil drug coated balloon,Seeking Alpha,https://seekingalpha.com/news/3980806-surmodics-stock-rises-fda-nod-surveil-drug-balloon?utm_source=businessinsider&utm_medium=referral
1288.0,6/20/2023 3:54:53 PM,"After FDA Rejection, Surmodics' SurVeil Drug-Coated Balloon Scores FDA Approval",Benzinga,/news/stocks/after-fda-rejection-surmodics-surveil-drug-coated-balloon-scores-fda-approval-1032399254
1289.0,6/22/2023 3:00:00 PM,Abbott's FreeStyle Libre® 2 Receives National Reimbursement in France for All People with Diabetes Who Use Insulin¹,PR Newswire,/news/stocks/abbott-s-freestyle-libre-2-receives-national-reimbursement-in-france-for-all-people-with-diabetes-who-use-insulin-1032404542
1290.0,6/22/2023 5:26:21 PM,Abbott gains expanded coverage for glucose monitoring device in France,Seeking Alpha,https://seekingalpha.com/news/3982051-abbott-nabs-wider-coverage-freestyle-libre-2-france?utm_source=businessinsider&utm_medium=referral
1291.0,6/27/2023 8:25:16 PM,GE HealthCare's Solid Demand And Sensible Margin Targets: Morgan Stanley Sees Potential Upside Despite Street's High Expectations,Benzinga,/news/stocks/ge-healthcare-s-solid-demand-and-sensible-margin-targets-morgan-stanley-sees-potential-upside-despite-street-s-high-expectations-1032413289
1292.0,6/29/2023 3:00:00 PM,Abbott Hosts Conference Call for Second-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-second-quarter-earnings-1032417840
1293.0,6/30/2023 4:41:16 PM,Medicare revises guidance on drug price negotiations amid lawsuits,Seeking Alpha,https://seekingalpha.com/news/3984642-medicare-revises-guidance-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral
1294.0,7/5/2023 3:00:00 PM,Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker,PR Newswire,/news/stocks/abbott-receives-fda-approval-for-world-s-first-dual-chamber-leadless-pacemaker-1032427497
1295.0,7/5/2023 3:46:15 PM,Abbott's Minimally Invasive Dual Chamber Leadless Pacemaker System Gets FDA Approval ,RTTNews,/news/stocks/abbott-s-minimally-invasive-dual-chamber-leadless-pacemaker-system-gets-fda-approval-1032427658
1296.0,7/5/2023 6:23:48 PM,FDA approves Abbott dual-chamber leadless pacemaker Aveir DR,Seeking Alpha,https://seekingalpha.com/news/3985737-fda-approves-abbott-dual-chamber-leadless-pacemaker-aveir-dr?utm_source=businessinsider&utm_medium=referral
1297.0,7/7/2023 10:24:04 AM,"BTIG unveils top picks for rest of '23: D.R. Horton, CrowdStrike, DraftKings among names",Seeking Alpha,https://seekingalpha.com/news/3986007-btig-unveils-2h23-top-picks-dr-horton-crowdstrike-draftkings-and-abbott-among-the-list?utm_source=businessinsider&utm_medium=referral
1298.0,7/7/2023 11:44:52 AM,Top 11 technical picks for the second half of 2023,Seeking Alpha,https://seekingalpha.com/news/3985847-top-11-technical-picks-for-the-second-half-of-2023?utm_source=businessinsider&utm_medium=referral
1299.0,7/9/2023 5:06:29 AM,"PEP, ABBV, or GM: Which Value Stock Could Offer the Highest Upside?",TipRanks,/news/stocks/pep-abbv-or-gm-which-value-stock-could-offer-the-highest-upside-1032433298
1300.0,7/9/2023 4:00:00 PM,Goldman Sachs sees rays of hope in underperforming health sector,Seeking Alpha,https://seekingalpha.com/news/3986286-goldman-sachs-sees-hope-underperforming-health-sector?utm_source=businessinsider&utm_medium=referral
1301.0,7/14/2023 7:00:24 PM,"Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown",Seeking Alpha,https://seekingalpha.com/news/3987769-catalyst-watch-microsoft-activision-blizzard-drama-splunk-event-and-nasdaq-100-rebalancing-countdown?utm_source=businessinsider&utm_medium=referral
1302.0,7/15/2023 1:46:44 AM,RBC Capital Remains a Buy on Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-remains-a-buy-on-abbott-labs-abt-1032448573
1303.0,7/17/2023 2:13:13 PM,"Biggest stock movers today: Ford, BridgeBio Pharma, Acumen Pharmaceuticals and more",Seeking Alpha,https://seekingalpha.com/news/3987892-biggest-stock-movers-today-bridgebio-pharma-zai-lab-argenx-and-more?utm_source=businessinsider&utm_medium=referral
1304.0,7/18/2023 11:00:01 PM,"Abbott seen reporting lower Q2 revenue, due in part to less COVID testing",Seeking Alpha,https://seekingalpha.com/news/3988561-abbott-seen-reporting-lower-q2-revenue-due-in-part-to-less-covid-testing?utm_source=businessinsider&utm_medium=referral
1305.0,7/19/2023 3:01:13 PM,Abbott Laboratories earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-q2-earnings-preview-1032458813
1306.0,7/19/2023 3:12:42 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3988764-notable-earnings-before-thursdays-open?utm_source=businessinsider&utm_medium=referral
1307.0,7/19/2023 3:57:54 PM,Senseonics begun at underperform at Jefferies on glucose monitoring market,Seeking Alpha,https://seekingalpha.com/news/3988786-senseonics-begun-underperform-jefferies-glucose-monitoring-market?utm_source=businessinsider&utm_medium=referral
1308.0,7/20/2023 11:30:59 AM,"Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M",Seeking Alpha,https://seekingalpha.com/news/3989100-abbott-laboratories-non-gaap-eps-of-1_08-beats-0_03-revenue-of-10b-beats-280m?utm_source=businessinsider&utm_medium=referral
1309.0,7/20/2023 12:20:21 PM,Abbott Q2 results top consensus as base business offsets COVID impact,Seeking Alpha,https://seekingalpha.com/news/3989128-abbott-q2-beats-consensus-as-base-business-offsets-covid-hit?utm_source=businessinsider&utm_medium=referral
1310.0,7/20/2023 1:24:00 PM,"4 stocks to watch on Thursday: Tesla, Johnson & Johnson and more",Seeking Alpha,https://seekingalpha.com/news/3989180-4-stocks-to-watch-on-thursday-tesla-johnson-johnson-and-more?utm_source=businessinsider&utm_medium=referral
1311.0,7/20/2023 1:38:34 PM,"Abbott Laboratories Q2 Profit Decreases, but beats estimates",RTTNews,/news/stocks/abbott-laboratories-q2-profit-decreases-but-beats-estimates-1032462194
1312.0,7/20/2023 1:50:20 PM,Abbott Laboratories Reaffirms FY23 Adj. EPS Outlook - Update ,RTTNews,/news/stocks/abbott-laboratories-reaffirms-fy23-adj-eps-outlook-update-1032462229
1313.0,7/21/2023 8:25:50 AM,Wolfe Research upgrades Abbott Labs (ABT) to a Hold,TipRanks,/news/stocks/wolfe-research-upgrades-abbott-labs-abt-to-a-hold-1032465148
1314.0,7/21/2023 12:07:24 PM,"J&J, Abbott Labs And JPM Among Jim Cramer's Top Picks As Market Shifts Focus From Tech",Benzinga,/news/stocks/j-j-abbott-labs-and-jpm-among-jim-cramer-s-top-picks-as-market-shifts-focus-from-tech-1032465409
1315.0,7/21/2023 12:19:53 PM,Abbott upgraded at Wolfe after Q2 beat,Seeking Alpha,https://seekingalpha.com/news/3989582-abbott-stock-upgraded-wolfe-after-q2-beat?utm_source=businessinsider&utm_medium=referral
1316.0,7/21/2023 5:00:31 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-21-2023-1032466422
1317.0,7/21/2023 7:18:18 PM,Abbott's Higher Than Expected Q2 Earnings: Analyst Foresees Strong Performance In 2024,Benzinga,/news/stocks/abbott-s-higher-than-expected-q2-earnings-analyst-foresees-strong-performance-in-2024-1032466675
1318.0,7/23/2023 4:00:31 PM,Johnson & Johnson’s Q2 is positive for MedTech - Baird,Seeking Alpha,https://seekingalpha.com/news/3989880-johnson-johnson-q2-positive-medtech-baird?utm_source=businessinsider&utm_medium=referral
1319.0,7/24/2023 1:45:00 PM,Apple To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Monday,Benzinga,/news/stocks/apple-to-rally-over-17-here-are-10-other-analyst-forecasts-for-monday-1032469793
1320.0,7/25/2023 1:50:56 AM,"Analysts’ Top Healthcare Picks: Abbott Labs (ABT), Marinus (MRNS)",TipRanks,/news/stocks/analysts-top-healthcare-picks-abbott-labs-abt-marinus-mrns-1032471743
1321.0,7/26/2023 10:20:25 AM,"Analysts Are Bullish on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX), Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-moonlake-immunotherapeutics-mltx-abbott-labs-abt-1032478866
1322.0,8/5/2023 8:00:22 PM,Medtech set for banner year after significant boost in H1 device approvals,Seeking Alpha,https://seekingalpha.com/news/3997951-medtech-banner-year-significant-boost-h1-device-approvals?utm_source=businessinsider&utm_medium=referral
1323.0,8/8/2023 1:20:07 AM,"Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Eli Lilly & Co (LLY)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-mineralys-therapeutics-inc-mlys-eli-lilly-co-lly-1032525803
1324.0,8/11/2023 6:53:19 PM,Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval,Benzinga,/news/stocks/boston-scientific-s-farapulse-eyes-stronger-us-market-position-with-potential-fda-approval-1032547558
1325.0,8/18/2023 12:31:21 AM,Trillion-Dollar Trio: These 3 Super Growth Stocks Will Dominate the Market by 2035,InvestorPlace,/news/stocks/trillion-dollar-trio-these-3-super-growth-stocks-will-dominate-the-market-by-2035-1032564852
1326.0,8/24/2023 1:44:18 PM,Drugs picked for Medicare price negotiations to be announced on Tuesday – Politico,Seeking Alpha,https://seekingalpha.com/news/4005992-drug-list-picked-medicare-price-negotiations-due-tuesday?utm_source=businessinsider&utm_medium=referral
1327.0,8/24/2023 2:13:39 PM,U.S. Credit Rating Concerns? Here Are 3 Stocks to Protect Your Portfolio,InvestorPlace,/news/stocks/u-s-credit-rating-concerns-here-are-3-stocks-to-protect-your-portfolio-1032580454
1328.0,8/29/2023 4:22:54 PM,Abbott a target in proposed baby formula legislation - WSJ,Seeking Alpha,https://seekingalpha.com/news/4007173-abbott-target-in-proposed-baby-formula-legislation?utm_source=businessinsider&utm_medium=referral
1329.0,8/29/2023 5:29:41 PM,JPMorgan says time to buy MedTech based on past,Seeking Alpha,https://seekingalpha.com/news/4007211-jpmorgan-says-buy-medtech-stocks?utm_source=businessinsider&utm_medium=referral
1330.0,9/1/2023 10:00:11 PM,The 3 Most Promising Healthcare Stocks to Own Now,InvestorPlace,/news/stocks/the-3-most-promising-healthcare-stocks-to-own-now-1032600808
1331.0,9/4/2023 4:00:00 PM,AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley,Seeking Alpha,https://seekingalpha.com/news/4008712-ai-eleven-percent-healthcare-budgets-2024-morgan-stanley?utm_source=businessinsider&utm_medium=referral
1332.0,9/4/2023 4:21:00 PM,"Despite a slower Q2, Needham sees medtech market growing 7% in 2023",Seeking Alpha,https://seekingalpha.com/news/4008713-despite-slower-q2-needham-sees-medtech-market-growing-7-percent-2023?utm_source=businessinsider&utm_medium=referral
1333.0,9/5/2023 10:15:07 PM,BTIG Sticks to Their Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/btig-sticks-to-their-buy-rating-for-abbott-labs-abt-1032606990
1334.0,9/5/2023 10:30:00 PM,"Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes",PR Newswire,/news/stocks/abbott-to-acquire-bigfoot-biomedical-furthering-efforts-to-develop-personalized-connected-solutions-for-people-with-diabetes-1032606828
1335.0,9/5/2023 10:53:32 PM,Abbott To Buy Bigfoot Biomedical ,RTTNews,/news/stocks/abbott-to-buy-bigfoot-biomedical-1032606891
1336.0,9/6/2023 9:50:16 AM,"Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Abbott Labs (ABT) and Thermo Fisher (TMO)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-abbott-labs-abt-and-thermo-fisher-tmo-1032608147
1337.0,9/6/2023 5:47:07 PM,DexCom cites rising glucose monitor use amid weight loss therapy,Seeking Alpha,https://seekingalpha.com/news/4009594-dexcom-stock-gains-cgm-use-rises-amid-weight-loss-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1338.0,9/7/2023 8:30:50 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Abbott Labs (ABT), BridgeBio Pharma (BBIO) and Teladoc (TDOC)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-abbott-labs-abt-bridgebio-pharma-bbio-and-teladoc-tdoc-1032611842
1339.0,9/7/2023 5:38:45 PM,"Insulet, Tandem Diabetes drop as weight loss drugs impact insulin use",Seeking Alpha,https://seekingalpha.com/news/4010020-insulet-tandem-drop-weight-loss-drugs-hurt-insulin-use?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1340.0,9/8/2023 1:14:42 PM,The 3 Best Pharma Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-3-best-pharma-stocks-to-buy-now-september-2023-1032616131
1341.0,9/8/2023 3:56:55 PM,September Rally? 3 Healthcare Stocks to Buy Before Liftoff.,InvestorPlace,/news/stocks/september-rally-3-healthcare-stocks-to-buy-before-liftoff-1032616887
1342.0,9/13/2023 8:29:54 PM,"Abbott recalls certain Proclaim, Infinity neurostimulation devices",Seeking Alpha,https://seekingalpha.com/news/4011571-abbott-recalls-certain-proclaim-infinity-neurostimulation-devices?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1343.0,9/15/2023 7:46:54 PM,Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch,Benzinga,/news/stocks/apple-taps-seasoned-executive-to-head-secret-team-developing-glucose-monitoring-device---stocks-to-watch-1032634559
1344.0,9/19/2023 2:00:00 PM,Abbott and WeightWatchers Connected App Experience is Now Available for People Living with Diabetes,PR Newswire,/news/stocks/abbott-and-weightwatchers-connected-app-experience-is-now-available-for-people-living-with-diabetes-1032639654
1345.0,9/20/2023 2:00:00 PM,Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets,PR Newswire,/news/stocks/abbott-broadens-access-to-cutting-edge-biosimilars-in-key-emerging-markets-1032643126
1346.0,9/20/2023 2:34:23 PM,Abbott Inks Deal With MAbxience To Commercialize Biosimilar Molecules In Emerging Markets ,RTTNews,/news/stocks/abbott-inks-deal-with-mabxience-to-commercialize-biosimilar-molecules-in-emerging-markets-1032643311
1347.0,9/21/2023 6:02:00 PM,Abbott Declares 399th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-399th-consecutive-quarterly-dividend-1032647755
1348.0,9/21/2023 6:37:40 PM,3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought,InvestorPlace,/news/stocks/3-unstoppable-nasdaq-100-stocks-just-waiting-to-be-bought-1032648036
1349.0,9/22/2023 2:48:00 PM,Abbott Completes Acquisition of Bigfoot Biomedical,PR Newswire,/news/stocks/abbott-completes-acquisition-of-bigfoot-biomedical-1032649630
1350.0,9/26/2023 8:30:00 PM,Quant Ratings Updated on 73 Stocks,InvestorPlace,/news/stocks/092623-quant-ratings-1032657450
1351.0,9/27/2023 3:00:00 PM,Abbott Hosts Conference Call for Third-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-third-quarter-earnings-1032659339
1352.0,10/2/2023 1:20:21 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Abbott Labs (ABT), Eli Lilly & Co (LLY) and Rocket Pharmaceuticals (RCKT)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-abbott-labs-abt-eli-lilly-co-lly-and-rocket-pharmaceuticals-rckt-1032670481
1353.0,10/10/2023 2:06:53 PM,3 Dividend Kings Every Investor Should Own to Survive a Market Crash,InvestorPlace,/news/stocks/3-dividend-kings-every-investor-should-own-to-survive-a-market-crash-1032693057
1354.0,10/11/2023 2:53:17 PM,Jim Cramer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business',Benzinga,/news/stocks/jim-cramer-is-a-seller-of-this-company-because-elon-musk-said-that-he-doesn-t-like-that-business-1032696493
1355.0,10/12/2023 10:57:02 PM,"As Israel-Palestine Conflict Escalates, Gold Ticks Up  - ETF Winners And Losers: Medium-Cap Returns",Benzinga,/news/etf/as-isreal-palestine-conflict-escalates-gold-ticks-up---etf-winners-and-losers-medium-cap-returns-1032702063
1356.0,10/12/2023 11:08:12 PM,CGDV: An Outperforming Dividend ETF with Lots to Like,TipRanks,/news/stocks/cgdv-an-outperforming-dividend-etf-with-lots-to-like-1032702142
1357.0,10/13/2023 10:33:32 PM,"Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets",Benzinga,/news/etf/israel-hamas-war-shakes-middle-east-inflation-reawakens-oil-surges-the-week-in-the-markets-1032705050
1358.0,10/16/2023 9:46:29 AM,BTIG Reaffirms Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/btig-reaffirms-their-buy-rating-on-abbott-labs-abt-1032707659
1359.0,10/16/2023 11:13:22 PM,"Amid Israel-Palestine And Ukraine Gas, Gold Up Big, Cathie Wood's ARKK Down Almost 4% - ETF Winners And Losers: Medium-Cap Returns",Benzinga,/news/etf/amid-israel-palestine-and-ukraine-gas-gold-up-big-cathie-wood-s-arkk-down-almost-4---etf-winners-and-losers-medium-cap-returns-1032709994
1360.0,10/17/2023 3:01:13 PM,Abbott Laboratories is about to announce earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-quarter-earnings-preview-q3-1032712436
1361.0,10/18/2023 1:33:34 PM,Abbott Laboratories Q3 Profit Beats Estimates,RTTNews,/news/stocks/abbott-laboratories-q3-profit-beats-estimates-1032716474
1362.0,10/18/2023 2:54:58 PM,Abbott Laboratories Lifts Midpoint Of FY23 Earnings Outlook Range - Update ,RTTNews,/news/stocks/abbott-laboratories-lifts-midpoint-of-fy23-earnings-outlook-range-update-1032716825
1363.0,10/18/2023 5:04:06 PM,"Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday",Benzinga,/news/stocks/abbott-laboratories-nasdaq-spirit-aerosystems-and-other-big-stocks-moving-higher-on-wednesday-1032717758
1364.0,10/18/2023 8:17:46 PM,Positive Growth Trajectory and Investment Returns Justify Buy Rating for Abbott Labs,TipRanks,/news/stocks/positive-growth-trajectory-and-investment-returns-justify-buy-rating-for-abbott-labs-1032718398
1365.0,10/19/2023 1:15:48 PM,Wells Fargo Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-labs-abt-1032721046
1366.0,10/19/2023 2:02:29 PM,"Analysts Are Bullish on Top Healthcare Stocks: SAB Biotherapeutics (SABS), Elevance Health (ELV)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-sab-biotherapeutics-sabs-elevance-health-elv-1032721518
1367.0,10/19/2023 6:00:17 PM,Expert Ratings for Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1032721841
1368.0,10/19/2023 6:48:18 PM,7 Blue-Chip Stocks to Buy on the Dip,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-on-the-dip-1032722154
1369.0,10/19/2023 8:28:20 PM,These Analysts Cut Their Forecasts On Abbott After Q3 Results,Benzinga,/news/stocks/these-analysts-cut-their-forecasts-on-abbott-after-q3-results-1032722131
1370.0,10/25/2023 12:18:00 AM,Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves,PR Newswire,/news/stocks/late-breaking-data-showcase-the-benefits-of-abbott-s-minimally-invasive-devices-for-people-with-leaky-heart-valves-1032735248
1371.0,10/25/2023 3:27:22 AM,Abbott : Data Showcase Benefits Of Minimally Invasive Devices For People With Leaky Heart Valves ,RTTNews,/news/stocks/abbott-data-showcase-benefits-of-minimally-invasive-devices-for-people-with-leaky-heart-valves-1032735467
1372.0,10/25/2023 10:17:09 AM,FDA Approves New Therapy For Rare Blood Cancers ,RTTNews,/news/stocks/fda-approves-new-therapy-for-rare-blood-cancers-1032737724
1373.0,10/25/2023 8:30:00 PM,Late-Breaking Data Show Esprit™ BTK Drug-Eluting Resorbable Scaffold Reduces Chronic Limb-Threatening Ischemia Progression Compared to the Standard of Care,PR Newswire,/news/stocks/late-breaking-data-show-esprit-btk-drug-eluting-resorbable-scaffold-reduces-chronic-limb-threatening-ischemia-progression-compared-to-the-standard-of-care-1032740166
1374.0,10/26/2023 3:00:00 PM,Ninety-One Percent of Young Adults With Student Loans Say Financial Stress is Impacting Their Wellness -- Abbott Launches Blueprint of Award-Winning Program to Help Companies Tackle This Problem,PR Newswire,/news/stocks/ninety-one-percent-of-young-adults-with-student-loans-say-financial-stress-is-impacting-their-wellness-abbott-launches-blueprint-of-award-winning-program-to-help-companies-tackle-this-problem-1032743944
1375.0,10/27/2023 11:01:36 AM,"Analysts Conflicted on These Healthcare Names: Blueprint Medicines (BPMC), Abbott Labs (ABT) and Merck & Company (MRK)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-blueprint-medicines-bpmc-abbott-labs-abt-and-merck-company-mrk-1032750111
1376.0,10/27/2023 11:20:40 AM,"Analysts Conflicted on These Healthcare Names: Bicycle Therapeutics (BCYC), Abbott Labs (ABT) and VolitionRX (VNRX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-bicycle-therapeutics-bcyc-abbott-labs-abt-and-volitionrx-vnrx-1032750128
1377.0,10/27/2023 8:15:50 PM,"MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024",Benzinga,/news/stocks/medtech-giant-dexcom-spotlight-is-on-g7-us-launch-analyst-forecasts-22-revenue-gain-in-2024-1032749666
1378.0,10/31/2023 1:00:00 PM,Abbott and Damar Hamlin Team Up to Build Heart Health Community with New HeartMates Program,PR Newswire,/news/stocks/abbott-and-damar-hamlin-team-up-to-build-heart-health-community-with-new-heartmates-program-1032758858
1379.0,11/1/2023 1:28:00 PM,Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology,PR Newswire,/news/stocks/abbott-and-sherri-shepherd-millions-not-using-affordable-diabetes-technology-1032764864
1380.0,11/2/2023 2:00:00 PM,"Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV",PR Newswire,/news/stocks/abbott-receives-fda-approval-for-hpv-test-to-run-on-alinity-m-offering-primary-hpv-screening-and-assessment-of-high-risk-cancer-causing-types-of-hpv-1032770285
1381.0,11/2/2023 2:48:45 PM,Abbott Obtains FDA Approval For HPV Test To Run On Alinity M ,RTTNews,/news/stocks/abbott-obtains-fda-approval-for-hpv-test-to-run-on-alinity-m-1032770593
1382.0,11/2/2023 3:17:56 PM,3 Dividend Stocks That Are Investor Safe Havens,InvestorPlace,/news/stocks/3-dividend-stocks-that-are-investor-safe-havens-1032771288
1383.0,11/6/2023 8:48:54 PM,3 Dividend Kings to Buy for Royal Returns,InvestorPlace,/news/stocks/3-dividend-kings-to-buy-for-royal-returns-1032783665
1384.0,11/8/2023 12:00:00 PM,Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes,PR Newswire,/news/stocks/participants-in-abbott-s-food-as-medicine-program-showed-clinically-significant-improvements-in-managing-diabetes-1032793532
1385.0,11/13/2023 3:00:00 PM,Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3™ Heart Pump,PR Newswire,/news/stocks/late-breaking-data-show-an-aspirin-free-medication-regimen-benefits-people-with-abbott-s-heartmate-3-heart-pump-1032813210
1386.0,11/13/2023 6:28:41 PM,Abbott Says Aspirin-free Medication Regimen Benefits People With HeartMate 3 Heart Pump ,RTTNews,/news/stocks/abbott-says-aspirin-free-medication-regimen-benefits-people-with-heartmate-3-heart-pump-1032814175
1387.0,11/22/2023 12:40:38 PM,"Analysts’ Top Healthcare Picks: Morphosys Ag (MOR), Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-top-healthcare-picks-morphosys-ag-mor-abbott-labs-abt-1032844342
1388.0,12/7/2023 10:11:15 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arvinas Holding Company (ARVN), Abbott Labs (ABT) and Owens & Minor (OMI)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-arvinas-holding-company-arvn-abbott-labs-abt-and-owens-minor-omi-1032883666
1389.0,12/13/2023 12:57:06 PM,Wells Fargo Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-labs-abt-1032899045
1390.0,12/13/2023 5:00:52 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1032897966
1391.0,12/14/2023 10:01:31 AM,"MDT, ABT: 2 Healthcare Dividend Aristocrat Stocks Hedge Funds are Bullish On",TipRanks,/news/stocks/mdt-abt-2-healthcare-dividend-aristocrat-stocks-hedge-funds-are-bullish-on-1032902886
1392.0,12/15/2023 5:25:00 PM,Abbott Increases Quarterly Dividend for 52nd Consecutive Year,PR Newswire,/news/stocks/abbott-increases-quarterly-dividend-for-52nd-consecutive-year-1032905469
1393.0,12/18/2023 3:00:00 PM,Abbott to Present at J.P. Morgan Healthcare Conference,PR Newswire,/news/stocks/abbott-to-present-at-j-p-morgan-healthcare-conference-1032908978
1394.0,12/19/2023 9:40:58 AM,Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Ascom Holding AG (OtherACMLF),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-and-ascom-holding-ag-otheracmlf-1032914124
1395.0,12/27/2023 7:37:23 PM,Silver Economy Successes: 3 Stocks Benefitting From an Aging Population,InvestorPlace,/news/stocks/silver-economy-successes-3-stocks-benefitting-from-an-aging-population-1032928709
1396.0,12/28/2023 1:33:14 PM,"Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts",Benzinga,/news/stocks/eli-lilly-johnson-johnson-and-other-health-care-stocks-from-wall-street-s-most-accurate-analysts-1032929866
1397.0,12/31/2023 10:10:57 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Keros Therapeutics (KROS) and Xencor (XNCR)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-keros-therapeutics-kros-and-xencor-xncr-1032934194
1398.0,1/2/2024 2:20:36 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Keros Therapeutics (KROS) and Xencor (XNCR)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-keros-therapeutics-kros-and-xencor-xncr-1032938368
1399.0,1/3/2024 7:00:17 PM,Beyond The Numbers: 5 Analysts Discuss Abbott Laboratories Stock,Benzinga,/news/stocks/beyond-the-numbers-5-analysts-discuss-abbott-laboratories-stock-1032940947
1400.0,1/4/2024 8:15:28 AM,Abbott Labs (ABT) Gets a Buy from Raymond James,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-raymond-james-1032944359
1401.0,1/11/2024 12:27:40 PM,RBC Capital Remains a Buy on Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-remains-a-buy-on-abbott-labs-abt-1032961211
1402.0,1/19/2024 2:38:28 PM,Abbott TriClip device set for FDA panel review in February,Seeking Alpha,https://seekingalpha.com/news/4056457-abbott-triclip-device-set-for-fda-panel-review-in-february?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1403.0,1/19/2024 8:00:29 PM,"Catalyst Watch: Tesla, Netflix and Procter & Gamble head into the earnings confessional",Seeking Alpha,https://seekingalpha.com/news/4056553-catalyst-watch-tesla-netflix-and-procter-gamble-head-into-the-earnings-confessional?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1404.0,1/21/2024 1:00:00 PM,"Earnings week ahead: Tesla, Netflix, AT&T, Johnson & Johnson, GE and more",Seeking Alpha,https://seekingalpha.com/news/4056510-earnings-week-ahead-tesla-netflix-att-johnson-johnson-general-electric-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1405.0,1/22/2024 3:23:05 PM,"BoFA picks Johnson & Johnson, Halliburton and Tesla for options opportunity ahead of earnings",Seeking Alpha,https://seekingalpha.com/news/4056847-bofa-picks-johnson-johnson-halliburton-and-tesla-for-options-opportunity-ahead-of-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1406.0,1/22/2024 7:34:59 PM,"S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?",Benzinga,/news/etf/stock-indexes-trade-at-all-time-highs-ahead-of-key-earnings-this-week-what-s-driving-markets-monday-1032984660
1407.0,1/23/2024 3:45:41 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/4057415-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1408.0,1/23/2024 4:10:51 PM,"Samsung, Apple race to shake up glucose monitoring market: Bloomberg",Seeking Alpha,https://seekingalpha.com/news/4057426-samsung-apple-race-shake-up-glucose-monitoring-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1409.0,1/23/2024 7:11:06 PM,Earnings preview: Abbott slated to roll out Q4 results Wednesday,Seeking Alpha,https://seekingalpha.com/news/4057173-abbott-slated-to-roll-out-q4-earnings-report-wednesday-morning?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1410.0,1/23/2024 7:56:11 PM,7 Safe-Haven Stocks to Protect Your Portfolio During a Recession,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-protect-your-portfolio-during-a-recession-1032989306
1411.0,1/23/2024 8:56:53 PM,"Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst",Benzinga,/news/stocks/arterial-device-focused-inari-medical-likely-acquisition-target-shares-are-attractively-valued-analyst-1032989277
1412.0,1/24/2024 12:33:04 PM,"Abbott Laboratories Non-GAAP EPS of $1.19 in-line, revenue of $10.24B beats by $50M",Seeking Alpha,https://seekingalpha.com/news/4057763-abbott-laboratories-non-gaap-eps-of-1_19-in-line-revenue-of-10_24b-beats-50m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1413.0,1/24/2024 1:00:56 PM,Abbott in charts: Medical Devices and Nutrition segment maintains double-digit growth momentum in Q4,Seeking Alpha,https://seekingalpha.com/news/4057771-abbott-in-charts?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1414.0,1/24/2024 1:13:12 PM,Abbott  Q4 beat driven by MedTech,Seeking Alpha,https://seekingalpha.com/news/4057797-abbott-stock-slips-medtech-drives-q4-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1415.0,1/24/2024 1:37:22 PM,"Abbott Laboratories Q4 Profit Increases, Inline With Estimates",RTTNews,/news/stocks/abbott-laboratories-q4-profit-increases-inline-with-estimates-1032991993
1416.0,1/24/2024 1:38:11 PM,Abbott Laboratories Guides FY24 Adj. EPS In Line With Estimates - Update ,RTTNews,/news/stocks/abbott-laboratories-guides-fy24-adj-eps-in-line-with-estimates-update-1032991992
1417.0,1/24/2024 8:38:32 PM,"Stock Market Extends Record Highs, S&P 500 Hits 4,900 On Tech Rally, Microsoft's $3 Trillion Mark: What's Driving Markets Wednesday?",Benzinga,/news/stocks/stock-market-extends-record-highs-s-p-500-hits-4-900-on-tech-rally-microsoft-s-3-trillion-mark-what-s-driving-markets-wednesday-1032993924
1418.0,1/24/2024 11:55:47 PM,Buy Rating Affirmed for Abbott Labs on Solid Core Growth and Positive Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-labs-on-solid-core-growth-and-positive-outlook-1032994488
1419.0,1/25/2024 2:31:52 AM,Analysts Have Conflicting Sentiments on These Healthcare Companies: BridgeBio Pharma (BBIO) and Abbott Labs (ABT),TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-bridgebio-pharma-bbio-and-abbott-labs-abt-1032995094
1420.0,1/25/2024 10:50:29 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Elevance Health (ELV) and AbbVie (ABBV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-elevance-health-elv-and-abbvie-abbv-1032996806
1421.0,1/25/2024 12:10:53 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Kura Oncology (KURA) and Exelixis (EXEL)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-kura-oncology-kura-and-exelixis-exel-1032997520
1422.0,1/25/2024 12:26:51 PM,RBC Capital Sticks to Its Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-abbott-labs-abt-1032997592
1423.0,1/25/2024 2:00:52 PM,Cracking The Code: Understanding Analyst Reviews For Abbott Laboratories,Benzinga,/news/stocks/cracking-the-code-understanding-analyst-reviews-for-abbott-laboratories-1032996472
1424.0,1/26/2024 5:50:28 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Johnson & Johnson (JNJ) and Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-elevance-health-elv-johnson-johnson-jnj-and-abbott-labs-abt-1032999669
1425.0,1/26/2024 8:11:36 AM,"Analysts Are Bullish on These Healthcare Stocks: Abbott Labs (ABT), Travere Therapeutics (TVTX)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-abbott-labs-abt-travere-therapeutics-tvtx-1033000235
1426.0,1/29/2024 1:07:57 AM,7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market,InvestorPlace,/news/stocks/7-agetech-stocks-to-profit-from-the-booming-longevity-market-1033003308
1427.0,1/29/2024 2:10:18 AM,"Analysts’ Top Healthcare Picks: Abbott Labs (ABT), eFFECTOR Therapeutics (EFTR)",TipRanks,/news/stocks/analysts-top-healthcare-picks-abbott-labs-abt-effector-therapeutics-eftr-1033003492
1428.0,1/31/2024 3:56:09 PM,Abbott launches nutritional brand for GLP-1 users (update),Seeking Alpha,https://seekingalpha.com/news/4060732-abbott-launches-nutritional-product-brand-for-glp-1-users?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1429.0,1/31/2024 5:07:52 PM,Abbott Launches New Protality Brand High-protein Nutrition Shake ,RTTNews,/news/stocks/abbott-launches-new-protality-brand-high-protein-nutrition-shake-1033016128
1430.0,1/31/2024 11:03:00 PM,"LLY, ABT, CVS: Which Healthcare Stock Do Analysts Prefer?",TipRanks,/news/stocks/lly-abt-cvs-which-healthcare-stock-do-analysts-prefer-1033017434
1431.0,2/1/2024 6:22:16 PM,"Lilly, Zoetis, Abbott least shorted stocks in S&P 500 health sector in mid-Jan",Seeking Alpha,https://seekingalpha.com/news/4061498-lilly-zoetis-abbott-least-shorted-stocks-in-health-sector-till-mid-jan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1432.0,2/2/2024 11:40:11 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Abbott Labs (ABT), Sanofi (OtherSNYNF) and Siemens Healthineers AG (OtherSEMHF)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-abbott-labs-abt-sanofi-othersnynf-and-siemens-healthineers-ag-othersemhf-1033025267
1433.0,2/2/2024 5:20:25 PM,"Edwards stock jumps 8% on FDA approval, Wells Fargo upgrade",Seeking Alpha,https://seekingalpha.com/news/4062258-edwards-stock-jumps-on-fda-approval-wells-fargo-upgrade?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1434.0,2/7/2024 11:00:00 AM,7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates,InvestorPlace,/news/stocks/7-tremendous-dividend-stocks-with-double-digit-5-year-growth-rates-1033039781
1435.0,2/7/2024 3:11:06 PM,Insulet gets CE Mark for Ominipod 5 with FreeStyle Libre 2 sensor,Seeking Alpha,https://seekingalpha.com/news/4063877-insulet-gets-ce-mark-for-ominipod-5-with-freestyle-libre-2-sensor?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1436.0,2/9/2024 6:55:19 PM,Positive Outlook for Abbott Labs on TriClip Device Efficacy and Anticipated FDA Approval,TipRanks,/news/stocks/positive-outlook-for-abbott-labs-on-triclip-device-efficacy-and-anticipated-fda-approval-1033052585
1437.0,2/11/2024 11:51:00 AM,3 Groundbreaking Healthcare Stocks to Buy for Robust Gains,InvestorPlace,/news/stocks/3-groundbreaking-healthcare-stocks-to-buy-for-robust-gains-1033053334
1438.0,2/12/2024 10:50:12 AM,"Analysts Offer Insights on Healthcare Companies: McKesson (MCK), Embecta Corporation (EMBC) and Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-mckesson-mck-embecta-corporation-embc-and-abbott-labs-abt-1033056910
1439.0,2/14/2024 2:01:00 AM,FDA Panel Votes In Favor Of Abbott's TriClip System To Treat Leaky Tricuspid Heart Valve ,RTTNews,/news/stocks/fda-panel-votes-in-favor-of-abbott-s-triclip-system-to-treat-leaky-tricuspid-heart-valve-1033063333
1440.0,2/14/2024 10:51:24 AM,"Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Abbott Labs (ABT) and Chemed (CHE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-elevance-health-elv-abbott-labs-abt-and-chemed-che-1033066460
1441.0,2/14/2024 11:38:56 AM,Wells Fargo Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-labs-abt-1033066815
1442.0,2/14/2024 11:41:19 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Edwards Lifesciences (EW) and Coya Therapeutics, Inc. (COYA)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-edwards-lifesciences-ew-and-coya-therapeutics-inc-coya-1033066810
1443.0,2/14/2024 11:53:36 AM,Abbott wins FDA AdComm backing for heart device,Seeking Alpha,https://seekingalpha.com/news/4066606-abbott-wins-fda-adcomm-backing-for-triclip?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1444.0,2/14/2024 12:20:13 PM,"Analysts Are Bullish on These Healthcare Stocks: QuidelOrtho (QDEL), Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-quidelortho-qdel-abbott-labs-abt-1033067335
1445.0,2/14/2024 12:51:10 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Madrigal Pharmaceuticals (MDGL) and Biogen (BIIB)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-madrigal-pharmaceuticals-mdgl-and-biogen-biib-1033067461
1446.0,2/14/2024 4:43:00 PM,CDC to relax COVID isolation requirements: WaPo,Seeking Alpha,https://seekingalpha.com/news/4066920-cdc-to-relax-covid-isolation-requirements?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1447.0,2/16/2024 3:40:26 PM,Abbott Laboratories declares $0.55 dividend,Seeking Alpha,https://seekingalpha.com/news/4068270-abbott-laboratories-declares-0_55-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1448.0,2/18/2024 5:00:00 PM,Medtronic Q3 in focus amid MedTech’s post-COVID gains,Seeking Alpha,https://seekingalpha.com/news/4068521-medtronic-q3-in-focus-amid-medtechs-gains?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1449.0,2/18/2024 8:20:31 PM,3 Cash Cows to Boost Your Confidence During the February Chill,InvestorPlace,/news/stocks/3-cash-cows-to-boost-your-confidence-during-the-february-chill-1033078339
1450.0,2/22/2024 10:04:58 AM,FDA warns against use of smartwatches to measure blood glucose,Seeking Alpha,https://seekingalpha.com/news/4070135-fda-warns-against-use-of-smartwatches-to-measure-blood-glucose?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1451.0,2/23/2024 12:05:00 PM,Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth,InvestorPlace,/news/stocks/recession-proof-riches-7-stocks-to-buy-for-bulletproof-portfolio-growth-1033097068
1452.0,2/23/2024 7:03:31 PM,Abbott Laboratories' stock trades in the green for seven straight sessions,Seeking Alpha,https://seekingalpha.com/news/4071277-abbott-laboratories-stock-on-track-for-seventh-straight-session-of-gains?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1453.0,2/26/2024 11:30:36 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Celldex (CLDX), Abbott Labs (ABT) and Morphic Holding (MORF)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-celldex-cldx-abbott-labs-abt-and-morphic-holding-morf-1033102868
1454.0,2/26/2024 11:45:20 AM,Looking for Growth? 7 Hot Trends That Have Been Flying Under Investors’ Radar.,InvestorPlace,/news/stocks/looking-for-growth-7-hot-trends-that-have-been-flying-under-investors-radar-1033102094
1455.0,2/26/2024 7:44:36 PM,3 Blue-Chip Stocks to Buy to Bolster Your Portfolio,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-to-bolster-your-portfolio-1033104264
1456.0,2/29/2024 11:50:51 AM,"Analysts Offer Insights on Healthcare Companies: Sensei Biotherapeutics (SNSE), Abbott Labs (ABT) and Personalis (PSNL)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-sensei-biotherapeutics-snse-abbott-labs-abt-and-personalis-psnl-1033118667
1457.0,3/6/2024 4:40:54 PM,"Abbott: FreeStyle Libre Systems, GLP-1 Medicines Together Is Beneficial For Type 2 Diabetes Patients ",RTTNews,/news/stocks/abbott-freestyle-libre-systems-glp-1-medicines-together-is-beneficial-for-type-2-diabetes-patients-1033138489
1458.0,3/6/2024 7:43:57 PM,3 Dividend Aristocrats With the Largest 10-Year Dividend Growth Rates,InvestorPlace,/news/stocks/3-dividend-aristocrats-with-the-largest-10-year-dividend-growth-rates-1033139286
1459.0,3/6/2024 10:48:40 PM,"FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's",Benzinga,/news/stocks/fda-approval-for-dexcom-s-stelo-opens-continuous-glucose-monitoring-to-masses-analyst-expects-competitive-pricing-against-abbott-s-1033139550
1460.0,3/7/2024 10:56:04 AM,Abbott Labs (ABT) Gets a Buy from Wells Fargo,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-wells-fargo-1033142271
1461.0,3/11/2024 8:45:47 PM,Abbott recalls HeartMate Touch System over software glitch,Seeking Alpha,https://seekingalpha.com/news/4078186-abbott-recalls-heartmate-touch-system-over-software-glitch?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1462.0,3/12/2024 9:20:08 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fortrea Holdings Inc. (FTRE) and Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-incyte-incy-fortrea-holdings-inc-ftre-and-abbott-labs-abt-1033154762
1463.0,3/12/2024 11:13:03 AM,Walgreens settles with New York over price gauging on baby formula,Seeking Alpha,https://seekingalpha.com/news/4078327-walgreens-settles-new-york-baby-formula-pricing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1464.0,3/13/2024 10:30:00 AM,SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster,InvestorPlace,/news/stocks/schd-etf-spotlight-the-top-6-stocks-inside-this-dividend-monster-1033158747
1465.0,3/15/2024 2:00:27 PM,Jury orders Reckitt Benckiser to pay $60M in baby formula case,Seeking Alpha,https://seekingalpha.com/news/4079971-jury-orders-reckitt-benckiser-to-pay-60m-in-baby-formula-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1466.0,3/15/2024 4:09:20 PM,Abbott falls after setback to Reckitt Benckiser in baby formula case,Seeking Alpha,https://seekingalpha.com/news/4080064-abbott-stock-falls-60m-jury-award-reckitt?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1467.0,3/15/2024 10:00:41 PM,"Perrigo has no exposure to infant formula litigation, CG says",Seeking Alpha,https://seekingalpha.com/news/4080219-perrigo-has-no-exposure-to-infant-formula-litigation-cg-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1468.0,3/18/2024 5:04:35 PM,Reckitt unsure how many cases have been filed over Enfamil: report,Seeking Alpha,https://seekingalpha.com/news/4080676-reckitt-unsure-how-many-cases-have-been-filed-over-enfamil-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1469.0,3/21/2024 6:22:02 PM,3 Resilient Stocks to Protect Your Wealth During a Recession,InvestorPlace,/news/stocks/3-resilient-stocks-to-protect-your-wealth-during-a-recession-1033186337
1470.0,3/21/2024 9:26:33 PM,3 Stocks to Buy Right Now for the Coming Recession,InvestorPlace,/news/stocks/3-stocks-to-buy-right-now-for-the-coming-recession-1033186702
1471.0,3/25/2024 6:04:05 PM,More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’,InvestorPlace,/news/stocks/more-than-86-of-analysts-who-cover-these-3-stocks-rate-them-a-buy-1033194410
1472.0,3/26/2024 8:47:13 AM,Abbott Labs (ABT) Gets a Buy from Wells Fargo,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-wells-fargo-1033196453
1473.0,3/26/2024 11:45:00 AM,Winning Over Wall Street: 3 Stocks Earning Overwhelming Analyst Approval,InvestorPlace,/news/stocks/winning-over-wall-street-3-stocks-earning-overwhelming-analyst-approval-1033196438
1474.0,3/28/2024 7:00:00 PM,"Catalyst Watch: Tesla deliveries, Disney board vote, DJT drama and Fortinet event",Seeking Alpha,https://seekingalpha.com/news/4084622-catalyst-watch-tesla-deliveries-disney-board-vote-djt-drama-and-fortinet-event?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1475.0,3/29/2024 2:51:29 PM,3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List,InvestorPlace,/news/stocks/3-strong-buy-healthcare-stocks-to-add-to-your-q2-must-watch-list-1033208715
1476.0,4/1/2024 1:52:48 PM,Abbott gets FDA clearance for i-STAT TBI cartridge for concussions,Seeking Alpha,https://seekingalpha.com/news/4085621-abbott-gets-fda-clearance-for-i-stat-tbi-cartridge-for-concussions?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1477.0,4/1/2024 3:30:07 PM,Abbott: I-STAT TBI Cartridge Receives FDA Clearance To Be Used With Whole Blood ,RTTNews,/news/stocks/abbott-i-stat-tbi-cartridge-receives-fda-clearance-to-be-used-with-whole-blood-1033211108
1478.0,4/2/2024 2:03:08 PM,Abbott wins FDA approval for heart valve repair device,Seeking Alpha,https://seekingalpha.com/news/4086362-abbott-wins-fda-approval-for-heart-valve-repair-device?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1479.0,4/2/2024 3:38:10 PM,Abbott Says FDA Approves First-of-Its-Kind TriClip Transcatheter Edge-to-edge Repair System ,RTTNews,/news/stocks/abbott-says-fda-approves-first-of-its-kind-triclip-transcatheter-edge-to-edge-repair-system-1033215117
1480.0,4/2/2024 11:05:21 PM,Buy Rating Affirmed for Abbott Labs Following TriClip’s Favorable FDA Approval and Market Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-labs-following-triclip-s-favorable-fda-approval-and-market-outlook-1033216886
1481.0,4/3/2024 6:00:24 PM,Analyst Ratings For Abbott Laboratories,Benzinga,/news/stocks/analyst-ratings-for-abbott-laboratories-1033219910
1482.0,4/4/2024 8:08:02 AM,Buy Rating Reaffirmed for Abbott Labs Amid Strong Growth and New Product Launches,TipRanks,/news/stocks/buy-rating-reaffirmed-for-abbott-labs-amid-strong-growth-and-new-product-launches-1033221957
1483.0,4/9/2024 3:10:29 PM,"Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'",Benzinga,/news/stocks/jim-cramer-was-upset-at-this-hostile-takeover-but-they-fixed-the-situation-stock-s-been-a-horse-1033233438
1484.0,4/10/2024 5:22:18 PM,7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape,InvestorPlace,/news/stocks/7-healthcare-stocks-to-keep-your-portfolio-in-tip-top-shape-1033238450
1485.0,4/12/2024 7:00:09 PM,"Catalyst Watch: Boeing hearing, Bitcoin halving event and new eyes on Reddit",Seeking Alpha,https://seekingalpha.com/news/4089283-catalyst-watch-boeing-hearing-bitcoin-halving-event-and-new-eyes-on-reddit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1486.0,4/14/2024 12:00:00 PM,"Earnings week ahead: BAC, JNJ, TSM, UNH, ABT, SLB, UAL, PG, NFLX and more",Seeking Alpha,https://seekingalpha.com/news/4089249-earnings-week-ahead-bac-jnj-tsm-unh-abt-slb-ual-pg-nflx-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1487.0,4/14/2024 9:56:08 PM,"Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down",Seeking Alpha,https://seekingalpha.com/news/4089446-needham-sees-bsx-cnmd-rmd-beating-street-despite-medtech-slow-down?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1488.0,4/15/2024 3:54:34 PM,Netflix and United Airlines to report highest move post earnings: BofA,Seeking Alpha,https://seekingalpha.com/news/4089597-bofa-picks-ppg-industries-netflix-and-united-airlines-for-options-opportunity-ahead-of-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1489.0,4/15/2024 5:28:34 PM,"Abbott, Thoratec recall HeartMate ventricular systems due to obstruction issue",Seeking Alpha,https://seekingalpha.com/news/4089709-abbott-thoratec-recall-heartmate-ventricular-systems-due-obstruction-issue?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1490.0,4/16/2024 5:10:06 PM,Abbott Q1 Earnings Preview: Return of core business strength could benefit top line,Seeking Alpha,https://seekingalpha.com/news/4090186-abbott-q1-earnings-preview-return-of-core-business-strength-could-benefit-top-line?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1491.0,4/17/2024 7:59:17 AM,RBC Capital Remains a Buy on Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-remains-a-buy-on-abbott-labs-abt-1033257345
1492.0,4/17/2024 11:31:30 AM,"Abbott Laboratories Non-GAAP EPS of $0.98 beats by $0.03, raises midpoint of FY guidance ranges",Seeking Alpha,https://seekingalpha.com/news/4090384-abbott-laboratories-non-gaap-eps-of-098-beats-by-003-raises-midpoint-of-fy-guidance-ranges?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1493.0,4/17/2024 11:47:26 AM,Abbott in charts: Q1 sees strong results in Medical Devices and Established Pharmaceuticals,Seeking Alpha,https://seekingalpha.com/news/4090393-abbott-in-charts-q1-sees-strong-results-in-medical-devices-and-established-pharmaceuticals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1494.0,4/17/2024 12:32:52 PM,Abbott posts Q1 beat on MedTech even as diagnostics slump,Seeking Alpha,https://seekingalpha.com/news/4090419-abbott-stock-slips-q1-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1495.0,4/17/2024 1:22:00 PM,"5 stocks to watch on Wednesday: LLY, ABT and more",Seeking Alpha,https://seekingalpha.com/news/4090463-5-stocks-to-watch-on-wednesday-lly-abt-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1496.0,4/17/2024 1:33:26 PM,Abbott Laboratories Reports Fall In Q1 Bottom Line,RTTNews,/news/stocks/abbott-laboratories-reports-fall-in-q1-bottom-line-1033257438
1497.0,4/17/2024 2:45:00 PM,Abbott Laboratories hosts conference call for investors,Markets Insider Automation,/news/stocks/abbott_laboratories_conference-1029943629
1498.0,4/17/2024 3:52:50 PM,"ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024",InvestorPlace,/news/stocks/abt-stock-earnings-abbott-laboratories-for-q1-of-2024-1033258773
1499.0,4/17/2024 4:07:53 PM,Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings,Benzinga,/news/stocks/dow-surges-200-points-abbott-laboratories-posts-upbeat-earnings-1033258475
1500.0,4/17/2024 8:09:41 PM,"Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?",Benzinga,/news/stocks/stocks-fall-as-geopolitics-economic-worries-spook-investors-chipmakers-sell-off-bitcoin-tumbles-to-60-000-what-s-driving-markets-wednesday-1033259256
1501.0,4/18/2024 9:56:56 AM,Strong Q1 Performance and Growth Prospects Justify Buy Rating for Abbott Labs,TipRanks,/news/stocks/strong-q1-performance-and-growth-prospects-justify-buy-rating-for-abbott-labs-1033262046
1502.0,4/18/2024 9:58:02 AM,Buy Rating Affirmed: Abbott Labs Outperforms with Strong Q1 Sales and Upward Earnings Revision,TipRanks,/news/stocks/buy-rating-affirmed-abbott-labs-outperforms-with-strong-q1-sales-and-upward-earnings-revision-1033262198
1503.0,4/18/2024 10:00:59 AM,"Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), US Physical Therapy (USPH)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-abbott-labs-abt-us-physical-therapy-usph-1033262193
1504.0,4/19/2024 1:30:56 AM,Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Elevance Health (ELV),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-and-elevance-health-elv-1033264552
1505.0,4/19/2024 7:19:41 PM,At least 70% of the S&P 500 names that reported results this week topped estimates - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4091620-at-least-70-of-the-sp-500-names-that-reported-results-this-week-topped-estimates-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1506.0,4/22/2024 6:50:43 AM,"Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN), Abbott Labs (ABT) and Arcutis Biotherapeutics (ARQT)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-terns-pharmaceuticals-tern-abbott-labs-abt-and-arcutis-biotherapeutics-arqt-1033270142
1507.0,4/22/2024 7:50:34 AM,Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Eli Lilly & Co (LLY),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-and-eli-lilly-co-lly-1033270364
1508.0,4/22/2024 12:00:00 PM,3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip,InvestorPlace,/news/stocks/3-dividend-kings-down-11-youll-regret-not-buying-on-the-dip-1033270787
1509.0,4/23/2024 8:41:25 PM,Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes,InvestorPlace,/news/stocks/dividend-growth-stars-7-stocks-with-10-year-double-digit-rate-hikes-1033278029
1510.0,4/26/2024 4:09:22 PM,"ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?",TipRanks,/news/stocks/abt-dhr-dxcm-which-strong-buy-healthcare-stock-has-more-upside-1033295655
1511.0,4/29/2024 1:24:45 PM,"DexCom, Insulet, Tandem seen benefitting the most in diabetes survey - Wells Fargo",Seeking Alpha,https://seekingalpha.com/news/4095444-dexcom-insulet-tandem-benefitting-most-diabetes-survey?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1512.0,4/29/2024 1:53:17 PM,Abbott gets FDA approval for Esprit BTK stent for PAD,Seeking Alpha,https://seekingalpha.com/news/4095497-abbott-gets-fda-approval-for-esprit-btk-stent-for-pad?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1513.0,4/29/2024 4:10:21 PM,Abbott's Dissolving Stent For People With Chronic Limb-Threatening Ischemia Gets FDA Nod ,RTTNews,/news/stocks/abbott-s-dissolving-stent-for-people-with-chronic-limb-threatening-ischemia-gets-fda-nod-1033300966
1514.0,4/30/2024 10:00:00 AM,7 Defensive Stocks Built to Withstand the Market’s Worst Storms,InvestorPlace,/news/stocks/7-defensive-stocks-built-to-withstand-the-markets-worst-storms-1033305170
1515.0,4/30/2024 10:20:55 AM,"Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), Iterum Therapeutics (ITRM)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-abbott-labs-abt-iterum-therapeutics-itrm-1033306721
1516.0,5/1/2024 7:57:17 PM,Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge,InvestorPlace,/news/stocks/stock-market-crash-alert-3-must-buy-healthcare-stocks-when-prices-plunge-1033315341
1517.0,5/7/2024 12:06:46 PM,RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-abbott-laboratories-abt-1033340710
1518.0,5/15/2024 3:21:16 PM,"Abbott recalls HeartMate 3 over potential blood leakage, air issues",Seeking Alpha,https://seekingalpha.com/news/4106629-abbott-recalls-heartmate-3-potential-blood-leakage-air-issues?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1519.0,5/15/2024 9:47:35 PM,Tudor Investment's top buys and sells in Q1,Seeking Alpha,https://seekingalpha.com/news/4107057-tudor-investments-top-buys-and-sells-in-q1?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1520.0,5/16/2024 8:15:56 AM,Buy Recommendation for Abbott Laboratories Backed by Strong Sales Growth and Promising Pipeline,TipRanks,/news/stocks/buy-recommendation-for-abbott-laboratories-backed-by-strong-sales-growth-and-promising-pipeline-1033392275
1521.0,5/20/2024 8:15:18 AM,Buy Rating Affirmed for Abbott Laboratories Based on Strong EP Business and Strategic Growth Prospects,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-based-on-strong-ep-business-and-strategic-growth-prospects-1033402951
1522.0,5/20/2024 9:50:12 AM,"Analysts Conflicted on These Healthcare Names: Abbott Laboratories (ABT), PolyPid (PYPD) and GoodRx Holdings (GDRX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-abbott-laboratories-abt-polypid-pypd-and-goodrx-holdings-gdrx-1033403235
1523.0,5/20/2024 11:20:28 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Immunocore Holdings (IMCR) and Madrigal Pharmaceuticals (MDGL)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-immunocore-holdings-imcr-and-madrigal-pharmaceuticals-mdgl-1033403918
1524.0,5/20/2024 6:47:45 PM,3 S&P 500 Stocks That Have Proven Themselves Recession-Proof,InvestorPlace,/news/stocks/3-sp-500-stocks-that-have-proven-themselves-recession-proof-1033404557
1525.0,5/21/2024 2:32:23 PM,Reckitt Benckiser ticks higher amid report activist Eminence Capital takes stake,Seeking Alpha,https://seekingalpha.com/news/4108852-reckitt-benckiser-ticks-higher-amid-report-activist-eminence-capital-takes-stake?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1526.0,5/22/2024 8:00:46 PM,Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know,Benzinga,/news/stocks/critical-insights-from-abbott-laboratories-analyst-ratings-what-you-need-to-know-1033412958
1527.0,5/27/2024 4:39:32 PM,Blue-Chip Bonanza: 3 Stocks to Ride the Market’s Coattails to Riches,InvestorPlace,/news/stocks/blue-chip-bonanza-3-stocks-to-ride-the-markets-coattails-to-riches-1033424830
1528.0,5/27/2024 4:46:20 PM,Reliable Rewards: 7 Dividend Stocks to Count On in Any Market,InvestorPlace,/news/stocks/reliable-rewards-7-dividend-stocks-to-count-on-in-any-market-1033424860
1529.0,5/28/2024 10:45:00 AM,Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024 ,InvestorPlace,/news/stocks/wall-street-favorites-3-healthcare-stocks-with-strong-buy-ratings-for-may-2024-1033426464
1530.0,5/29/2024 6:30:56 PM,The 3 Best MedTech Stocks to Buy Now: May 2024,InvestorPlace,/news/stocks/the-3-best-medtech-stocks-to-buy-now-may-2024-1033433166
1531.0,5/30/2024 8:25:42 AM,Optimistic Buy Rating for Abbott Laboratories on Diverse Portfolio and Growth Prospects,TipRanks,/news/stocks/optimistic-buy-rating-for-abbott-laboratories-on-diverse-portfolio-and-growth-prospects-1033435660
1532.0,6/3/2024 4:37:47 PM,"Berkshire Hathaway, Chipotle, More NYSE Stocks Hit With Trading Halts Triggered By Technical Issues (UPDATED)",Benzinga,/news/etf/berkshire-hathaway-chipotle-more-nyse-stocks-hit-with-trading-halts-triggered-by-technical-issues-1033446452
1533.0,6/3/2024 6:46:53 PM,Sell ideas in Staples and Health Care - Oppenheimer,Seeking Alpha,https://seekingalpha.com/news/4112419-sell-ideas-in-staples-and-health-care-oppenheimer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1534.0,6/4/2024 9:35:53 AM,Buy Rating Affirmed for Abbott Laboratories Amid Lingo CGM Market Expansion Opportunity,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-amid-lingo-cgm-market-expansion-opportunity-1033449297
1535.0,6/4/2024 12:21:07 PM,"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Eledon Pharmaceuticals (ELDN) and Abbott Laboratories (ABT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-eledon-pharmaceuticals-eldn-and-abbott-laboratories-abt-1033450389
1536.0,6/5/2024 3:21:33 PM,The most crowded longs and shorts in U.S. Med-Tech for May - UBS,Seeking Alpha,https://seekingalpha.com/news/4113240-the-most-crowded-longs-and-shorts-in-us-med-tech-for-may-ubs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1537.0,6/6/2024 9:40:27 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1033457301
1538.0,6/6/2024 9:33:43 PM,Abbott Is Considered a Good Investment by Brokers: Is That True?,Benzinga,/news/stocks/abbott-is-considered-a-good-investment-by-brokers-is-that-true-1033459085
1539.0,6/7/2024 10:08:34 AM,Buy Rating Affirmed for Abbott Laboratories Amid Strong Growth and Manageable Litigation Risks,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-amid-strong-growth-and-manageable-litigation-risks-1033461142
1540.0,6/7/2024 11:10:00 AM,The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash,InvestorPlace,/news/stocks/the-dividend-darlings-3-stocks-that-will-shower-your-portfolio-with-cash-1033460743
1541.0,6/10/2024 12:50:03 PM,Abbott receives FDA clearance for new continuous glucose monitoring systems,Seeking Alpha,https://seekingalpha.com/news/4114458-abbott-receives-fda-clearance-for-new-continuous-glucose-monitoring-systems?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1542.0,6/10/2024 3:29:58 PM,"Abbott's Lingo, Libre Rio OTC Continuous Glucose Monitoring Systems Gets FDA Clearance ",RTTNews,/news/stocks/abbott-s-lingo-libre-rio-otc-continuous-glucose-monitoring-systems-gets-fda-clearance-1033465675
1543.0,6/11/2024 9:26:02 AM,Wells Fargo Remains a Buy on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-remains-a-buy-on-abbott-laboratories-abt-1033468697
1544.0,6/13/2024 10:08:08 AM,"Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Abbott Laboratories (ABT) and Dyne Therapeutics (DYN)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-abbott-laboratories-abt-and-dyne-therapeutics-dyn-1033476155
1545.0,6/13/2024 7:05:33 PM,Abbott Gets FDA Nod for Two Glucose Monitoring Systems,Benzinga,/news/stocks/abbott-gets-fda-nod-for-two-glucose-monitoring-systems-1033477443
1546.0,6/14/2024 4:25:51 PM,Abbott Laboratories declares $0.55 dividend,Seeking Alpha,https://seekingalpha.com/news/4116301-abbott-laboratories-declares-0_55-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1547.0,6/20/2024 9:05:17 AM,Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1033492716
1548.0,6/24/2024 10:16:28 AM,Buy Rating on Abbott Laboratories Amid Strong Growth Prospects and Strategic Innovation,TipRanks,/news/stocks/buy-rating-on-abbott-laboratories-amid-strong-growth-prospects-and-strategic-innovation-1033500017
1549.0,6/24/2024 11:25:20 AM,TD Cowen Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/td-cowen-keeps-their-buy-rating-on-abbott-laboratories-abt-1033500534
1550.0,6/24/2024 3:25:55 PM,Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income,InvestorPlace,/news/stocks/hot-summer-dividends-3-sizzling-stocks-to-buy-for-reliable-income-1033500901
1551.0,6/24/2024 9:21:13 PM,Abbott's EPD Expansion Continues Despite FX Headwind,Benzinga,/news/stocks/abbott-s-epd-expansion-continues-despite-fx-headwind-1033501456
1552.0,6/29/2024 7:44:55 PM,Rising drug costs force a third of Americans to leave prescriptions unfilled: report,Seeking Alpha,https://seekingalpha.com/news/4120808-many-prescriptions-remain-unfilled-amid-soaring-drug-costs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1553.0,7/1/2024 10:00:00 AM,3 MedTech Stocks to Buy for Healthy Gains,InvestorPlace,/news/stocks/3-medtech-stocks-to-buy-for-healthy-gains-1033518933
1554.0,7/2/2024 11:00:39 AM,Barclays Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/barclays-keeps-their-buy-rating-on-abbott-laboratories-abt-1033523589
1555.0,7/2/2024 11:01:57 AM,Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Springworks Therapeutics (SWTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-and-springworks-therapeutics-swtx-1033523577
1556.0,7/2/2024 5:02:12 PM,7 Analysts Have This To Say About Abbott Laboratories,Benzinga,/news/stocks/7-analysts-have-this-to-say-about-abbott-laboratories-1033523740
1557.0,7/2/2024 8:45:00 PM,7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-will-have-investors-in-high-yield-heaven-1033524556
1558.0,7/4/2024 10:35:00 AM,The 3 Best Healthcare Stocks to Buy in July 2024,InvestorPlace,/news/stocks/the-3-best-healthcare-stocks-to-buy-in-july-2024-1033529151
1559.0,7/5/2024 8:58:12 PM,"DexCom, Abbott to Launch First FDA Cleared OTC CGMs",Benzinga,/news/stocks/dexcom-abbott-to-launch-first-fda-cleared-otc-cgms-1033532913
1560.0,7/9/2024 9:28:00 AM,Buy Rating Justified: Abbott Laboratories Poised to Surpass Q2 Expectations Amid Robust Core Growth and Solid Segment Performance,TipRanks,/news/stocks/buy-rating-justified-abbott-laboratories-poised-to-surpass-q2-expectations-amid-robust-core-growth-and-solid-segment-performance-1033539300
1561.0,7/10/2024 7:22:59 PM,7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-for-positive-inflation-adjusted-returns-1033544701
1562.0,7/11/2024 8:15:19 AM,Buy Rating Affirmed for Abbott Laboratories Amidst Strong Growth and Manageable Risks,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-amidst-strong-growth-and-manageable-risks-1033546616
1563.0,7/11/2024 9:16:13 PM,Wall Street Bulls Look Optimistic About Abbott: Should You Buy?,Benzinga,/news/stocks/wall-street-bulls-look-optimistic-about-abbott-should-you-buy-1033548448
1564.0,7/12/2024 7:00:29 PM,"Catalyst Watch: Netflix, Taiwan Semi, Amazon, and HashiCorp are in the spotlight",Seeking Alpha,https://seekingalpha.com/news/4123992-catalyst-watch-netflix-taiwan-semi-amazon-and-hashicorp-are-in-the-spotlight?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1565.0,7/13/2024 2:47:00 PM,Financial stocks deliver profits in Q2 amid rebound in investments - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4124042-wall-street-closes-higher-as-financials-stocks-deliver-profits-with-a-rebound-in-investments-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1566.0,7/13/2024 3:00:00 PM,The 7 Most Undervalued Healthcare Stocks to Buy in July 2024,InvestorPlace,/news/stocks/the-7-most-undervalued-healthcare-stocks-to-buy-in-july-2024-1033551810
1567.0,7/14/2024 12:00:00 PM,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, AXP and more",Seeking Alpha,https://seekingalpha.com/news/4124006-earnings-week-ahead-bac-gs-jnj-tsm-unh-abt-ual-nflx-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1568.0,7/15/2024 12:27:33 PM,Abbott Laboratories (ABT) Gets a Hold from Morgan Stanley,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-hold-from-morgan-stanley-1033556072
1569.0,7/16/2024 5:01:00 PM,"Incyte, Moderna among most shorted S&P 500 healthcare stocks in June",Seeking Alpha,https://seekingalpha.com/news/4124310-incyte-moderna-among-most-shorted-sp-500-healthcare-stocks-in-june?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1570.0,7/17/2024 2:51:20 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/4125062-notable-earnings-before-thursdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1571.0,7/17/2024 3:01:13 PM,What Wall Street expects from Abbott Laboratories's earnings,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-price-quarter-earnings-preview-q2-1033563972
1572.0,7/17/2024 5:14:43 PM,Abbott Q2 Earnings Preview: Strong fundamentals to see through a good quarter,Seeking Alpha,https://seekingalpha.com/news/4125139-abbott-q2-earnings-preview-strong-fundamentals-to-see-through-a-good-quarter?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1573.0,7/18/2024 9:05:12 AM,Abbott Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts,Benzinga,/news/stocks/abbott-gears-up-for-q2-print-here-are-the-recent-forecast-changes-from-wall-street-s-most-accurate-analysts-1033567040
1574.0,7/18/2024 11:31:16 AM,"Abbott Laboratories Non-GAAP EPS of $1.14 beats by $0.04, revenue of $10.4B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/4125401-abbott-laboratories-non-gaap-eps-of-1_14-beats-0_04-revenue-of-10_4b-beats-30m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1575.0,7/18/2024 11:47:33 AM,"Earnings Summary: Abbott Laboratories tops consensus in Q2, raises FY2024 EPS outlook",Seeking Alpha,https://seekingalpha.com/news/4125413-earnings-summary-abbott-laboratories-tops-consensus-in-q2-raises-fy2024-eps-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1576.0,7/18/2024 12:00:41 PM,Abbott Laboratories in charts: Medical Devices maintains Y/Y double-digit growth momentum in Q2,Seeking Alpha,https://seekingalpha.com/news/4125421-abbott-laboratories-in-charts-medical-devices-maintains-yy-double-digit-growth-momentum-in-q2?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1577.0,7/18/2024 1:05:24 PM,Abbott raises 2024 outlook after MedTech strength in Q2,Seeking Alpha,https://seekingalpha.com/news/4125472-abbott-stock-on-watch-after-guidance-raise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1578.0,7/18/2024 1:07:08 PM,Buy Rating Affirmed for Abbott Laboratories Amid Strong Financials and Growth Potential,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-amid-strong-financials-and-growth-potential-1033569706
1579.0,7/18/2024 1:15:00 PM,"4 stocks to watch on Thursday: NFLX, AMZN and more",Seeking Alpha,https://seekingalpha.com/news/4125483-4-stocks-to-watch-on-thursday-nflx-amzn-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1580.0,7/18/2024 1:36:23 PM,"Abbott Laboratories Q2 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/abbott-laboratories-q2-profit-decreases-but-beats-estimates-1033568024
1581.0,7/18/2024 1:52:04 PM,Abbott Laboratories Boosts FY24 Earnings Outlook - Update ,RTTNews,/news/stocks/abbott-laboratories-boosts-fy24-earnings-outlook-update-1033568058
1582.0,7/18/2024 2:06:53 PM,Least shorted S&P 500 stocks in June,Seeking Alpha,https://seekingalpha.com/news/4125485-least-shorted-sp-500-stocks-in-june?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1583.0,7/18/2024 3:52:56 PM,"ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q2 2024",InvestorPlace,/news/stocks/abt-stock-earnings-abbott-laboratories-for-q2-of-2024-1033569690
1584.0,7/18/2024 7:16:25 PM,7 Safe Stocks to Buy for Volatility Insurance,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-for-volatility-insurance-1033570022
1585.0,7/18/2024 8:05:29 PM,"VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?",Benzinga,/news/etf/vix-stages-double-digit-spike-as-risk-off-takes-over-chipmakers-fail-to-rebound-weight-loss-giants-eli-lilly-novo-tumble-what-s-driving-markets-thursday-1033569954
1586.0,7/18/2024 8:15:22 PM,Buy Rating Affirmed on Abbott Laboratories Amid Strong Q2 Results and Raised 2024 Guidance,TipRanks,/news/stocks/buy-rating-affirmed-on-abbott-laboratories-amid-strong-q2-results-and-raised-2024-guidance-1033570345
1587.0,7/19/2024 10:07:48 AM,Maintained Buy Rating for Abbott Laboratories on Strong Financials and Growth Prospects,TipRanks,/news/stocks/maintained-buy-rating-for-abbott-laboratories-on-strong-financials-and-growth-prospects-1033572319
1588.0,7/19/2024 12:56:30 PM,Morgan Stanley Keeps Their Hold Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/morgan-stanley-keeps-their-hold-rating-on-abbott-laboratories-abt-1033573145
1589.0,7/22/2024 5:50:56 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-elevance-health-elv-cvs-health-cvs-and-abbott-laboratories-abt-1033576809
1590.0,7/24/2024 8:18:53 PM,7 Trustworthy Dividend Stocks to Steadily Build Your Portfolio,InvestorPlace,/news/stocks/7-trustworthy-dividend-stocks-to-steadily-build-your-portfolio-1033590875
1591.0,7/26/2024 2:15:20 PM,Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?,InvestorPlace,/news/stocks/dexcom-dxcm-stock-is-plunging-on-an-execution-miss-what-is-really-going-on-1033600870
1592.0,7/26/2024 7:55:04 PM,DexCom reaches a multi-year low as downgrades follow guidance cut,Seeking Alpha,https://seekingalpha.com/news/4129136-dexcom-stock-falls-downgrades-guidance-cut?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1593.0,7/27/2024 12:07:00 AM,Abbott Labs falls after jury awards plaintiff $495M in damages in baby formula case (update),Seeking Alpha,https://seekingalpha.com/news/4129212-abbott-labs-falls-after-jury-awards-plaintiff-95m-in-damages-in-baby-formula-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1594.0,7/27/2024 9:07:04 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), CVS Health (CVS) and Tempest Therapeutics (TPST)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-cvs-health-cvs-and-tempest-therapeutics-tpst-1033602051
1595.0,7/29/2024 8:16:29 AM,Barclays Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/barclays-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1033605625
1596.0,7/29/2024 10:16:39 AM,Buy Rating for Abbott Laboratories Amid Manageable Litigation Costs and Strong Financial Position,TipRanks,/news/stocks/buy-rating-for-abbott-laboratories-amid-manageable-litigation-costs-and-strong-financial-position-1033606374
1597.0,7/29/2024 10:51:28 AM,Analysts Offer Insights on Healthcare Companies: 2seventy bio (TSVT) and Abbott Laboratories (ABT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-2seventy-bio-tsvt-and-abbott-laboratories-abt-1033606482
1598.0,7/29/2024 1:50:18 PM,3 High-Yield Dividend Stocks That Are Looking Super Hot,InvestorPlace,/news/stocks/3-high-yield-dividend-stocks-that-are-looking-super-hot-1033606477
1599.0,7/29/2024 2:06:09 PM,"Biggest stock movers today: Crypto stocks, PBI, PHG, and more",Seeking Alpha,https://seekingalpha.com/news/4129324-biggest-stock-movers-today-pbi-phg-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1600.0,7/29/2024 2:50:19 PM,Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.,InvestorPlace,/news/stocks/abbott-labs-abt-stock-falls-on-baby-formula-ruling-what-to-know-1033606979
1601.0,7/29/2024 3:09:06 PM,Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today?,InvestorPlace,/news/stocks/why-is-cognition-therapeutics-cgtx-stock-down-33-today-1033607106
1602.0,7/29/2024 3:30:21 PM,Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today?,InvestorPlace,/news/stocks/why-is-nls-pharmaceutics-nlsp-stock-up-48-today-1033607284
1603.0,7/29/2024 5:00:58 PM,Abbott likely to settle baby formula cases for $200M-$300M - analyst,Seeking Alpha,https://seekingalpha.com/news/4129595-abbott-likely-to-settle-baby-formula-cases-for-200m-300m-analyst?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1604.0,7/31/2024 6:30:32 PM,7 Leading MedTech Stocks for Next-Gen Health Solutions,InvestorPlace,/news/stocks/7-leading-medtech-stocks-for-next-gen-health-solutions-1033620457
1605.0,8/2/2024 6:31:20 PM,"DexCom, Abbott to benefit from the multi-billion-dollar OTC continuous glucose market",Seeking Alpha,https://seekingalpha.com/news/4133543-dexcom-abbott-benefit-multi-billion-dollar-otc-continuous-glucose-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1606.0,8/3/2024 6:44:06 PM,CVS stores in some cities run out of COVID tests as cases spike: Bloomberg,Seeking Alpha,https://seekingalpha.com/news/4133678-cvs-stores-in-some-cities-run-out-covid-tests?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1607.0,8/6/2024 2:50:34 PM,Abbott to collaborate with Cadrenal on anticoagulant tecarfarin,Seeking Alpha,https://seekingalpha.com/news/4134945-abbott-collaborate-cadrenal-anticoagulant-tecarfarin?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1608.0,8/7/2024 12:35:41 PM,Abbott to integrate CGM with Medtronic's insulin delivery devices,Seeking Alpha,https://seekingalpha.com/news/4135909-abbott-to-integrate-cgm-system-with-medtronics-insulin-delivery-devices?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1609.0,8/7/2024 1:23:06 PM,Medtronic wins FDA approval for Simplera CGM,Seeking Alpha,https://seekingalpha.com/news/4135964-medtronic-wins-fda-approval-for-simplera-cgm?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1610.0,8/7/2024 2:31:01 PM,Medtronic Announces FDA Approval Of Simplera CGM; Partners With Abbott To Expand CGM Options ,RTTNews,/news/stocks/medtronic-announces-fda-approval-of-simplera-cgm-partners-with-abbott-to-expand-cgm-options-1033652368
1611.0,8/8/2024 11:55:27 AM,Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-laboratories-abt-1033661521
1612.0,8/14/2024 5:41:54 PM,WHO declares mpox in Africa is a global health emergency,Seeking Alpha,https://seekingalpha.com/news/4139935-who-declares-mpox-in-africa-is-a-global-health-emergency?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1613.0,8/15/2024 3:06:09 PM,Medtronic upgraded at UBS on diabetes turnaround,Seeking Alpha,https://seekingalpha.com/news/4140605-medtronic-stock-upgraded-ubs-diabetes-unit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1614.0,8/15/2024 7:29:14 PM,First mpox case outside Africa reported amid ongoing outbreak,Seeking Alpha,https://seekingalpha.com/news/4140735-first-mpox-case-outside-africa-reported?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1615.0,8/16/2024 4:12:26 PM,Bavarian Nordic stock jumps 16% on EMA mpox vaccine update,Seeking Alpha,https://seekingalpha.com/news/4141101-bavarian-nordic-stock-jumps-on-ema-mpox-vaccine-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1616.0,8/16/2024 5:48:20 PM,European health authority sees mpox having low impact if precautions taken,Seeking Alpha,https://seekingalpha.com/news/4141150-european-health-authority-sees-mpox-having-low-impact-if-precautions-taken?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1617.0,8/19/2024 7:07:33 PM,Small-cap and mid-cap Health Care has room to rally - Roth MKM,Seeking Alpha,https://seekingalpha.com/news/4141609-small-cap-and-mid-cap-health-care-has-room-to-rally-roth-mkm?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1618.0,8/20/2024 10:20:47 AM,"WHO official says mpox is 'not the new COVID,' calls for coordinated response",Seeking Alpha,https://seekingalpha.com/news/4141757-who-official-says-mpox-is-not-the-new-covid-calls-for-coordinated-response?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1619.0,8/22/2024 11:02:57 AM,Bavarian Nordic rebounds as new mpox vaccine order boosts outlook,Seeking Alpha,https://seekingalpha.com/news/4142726-bavarian-nordic-stock-gains-outlook-boost?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1620.0,8/22/2024 1:14:36 PM,Mpox stocks in focus as Thailand reports first case in Asia linked to new strain,Seeking Alpha,https://seekingalpha.com/news/4142799-mpox-stocks-in-focus-thailand-reports-first-case-in-asia?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1621.0,8/23/2024 5:54:10 PM,U.S. to restart free COVID test program as cases spike,Seeking Alpha,https://seekingalpha.com/news/4143466-us-to-deliver-free-covid-tests-cases-spike?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1622.0,8/26/2024 3:58:52 PM,Tonix stock jumps on collaboration for mpox vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/4143842-tonix-stock-jumps-on-collaboration-for-mpox-vaccine-candidate?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1623.0,8/26/2024 8:20:15 PM,Labcorp considering ramping up mpox testing capacity: report,Seeking Alpha,https://seekingalpha.com/news/4143930-labcorp-considering-ramping-up-mpox-testing-capacity-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1624.0,8/26/2024 9:04:36 PM,"Trinity stock soars post-market on raised guidance, increased capacity",Seeking Alpha,https://seekingalpha.com/news/4143955-trinity-stock-soars-post-market-on-raised-guidance-increased-capacity?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1625.0,8/27/2024 12:25:43 PM,Hold Rating on Abbott Laboratories Amid NEC Litigation Uncertainties,TipRanks,/news/stocks/hold-rating-on-abbott-laboratories-amid-nec-litigation-uncertainties-1033726095
1626.0,8/31/2024 9:33:09 PM,UNICEF issues emergency tender to secure mpox vaccines,Seeking Alpha,https://seekingalpha.com/news/4145755-unicef-issues-emergency-tender-to-secure-mpox-vaccines?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1627.0,9/3/2024 11:35:34 AM,Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-laboratories-abt-1033744243
1628.0,9/5/2024 3:05:45 PM,Bavarian Nordic stock slides on Moderna mpox vaccine study,Seeking Alpha,https://seekingalpha.com/news/4147363-bavarian-nordic-stock-slides-on-moderna-mpox-vaccine-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1629.0,9/5/2024 3:37:07 PM,"Abbott launches over-the-counter glucose monitor, Lingo",Seeking Alpha,https://seekingalpha.com/news/4147380-abbott-launches-over-the-counter-glucose-monitor?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1630.0,9/6/2024 9:49:16 AM,Abbott Laboratories (ABT) Gets a Buy from Wells Fargo,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-buy-from-wells-fargo-1033753680
1631.0,9/6/2024 7:45:48 PM,Applied DNA stock jumps amid U.S. government mpox update,Seeking Alpha,https://seekingalpha.com/news/4147758-applied-dna-stock-jumps-amid-us-government-mpox-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1632.0,9/10/2024 9:51:01 AM,Wells Fargo Remains a Buy on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-remains-a-buy-on-abbott-laboratories-abt-1033760316
1633.0,9/10/2024 9:58:07 AM,Hold Rating on Abbott Laboratories Amid Lingo’s Launch: Balancing Positive User Experience with Market Challenges,TipRanks,/news/stocks/hold-rating-on-abbott-laboratories-amid-lingo-s-launch-balancing-positive-user-experience-with-market-challenges-1033760520
1634.0,9/12/2024 7:17:29 PM,Morocco reports first mpox case amid ongoing global outbreak,Seeking Alpha,https://seekingalpha.com/news/4149235-morocco-reports-first-mpox-case-amid-ongoing-outbreak?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1635.0,9/15/2024 10:17:50 AM,Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-laboratories-abt-1033772039
1636.0,9/15/2024 1:36:00 PM,Least shorted S&P 500 stocks in August,Seeking Alpha,https://seekingalpha.com/news/4149788-least-shorted-sp-500-stocks-in-august?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1637.0,9/16/2024 2:49:45 PM,Moderna was most shorted S&P 500 healthcare stock in August for second consecutive month,Seeking Alpha,https://seekingalpha.com/news/4149983-moderna-was-most-shorted-sp-500-healthcare-stock-in-august-for-second-consecutive-month?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1638.0,9/17/2024 11:52:23 AM,Senseonics Eversense 365 glucose monitor cleared in the U.S.,Seeking Alpha,https://seekingalpha.com/news/4150260-senseonics-stock-gains-on-fda-nod-for-eversense-365?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1639.0,9/18/2024 10:36:34 AM,Abbott Laboratories (ABT) Gets a Buy from Wells Fargo,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-buy-from-wells-fargo-1033780375
1640.0,9/19/2024 9:05:49 AM,Buy Rating on Abbott Laboratories: Undervalued with Strong Growth Prospects Despite NEC Litigation,TipRanks,/news/stocks/buy-rating-on-abbott-laboratories-undervalued-with-strong-growth-prospects-despite-nec-litigation-1033783088
1641.0,9/19/2024 4:22:40 PM,Abbott a new overweight at Piper Sandler; at attractive entry point,Seeking Alpha,https://seekingalpha.com/news/4151231-abbott-new-overweight-piper-sandler-attractive-entry-point?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1642.0,9/19/2024 5:20:13 PM,Abbott Laboratories declares $0.55 dividend,Seeking Alpha,https://seekingalpha.com/news/4151296-abbott-laboratories-declares-0_55-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1643.0,9/26/2024 2:27:27 PM,Piper Sandler’s Triple Select Stocks for September,Seeking Alpha,https://seekingalpha.com/news/4153735-piper-sandlers-triple-select-stocks-for-september?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1644.0,9/30/2024 9:07:31 AM,Wells Fargo Remains a Buy on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-remains-a-buy-on-abbott-laboratories-abt-1033807258
1645.0,9/30/2024 7:44:27 PM,"Abbott, Reckitt trial over infant formula safety starts in Missouri: report",Seeking Alpha,https://seekingalpha.com/news/4154711-abbott-reckitt-trial-over-infant-formula-safety-starts-in-missouri-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1646.0,10/3/2024 8:15:16 AM,Buy Rating on Abbott Laboratories: Strong Performance and Positive Outlook Amid New Product Launches,TipRanks,/news/stocks/buy-rating-on-abbott-laboratories-strong-performance-and-positive-outlook-amid-new-product-launches-1033817795
1647.0,10/4/2024 10:10:54 AM,WHO approves first mpox diagnostic test for emergency use,Seeking Alpha,https://seekingalpha.com/news/4156362-who-approves-first-mpox-diagnostic-test-for-emergency-use?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1648.0,10/4/2024 12:10:21 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Altimmune (ALT) and Steris (STE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-altimmune-alt-and-steris-ste-1033821800
1649.0,10/7/2024 10:05:52 AM,Buy Rating Affirmed for Abbott Laboratories Amid Strong Performance and Favorable Market Trends,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-amid-strong-performance-and-favorable-market-trends-1033824701
1650.0,10/8/2024 4:38:24 PM,"Abbott started at outperform by Oppenheimer, diversified portfolio cited",Seeking Alpha,https://seekingalpha.com/news/4157059-abbott-started-at-outperform-by-oppenheimer-diversified-portfolio-cited?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1651.0,10/11/2024 8:56:18 AM,Buy Rating on Abbott Laboratories: Swift Clinical Advances and Strategic International Expansion,TipRanks,/news/stocks/buy-rating-on-abbott-laboratories-swift-clinical-advances-and-strategic-international-expansion-1033838296
1652.0,10/11/2024 7:00:23 PM,"Catalyst Watch: Netflix earnings, Lenovo tech event, Paris Motor Show, and eyes on oil",Seeking Alpha,https://seekingalpha.com/news/4157956-catalyst-watch-netflix-earnings-lenovo-tech-event-paris-motor-show-and-eyes-on-oil?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1653.0,10/13/2024 12:00:00 PM,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, PG, AXP and more",Seeking Alpha,https://seekingalpha.com/news/4157923-earnings-week-ahead-bac-gs-jnj-tsm-unh-abt-ual-nflx-pg-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1654.0,10/14/2024 2:42:56 PM,Earnings Scorecard: 7 out of 8 S&P 500 companies deliver EPS wins this week,Seeking Alpha,https://seekingalpha.com/news/4157977-7-out-of-8-sp-500-companies-deliver-eps-wins-this-week?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1655.0,10/15/2024 6:02:21 PM,Abbott Laboratories Q3 Earnings Preview: Profit boost expected,Seeking Alpha,https://seekingalpha.com/news/4161998-abbott-laboratories-q3-earnings-preview-profit-boost-expected?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1656.0,10/15/2024 6:35:59 PM,Moderna continues to be the most shorted S&P 500 healthcare stock in September,Seeking Alpha,https://seekingalpha.com/news/4162080-moderna-continues-to-be-the-most-shorted-sp-500-healthcare-stock-in-september?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1657.0,10/15/2024 10:00:02 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4161921-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1658.0,10/16/2024 11:32:31 AM,"Abbott Laboratories Non-GAAP EPS of $1.21 beats by $0.01, revenue of $10.64B beats by $90M",Seeking Alpha,https://seekingalpha.com/news/4163981-abbott-laboratories-non-gaap-eps-of-1_21-beats-0_01-revenue-of-10_64b-beats-90m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1659.0,10/16/2024 11:48:24 AM,"Earnings Snapshot: Abbott Laboratories beats consensus in Q3, tightens FY2024 outlook",Seeking Alpha,https://seekingalpha.com/news/4164066-earnings-snapshot-abbott-laboratories-beats-consensus-in-q3-tightens-fy2024-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1660.0,10/16/2024 11:59:35 AM,Abbott in charts: Medical Devices sales sustain double-digit Y/Y growth with an 11.7% rise in Q3,Seeking Alpha,https://seekingalpha.com/news/4164147-abbott-in-charts-medical-devices-sales-sustain-double-digit-yy-growth-with-an-117-rise-in-q3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1661.0,10/16/2024 12:21:26 PM,"Abbott raises earnings outlook as MedTech, Pharma drive Q3 beat",Seeking Alpha,https://seekingalpha.com/news/4164061-abbott-stock-slips-despite-q3-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1662.0,10/16/2024 12:58:00 PM,"4 stocks to watch on Wednesday: INTC, MS and more",Seeking Alpha,https://seekingalpha.com/news/4164649-4-stocks-to-watch-on-wednesday-intc-ms-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1663.0,10/16/2024 1:34:20 PM,"Abbott Laboratories Q3 Profit Increases, Beats Estimates ",RTTNews,/news/stocks/abbott-laboratories-q3-profit-increases-beats-estimates-1033850935
1664.0,10/16/2024 1:47:28 PM,Abbott Laboratories Boosts FY24 Earnings Outlook - Update ,RTTNews,/news/stocks/abbott-laboratories-boosts-fy24-earnings-outlook-update-1033850980
1665.0,10/16/2024 4:21:34 PM,Least shorted S&P 500 stocks in September,Seeking Alpha,https://seekingalpha.com/news/4166027-least-shorted-sp-500-stocks-in-september?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1666.0,10/16/2024 7:55:12 PM,Abbott Laboratories: Strong Growth Prospects and Strategic Positioning Drive Buy Rating,TipRanks,/news/stocks/abbott-laboratories-strong-growth-prospects-and-strategic-positioning-drive-buy-rating-1033853121
1667.0,10/16/2024 8:25:11 PM,Cautious Outlook on Abbott Laboratories Amid Mixed Financials and Legal Challenges,TipRanks,/news/stocks/cautious-outlook-on-abbott-laboratories-amid-mixed-financials-and-legal-challenges-1033853132
1668.0,10/16/2024 8:35:11 PM,Abbott Laboratories: Strong Financial Performance and Growth Potential Justify Buy Rating,TipRanks,/news/stocks/abbott-laboratories-strong-financial-performance-and-growth-potential-justify-buy-rating-1033853141
1669.0,10/16/2024 8:35:21 PM,Abbott Laboratories: Balanced Prospects Lead to Hold Recommendation Amid Market Adjustments,TipRanks,/news/stocks/abbott-laboratories-balanced-prospects-lead-to-hold-recommendation-amid-market-adjustments-1033853140
1670.0,10/17/2024 9:36:48 AM,Abbott Laboratories: Buy Rating Reaffirmed Amid Strong Medical Device Performance and Positive Long-Term Growth Outlook,TipRanks,/news/stocks/abbott-laboratories-buy-rating-reaffirmed-amid-strong-medical-device-performance-and-positive-long-term-growth-outlook-1033855406
1671.0,10/17/2024 10:29:54 AM,Abbott Laboratories: Strong Buy Rating Driven by Robust Growth Prospects and Operational Improvements,TipRanks,/news/stocks/abbott-laboratories-strong-buy-rating-driven-by-robust-growth-prospects-and-operational-improvements-1033855721
1672.0,10/17/2024 10:31:11 AM,Travis Steed Reiterates Buy Rating on Abbott Laboratories Amid Promising Growth and Under-Ownership Potential,TipRanks,/news/stocks/travis-steed-reiterates-buy-rating-on-abbott-laboratories-amid-promising-growth-and-under-ownership-potential-1033855713
1673.0,10/17/2024 10:32:01 AM,Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Abbott Laboratories (ABT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-resmed-rmd-and-abbott-laboratories-abt-1033855705
1674.0,10/17/2024 10:46:51 AM,RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-abbott-laboratories-abt-1033855802
1675.0,10/17/2024 10:48:34 AM,Abbott Laboratories (ABT) Gets a Buy from Piper Sandler,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-buy-from-piper-sandler-1033855778
1676.0,10/17/2024 10:48:42 AM,Goldman Sachs Remains a Buy on Abbott Laboratories (ABT),TipRanks,/news/stocks/goldman-sachs-remains-a-buy-on-abbott-laboratories-abt-1033855776
1677.0,10/17/2024 12:05:47 PM,Oppenheimer Reaffirms Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/oppenheimer-reaffirms-their-buy-rating-on-abbott-laboratories-abt-1033856376
1678.0,10/17/2024 12:08:01 PM,Citi Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/citi-keeps-their-buy-rating-on-abbott-laboratories-abt-1033856346
1679.0,10/19/2024 1:30:00 PM,Over 60% of companies that reported earnings this week beat EPS and revenue estimates - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4175834-over-60-of-companies-that-reported-earnings-this-week-beat-eps-and-revenue-estimates-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1680.0,10/24/2024 1:10:27 PM,Abbott initiates clinical trial of its CardioMems in advanced heart failure,TipRanks,/news/stocks/abbott-initiates-clinical-trial-of-its-cardiomems-in-advanced-heart-failure-1033887963
1681.0,10/25/2024 5:34:10 PM,Apple reportedly tests a blood sugar app,Seeking Alpha,https://seekingalpha.com/news/4206329-apple-tests-blood-sugar-app?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1682.0,10/28/2024 6:25:27 PM,"Raymond James says Edwards’ EARLY TAVR data also positive for Medtronic, Abbott",TipRanks,/news/stocks/raymond-james-says-edwards-early-tavr-data-also-positive-for-medtronic-abbott-1033904067
1683.0,10/30/2024 7:30:10 PM,Edwards Life says pivotal study for Evoque hit one-year goal,Seeking Alpha,https://seekingalpha.com/news/4225583-edwards-lifesciences-hit-main-goal-evoque?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1684.0,10/31/2024 2:20:04 AM,Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1033922447
1685.0,10/31/2024 2:20:06 AM,"Analysts Are Bullish on These Healthcare Stocks: United Therapeutics (UTHR), Abbott Laboratories (ABT)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-united-therapeutics-uthr-abbott-laboratories-abt-1033922446
1686.0,10/31/2024 9:02:23 PM,"Abbott jumps as jury says company, Reckitt not liable in infant formula case",Seeking Alpha,https://seekingalpha.com/news/4231746-abbott-jumps-as-jury-says-company-reckitt-not-liable-in-infant-formula-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1687.0,11/1/2024 9:20:18 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (BMY), Abbott Laboratories (ABT) and Merck & Company (MRK)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-bristol-myers-squibb-bmy-abbott-laboratories-abt-and-merck-company-mrk-1033936132
1688.0,11/1/2024 11:55:11 AM,"Abbott, Mead Johnson secure win in infant formula trial, Reuters reports",TipRanks,/news/stocks/abbott-mead-johnson-secure-win-in-infant-formula-trial-reuters-reports-1033937199
1689.0,11/1/2024 12:12:35 PM,Oppenheimer Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/oppenheimer-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1033937779
1690.0,11/1/2024 12:55:57 PM,"Morning Movers: Apple dips, Amazon gains after earnings",TipRanks,/news/stocks/morning-movers-apple-dips-amazon-gains-after-earnings-1033937927
1691.0,11/1/2024 1:12:35 PM,Abbott shares rise following baby formula verdict,Seeking Alpha,https://seekingalpha.com/news/4233379-abbott-shares-rise-following-baby-formula-verdict?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1692.0,11/1/2024 3:00:13 PM,"Biggest stock movers Friday: AMZN, INTC, ABT, and more",Seeking Alpha,https://seekingalpha.com/news/4232637-biggest-stock-movers-friday-amzn-intc-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1693.0,11/4/2024 11:46:13 AM,Abbott Laboratories’ Legal Victory Strengthens Future Outlook and Supports Buy Rating,TipRanks,/news/stocks/abbott-laboratories-legal-victory-strengthens-future-outlook-and-supports-buy-rating-1033944528
1694.0,11/4/2024 12:26:23 PM,Abbott price target raised to $149 from $143 at Barclays,TipRanks,/news/stocks/abbott-price-target-raised-to-149-from-143-at-barclays-1033945017
1695.0,11/5/2024 10:35:25 AM,Abbott price target raised to $149 from $143 at Barclays,TipRanks,/news/stocks/abbott-price-target-raised-to-149-from-143-at-barclays-1033951682
1696.0,11/6/2024 4:56:17 PM,"Tandem, Insulet draw bullish views at Bernstein ahead of earnings",Seeking Alpha,https://seekingalpha.com/news/4256070-tandem-insulet-stocks-rated-bullish-bernstein?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1697.0,11/17/2024 6:50:37 AM,First mpox case linked to African outbreak reported in U.S.,Seeking Alpha,https://seekingalpha.com/news/4298232-first-mpox-case-african-outbreak-reported-us?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1698.0,11/17/2024 2:36:26 PM,Wells Fargo Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034027537
1699.0,11/19/2024 5:45:42 PM,Trump Trade: President-elect seeks to kill Biden fuel-efficiency rules,TipRanks,/news/stocks/trump-trade-president-elect-seeks-to-kill-biden-fuel-efficiency-rules-1034038710
1700.0,11/20/2024 9:57:32 AM,Wells Fargo Reaffirms Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-reaffirms-their-buy-rating-on-abbott-laboratories-abt-1034041869
1701.0,11/20/2024 3:06:06 PM,Insulet Says Omnipod 5 AID System Now Compatible With Abbott's FreeStyle Libre 2 Plus CGM Sensor ,RTTNews,/news/stocks/insulet-says-omnipod-5-aid-system-now-compatible-with-abbott-s-freestyle-libre-2-plus-cgm-sensor-1034042208
1702.0,11/20/2024 3:43:32 PM,Insulet's Omnipod 5 now compatible with Abbott's FreeStyle Libre 2 Plus,Seeking Alpha,https://seekingalpha.com/news/4312299-insulets-omnipod-5-now-compatible-with-abbotts-freestyle-libre-2-plus?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1703.0,11/21/2024 6:45:46 PM,Optimism over global healthcare sector rises: Jefferies,Seeking Alpha,https://seekingalpha.com/news/4318258-optimism-over-global-healthcare-sector-rise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1704.0,11/23/2024 2:25:05 AM,"Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC",Seeking Alpha,https://seekingalpha.com/news/4323803-trump-picks-surgeon-makary-to-head-fda-rep-dave-weldon-to-lead-cdc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1705.0,11/23/2024 7:48:06 PM,WHO extends mpox emergency; Canada reports first clade I case,Seeking Alpha,https://seekingalpha.com/news/4325199-who-extends-mpox-emergency-canada-reports-first-clade-i-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1706.0,11/25/2024 5:15:10 PM,Strategic Initiatives and Innovations Drive Buy Rating for Abbott Laboratories,TipRanks,/news/stocks/strategic-initiatives-and-innovations-drive-buy-rating-for-abbott-laboratories-1034062647
1707.0,11/26/2024 8:11:25 PM,"Judge denies Abbott request for retrial, lower damages in $500M baby formula case",Seeking Alpha,https://seekingalpha.com/news/4337061-judge-denies-abbott-request-for-retrial-lower-damages-in-500m-baby-formula-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
1708.0,11/27/2024 4:21:49 PM,‘Bunker’ and ‘Booster’ stocks in the U.S. – Which would perform better in a downturn vs. upturn?,Seeking Alpha,https://seekingalpha.com/news/4340374-bunker-and-booster-stocks-in-the-us-which-would-perform-better-in-a-downturn-vs-upturn?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/3/2024 10:46:39 AM,Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1034091545
,12/3/2024 11:47:42 AM,Piper Sandler Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/piper-sandler-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034092013
,12/10/2024 3:10:25 PM,"ADA guidelines ‘a positive step’ towards coverage, says Wells Fargo",TipRanks,/news/stocks/ada-guidelines-a-positive-step-towards-coverage-says-wells-fargo-1034120812
,12/11/2024 12:46:27 PM,Oppenheimer Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/oppenheimer-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034125527
,12/13/2024 4:05:49 PM,Abbott increases quarterly dividend 7.3% to 59c per share,TipRanks,/news/stocks/abbott-increases-quarterly-dividend-7-3-to-59c-per-share-1034136621
,12/13/2024 4:19:43 PM,Abbott Laboratories raises dividend by 7.3% to $0.59,Seeking Alpha,https://seekingalpha.com/news/4386424-abbott-laboratories-raises-dividend-by-73-to-059?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/17/2024 1:18:38 PM,Abbott Completes In-human Left Bundle Branch Area Pacing Procedures Using AVEIR CSP Pacemaker ,RTTNews,/news/stocks/abbott-completes-in-human-left-bundle-branch-area-pacing-procedures-using-aveir-csp-pacemaker-1034145202
,12/18/2024 3:37:04 PM,Least shorted S&P 500 stocks in November,Seeking Alpha,https://seekingalpha.com/news/4387575-least-shorted-sp-500-stocks-in-november?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/18/2024 9:15:27 PM,Abbott Laboratories (ABT) Gets a Buy from Piper Sandler,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-buy-from-piper-sandler-1034153489
,12/20/2024 6:10:56 PM,"Analysts Are Bullish on These Healthcare Stocks: Veru (VERU), Ascendis Pharma (ASND)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-veru-veru-ascendis-pharma-asnd-1034163825
,12/23/2024 12:35:16 PM,Abbott Laboratories (ABT) Receives a Buy from Wells Fargo,TipRanks,/news/stocks/abbott-laboratories-abt-receives-a-buy-from-wells-fargo-1034168340
,12/23/2024 9:15:37 PM,Abbott in settlement with DexCom over continuous glucose monitors,Seeking Alpha,https://seekingalpha.com/news/4390352-abbott-settlement-dexcom-continuous-glucose-monitors?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/24/2024 10:30:08 AM,"DexCom, Abbott agree to settle patent litigation",TipRanks,/news/stocks/dexcom-abbott-agree-to-settle-patent-litigation-1034171025
,12/24/2024 3:15:22 PM,"Abbott, DexCom settlement ‘not a complete surprise,’ says Wells Fargo",TipRanks,/news/stocks/abbott-dexcom-settlement-not-a-complete-surprise-says-wells-fargo-1034171972
,12/30/2024 10:35:11 AM,Wells Fargo Reaffirms Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-reaffirms-their-buy-rating-on-abbott-laboratories-abt-1034179399
,1/2/2025 11:41:01 AM,Abbott price target raised to $136 from $128 at Evercore ISI,TipRanks,/news/stocks/abbott-price-target-raised-to-136-from-128-at-evercore-isi-1034186788
,1/3/2025 8:00:09 PM,"Catalyst Watch: CES, M&A votes and the Supreme Court tackles the TikTok case",Seeking Alpha,https://seekingalpha.com/news/4392381-catalyst-watch-ces-ma-votes-and-the-supreme-court-tackles-the-tiktok-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/6/2025 5:52:14 PM,"FDA issues first draft guidance on use of AI in drug, medical device development",Seeking Alpha,https://seekingalpha.com/news/4392790-fda-issues-first-draft-guidance-use-ai-drug-medical-device-development?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/7/2025 12:06:05 AM,Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1034197494
,1/8/2025 1:46:42 AM,RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034202967
,1/8/2025 11:56:55 AM,Bernstein Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/bernstein-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034205502
,1/8/2025 11:31:17 PM,Abbott price target lowered to $135 from $138 at Bernstein,TipRanks,/news/stocks/abbott-price-target-lowered-to-135-from-138-at-bernstein-1034208056
,1/13/2025 10:26:27 PM,Insulet Omnipod 5 insulin system available in five more European countries,Seeking Alpha,https://seekingalpha.com/news/4394746-insulet-omnipod-5-insulin-system-available-five-more-european-countries?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/16/2025 11:10:11 AM,"Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Gilead Sciences (GILD) and Abbott Laboratories (ABT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insmed-insm-gilead-sciences-gild-and-abbott-laboratories-abt-1034235445
,1/16/2025 4:30:04 PM,Least shorted S&P 500 stocks in December,Seeking Alpha,https://seekingalpha.com/news/4395791-least-shorted-sp-500-stocks-in-december?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/17/2025 8:00:19 PM,"Catalyst Watch: Netflix earnings, Monster Beverage event, drug data, and quantum volatility",Seeking Alpha,https://seekingalpha.com/news/4396184-catalyst-watch-netflix-earnings-monster-beverage-event-drug-data-and-quantum-volatility?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/17/2025 8:35:26 PM,Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations,TipRanks,/news/stocks/sector-spotlight-big-pharma-will-push-to-pause-medicare-drug-price-negotiations-1034241772
,1/18/2025 6:05:00 PM,14 out of 20 names post earnings beat with blockbuster wins from banks-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4396193-14-out-of-20-names-post-earnings-beat-with-blockbuster-wins-from-banks-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/19/2025 1:12:00 PM,"Earnings week ahead: JNJ, NFLX, AAL, UAL, AXP, ABT, VZ, PG, and more",Seeking Alpha,https://seekingalpha.com/news/4396093-earnings-week-ahead-jnj-nflx-aal-ual-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/21/2025 1:48:23 AM,Abbott Laboratories (ABT) Gets a Buy from RBC Capital,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-buy-from-rbc-capital-1034246834
,1/21/2025 5:45:00 PM,Top Seeking Alpha Quant picks in Technology ahead of Q4 earnings,Seeking Alpha,https://seekingalpha.com/news/4396470-top-seeking-alpha-quant-picks-in-technology-ahead-of-q4-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/21/2025 6:45:12 PM,Notable companies reporting before tomorrow’s open,TipRanks,/news/stocks/notable-companies-reporting-before-tomorrow-s-open-1034251583
,1/21/2025 7:01:41 PM,Abbott Laboratories set for stellar Q4 2024 earnings amid optimism for 2025,Seeking Alpha,https://seekingalpha.com/news/4397028-abbott-laboratories-set-for-stellar-q4-2024-earnings-amid-optimism-for-2025?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/21/2025 11:00:20 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4396897-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 12:03:37 PM,"Abbott Laboratories Non-GAAP EPS of $1.34 in-line, revenue of $11B misses by $30M",Seeking Alpha,https://seekingalpha.com/news/4397216-abbott-laboratories-non-gaap-eps-of-1_34-in-line-revenue-of-11b-misses-by-30m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 12:05:29 PM,"Abbott sees Q1 adjusted EPS $1.05-$1.09, consensus $1.12",TipRanks,/news/stocks/abbott-sees-q1-adjusted-eps-1-05--1-09-consensus-1-12-1034255250
,1/22/2025 12:05:36 PM,"Abbott sees FY25 adjusted EPS $5.05-$5.25, consensus $5.16",TipRanks,/news/stocks/abbott-sees-fy25-adjusted-eps-5-05--5-25-consensus-5-16-1034255248
,1/22/2025 12:06:10 PM,"Abbott reports Q4 adjusted EPS $1.34, consensus $1.34",TipRanks,/news/stocks/abbott-reports-q4-adjusted-eps-1-34-consensus-1-34-1034255235
,1/22/2025 12:11:30 PM,Abbott sees FY25 adjusted operating margin 23.5%-24.0% of sales,TipRanks,/news/stocks/abbott-sees-fy25-adjusted-operating-margin-23-5--24-0-of-sales-1034255220
,1/22/2025 12:23:44 PM,Earnings Snapshot: Abbott Laboratories Q4 misses revenue estimates; initiates Q1 and FY25 outlook,Seeking Alpha,https://seekingalpha.com/news/4397229-earnings-snapshot-abbott-laboratories-q4-misses-revenue-estimates-initiates-q1-and-fy25-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 12:27:57 PM,Abbott in charts: Medical Devices sales reach all-time high in Q4,Seeking Alpha,https://seekingalpha.com/news/4397233-abbott-in-charts-medical-devices-sales-reach-all-time-high-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 12:51:58 PM,Abbott Laboratories slips after Q4 topline miss,Seeking Alpha,https://seekingalpha.com/news/4397224-abbott-laboratories-stock-slips-q4-miss?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 1:04:30 PM,"Abbott Laboratories Q4 Profit Increases, Inline With Estimates ",RTTNews,/news/stocks/abbott-laboratories-q4-profit-increases-inline-with-estimates-1034253924
,1/22/2025 1:22:20 PM,"Abbott Q4 Profit Meets View; Sees Q1 Below Market, Growth In FY25 - Update ",RTTNews,/news/stocks/abbott-q4-profit-meets-view-sees-q1-below-market-growth-in-fy25-update-1034254025
,1/22/2025 1:55:22 PM,Morning Movers: Netflix shares rise following subscriber blowout,TipRanks,/news/stocks/morning-movers-netflix-shares-rise-following-subscriber-blowout-1034255934
,1/22/2025 2:47:47 PM,"4 stocks to watch on Wednesday: PG, JNJ and more",Seeking Alpha,https://seekingalpha.com/news/4397307-4-stocks-to-watch-on-wednesday-pg-jnj-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/22/2025 3:00:23 PM,Abbott sees FY25 tax rate 16%-17%,TipRanks,/news/stocks/abbott-sees-fy25-tax-rate-16--17-1034256340
,1/22/2025 5:05:34 PM,"Netflix, Seagate, J&J report quarterly beats: Morning Buzz",TipRanks,/news/stocks/netflix-seagate-j-j-report-quarterly-beats-morning-buzz-1034256527
,1/22/2025 7:05:22 PM,Abbott Laboratories’ Growth Prospects and Market Leadership in MedTech Justify Buy Rating,TipRanks,/news/stocks/abbott-laboratories-growth-prospects-and-market-leadership-in-medtech-justify-buy-rating-1034256870
,1/22/2025 7:05:23 PM,Abbott price target raised to $140 from $139 at BTIG,TipRanks,/news/stocks/abbott-price-target-raised-to-140-from-139-at-btig-1034256869
,1/22/2025 11:35:22 PM,Strong Performance and Promising Growth: Josh Jennings’ Buy Rating on Abbott Laboratories,TipRanks,/news/stocks/strong-performance-and-promising-growth-josh-jennings-buy-rating-on-abbott-laboratories-1034257202
,1/23/2025 9:57:07 AM,Mizuho Securities Reaffirms Their Hold Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/mizuho-securities-reaffirms-their-hold-rating-on-abbott-laboratories-abt-1034259287
,1/23/2025 10:40:08 AM,"Abbott price target raised to $148 from $146 at UBS, shares remain undervalued",TipRanks,/news/stocks/abbott-price-target-raised-to-148-from-146-at-ubs-shares-remain-undervalued-1034259540
,1/23/2025 10:57:27 AM,Strong Performance and Promising Growth: Rick Wise’s Buy Rating on Abbott Laboratories,TipRanks,/news/stocks/strong-performance-and-promising-growth-rick-wise-s-buy-rating-on-abbott-laboratories-1034259605
,1/23/2025 10:57:35 AM,Abbott Laboratories: Solid Performance in Key Sectors but Hold Rating Due to Mixed Outlook,TipRanks,/news/stocks/abbott-laboratories-solid-performance-in-key-sectors-but-hold-rating-due-to-mixed-outlook-1034259604
,1/23/2025 11:05:42 AM,Abbott Laboratories: Strong Performance and Promising Outlook Support Buy Rating,TipRanks,/news/stocks/abbott-laboratories-strong-performance-and-promising-outlook-support-buy-rating-1034259771
,1/23/2025 11:26:22 AM,Abbott price target raised to $138 from $135 at Bernstein,TipRanks,/news/stocks/abbott-price-target-raised-to-138-from-135-at-bernstein-1034259855
,1/23/2025 11:38:39 AM,Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1034259997
,1/23/2025 11:40:23 AM,"Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Arrowhead Pharmaceuticals (ARWR)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-abbott-laboratories-abt-arrowhead-pharmaceuticals-arwr-1034259971
,1/23/2025 11:56:16 AM,RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034260128
,1/23/2025 12:30:11 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1034260730
,1/23/2025 12:30:56 PM,Abbott price target raised to $135 from $130 at Stifel,TipRanks,/news/stocks/abbott-price-target-raised-to-135-from-130-at-stifel-1034260723
,1/25/2025 6:46:00 PM,Over 80% of companies deliver EPS wins this week-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4398494-over-80-companies-deliver-eps-wins-this-week-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,1/27/2025 9:35:58 AM,Barclays Remains a Buy on Abbott Laboratories (ABT),TipRanks,/news/stocks/barclays-remains-a-buy-on-abbott-laboratories-abt-1034271285
,1/27/2025 10:35:04 AM,Abbott price target raised to $158 from $149 at Barclays,TipRanks,/news/stocks/abbott-price-target-raised-to-158-from-149-at-barclays-1034271597
,1/28/2025 5:10:52 PM,Abbott price target raised to $150 from $145 at Argus,TipRanks,/news/stocks/abbott-price-target-raised-to-150-from-145-at-argus-1034278978
,1/28/2025 5:16:04 PM,Argus Research Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/argus-research-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1034279020
,2/1/2025 12:53:24 PM,Are healthcare stocks on the rebound?,Seeking Alpha,https://seekingalpha.com/news/4401695-are-healthcare-stocks-rebound?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,2/3/2025 9:00:22 AM,Elon Musk’s X Adds More Companies to Ad-Boycott Lawsuit,TipRanks,/news/stocks/elon-musk-s-x-adds-more-companies-to-ad-boycott-lawsuit-1034302159
,2/5/2025 6:15:15 PM,FDA advises diabetes device users to check alert settings,Seeking Alpha,https://seekingalpha.com/news/4403792-fda-advises-diabetes-device-users-to-check-alert-settings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
